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Summary 
This report describes changes in general practitioners’ (GPs) ordering of imaging tests in 
Australia over the decade 2002–03 to 2011–12 and an evaluation of the quality of GP imaging 
ordering against the available guidelines. This project was funded by a grant from the 
Diagnostic Imaging Quality Program, through the Australian Government Department of 
Health. 
This study uses data collected from the BEACH program (Bettering the Evaluation and Care 
of Health), a continuous national study of GP clinical activity in Australia. Over the decade 
2002–12, 9,802 GPs participated in BEACH, providing details of 980,200 GP–patient 
encounters. Changes in GP ordering behaviour were assessed by comparing data from two 
3-year data periods: Period 1, April 2002–March 2005 inclusive; and Period 2, April 2009–
March 2012 inclusive. Assessment of alignment between recommendations in guidelines and 
GPs’ imaging test ordering behaviour was made on the basis of recent GP test ordering 
behaviour in Period 2. 
This report is divided into three sections. Section 1 discusses GPs’ overall imaging ordering 
patterns and changes over time. Section 2 includes detailed investigation of GPs’ imaging 
ordering in the management of specific problems. Section 3 investigates GPs’ ordering of 
selected imaging types. 
SECTION 1 
There was significant growth over the decade in the total number of imaging services funded 
through the Medicare Benefits Schedule (MBS). The following factors influence the total 
number of imaging tests ordered by GPs: 
• the number of GP–patient encounters claimed through the MBS nationally 
• the number of problems managed at encounters 
• the rate of GPs’ imaging test ordering in the management of problems at encounters. 
This rate is a function of two factors: 
– the likelihood of testing the problems being managed  
– the number of tests ordered for the problem once the decision to test is made. 
Over time (from Period 1 to Period 2), there were statistically significant increases in almost 
all of these factors. The only factor to remain steady was the number of tests ordered once 
the decision to test was made.  
The average number of GP encounters across the country (measured using number of MBS 
GP services claimed) increased by approximately 23 million, from about 97 million per year 
in Period 1, to 120 million per year in Period 2.  
The number of problems GPs managed at encounters significantly increased from an average 
of 149.1 per 100 encounters in Period 1, to 157.6 in Period 2. 
The rate of imaging tests ordered significantly increased from 8.7 per 100 encounters in 
Period 1, to 10.2 per 100 in Period 2. Extrapolation of this result suggests an average 
8.45 million imaging tests ordered by GPs per year in Period 1 and 12.23 million per year in 
Period 2, an increase of 44.7%, equating to approximately 3.78 million more orders per year 
over the 3 years in Period 2 than in the years of Period 1. 
The likelihood of an imaging order being placed in the management of problems increased 
significantly from 5.3% to 5.8%. The average number of imaging tests ordered per 100 tested 
problems remained steady (111.0 per 100 tested problems in Period 1 and 112.1 in Period 2). 
  
xiii 
Therefore the increased number of test orders in Period 2 reflected increases in three factors: 
number of GP encounters, number of problems managed, and the likelihood of ordering 
imaging for a problem being managed.  
Independent predictors 
The strongest predictors of imaging test orders (by multiple regression) were:  
• Problems managed—number of problems: each additional problem increased the chance 
of testing by 41%. Type of problem managed: management of musculoskeletal problems 
(odds ratio, OR: 3.72); female genital problems (OR: 1.97); pregnancy and family 
planning (OR: 1.60); male genital problems (OR: 1.36); urinary problems (OR: 1.32), 
neurological problems (OR: 1.33), and digestive problems (OR: 1.18). 
• Patient characteristics—female (OR: 1.04); in age groups from 45 years and up (OR 
range: 1.77–1.94); new to the practice (OR: 1.40). 
• GP characteristics—sex female (OR: 1.12); age 35–44 years (OR: 1.10), in solo practice 
(OR: 1.10); in practice with co-located imaging service (OR: 1.10). 
Types of imaging tests 
In both data periods, orders for diagnostic radiology accounted for the majority of test 
orders, followed by ultrasound, and computerised tomography (CT) scans. Orders for 
magnetic resonance imaging (MRI), nuclear medicine, and other tests were relatively rare. 
However, between Period 1 and Period 2 there was a significant decrease in the order rate of 
diagnostic radiology, and significant increases in orders for ultrasound, CT scan and MRI. 
SECTION 2 
Eight problems accounting for high volumes of GPs’ imaging orders are investigated in 
detail in chapters 5 to 8. These are: back problems; osteoarthritis, shoulder problems; 
sprains/strains; bursitis/tendonitis/synovitis; abdominal pain; knee problems; other 
musculoskeletal injuries. Guidelines for imaging tests in the management of these problems 
were identified, and the extent of alignment between guideline recommendations and GP 
ordering behaviour assessed. Results for each problem are summarised, describing recent 
practice (Period 2, 2009–12), changes over time (from Period 1 to Period 2), and alignment 
with guidelines. 
Back problems (Chapter 5) 
In recent practice, back problems were managed at a rate of 3.6 per 100 encounters, and 
imaging was ordered at a rate of 16.8 per 100 back problem contacts. New cases accounted 
for one-quarter of all cases, but generated 54% of total imaging ordered because new cases 
were twice as likely to result in testing than old cases. Diagnostic radiology was most 
frequently ordered (54%), followed by CT scan (36%), MRI (5%) and ultrasound (3%).  
There was no change over time in the management rate or likelihood of testing. However, 
there were changes in the types of tests: there was a marginal decrease in diagnostic 
radiology (i.e. plain radiography of the spine) and small but significant increases in CT scan 
and MRI imaging orders. Although small, this change is consistent with changes in the 
guidelines favouring MRI investigation of complex back problems. The lack of MBS cover for 
GP-ordered MRI probably explains the greater increase in orders for CT scans.  
The high rate of imaging at initial encounters for these problems is inconsistent with all 
established guidelines for the management of back problems. 
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Osteoarthritis (Chapter 6) 
Osteoarthritis was managed at a rate of 2.8 per 100 encounters. New cases accounted for 
one-fifth of all osteoarthritis contacts, but were four times more likely to result in an imaging 
order than old cases (accounting for 47% of all tests). Diagnostic radiology accounted for 
almost 90% of imaging ordered, followed by ultrasound (6%), CT scan (2%) and MRI (2%). 
On those occasions where ultrasound, CT scan or MRI were ordered, there was no difference 
in the order rate for new presentations or in continuing care. 
Over time there was a marginal decrease in the management rate of all osteoarthritis, but an 
increased proportion were new cases; the likelihood of testing significantly increased for all 
cases, new and old, leading to increased imaging order rates per 100 problems. Orders for 
diagnostic radiology increased over time. Ultrasound and MRI also increased, but numbers 
were small.  
Ordering of imaging for osteoarthritis by GPs appears consistent with existing guidelines. 
Shoulder problems (Chapter 7) 
Shoulder problems were managed at a rate of 0.9 per 100 encounters. Shoulder syndromes 
were managed at a far higher rate than shoulder symptoms/complaints. Ultrasound (65%) 
and diagnostic radiology (32%) were the most commonly ordered tests.  
The management rate of shoulder problems increased, with increased likelihood of testing, 
resulting in increased imaging orders per 100 cases, but this was only reflected in the 
management of shoulder syndromes, not in management of symptoms/complaints. There 
was a move away from diagnostic radiology toward ultrasound in test ordering for shoulder 
problems. 
These results indicate broad compliance with the published guidelines for the selection of 
imaging modalities. 
Sprains/strains (Chapter 8) 
Sprains/strains were managed at a rate of 1.0 per 100 encounters. New cases accounted for 
nearly two-thirds of all sprain/strain problems, and these presentations were more likely to 
involve orders for imaging than previously managed sprains/strains. Diagnostic radiology 
accounted for 61% of imaging ordered, followed by ultrasound (35%). Order rates for CT and 
MRI were low and did not differ between new and old cases. 
While there was a marginal decrease in the management rate over time, the likelihood of 
testing increased, resulting in an increased number of tests ordered per 100 sprain/strain 
problems managed. There was a move away from diagnostic radiology, although there was a 
singular increase in x-rays for sprain/strain of the shoulder. There was a general increase in 
ultrasound and MRI orders, although each remained infrequent.  
Compliance with published guidelines was assessed based on the site of the sprain/strain. 
• Ankle: the investigation of new ankle sprain/strain frequently involved orders for 
ultrasound, and ordering of x-ray and ultrasound together was common. Neither the 
Australian guidelines nor the American College of Radiology Appropriateness Criteria 
suggest use of ultrasound in investigation of ankle sprain/strain. There is considerable 
room for improvement in this area. 
• Shoulder: test ordering patterns for sprain/strain paralleled those for shoulder 
syndrome, and similarly we conclude they were consistent with published guidelines, 
taking into consideration the lack of MBS coverage of MRIs for these problems.  
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• Knee: guidelines for imaging for knee sprain/strain are complex, but rely heavily on the 
Ottawa knee rules. Encouraging use of the Ottawa rules by GPs may assist improved test 
selection for these problems. 
• Wrist: the current ordering of x-ray for wrist sprain/strain is consistent with guidelines.  
Bursitis/tendonitis/synovitis (Chapter 9) 
Bursitis problems were managed at a rate of 1.1 per 100 encounters, and almost one-quarter 
of presentations resulted in a test order. New cases were managed more often than old cases, 
and were more likely to have imaging ordered. Ultrasound accounted for 63% of tests, 
followed by diagnostic radiology (34%), and both were ordered more often for new cases. 
Over time there was an increase in the management rate of bursitis, and a 51% increase in the 
likelihood of testing. This resulted in an increased test order rate per 100 problems. Orders 
for ultrasound more than doubled over time and has become the most commonly ordered 
type of imaging test for bursitis problems in recent practice. Diagnostic radiology 
significantly decreased as a proportion of all imaging ordered for bursitis problems, but the 
order rate did not change.  
The range of investigation is consistent with the current guidelines. CT scan and MRI were 
infrequently ordered by GPs for these problems. 
Abdominal pain (Chapter 10) 
Abdominal pain was managed by GPs at a rate of 0.7 per 100 encounters, and one-third of 
presentations resulted in an imaging test order. Ultrasound was the most frequently ordered 
test (70%), followed by CT scans (18%) and diagnostic radiology (12%). New problems 
accounted for 52% of all cases, and generated 61% of tests. Likelihood of ordering was higher 
for new problems than for old, with CT scans and ultrasounds the most common tests 
ordered.  
There was no change over time in the management rate of abdominal pain, but there was an 
increase in likelihood of testing. This resulted in an increased number of tests ordered per 
100 abdominal pain problems managed. Ultrasound remained the most frequently ordered 
test over both data periods, but the order rate of CT scan significantly increased.  
An appropriate range of modalities appear to be used by Australian GPs for these problems. 
Ultrasound remains the imaging of choice for GPs, and there has been a move away from 
plain x-ray to CT scan. These findings are consistent with the guidelines. However, due to 
the low yield of imaging investigations demonstrated in the literature, advice to GPs 
regarding use of ’red flag’ symptoms and signs to guide ordering may decrease unnecessary 
imaging. Advice for a sequential approach to imaging orders should be considered in 
revisions of guidelines.  
Knee problems (Chapter 11) 
Knee problems were managed at a rate of 0.6 per 100 encounters. Knee syndrome and knee 
symptom/complaint each accounted for half of all knee problems. GPs were far more likely 
to order imaging at new presentations of knee problems than at follow-up consultations. The 
test order rate was significantly higher for knee symptom/complaint than for knee 
syndrome, and in both, far higher for new cases than for those previously managed.  
The majority of tests for all knee problems were diagnostic radiology (73% of tests), followed 
by MRI (13%). MRI ranked second in test choice for both new and old problems, but 
ultrasound was the second choice when testing new knee symptoms/complaints. 
For all knee problems the management rate and likelihood of testing increased, largely due 
to increases in follow-up consultations for old problems rather than new cases. There was a 
  
xvi 
move away from diagnostic radiology toward MRI, but the former remained the 
predominant test group.  
If the Ottawa knee rules were applied in the Australian context they have the potential to 
significantly reduce the need for diagnostic radiology (i.e. plain x-rays) without losing 
sensitivity of fracture detection. 
Ultrasound and CT scan were ordered infrequently, and this is consistent with guidelines.  
Use of MRI for knee syndrome is consistent with guidelines. MRI ordering increased over 
the study period, even though during this time, MRI ordered by GPs were not covered by 
the MBS. With the recent inclusion of GP-ordered knee MRI under the MBS, use of MRI is 
likely to continue to rise.  
Other musculoskeletal injuries (Chapter 12) 
Other musculoskeletal injuries (OMI) were managed at a rate of 0.5 per 100 encounters, and 
at least one test was ordered at 38% of contacts. The likelihood of ordering for new cases 
(49%) was double that for old cases (23%). Diagnostic radiology was ordered most frequently 
(67% of tests), followed by ultrasound (26%). 
There was no change in the management rate of OMI, but the likelihood of testing increased. 
Diagnostic radiology remained the most commonly ordered test type over time, but there 
were increases in the rate of ultrasound and MRI orders.  
The rise in orders for ultrasound is consistent with the increasing use of ultrasound in soft 
tissue injuries as recommended in site-specific guidelines. 
SECTION 3  
Section 3 of this report centres on the use of each of the four types of tests: diagnostic 
radiology, ultrasound, CT, and MRI. Over time there was a statistically significant decrease 
in the order rate of diagnostic radiology, and statistically significant increases in the order 
rates of ultrasound, CT scan and MRI. For each test group, we report the problems for which 
tests were most often ordered, and the extent to which management of each problem 
involved imaging from that test group. 
The problems for which diagnostic radiology were most commonly ordered were 
osteoarthritis, back problems, fracture, and sprain/strain, which together accounted for 28% 
of diagnostic radiology in Period 2.  
Ultrasound was ordered most commonly by GPs in the management of pregnancy and 
pregnancy-related check-ups, abdominal pain, and shoulder problems. Together these 
problems accounted for 24% of all ultrasound in Period 2. 
CT scan was commonly ordered in the management of back problems, headache, sinusitis, 
abdominal pain, and neck syndrome, which together accounted for 36% of CT scans ordered. 
The most common problems generating orders for MRI tests were: back problems, knee 
problems, osteoarthritis, sprain/strains, and other musculoskeletal injuries. These problems 
accounted for 52% of MRI orders.  
This section demonstrates that the changes in GPs’ ordering of the selected test types are due 
to the combined effect of the frequency of management for selected problems and the 
likelihood of testing in the management of problems. For example, a low test order rate for a 
very frequently managed problem usually results in a greater number of test orders than a 
very infrequently managed problem with a high test order rate. 
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Summary of the review of the guidelines 
Following review of available diagnostic imaging guidelines in Australia and other 
countries, it appears that the Diagnostic Imaging Pathways (DIP) guidelines produced under 
the sponsorship of the Government of Western Australia Department of Health are the most 
appropriate and useful guidance for GPs in Australia. DIP is described as “an evidence-
based and consensus-based educational and decision support resource for clinicians, to 
guide them in their choice of the most appropriate diagnostic examinations in the correct 
sequence for a range of clinical cases”‡. There were no reported studies found in the 
literature of the effect of the DIP guidelines on GP imaging ordering behaviour.  
Promulgation of diagnostic imaging guidelines to GPs has not been demonstrated in the 
literature to significantly change behaviour in the ordering of imaging. Electronic decision 
support tied to electronic ordering of imaging also has limited effect. Financial barriers, such 
as restriction of insurance benefits to patients for certain tests, do have a demonstrated effect, 
but unless carefully designed may lead to a reduction in appropriate tests as well as 
inappropriate tests. 
Broad interventions to improve clinical performance through education, training and clinical 
audit, combined with peer review processes have been shown to be effective in other 
dimensions of clinical care. These may be more effective than interventions addressed 
specifically toward ordering of imaging by GPs. 
Summary of compliance with diagnostic imaging guidelines 
In general this report shows that Australian GPs select appropriate diagnostic imaging 
modalities for specific clinical problems given the restraint imposed by restriction of MBS 
rebates for MRIs ordered by GPs.  
Imaging ordering behaviour suggests broad compliance with published guidelines in the 
management of: osteoarthritis, bursitis/tendonitis/synovitis, sprain/strain of the wrist, and 
other musculoskeletal injuries.  
Current ordering patterns for shoulder sprains/strains, knee problems, and knee 
sprains/strains, have potential for improvement. If the Ottawa knee rules were applied, 
significant reduction in diagnostic radiology of the knee could be gained without losing 
sensitivity of fracture detection.  
Considering the lack of MBS coverage of MRI ordered by GPs for shoulder sprains and 
strains, current ordering patterns are appropriate. The same can be said for back problems 
overall. However the order rate for new presentations of back problems is inconsistent with 
all established guidelines for the management of back problems. 
Order patterns for abdominal pain may benefit from increased GP use of ‘red flag’ 
symptoms and signs to guide ordering, and added guidance in any future revision of the 
guidelines, to take a sequential approach in ordering. 
Some possibly unnecessary ordering is evident in both time periods of this study as it was in 
the previous Family Medicine Research Centre report on imaging ordering by GPs. The 
perceived unnecessary ordering occurs in situations such as back and joint imaging where 
the literature indicates that careful clinical assessment, derived from clinical history and 
physical examination, can improve the specificity of imaging examinations without reducing 
the sensitivity in the detection of abnormalities. The use of the Ottawa rules, for example, has 
been shown to result in improved cost-effectiveness of imaging examinations of the knee and 
ankle. 
‡  Healthdirect Australia. Diagnostic Imaging Pathways. 2012. Viewed 7 May 2014, www.healthdirect.gov.au/partner/diagnostic-imaging-
pathways. 
  
 
  
 
 
 
Section 1 
 
Background, method and overview of 
GPs’ imaging ordering 
  
 
1 Introduction 
This is the final report for the project titled: ‘Evaluation of imaging ordering by general 
practitioners in Australia, 2002–03 to 2011–12’ funded by a grant from the Diagnostic Imaging 
Quality Program through the Australian Government Department of Health (ITA455, 2012).  
This project aimed to assess changes in the imaging test ordering behaviour of general 
practitioners (GPs) since the last published report on this subject in 2001,1 and to evaluate the 
appropriateness of recent test ordering behaviour, in terms of its level of alignment with 
guidelines for GPs.  
This study relies on analyses of data from the BEACH (Bettering the Evaluation and Care of 
Health) program, a continuous national study of general practice activity in Australia. The 
BEACH program began in April 1998 and was the culmination of about 20 years research 
and development work at the University of Sydney. BEACH is currently supported 
financially by government and private industry (see Acknowledgments).  
BEACH is the only continuous randomised study of general practice activity in the world, 
and the only national program that provides direct linkage of management actions (such as 
imaging test orders) to the problem under management. In March 2014, the BEACH database 
included information pertaining to almost 1.6 million encounters from about 16,000 GP 
participants, who together represent about 10,000 individuals. 
1.1 Background 
In June 2012, the population of Australia was estimated to be 22.7 million people.2 Australia’s 
health expenditure in 2010–11 was $130.3 billion, an average $5,796 per head of population, 
and accounted for 9.3% of GDP. Governments funded 69.9%, with the remainder (30.1%) 
being paid by the non-government sector.3 Government expenditure on general practice 
services (including those of practice nurses) was almost $5.6 billion dollars in the 2011–12 
financial year.4 
GPs are usually the first port of call in the Australian healthcare system, as they act as gate-
keepers to secondary and tertiary services. Payment for GP visits is largely on a fee-for-
service system, and there are no compulsory patient lists or registration. People are free to 
see multiple practitioners and visit multiple practices of their choice. There is a universal 
medical insurance scheme (called the Medicare Benefits Schedule [MBS], managed by 
Medicare Australia), which covers all or most of an individual’s cost for a GP visit, and all or 
some of MBS approved imaging tests ordered by GPs from radiologists.4 
In the 2002–03 financial period, there were 96.3 million claims made to Medicare for GPs 
items of service. In the last year of the data period used in this report (2011–12), there were 
122.5 million such claims. This demonstrates that over the decade 2002–03 to 2011–12, the 
annual attendance rate to GPs increased by more than one visit per head of population.  
In Australia in 2011, there were 25,056 practising GPs (medical practitioners self-identifying 
as GPs), and in the April 2012 to March 2013 year, about 85% of the Australian population 
claimed at least one GP service from Medicare (personal communication, Department of 
Health, June 2013). In the 2012–13 period, Medicare paid rebates for about 126.8 million 
claimed GP service items,5 at an average of about 5.6 GP visits per head of population. This 
equates to about 2.4 million GP–patient encounters per week. 
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In 2002–03, MBS paid benefits for 13.23 million imaging tests (ordered by all types of medical 
practitioners) at a cost of $1.17 billion. In 2011–12, the number of imaging tests to which 
Medicare contributed had increased by about 50% to 20.33 million, but the cost had more 
than doubled to $2.53 billion, or about $111 per head of population. 
Previously published data from the BEACH study demonstrate that GPs’ ordering of 
imaging tests increased significantly over the decade 2002–03 to 2011–12. The proportion of 
all problems managed for which imaging was ordered rose from 5.3% to 5.8%. Further, the 
number of imaging tests ordered increased from 5.9 tests per 100 problems managed to 6.6 
per 100 in 2011–12.6 
In the context of the increasing resources associated with this testing, it is important to 
understand the types of imaging tests ordered by GPs and the indications (i.e. patient 
problems) for which these tests are ordered, the tests and indications contributing to growth, 
and to evaluate the quality of GPs’ ordering.  
The imaging data in MBS reflect the imaging undertaken by radiologists and billed to 
Medicare. The data include all imaging billed to Medicare, irrespective of the type of medical 
practitioner ordering the test from the radiologist. Further, when a radiologist receives a 
request for a specific test from a medical practitioner, they can decide whether the test 
ordered is the most suitable and may decide a different test should be undertaken, and 
whether to undertake other tests of their choosing.  
Further, when claims are made for imaging tests undertaken by the radiologist, the claim is 
made for a specific MBS item number. These item numbers often represent iso-resource 
groups, rather than individual tests. For example: “Item 58115: Ultrasound of the spine, three 
examinations of the kind mentioned in items 58100, 58103, 58106 and 58109”.7  
The MBS data therefore reflect the tests that are actually undertaken by the radiologist, in 
response to a request from a medical practitioner, and possibly after doing additional tests or 
selecting an alternative test to that requested, then claimed from Medicare as an item 
number. These items may represent an iso-resource group, rather than an individual test. 
The data cannot tell us what GPs actually requested to be done from the radiologist, nor 
about the indications for which tests were ordered. MBS data therefore cannot be used to 
assess the extent to which GP test ordering follows available guidelines for testing of specific 
health problems. The BEACH program fills this gap.  
This study uses BEACH data to describe GPs’ imaging ordering and the changes in this 
ordering. The appropriateness of GPs’ imaging ordering is evaluated for selected imaging 
tests and/or indications of interest, though comparisons of GPs’ ordering (as measured in 
BEACH) with current practice guidelines to determine areas in which quality improvement 
is needed. Highlighting these areas will provide a direction for those involved in educational 
programs and interventions to improve the quality of test ordering by GPs. It will also 
identify areas where guidelines may warrant improvement. 
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Objectives 
The objectives of this study are to: 
• describe recent patterns of general practitioner ordering for diagnostic imaging in 
Australia, the indications for which imaging tests are ordered, and how GP test ordering 
patterns have changed over the decade 2002–03 to 2011–12 
• determine areas where intervention may be beneficial, and where guidelines may 
warrant improvement, through comparison of GP ordering behaviour with current 
practice guidelines. 
1.2 Literature review 
The literature review in this report builds on that undertaken for the 2001 publication on 
imaging orders by GPs produced by the Family Medicine Research Centre (FMRC) and 
published by the Australian Institute of Health and Welfare (AIHW).1 Parts of the original 
review are included in this current updated review. 
The FMRC undertook an extensive review of guidelines for diagnostic imaging using 
Medline, and national and international sources of guidelines such as the National Health 
and Medical Research Council (NHMRC), the United States Agency for Healthcare Research 
and Quality (AHRQ), the UK National Institute for Health and Care Excellence (NICE); and 
local and overseas colleges of radiology/radiologists. 
The final group of guidelines considered for this report were:  
• Government of Western Australia Department of Health (WADoH) Diagnostic Imaging 
Pathways.8-18 These guidelines could be considered as the successor of the now obsolete 
Royal Australian and New Zealand College of Radiologists (RANZCR) Imaging 
Guidelines 2001,19 and are endorsed by the RANZCR 
• the American College of Radiology Appropriateness Criteria™ (ACRAC)20-28  
• the New Zealand Accident Compensation Corporation guidelines endorsed by the New 
Zealand Guidelines Group (NZGG)29-32  
• the NHMRC guidelines distributed by the Royal Australian College of General 
Practitioners.33,34  
The FMRC was unsuccessful in obtaining agreement from the Royal College of Radiologists 
for access to the iRefer guidelines used in the National Health Service (NHS) in the United 
Kingdom. 
An additional review of the literature over the past 10 years regarding the use of imaging 
guidelines was undertaken using Medline. The Medline databases were searched by crossing 
several subject headings (diagnostic imaging, family practice, physician’s practice patterns, 
utilisation review, clinical guidelines, sensitivity and specificity, meta-analysis and quality 
assurance health care, plus various more specific imaging labels and problem labels). A total 
of 1,413 articles were retrieved, of which 24 were of sufficient relevance and quality to be 
included in this review in addition to those retrieved for the previous report. Berry et al. 
have demonstrated that in the specific area of medical imaging, electronic databases, 
including Medline, are reliable sources of articles.35  
Articles pertaining to individual diagnostic imaging tests, patient problems or anatomical 
sites are cited in those sections of the report. 
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Bairstow et al. outlined the development of the Government of Western Australia 
Department of Health sponsored Diagnostic Imaging Pathways.36 The Australian 
Government Healthdirect website states:  
The Diagnostic Imaging Pathways Group produces, updates and maintains the content 
of the Diagnostic Imaging Pathways (DIP) web-site. DIP is an evidence-based and 
consensus-based educational and decision support resource for clinicians, to guide them 
in their choice of the most appropriate diagnostic examinations in the correct sequence 
for a range of clinical cases.37 
The Australasian College for Emergency Medicine has adapted the Diagnostic Imaging 
Pathways for use in emergency departments.38 The Diagnostic Imaging Pathways have also 
been adapted for use on electronic tablets.39 There were no reported studies found in the 
literature of the effect of the Diagnostic Imaging Pathways on GP imaging ordering 
behaviour. 
The Royal Australian and New Zealand College of Radiologists produced the fourth edition 
of Imaging Guidelines.19 The first edition was published in 1990. These guidelines, like the 
Pathways, used an algorithm approach to illustrate the diagnostic choices in a wide range of 
circumstances. Some of the algorithms are supported with a brief list of references. Reference 
to the ACRAC and its more comprehensive literature reviews is not uncommon. Unlike the 
ACRAC, no quantification of ‘appropriateness’ is provided in Imaging Guidelines nor in the 
Pathways. The Imaging Guidelines are now out of print although electronic versions are still 
available on the Web. 
The American College of Radiology (ACR) approach of developing appropriateness criteria 
for imaging in various clinical conditions has been described by Cascade40 and Vydareny.41 
Cascade commented that in most cases there are insufficient data available for meta-analysis 
and determination of a conclusion based on science alone. Therefore a broad-based 
consensus process was used to complement the scientific data. This utilised a modified 
Delphi technique. The ACRAC were first published in 1995 and have been progressively 
updated. Blackmore and Medina expressed concern that after 10 years of use, substantial 
improvements to the criteria were needed if they are to meet standards for evidence-based 
medicine.42 The ACR has defended the development process as being a good synthesis of 
evidence and expert opinion.43 
The ACRAC are published with a well summarised literature review that allows assessment 
of the evidence used in the preparation of the criteria. In common with other literature on 
diagnostic testing, little of the evidence has been gathered in general/family practice where 
the circumstance of low prevalence makes the predictive value of tests much lower. The 
extent to which such guidelines are ‘portable’ to general practice in Australia is therefore 
open to question. However, in the absence of better evidence, the ACRAC probably 
represent the state-of-the-art advice on appropriateness of diagnostic imaging tests for the 
conditions that they cover.  
Guidelines have also been developed by the Royal College of Radiologists (RCR) under the 
title iRefer.44 These are available free to all clinicians in the NHS in the United Kingdom, and 
on subscription to other clinicians. Unfortunately, a request for access to these guidelines for 
this project remains unanswered. 
The New Zealand Accident Compensation Corporation guidelines are clinical guides for the 
management of patients covered by the New Zealand universal accident compensation 
scheme. They are endorsed by a joint clinical colleges group, the NZGG. While they have 
some wider applicability, they are primarily designed for accident victims. 
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While there was no published literature on the effect of the release of the earlier editions of 
Australian guidelines on the ordering behaviours of GPs, general conclusions regarding the 
effect of imaging guidelines can be drawn from research on other imaging guidelines in the 
United States, the United Kingdom and Canada. 
In 1992, the Royal College of Radiologists Working Party reported a baseline audit of 
radiology referrals from hospital inpatient and outpatient sources which revealed high levels 
of variance in radiology ordering.45 It concluded that the data supported the proposition that 
at least 20% of radiology orders in the United Kingdom were unnecessary. A subsequent 
uncontrolled pre-post intervention study by the Working Party in 1989–90 to measure the 
effect of introduction of the RCR guidelines in general practice showed a fall in chest, spine, 
limb and skull radiography.46 A subsequent controlled study by Oakeshott et al. of the 
introduction of RCR guidelines showed a reduction of spinal x-ray orders and a higher 
proportion of requests that conformed to the guidelines in the intervention group.47 A 
further study by the same group in 1995, using a combination of guidelines and feedback on 
radiology ordering, found a 20% reduction in spinal x-rays; however because of inter-
practice variance, a trend to lower overall ordering by the intervention group failed to reach 
statistical significance.48  
However, studies by Shye et al. in a large group–model HMO in the United States found no 
benefit from the use of either guidelines alone, or guidelines plus feedback, in reducing the 
number of spinal x-rays. He concluded that the influence of practice and patient 
characteristics, and of patient expectations needed to be identified and addressed.49,50 
This conclusion is supported by Wilson who found that patient attitude and expectation was 
a strong predictor of the ordering of spinal x-rays for low back pain.51 On the other hand, 
Gallagher found the introduction of guidelines successful in reducing lumbosacral spine  
x-rays in the controlled environment of a United States emergency department.52 
Bearcroft in Cambridge, United Kingdom, found a 30% reduction in the small number of GP 
chest x-ray requests that were contrary to locally developed guidelines, but no overall 
reduction in the referral rate.53 
Martin et al. undertook a study of the applicability of the ACRAC and found that they could 
be effectively applied in an internal medicine clinic situation.54 However, a Canadian study 
of the potential effect of introduction of the Agency for Health Care Policy and Research 
guidelines for the management of acute low back pain (which are very similar to the 
ACRAC)55 showed that introduction of the guidelines in Alberta would result in a 
significantly increased utilisation of imaging without an increase in clinical utility. Little 
information is available in the literature on the use or impact of the ACRAC in family 
practice in the United States. 
Curry and Reed, and Bowen et al. have shown that electronic decision support for diagnostic 
imaging ordering had limited support and success in a clinical primary care setting.56,57 
While Kahn et al. have written extensively on the use of the ACRAC in computerised 
decision support systems in the United States, there do not appear to have been any studies 
on the effectiveness of this method of using these guidelines in changing ordering 
behaviours.58-60 
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2 Methods 
This study relies on analyses of data from the Bettering the Evaluation and Care of Health 
(BEACH) program, a continuous cross-sectional national study that began in April 1998. The 
BEACH database now includes information for almost 1.6 million encounters from nearly 
16,000 participants.  
The BEACH methods are summarised in this chapter. Detailed BEACH methods have been 
published in A decade of general practice activity 2002–03 to 2011–12.6 This chapter also provides 
the methods used in this particular analysis of imaging test ordering by GPs. 
2.1 The BEACH program 
Each year about 1,000 ever changing, randomly selected GPs, each records details of 100 
consecutive encounters on structured paper recording forms, and provides information about 
themselves and their practice.  
BEACH is the only continuous randomised study of general practice activity in the world, and 
the only national program that provides direct linkage of management actions such as orders 
for imaging tests, to the problem under management.  
Data elements used in this report 
The 2011–12 GP Profile (information about the GP and their practice) is shown in Appendix 1.  
The GP and practice data elements collected that pertain to this report are as follows. 
•  GP characteristics: age; sex; years in general practice; country of graduation (analysed in 
this report as Australia/other); Fellowship of the Royal Australian College of General 
Practitioners (RACGP) (Yes/No). 
• Characteristics of major practice: number of individual GPs; number of GPs working in 
the practice; geographic status of practice (metropolitan/rural, using ASGC – Australian 
Standard Geographical Classification);61 co-located imaging service (Yes/No). 
The 2011–12 BEACH encounter form is provided as Appendix 2. The data elements drawn 
from the encounter record that pertain to this study are as follows. 
• Patient characteristics: date of birth (reported as age group); sex; status of the patient to 
the practice (new/seen before); concession cardholder status (including Commonwealth 
and/or Department of Veterans’ Affairs repatriation) (Yes/No); non-English-speaking 
background (patient self-report – a language other than English is the primary language 
at home) (Yes/No); Aboriginal person (self-identification) and/or Torres Strait Islander 
person (self-identification) (Yes/No). 
• The problems managed at encounter (at least one and up to four per encounter); status 
of the problem to the patient (new/old). 
• Imaging tests ordered at the encounter, and body site specified (all recorded in free 
text), and designation of the problem or problems managed at this encounter for which 
each test was ordered.  
The Patient Information Sheet, provided to participating GPs for their patients is shown in 
Appendix 3. 
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Sampling methods 
The source population includes all vocationally registered GPs and all general practice 
registrars who claimed a minimum of 375 Medicare general practice items of service in the 
most recently available 3-month Medicare data period (which equates to 1,500 such claims in 
a year). The Medical Benefits Division of the Department of Health (DoH) updates the 
sample frame quarterly from Medicare claims data, removes from the sample frame any GPs 
already randomly sampled in the current quality improvement triennium, and draws a new 
sample from those remaining. This ensures the timely addition of new entries to the 
profession, and timely exclusion of those GPs who have stopped practising, or have been 
previously approached in the current triennium. 
Recruitment methods 
• The randomly selected GPs are sent a letter, posted to the address provided by DoH. 
• The GPs are then telephoned in the order they were approached and, referring to the 
letter, asked whether they will participate. 
• GPs who agree to participate are set an agreed recording date several weeks ahead. 
• A research pack is sent to each participant before the planned start date. 
• Non-returns are followed up by regular telephone calls for 3 months. 
• Participating GPs earn clinical audit points toward their Quality Improvement and 
Continuing Professional Development (QI & CPD) requirements through the RACGP 
and/or the Australian College of Rural and Remote Medicine (ACRRM).  
Ethics approval and informed patient consent 
Ethics approval for the BEACH program in 2011–12 was obtained from the Human Ethics 
Committee of the University of Sydney.  
Although the data collected by the GPs is not sufficient to identify an individual patient, 
informed consent for GP recording of the encounter details is required from each patient. 
GPs are provided with a Patient Information Card (Appendix 3) and are instructed to ask the 
patient if they are happy for their data to be included. If the patient refuses, details of the 
encounter are not recorded. This is in accordance with the ethics requirements for the 
BEACH program. 
Classification of data 
Imaging test orders and problems managed are classified according to the International 
Classification of Primary Care – Version 2 (ICPC-2), a product of the World Organization of 
Family Doctors (Wonca).62  
The ICPC-2 has a biaxial structure, with 17 chapters on one axis (each with an alphabetic 
code) and seven components on the other (numeric codes) (Figure 1). Chapters are based on 
body systems, with additional chapters for psychological and social problems.  
The ICPC-2 is an excellent epidemiological tool. The diagnostic and symptom rubrics have 
been selected for inclusion on the basis of their relative frequency in primary care settings, or 
because of their relative importance in describing the health of the community. ICPC-2 has 
about 1,370 rubrics and these are sufficient for meaningful analyses.  
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 Components A B D F H K L N P R S T U W X Y Z  
 1. Symptoms, complaints                    
 2. Diagnostic, screening, prevention                   
 3. Treatment, procedures, medication                   
 4. Test results                   
 5. Administrative                   
 6. Other                   
 7. Diagnoses, disease                   
 A General and unspecified L Musculoskeletal U Urinary 
 B Blood & blood-forming organs N Neurological W Pregnancy, family planning 
 D Digestive P Psychological X Female genital  
 F Eye R Respiratory Y Male genital  
 H Ear S Skin Z Social  
 K Circulatory T Endocrine, nutritional & metabolic   
 
Figure 2.1: The structure of the International Classification of Primary Care – Version 2 (ICPC-2) 
 
When the free-text data are received from the GPs, trained secondary coders code the data in 
more specific terms using ICPC-2 PLUS.63,64 This is an interface terminology, developed from 
all the terms used by GPs in about 2.5 million encounter records. Readers interested in seeing 
how coding works can download the ICPC-2 PLUS Demonstrator at 
<sydney.edu.au/medicine/fmrc/icpc-2-plus/demonstrator/index.php>. 
All the imaging tests recorded by GPs are coded very specifically in ICPC-2 PLUS, but 
ICPC-2 classifies imaging tests very broadly (for example, a CT scan of the lumbar spine is 
classified as L41 – Diagnostic radiology/imaging of the musculoskeletal system). In 
Australia, the Medicare Benefits Schedule (MBS) classifies imaging tests in groups that are 
relatively well recognised. We therefore re-classified all ICPC-2 PLUS codes for imaging 
orders into MBS standard groups, and report imaging test orders using these groups. 
Inclusions are provided in Appendix 5, Table A5.3. 
BEACH data and imaging data from the MBS 
The imaging data from the MBS and that from BEACH are very different. 
The imaging tests recorded by GPs in the BEACH program reflect the GP’s intent that the 
patient should have the test undertaken. Two steps affect the extent to which this test order 
results in a claim from the MBS: 
• the patient may choose not to have the test done, or 
• the patient has the test done, but the test is not covered by the MBS if it is ordered by a 
GP, so again no claim is made through the MBS for this action. 
An example of the latter is GP orders for MRI. At the time the data were collected for this 
study, the costs of a MRI ordered by a GP directly (rather than through referral to a specialist 
with a request for a MRI) were not claimable from the MBS. 
Imaging data in the MBS reflect the imaging undertaken by radiologists and billed to 
Medicare. The data include all private radiology billed to Medicare, irrespective of the type 
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of medical practitioner ordering the test from the radiologist. Further, when a radiologist 
receives a request for a specific test from a medical practitioner, they can decide whether the 
test ordered is the most suitable and may decide a different test should be undertaken, and 
whether to undertake other tests of their choosing.  
The MBS data therefore reflect the tests that are actually undertaken by the radiologist in 
response to a request from a medical practitioner, possibly after doing additional tests or 
selecting an alternative test to that requested.  
Further, when claims are made for imaging tests undertaken by the radiologist the claim is 
made for a specific MBS item number. These item numbers are often iso-resource groups, for 
example: “Item 58115: Ultrasound of the spine, three examinations of the kind mentioned in 
items 58100, 58103, 58106 and 58109”.7 
2.2 Methods specifically adopted for this project 
To assess how GP test ordering patterns changed over the decade, we first undertook 
descriptive analyses of BEACH data for each year from 2002–03 to 2011–12 inclusive. From 
this we determined the patterns of GPs’ diagnostic imaging ordering, the most frequent 
imaging tests ordered by GPs, and changes over time in GPs’ ordering. This allowed us to 
assess the consistency of the data over time and identify any period in which dramatic 
change in behaviour occurred. 
These initial analyses of annual data demonstrated linear growth in imaging ordering over 
the decade. However, the statistical power of each individual year of data was relatively low, 
particularly when investigating GPs’ ordering of specific imaging tests and detailed imaging 
ordering for specific health problems. 
Further, as the growth was relatively slow and linear in nature we decided to use two groups 
of three BEACH data years, to measure change in behaviour over the decade:  
• Period 1: data collected between 1 April 2002 and 31 March 2005 inclusive 
• Period 2: data collected in between 1 April 2009 and 31 March 2012 inclusive. 
Those readers wishing to view the annual results by year for the period 2002–03 to 2011–12, 
should see Appendix 4. 
The initial search for guidelines demonstrated that they were largely problem-based, and 
site-based. For example, the guidelines for imaging in the management of sprains and 
strains, were site-based. Further, in the site-specific guidelines there was often different 
advice for diagnosed problems (which we refer to in this report as ‘syndromes’) than for 
undiagnosed conditions, which we refer to in this report as ‘symptoms/complaints’. Test 
ordering for syndromes could be considered as more likely to be monitoring of the problem, 
while test ordering for symptoms/complaints should be considered part of the diagnostic 
process.  
Further, guidance was often specifically aimed at imaging testing of new presentations of 
conditions. Therefore test ordering for new problems (those not previously managed by a 
medical practitioner for this patient, or the first visit for a new episode of a recurrent 
condition), was investigated separately. 
We initially went through a process of creating problem groups (some of which differed 
from those usually used in BEACH reporting), that aligned with the problem subjects 
addressed by each group of guidelines. This facilitated the comparison of GP practise with 
guidelines and with published evidence. In areas of morbidity for which guidelines differed 
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for ‘syndromes’ and for ‘symptoms/complaints’, groups of problems were also created for 
these two aspects of the problem area.  
All ICPC-2 and/or ICPC-2 PLUS codes for each problem group and subgroup (where 
applicable) investigated in detail in this report, are listed in Appendix 5.  
We then identified problems/indications for which imaging was frequently ordered by GPs. 
Problems that accounted for at least 1.0% of problem–imaging links in 2009–12 were 
identified. The top 17 problems accounted for more than 45% of problem–imaging links in 
2009–12.  
The ten problems/indications each generating >2% of problem-imaging links in 2009–12 
were identified as priority areas. As explained in the introduction to Section 2 of this report, 
two of these were rejected, leaving eight individual problem types for further investigation.  
Statistical methods 
The analysis of BEACH data for this report was conducted with Statistical Analysis System 
(SAS) version 9.3,65 and the encounter is the unit of analysis. Proportions are used when 
describing the distribution of an event that can arise only once at a consultation (for example, 
patient or GP age and sex), or to describe the distribution of events within a class of events 
(for example, imaging test type A as a percentage of all imaging tests in that MBS group of 
tests). Due to rounding, proportions may not always add to exactly 100%. 
Rates per 100 encounters are used when an event can occur more than once at the 
consultation (for example, problems managed or imaging test orders). These rates are used 
as the basis of extrapolations for estimates of national annual occurrence of a selected event, 
because the extrapolation to the estimated number of encounters at which an event occurred 
in any given period must be based on the total claims from Medicare for GP items of service 
in that period.  
Rates per 100 or 1,000 problems are also used when a management event can occur more 
than once per problem managed. In general, the results present the number of observations 
(n), and (in the case of management actions) the rate per 100 problems managed, and the 95% 
confidence interval. These figures are used for comparison between Period 1 and 2, because 
the calculation takes account of the greater number of problems managed at encounters in 
Period 2 than in Period 1.  
BEACH is a single stage cluster sample study design, with each 100 encounters forming a 
cluster around each GP participant. In cluster samples, variance needs to be adjusted to 
account for the correlation between observations within clusters. Procedures in SAS 
version 9.3 were used to calculate the intra-cluster correlation, and adjust the confidence 
intervals accordingly, to create robust 95% confidence intervals.65  
Chi-squares are provided in tables comparing GP characteristics and patient characteristics, 
but 95% confidence intervals are also presented (and these are the results described in the 
body of the report), because the chi-square statistic cannot adjust for the cluster sample study 
design of BEACH. 
Significance of differences in rates is judged by non-overlapping 95% confidence intervals of 
the results being compared. The magnitude of this difference can be described as p < 0.005.66 
Assessment using non-overlapping 95% confidence intervals (CIs) is a conservative measure 
of significance,67-69 particularly when differences are assessed by comparing results from 
independent random samples, as is the case when changes over time are investigated using 
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BEACH data. Due to the number of comparisons made in this report, we believe this 
conservative approach is warranted. 
• Changes over time in the frequency of these events are judged significant (that is, a real 
change has occurred) if the two sets of confidence intervals do not overlap. For example, 
Result A: 11.5 per 100 problems (95% CI: 11.3–11.7) is significantly less than Result B: 
11.9 per 100 problems (95% CI: 11.8–12.0). 
• If the two sets of confidence intervals butt together the difference is regarded as 
marginal. For example, Result A: 11.5 per 100 problems (95% CI: 11.3–11.7) is marginally 
lower than Result B: 11.9 (95% CI: 11.7–12.1). 
• In this report, highlighting in tables indicates a significant (or marginal) difference 
between Period 1 and Period 2. 
• If the two sets of 95% confidence intervals overlap, then no change was measured. 
Regression analyses  
In the investigation of the predictors of imaging test ordering by GPs, we used logistic 
regression to identify at the univariate level (i.e. unadjusted), those factors which appeared 
to significantly influence the likelihood of imaging being ordered at a GP–patient encounter. 
Descriptive univariate analyses were performed using SAS V9.3,65 adjusting for the cluster 
sample study design. Stata version 1170 was used for univariate and multivariate logistic 
regression, adjusting for the cluster sample study design. Variables were regarded as 
significant at p < 0.05. 
In this analysis, logistic regression was used with ‘at least one imaging test ordered at the 
encounter’ (No = 0, Yes = 1) as the outcome variable, with the following independent 
(explanatory) groups: 
• GP/practice characteristics 
• patient characteristics 
• encounter characteristics. 
Multiple regression analysis was then conducted. To select the best regression model for 
each group of characteristics, all predictor variables were fitted into the model, and the 
model was reduced using stepwise backward elimination, whereby non-significant variables 
were eliminated in turn (starting with the least significant variable), and the model refitted. 
The process ended when all the retained variables were significant. 
These results are expressed as odds ratios with one group as the reference group. If the 95% 
confidence intervals do not include 1.0, the difference between the group under investigation 
and the reference group is statistically significant. An odds ratio of 1.0 implies that the event 
is equally likely in both groups.  
For example, in investigating the extent to which the sex of the GP affects GP imaging test 
ordering at the univariate level, male GPs are used as the reference group, and the odds ratio 
for female (versus males) was OR: 1.12 (95% CI: 1.07–1.17). Strictly speaking, this is 
interpreted as: the odds of a female GP ordering imaging at an encounter are 12% higher 
than the odds of a male GP ordering imaging. However, in practice it is reasonable to say 
‘female GPs are 12% more likely to order imaging at encounters than male GPs’ when the outcome 
is not a very frequent event (as is the case with imaging test orders). 
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Extrapolated national estimates 
In most chapters of this report, changes that have occurred between two data periods  
(2002–05 and 2009–12) are highlighted. Where the results demonstrate a significant change, 
the estimated national change across total GP Medicare items of services is calculated for 
each period, to demonstrate the impact of this finding on national GP imaging order activity. 
Note that extrapolations are always based on the rate per 100 encounters rather than the rate 
per 100 problems because there is no independent measure of the total number of problems 
managed in Australian general practice. In contrast, the number of national encounters can 
be drawn from Medicare claims data. 
When extrapolating from a single time period (e.g. Period 1, 2002–05): 
• divide the ‘rate per 100 encounters’ of the selected event by 100, and then multiply by the 
average annual number of GP service items claimed through Medicare per year in 
Period 1, rounded to the nearest 100,000, see Table 2.1), to give the estimated average 
number of the selected event per year across Australia in Period 1 (2002–05).  
When extrapolating measured change between Period 1 (2002–05) and Period 2 (2009–12) to 
the national estimated change, we: 
• divide the ‘rate per 100 encounters’ of the selected event for Period 1 by 100, and then 
multiply by the average annual total GP service items claimed through Medicare, for 
Period 1 (rounded to the nearest 100,000, see Table 2.1), to give the estimated national 
annual number of events in each year from 2002–03 to 2004–05 
• repeat the process using data for 2009–12. 
The difference between the two estimates gives the estimated national change in the 
frequency of that event over the decade. Average annual estimates for the two data periods 
are rounded to the nearest 10,000. 
Change is expressed as the estimated increase or decrease from Period 1 to Period 2, in the 
average annual number of general practice contacts for that event in the 3 years of Period 2, 
compared with the same annual average estimate for the 3 years in Period 1. 
Table 2.1 provides the average (rounded) number of GP service items claimed from Medicare 
over the two data periods reported in this study: Period 1 (2002–05), and Period 2 (2009–12). 
It is clear from these figures that the national average number of visits per year increased. In 
fact, in the first year of the study period (2002–03) there were 96.9 million visits claimed 
through Medicare and in the last year (2011–12) there were 123.9 million.4 This increase 
reflects more than one additional visit per head of population in 2011–12 than 10 years 
earlier. 
Table 2.1: Rounded average annual number of GP service items claimed from Medicare Australia, 
in 2002–05 and 2009–12, and total sample size from BEACH for each period 
 Period 1: 2002–05  Period 2: 2009–12 
Annual average rounded number of MBS 
GP items of service claimed per year 97,100,000 119,900,000 
Total sample of encounters  296,100 293,000 
Source: Medicare statistics 4 
Note: MBS – Medicare Benefits Schedule. 
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Example of extrapolation and estimated national change:  
This example estimates the extrapolation of the average change in the annual number of GP 
encounters at which imaging was ordered in the management of osteoarthritis between 
Period 1 and Period 2 (see Chapter 6). 
How many times was osteoarthritis managed by GPs in Australia on average per year over Period 1?  
Locate the number of times it was managed (raw figure), (in this case in Table 6.2 and in 
the parallel tables in each of chapters 5–8), and divide this figure by the total sample 
from BEACH for that period (from Table 2.1 above), then multiply by the average 
annual total claims from Medicare for GP service items (from Table 2.1 above). 
Calculation A: (8,857/296,100) x 97,100,000 = 2,904,000 
Alternatively you can use the management rate of osteoarthritis (3.0 per 100 encounters 
from Table 6.3) to calculate the same extrapolation, by dividing it by 100 and 
multiplying by the total average annual claims to gain the same answer. 
Calculation B: (i.e. 3.0/100 x 97,100,000) = 2,913,000 
Using this method also allows you to calculate the confidence interval around this 
estimate: (from Table 6.3 the lower 95% CI was 2.9 per 100 encounters and the upper 
confidence level was 3.1 per 100. To extrapolate these lower confidence level (LCL) and 
upper confidence levels (UCL):  
LCL = (2.9/100)*97,100,000 = 2,815,900 and UCL = (3.1/100)*97,100,000 = 3,010,100 times 
We can then say that the best estimate of the number of times osteoarthritis was 
managed by GPs on average per year in Period 1 was 2.91 million times, and that we are 
95% confident that the true estimate lies between 2.82 million and 3.01 million. 
However, the figures presented using the two extrapolation methods differ slightly. 
Calculation A is a more precise extrapolation, and has been used for all extrapolations 
presented in this report. Calculation B has been presented to allow readers to calculate 
their own extrapolations. As previously stated, readers should be aware that all 
extrapolations are estimates and are rounded to the nearest 100,000 or 10,000 (depending 
on the size of the figure). After rounding, both calculations equate to 2,900,000 occasions 
of osteoarthritis management in Period 1. 
What was the average annual national number of imaging test orders made by GPs in management of 
osteoarthritis per year in Period 2?  
We repeat this calculation for Period 2 (again using results from Table 6.3). 
Our best estimate is that osteoarthritis was managed 3.36 million times per year in 
Period 2 but we are 95% confident that the true number lies between 3.24 million and 
3.48 million. We can therefore state that in Period 2, osteoarthritis was managed by GPs 
in Australia 0.45 million more times per year on average than it was in Period 1, and we 
are 95% confident that the true increase was between 0.45 million and 0.47 million 
contacts with this problem per year on average. 
How many imaging tests were ordered on average per annum in the two time periods? 
We apply the imaging test order rate per 100 osteoarthritis problems managed (from 
Table 6.3) to estimate that: 
In Period 1, there were 14.3 tests ordered per 100 osteoarthritis problems managed 
(95% CI: 13.4–15.2). We apply this result to the extrapolated estimate above  
((14.3/100)*2.91 million) and we estimate that 0.42 million imaging tests were ordered 
per 100 osteoarthritis problems in Period 1.  
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The result for Period 2 was 0.62 million tests per annum on average, an increase of about 
200,000 per annum between Period 1 and Period 2.  
You can also continue, and apply this calculation to the 95% confidence interval. 
Limitations of extrapolations 
The extrapolations to the total events occurring nationally in any one year are only estimates. 
They may provide: 
• an underestimate of the true ‘GP workload’ of a condition/treatment because the 
extrapolations are made to GP Medicare items claimed, not to the total number of GP 
encounters per year – an additional 5% or so of BEACH encounters annually include 
encounters paid by sources other than Medicare, such as Department of Veterans’ 
Affairs (DVA), state governments, workers compensation insurance, and employers, or 
not charged to anyone. 
• an underestimate of activities of relatively low frequency with a skewed distribution 
across individual GPs— a national random sample will provide an underestimate of 
activity because the sample reflects the population rather than the minority. 
Further, the base numbers used in the extrapolations are rounded to the nearest 100,000, and 
extrapolation estimates are rounded to the nearest 10,000, so can only be regarded as 
approximations. However, the rounding has been applied to both study periods, so the effect 
on measures of change will be very small. Therefore, the extrapolation still provides an 
indication of the size of the effect nationally, of measured change.  
Extrapolations are based on the unit of the encounter because the number of national 
encounters is quantifiable using Medicare claims data. However, the reader should be aware 
that where an event can occur more than once per encounter, the extrapolation represents 
the number of times that event occurs in general practice encounters across the country, 
rather than the number of encounters where that event occurs.  
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3 The BEACH database 
Over the decade investigated in this study (2002–12), 9,802 GPs participated in BEACH, 
providing details of 980,200 GP–patient encounters. This chapter provides an overview of the 
whole BEACH database for the two time periods examined in detail (Period 1: April 2002–
March 2005 and Period 2: April 2009–March 2012). Readers interested in an overview of the 
BEACH database for each individual year included in this report can refer to Appendix 4 or 
the published book A decade of general practice activity 2002–03 to 2011–12.6  
3.1 GP characteristics 
Table 3.1 outlines the characteristics of GPs who participated in BEACH during the two time 
periods. These data were drawn from the BEACH GP profile questionnaire, which 
participants return with their completed recording forms. Statistical comparisons were made 
between the two time periods, using both the chi-square statistic (χ2) (significant at the 5% 
level) and 95% confidence intervals. As described in Chapter 2, comparisons using the 95% 
confidence intervals are a more conservative estimate of significance than the chi-square 
statistic, and are adjusted for the cluster sample study design in BEACH. Therefore all 
comparisons reported use 95% confidence intervals, although the chi-square statistic is also 
reported for interest. 
Table 3.1 shows the following significant differences between BEACH participants in the two 
time periods. 
• A significantly greater proportion of the GP sample was female in Period 2 (41.0% of 
participants) than in Period 1 (33.4%). 
• A significantly greater proportion of the GP sample was aged 55 years and over in 
Period 2 (39.3%) than in Period 1 (32.4%), and a significantly smaller proportion aged  
35–44 years (19.2% in Period 2, compared with 25.7% in Period 1). 
• In Period 2, there were significantly fewer GPs working 45–54 hours (19.2% compared 
with 24.0% in Period 1) or 55 hours and over (9.7% compared with 15.1% in Period 1). 
• There was a general move toward larger group practices, with the proportion of GPs 
working in practices of 10 or more GPs rising from 12.8% in Period 1 to 20.7% in 
Period 2, and the proportion in practices of 2–4 GPs decreasing (from 37.6% in Period 1 
to 28.3% in Period 2) (Table 3.2). 
These differences align with the general changes in characteristics of the total GP workforce 
over the study period,6 and so reflect true changes rather than sampling error. 
3.2 Characteristics of the patients 
The characteristics of all patients sampled during BEACH over the two time periods are 
described in Table 3.2. Chi-square statistics and confidence intervals are also reported in 
Table 3.2, with differences assessed according to non-overlapping confidence intervals. In 
Period 2:  
• there were significantly fewer patients in the 5–14, 15–24 and 25–44 year age groups, and 
more patients in the 65–74 and 75+ age groups than in Period 1 
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• a smaller proportion of the patients at encounters were new to the practice than in 
Period 1 (8.1% compared with 10.0%)  
• a smaller proportion of patients had a health care card and/or Veterans’ Affairs card 
(46.0% compared with 48.4% in Period 1) (Table 3.2). 
These differences again reflect changes seen over the 16 years of the BEACH program, and 
thus represent true changes in the characteristics of patients seen at general practice 
encounters in Australia. 
Table 3.1: Characteristics of participating GPs and their practices, 2002–05 and 2009–12 
GP characteristic 
2002–05 (Period 1)  2009–12 (Period 2) 
Number(a) 
Per cent 
of GPs(a) 
(n = 2,961) 
95% 
LCL 
95% 
UCL  Number(a) 
Per cent 
of GPs(a) 
(n = 2,930) 
95% 
LCL 
95% 
UCL 
Sex (missing n) 
(χ2 = 36.33, p = <0.001) 
(0)     (0)    
 Male 1,973 66.6 64.9 68.3  1,730 59.0 57.3 60.8 
 Female 988 33.4 31.7 35.1  1,200 41.0 39.2 42.7 
Age (missing n)  
(χ2 = 48.02, p = <0.001) 
(2)     (17)    
 < 35 years 218 7.4 6.4 8.3  197 6.8 5.9 7.7 
 35–44 years 760 25.7 24.1 27.3  559 19.2 17.8 20.6 
 45–54 years 1,023 34.6 32.9 36.3  1,012 34.7 33.0 36.5 
 55+ years 958 32.4 30.7 34.1  1,145 39.3 37.5 41.1 
Direct patient care hours 
worked (missing n) 
(χ2 = 77.36, p = <0.001) 
(69)     (44)    
 <= 20 hours 299 10.3 9.2 11.4  321 11.1 10.0 12.3 
 21–34 hours 571 19.7 18.3 21.2  732 25.4 23.8 27.0 
 35–44 hours 891 30.8 29.1 32.5  999 34.6 32.9 36.4 
 45–54 hours 693 24.0 22.4 25.5  555 19.2 17.8 20.7 
 55+ hours 438 15.1 13.8 16.5  279 9.7 8.6 10.7 
Size of practice – 
number of individual 
GPs (missing n) 
(χ2 = 101.20, p = <0.01) 
(24)     (39)    
 Solo 358 12.2 11.0 13.4  296 10.2 9.1 11.3 
 2–4  1,103 37.6 35.8 39.3  819 28.3 26.7 30.0 
 5–9  1,101 37.5 35.7 39.2  1,178 40.7 39.0 42.5 
 10+ 375 12.8 11.6 14.0  598 20.7 19.2 22.2 
Practice location by 
ASGC (missing n) 
(χ2 = 7.23, p = 0.027) 
(4)     (5)    
 Major cities 1,995 67.4 65.8 69.1  2,047 70.0 68.3 71.6 
 Inner regional 601 20.3 18.9 21.8  582 19.9 18.4 21.3 
 Outer regional/remote 361 12.2 11.0 13.4  296 10.1 9.0 11.2 
(a) Missing data removed. 
Note: LCL – lower confidence limit; UCL – upper confidence limit; ASGC – Australian Standard Geographical Classification. 
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Table 3.2: Characteristics of the patients at encounters, 2002–05 and 2009–12 
Patient characteristic 
2002–05 (Period 1)  2009–12 (Period 2) 
Number(a) 
Per cent 
(n = 296,100) 
95% 
LCL 
95% 
UCL  Number(a) 
Per cent 
(n = 293,000) 
95% 
LCL 
95% 
UCL 
Sex (missing n) 
(χ2 = 17.09, p = <0.001) 
(2,732) — — —  (2,625) — — — 
 Male 119,948 40.9 40.4 41.4  117,181 40.4 39.9 40.9 
 Female 173,420 59.1 58.6 59.6  173,194 59.6 59.1 60.1 
Age (missing n) 
(χ2 = 721.68, p = <0.001) 
(2,792) — — —  (2,244) — — — 
 <1 5,619 1.9 1.8 2.0  5,906 2.0 1.9 2.1 
 1–4 13,176 4.5 4.3 4.6  13,384 4.6 4.5 4.8 
 5–14 16,933 5.8 5.6 5.9  15,525 5.3 5.2 5.5 
 15–24 27,965 9.5 9.3 9.8  24,921 8.6 8.4 8.8 
 25–44 72,507 24.7 24.3 25.1  66,933 23.0 22.6 23.4 
 45–64 79,816 27.2 26.9 27.5  80,516 27.7 27.4 28.0 
 65–74 35,432 12.1 11.8 12.3  37,459 12.9 12.6 13.1 
 75+ 41,860 14.3 13.8 14.7  46,112 15.9 15.4 16.3 
Status to the practice 
(missing n) 
(χ2 = 642.02, p = <0.001) 
(6,167) — — —  (4,268) — — — 
 New patient to practice 29,051 10.0 9.6 10.4  23,408 8.1 7.7 8.5 
Health care/VA card 
status (missing n) 
(χ2 = 318.64, p = <0.001) 
(27,478) — — —  (23,445) — — — 
 Has a HCC/VA card 130,020 48.4 47.6 49.2  123,923 46.0 45.2 46.8 
Language status (missing n) 
(χ2 = 54.4, p = <0.001) 
(31,834) — — —  (28,730) — — — 
 Non-English-speaking 
background 
23,647 8.9 8.2 9.7  22,139 8.4 7.7 9.0 
Indigenous status (missing n) 
(χ2 = 58.5, p = <0.001) 
(32,711) — — —  (28,722) — — — 
 Aboriginal and/or Torres 
Strait Islander 
5,385 2.0 1.7 2.4  4,643 1.8 1.5 2.1 
(a) Missing data removed. 
Note: UCL—upper confidence limit; LCL—lower confidence limit; HCC – Health Care Card; VA – Veterans’ Affairs. 
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3.3 Content of the encounters 
Table 3.3 provides a summary of the content of GP–patient encounters in Period 1 and 
Period 2. This table is divided into two sections—one section showing encounter-based 
analysis and the other problem-based analysis. Significant differences between Period 1 and 
Period 2 are highlighted.  
The number of reasons for encounter given by patients significantly increased from 151.1 per 
100 encounters in Period 1, to 155.8 in Period 2. The number of problems managed per 100 
encounters also significantly increased from 149.1 to 157.6 per 100 encounters. This suggests 
that any significant change from Period 1 to Period 2 in a management action (such as 
ordering imaging) per 100 encounters may simply reflect the overall increase in the number 
of problems managed per encounter.  
We account for this by also reporting the rates per 100 problems managed, and these results 
are used as the basis for reporting all changes in management actions. However, we also 
report the rate of each management action per 100 encounters because this forms the basis of 
extrapolations of the national effect of change in GP behaviour. 
There was a significant decrease in the rate of medications recorded per 100 problems 
managed between Period 1 and Period 2. This was reflected by a decrease in the rate of 
medications prescribed, from 55.9 per 100 problems to 52.5 per 100 problems. In contrast, the 
rate of medications supplied by the GP directly to the patient significantly increased from 6.2 
per 100 problems to 7.7 per 100 (Table 3.4). 
The rate of clinical treatments (including counselling, advice and education) decreased 
between Period 1 and Period 2, from 26.3 per 100 problems to 23.9 per 100 problems. 
However the rate of procedures increased from 10.4 per 100 problems to 11.3 per 100 over 
the two time periods. 
Increases were shown in the overall rate of referrals per 100 problems managed, from 8.1 per 
100 problems in Period 1 to 9.5 per 100 in Period 2, reflected in increases in referrals to both 
specialists and to allied health services. Orders for pathology tests also significantly 
increased from 25.4 per 100 problems in Period 1 to 31.8 per 100 problems managed in 
Period 2. 
Orders for imaging tests increased from 5.9 per 100 problems managed in Period 1, to 6.5 per 
100 in Period 2, an increase of 10.2%. However, the rate per 100 encounters increased by 
17.2% (being influenced by the increasing number of problems managed at encounters).  
Detailed analyses about imaging test ordering in the two time periods are described in 
Chapter 4. 
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Table 3.3: Summary of morbidity and management at GP–patient encounters, 2002–05 and 2009–12 
Variable 
ENCOUNTERS  PROBLEMS 
2002–05 (Period 1)  2009–12 (Period 2)  2002–05 (Period 1)  2009–12 (Period 2) 
Number 
(n = 296,100) 
Rate per 100 encounters 
(95% CI)  
Number 
(n = 293,000) 
Rate per 100 encounters 
(95% CI)  
Rate per 100 problems 
(95% CI)  
Rate per 100 problems 
(95% CI) 
General practitioners 2,961 —  2,930 —  —  — 
Encounters 296,100 —  293,000 —  —  — 
Reasons for encounter 447,432 151.1 
(150.2–152.0) 
 456,398 155.8 
(154.8–156.7)  
—  — 
Problems managed 441,591 149.1 
(148.1–150.2) 
 461,761 157.6 
(156.4–158.8)  
—  — 
 New problems 166,704 56.3 
(55.6–57.0) 
 173,427 59.2 
(58.5–59.9) 
 37.8 
(37.3–38.2) 
 37.6 
(37.1–38.0) 
 Chronic problems 153,593 51.9 
(51.0–52.8) 
 160,933 54.9 
(53.9–55.9) 
 34.8 
(34.3–35.2) 
 34.9 
(34.4–35.3) 
Medications 302,735 102.2 
(101.0–103.5) 
 307,136 104.8 
(103.5–106.1) 
 68.6 
(67.8–69.3) 
 66.5 
(65.8–67.2) 
 Prescribed 246,691 83.3 
(82.1–84.6) 
 242,515 82.8 
(81.6–84.0) 
 55.9 
(55.1–56.6) 
 52.5 
(51.8–53.2) 
 GP-supplied 27,405 9.3 
(8.7–9.8) 
 35,388 12.1 
(11.5–12.6) 
 6.2 
(5.8–6.6) 
 7.7 
(7.3–8.0) 
 Advised OTC 28,639 9.7 
(9.3–10.0) 
 29,233 10.0 
(9.6–10.4) 
 6.5 
(6.2–6.7) 
 6.3 
(6.1–6.6) 
Other treatments(a) 162,307 54.8 
(53.6–56.1) 
 162,603 55.5 
(54.2–56.8) 
 36.8 
(36.0–37.5) 
 35.2 
(34.5–36.0) 
 Clinical* 116,225 39.3 
(38.2–40.3) 
 110,545 37.7 
(36.6–38.9) 
 26.3 
(25.6–27.0) 
 23.9 
(23.3–24.6) 
 Procedural* 46,082 15.6 
(15.1–16.0) 
 52,058 17.8 
(17.3–18.2) 
 10.4 
(10.1–10.7) 
 11.3 
(11.0–11.5) 
(continued) 
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Table 3.3 (continued): Summary of morbidity and management at GP–patient encounters, 2002–05 and 2009–12  
Variable 
ENCOUNTERS  PROBLEMS 
2002–05 (Period 1)  2009–12 (Period 2)  2002–05 (Period 1)  2009–12 (Period 2) 
Number 
(n = 296,100) 
Rate per 100 encounters 
(95% CI)  
Number 
(n = 293,000) 
Rate per 100 encounters 
(95% CI)  
Rate per 100 problems 
(95% CI)  
Rate per 100 problems 
(95% CI) 
Referrals 35,877 12.1 
(11.9–12.4) 
 43,994 15.0 
(14.7–15.3) 
 8.1 
(8.0–8.3) 
 9.5 
(9.4–9.7) 
 Medical specialist* 24,002 8.1 
(7.9–8.3) 
 26,799 9.1 
(8.9–9.3) 
 5.4 
(5.3–5.6) 
 5.8 
(5.7–5.9) 
 Allied health services* 8,435 2.8 
(2.7–3.0) 
 13,666 4.7 
(4.5–4.8) 
 1.9 
(1.8–2.0) 
 3.0 
(2.9–3.0) 
 Hospital* 1,680 0.6 
(0.5–0.6) 
 1,070 0.4 
(0.3–0.4) 
 0.4 
(0.3–0.4) 
 0.2 
(0.2–0.3) 
 Emergency 
 department* 
485 0.2 
(0.1–0.2) 
 857 0.3 
(0.3–0.3) 
 0.1 
(0.1–0.1) 
 0.2 
(0.2–0.2) 
 Other referrals* 1,247 0.4 
(0.4–0.5) 
 1,602 0.5 
(0.5–0.6) 
 0.3 
(0.3–0.3) 
 0.3 
(0.3–0.4) 
Pathology 112,072 37.8 
(37.0–38.7) 
 146,730 50.1 
(49–51.1) 
 25.4 
(24.9–25.9) 
 31.8 
(31.2–32.4) 
Imaging 25,863 8.7 
(8.5–9.0) 
 29,996 10.2 
(10.0–10.5) 
 5.9 
(5.7–6.0) 
 6.5 
(6.4–6.6) 
Other investigations(b) 3,208 1.1 
(1.0–1.1) 
 2,602 0.9 
(0.8–0.9) 
 0.7 
(0.7–0.8) 
 0.6 
(0.5–0.6) 
(a) Other treatments include treatment given by practice nurses in the context of the GP–patient encounter and treatment given by GPs. 
(b) Other investigations reported here include only those ordered by the GP. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Tables A4.4 to A4.7 available from Appendix 4 <http://hdl.handle.net/2123/9365>). 
Note: CI – confidence interval; OTC – over-the-counter. Highlighting indicates significant change in the rate per 100 problems between Period 1 and Period 2. 
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4 Imaging test ordering by GPs 
This chapter provides an overview of the imaging tests ordered by GPs, with comparisons 
between Period 1 (2002–05) and Period 2 (2009–12). 
Table 4.1 shows that the vast majority of GPs recorded at least one imaging test over their 
100 encounters, and that the proportion who ordered imaging at least once significantly 
increased between Period 1 and Period 2, from 97.7% in Period 1 to 98.9% in Period 2.  
The number of imaging tests ordered per 100 encounters significantly increased from 8.7 
(95% CI: 8.5–9.0) per 100 encounters in Period 1, to 10.2 (95% CI: 10.0–10.5) per 100 in 
Period 2. Extrapolating this result to the average number of GP–patient encounters claimed 
through Medicare per year in each of the time periods (see Chapter 2, Methods) suggests that 
in Period 1 there were about 8.45 million (95% CI: 8.25–8.74) imaging tests ordered by GPs 
per year, and in Period 2, 12.23 million (95% CI: 12.0–12.58) per year, an increase of 44.7%, or 
about 3.78 million test more orders per year on average over the 3 years of Period 2. The 
likelihood of an imaging order being placed at encounter increased by 15.8%, from 7.6% in 
Period 1 to 8.8% in Period 2. There was no change in the average number of imaging tests 
ordered per 100 tested problems, (111.0 in Period 1 and 112.1 in Period 2), which suggests 
that the growth in ordering was largely due to an increased likelihood of testing. 
Table 4.1: Summary of imaging test order rates 2002–05 and 2009–12  
BEACH data set 
2002–05  
(Period 1)  
2009–12  
(Period 2) 
Number of participating GPs 2,960  2,930 
Number of encounters 296,000  293,000 
Number of problems managed 441,591  461,761 
Number of GPs who ordered at least one imaging test in their 100 encounters 2,892  2,898 
Per cent of all participating GPs ordering at least one imaging test (95% CI) 97.7 
(97.1–98.2)  
98.9 
(98.5–99.3) 
Total imaging test orders    
 Number of imaging test orders 25,863  29,996 
 Imaging order rate per 100 encounters (95% CI) 8.7 
(8.5–9.0)  
10.2 
(10.0–10.5) 
 Imaging order rate per 100 problems (95% CI) 5.9 
(5.7–6.0)  
6.5 
(6.4–6.6) 
At least one imaging order    
 Number of encounters with at least one imaging order 22,445  25,697 
 Per cent of all encounters that involved at least one imaging order (95% CI) 7.6 
(7.4–7.8) 
 8.8 
(8.6–8.9) 
 Number of problems managed with at least one imaging order 23,291  26,755 
 Per cent of problems managed that involved at least one imaging order 
(95% CI) 
5.3 
(5.1–5.4) 
 5.8 
(5.7–5.9) 
 Average number of imaging tests ordered per 100 tested problems 111.0  112.1 
Note: GP – general practitioner; CI – confidence interval. Highlighting indicates a significant difference between data periods. 
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There was a 10% increase in the proportion of all problems managed that involved at least 
one imaging order, from 5.3% in Period 1 to 5.8% in Period 2 (Table 4.1). The order rate per 
100 problems managed also increased between the two time periods, from 5.9 per 100 
problems in Period 1 to 6.5 per 100 in Period 2.  
This result is reflected in Figure 4.1, which shows the proportion of GPs who ordered 
imaging tests as a rate per 100 problems managed. It indicates an overall increase in imaging 
test ordering in the GP profession across the lower and middle range of the ordering 
spectrum, with order rates relatively steady for those GPs who ordered most frequently. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4.1: Distribution of GP imaging test order rates per 100 problems managed, 2002–05 
and 2009–12 
4.1 Imaging tests ordered by Medicare group 
Table 4.2 shows the changes between Period 1 and Period 2 in imaging orders by Medicare 
imaging group as a rate per 1,000 problems managed. Analyses reported in Table 4.2 have 
been conducted per 1,000 problems rather than per 100 problems, as some of the rates 
presented in this table are relatively small. 
The GP order rate for imaging tests increased significantly between the two time periods, 
from 58.6 to 65.0 per 1,000 problems. Diagnostic radiology was the imaging type recorded 
most often in both time periods, although there was a significant decrease in the diagnostic 
radiology order rate from Period 1 (32.7 per 1,000 problems) to Period 2 (29.8 per 1,000). This 
decrease was reflected in falls in order rates for x-rays of the chest, ankle, lumbosacral spine, 
cervical spine and marginal fall for finger/thumb. In contrast, the order rate for 
densitometry tests increased from 1.6 per 1,000 problems in Period 1 to 1.9 in Period 2.  
Orders for ultrasound increased by 37.4% from Period 1 (17.1 per 1,000 problems) to Period 2 
(23.5 per 1,000). Pelvic ultrasounds were the most often ordered, increasing from 3.7 per 
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1,000 problems in Period 1 to 4.5 per 1,000 in Period 2, an increase of 21.6%. The greatest 
increase was in orders for shoulder ultrasounds, which grew by 68.8% between the two time 
periods (from 1.6 to 2.7 per 1,000 problems). Ultrasounds of the renal tract decreased, from 
0.7 per 1,000 problems in Period 1 to 0.4 per 1,000 in Period 2. 
Computerised tomography (CT) scans grew by 25.4% between Period 1 and Period 2, from 
5.9 per 1,000 problems to 7.4 per 1,000. This increase was reflected in orders for CT scans of 
the abdomen (0.7 per 1,000 in Period 1 and 1.0 per 1,000 in Period 2) and lumbar spine CT 
scans (0.6 per 1,000 and 0.8 per 1,000 problems managed). 
Magnetic resonance imaging (MRI) increased from 0.3 per 1,000 problems in Period 1 to 1.0 
per 1,000 in Period 2, representing growth of 333%. Reasons for this growth will be discussed 
in Section 13.4. An increase in other tests was reflected in the ordering rate for 
echocardiography, which rose by 57.1% (from 0.7 per 1,000 problems to 1.1 per 1,000). 
Table 4.2: Imaging orders by Medicare imaging groups (rate per 1,000 problems), 2002–05 and 
2009–12 
 Rate per 1,000 problems (95% CI) 
Imaging type 2002–05 (Period 1) (n = 441,591)  
2009–12 (Period 2) 
(n = 461,761) 
Diagnostic radiology 32.7 
(31.7–33.7) 
 29.8 
(29.0–30.6) 
 X-ray; chest 7.3 
(6.9–7.7) 
 6.5 
(6.2–6.9) 
 X-ray; knee 2.9 
(2.7–3.1) 
 3.0 
(2.8–3.2) 
 Mammography; F 3.0 
(2.6–3.4) 
 2.5 
(2.3–2.7) 
 Densitometry 1.6 
(1.4–1.7) 
 1.9 
(1.8–2.1) 
 X-ray; foot/feet 1.5 
(1.4–1.6) 
 1.6 
(1.5–1.8) 
 X-ray; hip 1.5 
(1.3–1.6) 
 1.6 
(1.5–1.7) 
 X-ray; shoulder 1.4 
(1.3–1.6) 
 1.6 
(1.5–1.7) 
 X-ray; ankle 1.4 
(1.3–1.5) 
 1.1 
(1.0–1.2) 
 X-ray; spine; lumbosacral 1.2 
(1.1–1.4) 
 0.7 
(0.6–0.8) 
 X-ray; wrist 1.1 
(1.0–1.2) 
 1.0 
(0.9–1.1) 
 X-ray; hand 0.9 
(0.8–1.0) 
 0.9 
(0.8–1.0) 
 X-ray; spine; cervical 0.8 
(0.8–0.9) 
 0.6 
(0.5–0.6) 
 X-ray; finger/thumb(s) 0.7 
(0.7–0.8) 
 0.6 
(0.6–0.7) 
 X-ray; spine; lumbar 0.7 
(0.6–0.8) 
 0.7 
(0.6–0.8) 
 X-ray; abdomen 0.6 
(0.5–0.7) 
 0.6 
(0.5–0.7) 
(continued) 
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Table 4.2 (continued): Imaging orders by Medicare imaging groups (rate per 1,000 problems),  
2002–05 and 2009–12 
 Rate per 1,000 problems (95% CI) 
Imaging type 2002–05 (Period 1) (n = 441,591)  
2009–12 (Period 2) 
(n = 461,761) 
Ultrasound 17.1 
(16.4–17.8) 
 23.5 
(22.9–24.1) 
 Ultrasound; pelvis 3.7 
(3.4–4.0) 
 4.5 
(4.2–4.8) 
 Ultrasound; breast; F 2.0 
(1.6–2.4) 
 2.3 
(2.1–2.4) 
 Ultrasound; abdomen 2.0 
(1.8–2.1) 
 2.5 
(2.4–2.7) 
 Ultrasound; shoulder 1.6 
(1.4–1.7) 
 2.7 
(2.5–2.9) 
 Ultrasound; obstetric 1.5 
(1.4–1.7) 
 2.0 
(1.8–2.2) 
 Ultrasound; renal tract 0.7 
(0.6–0.8) 
 0.4 
(0.3–0.5) 
 Ultrasound; NOS 0.7 
(0.6–0.8) 
 0.3 
(0.2–0.4) 
 Ultrasound; abdomen upper 0.7 
(0.6–0.7) 
 0.6 
(0.5–0.7) 
Computerised tomography 5.9 
(5.6–6.2) 
 7.4 
(7.1–7.8) 
 CT scan; brain 1.1 
(1.0–1.2) 
 1.1 
(1.0–1.2) 
 CT scan; abdomen 0.7 
(0.6–0.8) 
 1.0 
(0.9–1.1) 
 CT scan; head 0.7 
(0.6–0.8) 
 0.7 
(0.6–0.7) 
 CT scan; spine; lumbar 0.6 
(0.5–0.6) 
 0.8 
(0.8–0.9) 
 CT scan; spine; lumbosacral 0.6 
(0.5–0.6) 
 0.5 
(0.4–0.5) 
Magnetic resonance imaging 0.3 
(0.2–0.3) 
 1.0 
(0.9–1.1) 
Nuclear medicine imaging 0.8 
(0.7–0.9) 
 0.7 
(0.6–0.8) 
 Scan; bone(s) 0.6 
(0.5–0.7) 
 0.4 
(0.3–0.5) 
Other tests 1.7 
(1.6–1.9) 
 2.5 
(2.3–2.6) 
 Echocardiography 0.7 
(0.6–0.8) 
 1.1 
(1.0–1.2) 
 Test; Doppler 0.7 
(0.6–0.8) 
 0.8 
(0.7–0.9) 
Total imaging tests 58.6 
(57.0–60.1) 
 65.0 
(63.6–66.3) 
Note: CI – confidence interval; CT – computerised tomography; NOS – not otherwise specified. Highlighting indicates a significant difference 
between data periods. 
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4.2 Predictors of GP imaging test ordering at 
encounter 
We estimated that nationally, the average annual number of GP imaging test orders 
increased from 8.45 million in Period 1 to 12.23 million in Period 2. Some of this growth 
would be due to the increasing visit rate of the population and the resulting increase in the 
total number of claims from Medicare for GP items of service. If there had been no change in 
the ordering behaviour of the GPs, using the order rate from Period 1 we can extrapolate the 
order rate for Period 1 to total claims in Period 2. We found that the increased population 
attendance rate alone would have resulted in 10.43 million tests on average per year in 
Period 2 with no change in GP ordering behaviour. Since the true extrapolated estimate was 
12.23 million in Period 2, we can conclude that 1.8 million of the estimated average 
3.8 million extra imaging tests ordered each year in Period 2 (compared with Period 1),  
were due to the increasing attendance rate of the population. The remaining 2 million per 
year extra test orders therefore must be due to changes in other factors including (but not 
limited to):  
• the likelihood of testing a problem 
• an increase in the number of tests ordered when the decision to test is made 
• characteristics of GPs and their practices 
• characteristics of patients seeing a GP (in terms of workload distribution) 
• the content of the encounters, including number and types of problems managed. 
We have earlier demonstrated in this chapter that there was a significant increase in the 
likelihood of GPs ordering at least one imaging test for a problem and we have also shown 
that once the decision to test was made there was no change between Period 1 and Period 2 
in the number of tests ordered per 100 problems managed.  
In Chapter 3 we demonstrated that compared with GPs in Period 1, those participating in 
Period 2 were older, more often female, and worked at practices that were on average larger. 
We also showed that patients at encounters in Period 2 were older, less likely to be new to 
the practice and less likely to hold a concession health card. 
The content of the GP–patient encounters also changed from Period 1 to Period 2, the latter 
being more complex, involving more patient reasons for encounter, more problems managed 
(including more new problems and more chronic problems) (see Chapter 3). 
In this section we seek to identify those factors which best predict GP imaging test ordering 
in Period 2, as this may help us to understand some of the reasons for the increase in 
imaging tests ordered, that are unrelated to the increased national visit rate. We used logistic 
regression at the univariate level, followed by multivariate analysis (see Chapter 2). 
In this analysis, logistic regression was used with ‘at least one imaging test ordered at the 
encounter’ (No = 0, Yes = 1) as the outcome variable, with the following independent 
(explanatory) groups: 
• GP/practice characteristics 
• patient characteristics 
• encounter characteristics. 
Logistic regression 
In logistic regression, results can be expressed as odds ratios where one group is used as the 
reference group. If the 95% confidence intervals around the odds ratio (OR) do not include 
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1.0, the difference between the group under investigation and the reference group is 
statistically significant. An odds ratio of 1.0 implies that the event is equally likely in both 
groups. For example, an odds ratio of 1.3 (OR=1.32, 95% CI: 1.26–1.38) is interpreted as: this 
event is 30% more likely at encounters with GPs/patients/encounters with this characteristic 
than at those without this characteristic. 
Multivariate analysis 
The multiple variables collected in BEACH necessitated adjustment for multiple potential 
confounding variables. This allows us to determine whether there were independent 
associations between GPs’ imaging test ordering and specific characteristics of the GPs (e.g. 
their age and sex), their practices, and/or the types of patients and problems they manage. 
To select the best regression model for each group of characteristics, the model was reduced 
using stepwise elimination: all predictor variables are fitted into the model, and the non-
significant variables are eliminated in turn, (starting with the least significant variable) and 
the model refitted. The process stops when all the retained odds ratios are significant. 
Descriptive univariate analyses were performed using SAS V9.3,65 adjusting for the cluster 
design. Stata version 1170 was used for univariate and multivariate logistic regression, also 
adjusting for the cluster design. Variables were significant at p < 0.05. 
The variables included in the simple logistic regression within each group are listed in Box 1. 
Those marked with  are those retained in the final model. 
Box 1: Characteristics of GPs, patients and encounters used in multiple regression analyses 
GP/practice characteristics 
• GP sex 
• GP age (<35 yrs; 35–44 yrs; 45–54 yrs; 55–64 yrs; 65+ yrs)  
• Fellowship of Royal Australian College of General Practitioners 
• Place of graduation for primary medical degree (Australia/overseas) 
• Co-located imaging service at practice 
• Size of practice 
• Location of practice 
Patient characteristics 
• Patient sex 
• Patient age (<15 yrs; 15–24 yrs; 25–44 yrs; 45–64 yrs; 65–74 yrs; 75+ yrs)  
• Indigenous status 
• Concession card holder status (HCC and/or DVA)  
• Non-English-speaking background status 
• New patient to practice status 
Encounter characteristics 
• Number of problems managed 
• Morbidity managed (presence/absence of 1+ problem managed in each ICPC-2 chapter  
 Denotes variables retained in the final multivariate regression model. 
Note: HCC – Health Care Card; DVA – Department of Veterans’ Affairs. 
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Results 
The results of the univariate (unadjusted) and multivariate (adjusted) analyses are presented 
in Table 4.3. The positive predictive variables identified in the unadjusted analysis did not 
change after adjustment for all other confounding variables.  
Only the adjusted results are summarised here.  
Positive predictors of GP imaging ordering 
GP and practice characteristics 
• GP female – after adjustment, female GPs were 12% (OR: 1.12, 95% CI: 1.07–1.17) more 
likely to order at least one imaging test at encounters than male GPs (Ref: male GPs). 
• GP aged 35–44 years (OR: 1.10, 95% CI: 1.01–1.19) (Ref: age <35 years). 
• GP working in practice of 2–9 GPs (OR: 1.10, 95% CI: 1.01–1.19) (Ref: solo). 
• GP working in practice with a co-located imaging service (i.e. imaging service is located 
in the practice premises or within 50 metres) (OR: 1.10, 95% CI: 1.03–1.08) (Ref: practice 
not co-located). 
Patient characteristics 
• Female (OR: 1.04, 95% CI: 1.00–1.07) (Ref: Male). 
• Age group: the likelihood of ordering imaging was significantly higher at encounters 
with all age groups than at encounters with children aged less than 15 years. The patient 
age group with the strongest predictive value was 45–64 years (1.94, 95% CI: 1.81–2.07) 
followed by 65–74 years (OR: 1.89) and then 25–44 years (OR: 1.77).  
• Patients who were new to the practice at the encounter (OR: 1.40, 95% CI: 1.30–1.51).  
Encounter characteristics  
• Number of problems managed 
For each additional problem managed the odds of an imaging order resulting from the 
encounter increased by 41% (OR: 1.41, 96% CI: 1.36–1.48). 
• The types of problems managed at the encounter 
By far the strongest predictor of imaging test ordering at encounter was the management 
of one or more musculoskeletal problems—there was a 372% higher likelihood of an 
order for imaging (OR: 3.72, 95% CI: 3.52–3.93) than at encounters where no 
musculoskeletal problem was managed. Other positive predictors were management of: 
– pregnancy and family planning (OR: 1.60) 
– urinary problem(s) (OR: 1.32)  
– neurological problem(s) (OR: 1.33)  
– digestive problem(s) (OR: 1.18)  
– female genital problem(s) (OR: 1.97) and male genital problem(s) (OR: 1.36). 
Negative predictors of GP imaging ordering 
• Patient holds a health concession card (OR: 0.88) 
• The encounter involved management of at least one: 
– psychological problem (OR: 0.41) 
– ear problem (OR: 0.42)  
– eye problem (OR: 0.42) 
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– skin problem (OR: 0.59)  
– endocrine problem (OR: 0.64)  
– respiratory problem (OR: 0.73). 
Table 4.3: Univariate and multivariate analysis of likelihood of GP imaging ordering, 2009–12 
 Odds ratio of imaging order at encounter against reference group 
Direction 
of odds 
ratio 
Explanatory variable –  
characteristic 
Univariate  Multivariate 
Odds 
ratio 95% CI p value  
Odds 
ratio  95% CI p value 
GP/practice characteristics         
 GP sex 
 Ref = Male         
  Female 1.25 1.20–1.31 <0.001  1.12 1.07–1.17 <0.001 ↑ 
 GP age  
 Ref = <35 yrs 
        
  35–44 yrs 1.11 1.02–1.21 0.018  1.10 1.01–1.19 0.038 ↑ 
  45–54 yrs 1.07 0.98–1.16 0.104  1.04 0.96–1.12 0.378 — 
  55–64 yrs 0.98 0.90–1.07 0.662  0.97 0.89–1.06 0.455 — 
  65+ yrs 0.95 0.86–1.05 0.334  0.99 0.89–1.10 0.879 — 
 Size of practice  
 Ref = solo GP 
        
  2–9 GPs 1.17 1.08–1.26 <0.001  1.10 1.01–1.19 0.024 ↑ 
  10+ GPs 1.19 1.09–1.29 <0.001  1.07 0.98–1.18 0.123 — 
 Co-located imaging 
 Ref = No 
        
 Yes 1.13 1.06–1.20 <0.001  1.10 1.03–1.18 0.003 ↑ 
Patient characteristics         
 Patient sex  
 Ref = Male 
        
  Female 0.51 0.36–0.72 <0.001  1.04 1.00–1.07 0.039 ↑ 
 Patient age  
 Ref = 0–14 yrs 
 
   
 
  
 
  15–24 yrs 2.14 1.99–2.30 <0.001  1.49 1.38–1.62 <0.001 ↑ 
  25–44 yrs 2.70 2.54–2.88 <0.001  1.77 1.65–1.89 <0.001 ↑ 
  45–64 yrs 2.97 2.80–3.16 <0.001  1.94 1.81–2.07 <0.001 ↑ 
  65–74 yrs 2.59 2.42–2.77 <0.001  1.89 1.75–2.04 <0.001 ↑ 
  75+ yrs 1.86 1.74–1.99 <0.001  1.46 1.34–1.59 <0.001 ↑ 
 Concession card holder 
 Ref = non-card holder      
  Concession. card holder 0.86 0.83–0.89 <0.001  0.88 0.84–0.91 <0.001 ↓ 
 Patient status to practice 
 Ref = seen previously  
    
  New patient 1.19 1.11–1.28 <0.001  1.40 1.30–1.51 <0.001 ↑ 
(continued) 
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Table 4.3 (continued): Univariate and multivariate analysis of likelihood of GP imaging ordering, 
2009–12 
 Odds ratio of imaging order at encounter against reference group  
Explanatory variable –  
characteristic 
Univariate 
 
Multivariate 
Direction 
of odds 
ratio 
Odds 
ratio 95% CI p value 
Odds 
ratio  95% CI p value 
Encounter characteristics     
 No. of problems managed at encounter  
 Ref = 1,2,3,4      
 
  Per additional problem 1.31 1.29–1.34 <0.001  1.41 1.36–1.48 <0.001 ↑ 
 At least one problem in following ICPC-2 Chapters  
 Ref = No     
 
  General/unspecified 0.72 0.69–0.75 <0.001  0.67 0.63–0.72 <0.001 ↓ 
  Digestive 1.34 1.28–1.39 <0.001  1.18 1.11–1.26 <0.001 ↑ 
  Eye 0.45 0.40–0.51 <0.001  0.42 0.36–0.48 <0.001 ↓ 
  Ear 0.38 0.35–0.42 <0.001  0.42 0.38–0.47 <0.001 ↓ 
  Circulatory 0.82 0.79–0.85 <0.001  0.64 0.60–0.69 <0.001 ↓ 
  Musculoskeletal 4.76 4.60–4.92 <0.001  3.72 3.52–3.93 <0.001 ↑ 
  Neurological 1.54 1.45–1.63 <0.001  1.33 1.23–1.44 <0.001 ↑ 
  Psychological 0.53 0.50–0.56 <0.001  0.41 0.38–0.44 <0.001 ↓ 
  Respiratory 0.67 0.64–0.70 <0.001  0.73 0.69–0.78 <0.001 ↓ 
  Skin 0.62 0.59–0.65 <0.001  0.59 0.55–0.62 <0.001 ↓ 
  Endocrine/metabolic 0.87 0.83–0.91 <0.001  0.64 0.60–0.68 <0.001 ↓ 
  Urinary 1.43 1.34–1.53 <0.001  1.32 1.21–1.43 <0.001 ↑ 
  Pregnancy, family planning 1.74 1.65–1.87 <0.001  1.60 1.47–1.74 <0.001 ↑ 
  Female genital 2.65 2.53–2.77 <0.001  1.97 1.85–2.11 <0.001 ↑ 
  Male genital 1.33 1.21–1.47 <0.001  1.36 1.22–1.53 <0.001 ↑ 
  Social 0.59 0.49–0.70 <0.001  0.44 0.37–0.53 <0.001 ↓ 
Note: CI – confidence interval; Ref – reference category. Highlighting indicates a significant difference between data periods. 
 
We can conclude from these results that the proportion of the increase in imaging test 
ordering not explained by the increased GP visit rate between Period 1 and Period 2 can be 
partially explained by the increases in variables that have higher predictive value of GP 
imaging ordering. Namely:  
• the proportion of GPs that were female (see Chapter 3, Table 3.1)  
• the proportion of patients encountered who were aged 25–44, 45–64, and 65–74 years 
(see Chapter 3, Table 3.2) 
• the increasing numbers of problems managed at encounter (see Appendix 4, Table A4.1) 
• increases between 2002–03 and 2011–12 in the management rate of musculoskeletal 
problems, digestive problems, and urological problems (see published results in A decade 
of general practice activity 2002–03 to 2011–126).  
This then combines with the overall significant increase in likelihood of testing the problem 
managed (reported earlier in this chapter), to result in increased numbers of imaging tests 
ordered across the country.  
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4.3 Problems for which imaging tests were ordered 
Table 4.4 lists the problems for which imaging was frequently ordered, the proportion of 
each problem that resulted in an imaging test, and the imaging test order rate per 100 
specified problems when at least one test was ordered.  
Imaging orders for back problems accounted for 6.9% of all imaging orders in Period 1, 
falling to 5.9% in Period 2. However, there was no change in the proportion of back problems 
investigated using imaging between the two time periods. 
The proportion of osteoarthritis problems for which imaging was ordered increased from 
Period 1 (12.4%) to Period 2 (16.0%), but this was not reflected in any change in the 
proportion of total imaging orders that was attributable to osteoarthritis (see Table 4.4). 
There were increases in both the proportion of imaging orders attributed to a problem and in 
the proportion of problems for which imaging was ordered, for each of the following 
problems: 
• pregnancy and related check-ups 
• shoulder problems (excluding arthritis and osteoarthritis) 
• bursitis/tendonitis/synovitis NOS 
• menstrual problems. 
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Table 4.4: The problems for which an imaging test was most frequently ordered, 2002–05 and 2009–12 
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem managed 
Number 
of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-
test links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 100 
tested 
problems(c)  
Number 
of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links  
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 100 
tested 
problems(c) 
Back problems* 11,146 1,800 6.9 
(6.5–7.3) 
13.9 
(13.1–14.6) 
116.4  10,584 1,776 5.9 
(5.5–6.2) 
14.5 
(13.7–15.2) 
116.0 
Osteoarthritis (excl back)* 8,857 1,264 4.8 
(4.5–5.2) 
12.4 
(11.7–13.2) 
115.0  8,329 1,537 5.1 
(4.8–5.4) 
16.0 
(15.1–16.9) 
115.3 
Pregnancy & related  
check-ups* 
4,887 754 2.9 
(2.5–3.3) 
15.4 
(13.6–17.2) 
100.3  5,027 1,199 4.0 
(3.6–4.3) 
23.3 
(21.8–24.8) 
102.4 
Shoulder problems (excl 
arthritis/OA)* 
2,161 703 2.7 
(2.4–3.0) 
24.2 
(22.3–26.2) 
134.2  2,637 1,173 3.9 
(3.6–4.1) 
33.2 
(31.3–35.2) 
133.9 
Fracture (excl head/back)* 2,936 1,245 4.8 
(4.4–5.1) 
39.1 
(37.1–41.1) 
108.4  2,586 1,012 3.3 
(3.1–3.6) 
36.2 
(34.2–38.2) 
108.1 
Sprain/Strain (excl back)* 3,249 696 3.1 
(2.8–3.3) 
21.4 
(19.9–23.0) 
115.5  2,861 940 3.1 
(2.8–3.4) 
26.7 
(25.0–28.5) 
122.9 
Bursitis/tendonitis/ 
synovitis NOS 
2,751 499 1.9 
(1.7–2.1) 
15.6 
(14.2–17.0) 
116.3  3,260 911 3.0 
(2.8–3.2) 
23.6 
(22.1–25.2) 
118.3 
Abdominal pain* 2,053 729 2.8 
(2.6–3.0) 
31.4 
(29.3–33.5) 
113.0  2,182 905 3.0 
(2.8–3.2) 
36.1 
(34.0–38.1) 
115.0 
Knee problems* 1,437 506 1.9 
(1.7–2.1) 
33.1 
(30.6–35.6) 
106.3  1,668 664 2.2 
(2.0–2.4) 
35.9 
(33.5–38.3) 
110.9 
Injury musculoskeletal (excl 
shoulder/back/knee)* 
1,527 538 2.1 
(1.8–2.3) 
31.8 
(29.2–34.3) 
110.9  1,514 651 2.1 
(2.0–2.3) 
38.3 
(35.8–40.8) 
112.2 
Breast lump* 621 555 2.1 
(1.8–2.4) 
62.3 
(57.8–66.8) 
143.4  584 584 1.9 
(1.7–2.1) 
69.3 
(65.4–73.3) 
144.2 
Menstrual problems* 2,265 359 1.4 
(1.2–1.5) 
15.6 
(14.1–17.2) 
101.4  2,238 488 1.6 
(1.5–1.8) 
21.8 
(20.0–23.6) 
100.0 
(continued) 
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Table 4.4 (continued): The problems for which an imaging test was most frequently ordered, 2002–05 and 2009–12  
 Period 1 (2002–05)  Period 2 (2009–12) 
 
Number 
of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-
test links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 100 
tested 
problems(c)  
Number 
of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 100 
tested 
problems(c) 
Female genital check-
up/Pap smear* 
6,524 635 2.4 
(1.5–3.4) 
8.0 
(5.8–10.2) 
121.4  6,832 471 1.6 
(1.3–1.8) 
5.5 
(4.8–6.2) 
124.3 
Acute bronchitis/ 
bronchiolitis 
7,017 398 1.5 
(1.4–1.7) 
5.6 
(5.0–6.2) 
101.0  6,879 447 1.5 
(1.3–1.6) 
6.5 
(5.8–7.1) 
100.9 
Osteoporosis (excluding 
osteoporotic fracture)* 
2,573 373 1.4 
(1.2–1.6) 
13.5 
(12.0–15.0) 
107.5  2,392 423 1.4 
(1.2–1.5) 
17.1 
(15.4–18.7) 
103.7 
Injury skin, other 1,869 467 1.8 
(1.6–2.0) 
21.7 
(19.5–23.9) 
115.0  1,487 379 1.2 
(1.1–1.4) 
22.2 
(19.9–24.5) 
114.8 
Pneumonia 947 282 1.1 
(0.9–1.2) 
29.4 
(26.1–32.6) 
101.4  1,028 341 1.1 
(1.0–1.3) 
32.1 
(29.1–35.1) 
103.3 
Subtotal  11,911 45.6 — —   13,901 45.8 — — 
Total 441,591 26,121 100.0 8.0 
(5.8–10.2) 
121.4  461,761 30,350 100.0 5.5 
(4.8–6.2) 
124.3 
(a) A test was counted more than once if it was ordered for the management of more than one problem at an encounter. There were 25,863 imaging test orders and 26,121 problem–imaging links in Period 1, and 29,996 
imaging test orders and 30,350 problem–imaging links in Period 2. 
(b) The percentage of total contacts with the problem that generated at least one order for imaging.  
(c) The rate of imaging orders placed per 100 tested problem contacts with at least one order for imaging. 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table 5.3). 
Note: CI – confidence interval; excl – excluding; OA – osteoarthritis; NOS – not otherwise specified. Highlighting indicates a significant difference between data periods.
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Section 2 
 
Problem-based investigation 
 
Introduction 
In Chapter 4 we identified 17 problems that each accounted for >1% of problem–imaging test 
links. Since time and funds available for this project did not allow detailed investigation of 
17 problem areas, the top 10 problems/indications, each generating >2% of problem–
imaging links in Period 2 (2009–12) were identified as priority areas.  
Each of these problem types was given further consideration. We considered the changes 
from Period 1 to Period 2 in the proportion of imaging orders accounted for by each 
problem, and GPs’ imaging ordering in the management of these problems. Eight problems 
were selected for detailed investigation in this section. Box S2.1 summarises the reasons for 
our selection of the eight problems investigated: 
• Back problems (Chapter 5) 
• Osteoarthritis (excluding back) (Chapter 6) 
• Shoulder problems (excluding arthritis/osteoarthritis) (Chapter 7) 
• Sprain/Strain (excluding back) (Chapter 8) 
• Bursitis/tendonitis/synovitis NOS (Chapter 9) 
• Abdominal pain (Chapter 10) 
• Knee problems (Chapter 11) 
• Injury musculoskeletal (excluding shoulder/back/knee) (Chapter 12). 
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Box 2: Selection of indications for further investigation 
Problem Description of changes from 2002–05 to 2009–12 and comments regarding further investigation  
Investigate 
further? 
Back problems* Back problems generate the majority of GPs’ imaging ordering. The proportion of 
problem-imaging combinations generated by GPs’ management of back problems 
has decreased over time, and there has been no change in the likelihood of GPs’ 
ordering imaging over time. 
We chose to investigate the quality of GPs’ imaging ordering for back problems 
due to the large volume of imaging orders generated in its management. 
Yes 
Osteoarthritis (excluding 
back)* 
The proportion of problem-imaging combinations generated by GPs’ management 
of osteoarthritis has not changed. However there has been a statistically significant 
increase over time in the likelihood of GPs’ ordering imaging for this indication. 
We chose to investigate the quality of GPs’ imaging ordering for osteoarthritis due 
to the increase in the likelihood of imaging being ordered. Arthritis is a national 
health priority area and the management of osteoarthritis problems generates the 
second highest amount of GPs’ imaging orders. Further, it is likely that the 
prevalence of osteoarthritis will increase in the future due to the ageing population. 
Yes 
Pregnancy & related 
check-up* 
The proportion of problem-imaging combinations and the likelihood of GPs’ 
ordering imaging in the management of pregnancy increased significantly over 
time. 
BEACH does not collect information about the stage of pregnancy, which is 
essential data when determining the quality of GPs’ imaging ordering for 
pregnancy. Therefore we decided not to further investigate imaging ordered for this 
problem. 
No 
Shoulder problems 
(excluding arthritis/ 
osteoarthritis)* 
The proportion of problem-imaging combinations and the likelihood of GPs’ 
ordering imaging in the management of shoulder problems increased significantly. 
These increases led us to further investigate GPs’ imaging ordering in the 
management of shoulder problems. 
Yes 
Fracture (excluding 
head/back)* 
The proportion of problem-imaging combinations generated by GPs’ management 
of fractures has decreased over time, and there has been no change in the 
likelihood of GPs’ ordering imaging in its management. Therefore this problem was 
excluded from those to be further investigated. 
No 
Sprain/Strain (excluding 
back)* 
The proportion of problem-imaging combinations generated by GPs’ management 
of sprain/strain did not change. However there was a statistically significant 
increase over time in the likelihood of GPs’ ordering imaging for this indication. The 
latter result led us to include this indication for further investigation. 
Yes 
Bursitis/tendonitis/ 
synovitis NOS 
The proportion of problem-imaging combinations accounted for by this problem, 
and the likelihood of GPs’ ordering imaging in the management of 
bursitis/tendonitis/synovitis increased significantly. These increases led us to 
investigate this indication in more detail. 
Yes 
Abdominal pain* The proportion of problem-imaging combinations generated by GPs’ management 
of abdominal pain has not changed. However there has been a statistically 
significant increase over time in the likelihood of GPs’ ordering imaging for this 
indication. The latter result led us to include this indication for further investigation. 
Yes 
Knee problems* The proportion of problem-imaging combinations and the likelihood of GPs’ 
ordering imaging in the management of knee problems did not change over time. 
This indication was identified as an area of poor quality of GPs’ imaging ordering in 
the 2001 report and for this reason we decided to investigate further. 
Yes 
Injury musculoskeletal 
(excluding shoulder/back/ 
knee)* 
The proportion of problem-imaging combinations generated by GPs’ management 
of musculoskeletal injury has not changed. However there has been a statistically 
significant increase over time in the likelihood of GPs’ ordering imaging for this 
indication. The latter result led us to include this indication for further investigation 
Yes 
   
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5). 
Note: NOS – not otherwise specified. 
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5 Back problems 
This chapter investigates imaging orders for back problems, recorded by GPs from April 
2002–March 2005 (Period 1) to April 2009–March 2012 (Period 2). As reported at the 
beginning of Section 2, GP imaging orders for back problems were selected for investigation 
because: 
• the management of back problems generates the majority of GPs’ imaging orders, and  
• a large volume of imaging orders was generated in the management of back problems.  
Based on the rationale that guidelines recommend different management of back problems 
depending on their status as a symptom/complaint or as a defined condition (see Chapter 2), 
back problems were grouped and categorised as: 
• ‘back symptom/complaint (all)’ and 
• ‘back syndrome (all)’.  
The full list of ICPC-2 rubrics and ICPC-2 PLUS codes and terms included in each group are 
provided in Appendix 5, Table A5.1.  
Imaging orders are investigated for: 
• all back problems 
• all back problems grouped as ‘back syndrome’ 
• new problems grouped as ‘back syndrome’ 
• all back problems grouped as ‘back symptom/complaint’ 
• new problems grouped as ‘back symptom/complaint’. 
Changes in ordering over time between Period 1 and Period 2 are reported. 
5.1 All back problems 
Table 5.1 shows the total number of back problems managed, and the distribution of the back 
problems across back syndrome and back symptoms/complaints in Period 1 and Period 2.  
There were no significant differences between the two data periods in the management rates 
reported for either of the back problem groups. Back symptoms/complaints and back 
syndromes each accounted for approximately 50% of all back problems in both data periods, 
and each were managed about twice in every 100 encounters.  
However, while the management rate of total back problems per 100 encounters did not 
significantly change, there was a significant increase in the estimated annual encounters 
involving back problems nationally. These increased by 673,000, from 3.64 million 
encounters (95% CI: 3.52–3.77) in Period 1 to 4.32 million (95% CI: 4.19–4.44) in Period 2.  
This is due to the increased GP visit rate described in Chapter 2. 
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Table 5.1: Back problems managed by problem type, 2002–05 and 2009–12 
Back problems(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
problems 
Per cent of 
back 
problems 
Per 100 
encounters 
(95% CI)  
Number of 
problems 
Per cent of 
back 
problems 
Per 100 
encounters 
(95% CI) 
Back syndrome  5,712 51.2 1.9 
(1.9–2.0) 
 5,280 49.9 1.8 
(1.7–1.9) 
Back symptom/complaint 5,434 48.8 1.8 
(1.7–1.9) 
 5,304 50.1 1.8  
(1.7–1.9) 
Total back problems 11,146 100.0 3.8 
(3.6–3.9)  
10,584 100.0 3.6 
(3.5–3.7) 
(a) For a list of inclusions refer to Appendix 5, Table A5.1. 
Note: CI – confidence interval. 
Table 5.2 shows that the rate at which imaging was ordered in the management of back 
problems did not change significantly over time.  
In 2002–05, there were 11,146 back problems managed and at least one imaging test was 
ordered for 1,546 of these (13.9% likelihood). A total of 1,800 imaging test orders were 
placed, at a rate of 16.1 tests per 100 back problems managed. 
In 2009–12, there were 10,584 back problems managed, and GPs ordered at least one imaging 
test for 1,531 of these (14.5% likelihood). In total, 1,776 imaging test orders were placed, at a 
rate of 16.8 imaging tests per 100 back problems managed. As discussed in Chapter 4, back 
problems contributed a smaller proportion of total imaging orders generated for all 
problems in Period 2 (5.9%) than in Period 1 (6.9%) (see Table 4.4). 
When these results are considered with the increased GP visit rate (see Chapter 2) we 
calculate that in Period 1, 590,000 imaging orders were placed nationally by GPs for the 
management of back problems. In Period 2, there were 730,000 imaging orders placed, or 
about 140,000 more than in Period 1. 
In summary, there were no changes in: the management rate of back problems (3.8 per 100 
encounters in Period 1 and 3.6 in Period 2); the likelihood of ordering a test (13.9% in 
Period 1 and 14.5% in Period 2); or the rate at which imaging tests were ordered for back 
problems (16.1 per 100 problems in Period 1 and 16.8 in Period 2). There was also no change 
in the number of tests ordered per tested back problem (1.16 per tested problem in both 
periods) (results not tabled). Therefore we can conclude that the increase in the number of 
tests ordered nationally was entirely due to the increased GP visit rate. 
Table 5.2: Back problem management generating GP imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total back problems managed 11,146  10,584 
Back problems for which at least one imaging test ordered (n) 1,546  1,531 
Likelihood of ordering 1+ tests (per cent of problems)  
(95% CI) 
13.9 
(13.1–14.6) 
 14.5 
(13.7–15.2) 
Total imaging orders generated for back problems (n) 1,800  1,776 
Imaging orders per 100 back problems (95% CI) 16.1 
(15.2–17.1) 
 16.8 
(15.8–17.7) 
Note: CI – confidence interval. 
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Age-specific and sex-specific likelihood of management  
In both data periods there was a significantly higher likelihood of management of back 
problems at encounters with males than females. There was a marginal decrease in the 
likelihood of management at encounters with males between Period 1 and Period 2. 
Table 5.3 shows that the majority of patients for whom back problems were managed were 
aged between 45 and 64 years, in both data periods. The age-specific likelihood of 
management in the 25–44 year age group decreased significantly over time, from 4.5% of 
encounters with patients in this age group to 3.9%, but there was a marginal increase in the 
management among patients aged 75 years and over, from 3.3% to 3.7%.  
There were no changes between Period 1 and Period 2 in either the age-specific or 
sex-specific imaging test order rates for back problems, although the order rate for females 
was marginally higher than for males in Period 1, and significantly higher in Period 2. 
Table 5.3: Age-specific and sex-specific management of back problems, 2002–05 and 2009–12 
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 5,161 4.3 
(4.1–4.5) 
14.8 
(13.7–16.0) 
 4,661 4.0 
(3.8–4.1) 
14.7 
(13.5–15.9) 
 Females 5,842 3.4 
(3.2–3.5) 
17.2 
(16.0–18.5) 
 5,801 3.3 
(3.2–3.5) 
18.5 
(17.2–19.8) 
Age        
 <15 years 111 0.3 
(0.3–0.4) 
27.0 
(17.6–36.4) 
 64 0.2 
(0.1–0.2) 
26.6 
(15.3–37.8) 
 15–24 years 601 2.1 
(1.9–2.4) 
16.4 
(13.1–19.7) 
 458 1.8 
(1.7–2.0) 
18.3 
(14.5–22.2) 
 25–44 years 3,293 4.5 
(4.3–4.8) 
15.1 
(13.6–16.5) 
 2,618 3.9 
(3.7–4.1) 
16.0 
(14.3–17.6) 
 45–64 years 4,252 5.3 
(5.1–5.6) 
16.8 
(15.3–18.2) 
 4,066 5.0 
(4.9–5.2) 
15.7 
(14.3–17.0) 
 65–74 years 1,369 3.9 
(3.6–4.1) 
16.5 
(14.1–18.9) 
 1,562 4.2 
(3.9–4.4) 
20.7 
(18.2–23.1) 
 75+ years 1,378 3.3 
(3.1–3.5) 
15.5 
(13.1–17.9) 
 1,702 3.7 
(3.5–3.9) 
16.4 
(14.2–18.5) 
Total 11,109 3.8 
(3.6–3.9) 
16.1 
(15.2–17.1) 
 10,584 3.6 
(3.5–3.7) 
16.8 
(15.8–17.7) 
(a) Missing data removed: 2002–05 n=105 (age), n=106 (sex); 2009–12 n=78 (age), n=86 (sex). 
(b) Number of encounters with at least one back problem managed at encounter. It is possible for more than one back problem to be managed 
per encounter, therefore this total may differ from the total number of problems (reported in Table 5.2). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes over time in imaging test types ordered 
While the overall rate of imaging test orders per 100 back problems did not change over time 
(Table 5.3), there were considerable changes in the types of tests ordered across MBS groups. 
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There was a move away from diagnostic radiology (although this remained the predominant 
test group) toward CT and MRI orders. Table 5.4 shows there was: 
• a marginal decrease in diagnostic radiology orders per 100 back problems managed, 
between Period 1 (10.5 per 100 back problems managed) and Period 2 (9.1 per 100). In 
particular, x-ray of the lumbosacral spine decreased from 3.5 to 2.3 tests per 100 back 
problems managed 
• a significant increase in the rate of CT orders, from 4.7 to 6.1 per 100 back problems 
managed, and particularly CT of the lumbar spine. This increased by about 50% from 1.9 
to 3.0 per 100 back problems managed 
• a significant increase in the rate of MRI orders, from 0.2 per 100 back problems managed 
in Period 1 to 0.8 per 100 in Period 2. 
Table 5.4: Imaging test orders by MBS test group and the most frequent individual tests ordered for 
back problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 1,170 65.0 
(62.7–67.3) 
10.5 
(9.8–11.2) 
 963 54.2 
(51.6–56.8) 
9.1 
(8.4–9.8) 
 X-ray; spine; lumbosacral 387 21.5 
(19.5–23.5) 
3.5 
(3.1–3.9) 
 246 13.9 
(12.1–15.6) 
2.3 
(2.0–2.7) 
 X-ray; spine; lumbar 206 11.4 
(9.9–13.0) 
1.8 
(1.6–2.1) 
 222 12.5 
(10.9–14.1) 
2.1 
(1.8–2.4) 
 X-ray; spine; thoracic 107 5.9 
(4.8–7.1) 
1.0 
(0.8–1.1) 
 83 4.7 
(3.7–5.6) 
0.8 
(0.6–0.9) 
 X-ray; back 81 4.5 
(3.5–5.5) 
0.7 
(0.6–0.9) 
 49 2.8 
(1.9–3.6) 
0.5 
(0.3–0.6) 
 X-ray; spine 61 3.4 
(2.5–4.3) 
0.5 
(0.4–0.7) 
 51 2.9 
(2.1–3.6) 
0.5 
(0.4–0.6) 
 X-ray; hip 53 2.9 
(2.2–3.7) 
0.5 
(0.3–0.6) 
 67 3.8 
(2.9–4.6) 
0.6 
(0.5–0.8) 
 Test; densitometry 30 1.7 
(1.1–2.3) 
0.3 
(0.2–0.4) 
 49 2.8 
(2.0–3.5) 
0.5 
(0.3–0.6) 
Computerised tomography 526 29.2 
(27.0–31.4) 
4.7 
(4.3–5.1) 
 643 36.2 
(33.8–38.6) 
6.1 
(5.6–6.6) 
 CT scan; spine; lumbar 209 11.6 
(10.1–13.1) 
1.9 
(1.6–2.1) 
 315 17.7 
(15.8–19.7) 
3.0 
(2.6–3.3) 
 CT scan; spine; lumbosacral 203 11.3 
(9.7–12.9) 
1.8 
(1.5–2.1) 
 179 10.1 
(8.5–11.7) 
1.7 
(1.4–2.0) 
 CT scan; spine 52 2.9 
(2.1–3.7) 
0.5 
(0.3–0.6) 
 46 2.6 
(1.8–3.4) 
0.4 
(0.3–0.6) 
Ultrasound 49 2.7 
(1.9–3.5) 
0.4 
(0.3–0.6) 
 61 3.4 
(2.5–4.4) 
0.6 
(0.4–0.7) 
Magnetic resonance imaging 24 1.3 
(0.8–1.9) 
0.2 
(0.1–0.3) 
 87 4.9 
(3.8–6.0) 
0.8 
(0.6–1.0) 
Nuclear medicine 31 1.7 
(1.1–2.3) 
0.3 
(0.2–0.4) 
 22 1.2 
(0.7–1.8) 
0.2 
(0.1–0.3) 
Total imaging tests 1,800 100.0 16.1 
(15.2–17.1) 
 1,776 100.0 16.8 
(15.8–17.7) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule. Highlighting indicates a significant difference between data periods. Only the 
most frequent test descriptors are presented in each MBS group. 
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5.2 Back syndrome 
Table 5.5 shows the rate at which imaging was ordered in the management of back 
syndrome over the two time periods.  
In 2002–05, there were 5,712 back syndrome problems managed and GPs ordered at least one 
imaging test for 775 of these (13.6% likelihood). A total of 893 imaging test orders were 
placed, at a rate of 15.6 imaging tests per 100 back syndrome problems managed.  
In 2009–12, there were 5,280 back syndrome problems managed, and for 770 of these, at least 
one imaging test order was made (14.6% likelihood). In total, 895 imaging test orders were 
placed at a rate of 17.0 imaging tests per 100 back syndrome problems managed.  
This shows that there was no change in the GP imaging order rate for back syndrome 
problems between Period 1 and Period 2. 
In Period 1, an estimated 290,000 imaging orders per annum were placed nationally by GPs 
for the management of back syndrome problems. In Period 2, there were about 360,000 per 
year on average, or about 80,000 more per year than in Period 1. 
In summary, there were no changes in: the management rate of back syndrome problems (1.9 
per 100 encounters in Period 1 and 1.8 in Period 2); the likelihood of ordering a test (13.6% in 
Period 1 and 14.6% in Period 2); or the rate at which imaging tests were ordered for back 
syndrome problems (15.6 per 100 problems in Period 1 and 17.0 in Period 2). There was also 
no change in the number of tests ordered per back syndrome problem (1.15 per tested 
problem in both periods) (results not tabled). Therefore, we can conclude that the increase in 
the number of tests ordered nationally was entirely due to the increased GP visit rate. 
Table 5.5: Back syndrome management generating GP imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total back syndrome problems managed 5,712  5,280 
Back syndrome problems for which at least one imaging test 
ordered (n) 
775  770 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 13.6 
(12.6–14.6) 
 14.6 
(13.5–15.6) 
Total imaging orders generated for back syndrome problems (n) 893  895 
Imaging orders per 100 back syndrome problems (95% CI) 15.6 
(14.4–16.8) 
 17.0 
(15.7–18.2) 
Note: CI – confidence interval.  
Age-specific and sex-specific management of back syndrome 
In both data periods, the sex-specific likelihood of management of back syndrome was 
significantly higher at encounters with males than at those with females. Likelihood of 
management for males significantly decreased over the data period, but no change was 
noted for females (Table 5.6). 
There were some significant changes in age-specific likelihood of management. There was a 
significant decrease for patients aged 25–44 years, and marginal decreases for patients in the 
15–24 and 45–54 year age groups between Period 1 and Period 2. 
However, there were no changes in the test ordering rates for back syndrome over the time 
period for any age or sex group. 
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Table 5.6: Age-specific and sex-specific management of back syndrome, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 2,721 2.3 
(2.2–2.4) 
15.2 
(13.7–16.8) 
 2,337 2.0 
(1.9–2.1) 
15.1 
(13.4–16.9) 
 Females 2,914 1.7 
(1.6–1.8) 
15.9 
(14.2–17.5) 
 2,886 1.7 
(1.6–1.8) 
18.6 
(16.8–20.3) 
Age        
 <15 years 40 0.1 
(0.1–0.2) 
27.5 
(10.3–44.7) 
 17 0.1 
(0.0–0.1) 
23.5 
(2.3–44.8) 
 15–24 years 276 1.0 
(0.9–1.1) 
13.4 
(8.9–17.9) 
 185 0.7 
(0.6–0.9) 
14.6 
(9.0–20.2) 
 25–44 years 1,451 2.0 
(1.9–2.1) 
15.5 
(13.3–17.8) 
 1,107 1.7 
(1.5–1.8) 
15.5 
(13.0–18.1) 
 45–64 years 2,133 2.7 
(2.5–2.8) 
17.0 
(15.0–19.0) 
 1,931 2.4 
(2.3–2.5) 
17.3 
(15.3–19.4) 
 65–74 years 828 2.3 
(2.2–2.5) 
16.0 
(13.1–18.9) 
 911 2.4 
(2.3–2.6) 
20.9 
(17.7–24.0) 
 75+ years 915 2.2 
(2.0–2.4) 
12.6 
(10.0–15.2) 
 1,074 2.3 
(2.2–2.5) 
14.6 
(12.2–17.1) 
Total  5,696 1.9 
(1.8–2.0) 
15.6 
(14.4–16.8) 
 5,262 1.8 
(1.7–1.9) 
17.0 
(15.7–18.2) 
(a) Missing data removed: 2002–05 n=53 (age), n=61 (sex); 2009–12 n=37 (age), n=39 (sex).  
(b) Number of encounters with at least one back syndrome managed at encounter. It is possible for more than one back syndrome problem to 
be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 5.5). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods.  
Changes over time in imaging test types ordered 
Table 5.7 shows there were considerable changes in the types of tests ordered across MBS 
groups. Between Period 1 and Period 2 the order rate for:  
• x-ray of the lumbosacral spine significantly decreased from 3.2 to 2.1 per 100 back 
syndrome problems managed 
• CT of the lumbar spine significantly increased, from 2.5 per 100 back syndrome 
problems managed, to 3.8 per 100 
• MRI significantly increased from 0.2 to 0.9 per 100 back syndrome problems managed.  
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Table 5.7: Imaging test orders by MBS test group and the most frequent individual tests ordered for 
back syndrome, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 510 57.1 
(53.7–60.5) 
8.9 
(8.0–9.8) 
 424 47.4 
(43.7–51.1) 
8.0 
(7.1–9.0) 
 X-ray; spine; lumbosacral 181 20.3 
(17.5–23.1) 
3.2 
(2.7–3.7) 
 111 12.4 
(10.1–14.7) 
2.1 
(1.7–2.5) 
 X-ray; spine; lumbar 103 11.5 
(9.2–13.8) 
1.8 
(1.4–2.2) 
 89 9.9 
(7.9–12.0 
1.7 
(1.3–2.1) 
 X-ray; spine; thoracic 32 
 
3.6 
(2.4–4.8) 
0.6 
(0.4–0.8) 
 28 3.1 
(2.0–4.3) 
0.5 
(0.3–0.7) 
 X-ray; back 29 3.2 
(2.0–4.5) 
0.5 
(0.3–0.7) 
 21 2.3 
(1.2–3.5) 
0.4 
(0.2–0.6) 
 X-ray; spine 27 3.0 
(1.9–4.1) 
0.5 
(0.3–0.6) 
 21 2.3 
(1.4–3.3) 
0.4 
(0.2–0.6) 
 X-ray; hip 25 2.8 
(1.8–3.8) 
0.4 
(0.3–0.6) 
 41 4.6 
(3.3–5.9) 
0.8 
(0.5–1.0) 
 Test; densitometry 18 2.0 
(1.1–2.9) 
0.3 
(0.2–0.5) 
 30 3.4 
(2.2–4.5) 
0.6 
(0.4–0.8) 
Computerised tomography 349 39.1 
(35.7–42.4) 
6.1 
(5.4–6.8) 
 386 43.1 
(39.6–46.7) 
7.3 
(6.5–8.1) 
 CT scan; spine; lumbar 142 15.9 
(13.4–18.4) 
2.5 
(2.1–2.9) 
 199 22.2 
(19.3–25.2) 
3.8 
(3.2–4.3) 
 CT scan; spine; lumbosacral 138 15.5 
(12.9–18.0) 
2.4 
(2.0–2.8) 
 109 12.2 
(9.8–14.5) 
2.1 
(1.6–2.5) 
 CT scan; spine 36 4.0 
(2.8–5.3) 
0.6 
(0.4–0.8) 
 28 3.1 
(2.0–4.3) 
0.5 
(0.3–0.7) 
Ultrasound 13 1.5 
(0.7–2.2) 
0.2 
(0.1–0.4) 
 28 3.1 
(1.8–4.4) 
0.5 
(0.3–0.8) 
Magnetic resonance imaging 10 1.1 
(0.4–1.8) 
0.2 
(0.1–0.3) 
 48 5.4 
(3.8–6.9) 
0.9 
(0.6–1.2) 
Nuclear medicine 11 1.2 
(0.5–1.9) 
0.2 
(0.1–0.3) 
 9 1.0 
(0.4–1.7) 
0.2 
(0.1–0.3) 
Total imaging tests 893 100.0 15.6 
(14.4–16.8) 
 895 100.0 17.0 
(15.7–18.2) 
Note: CI – confidence interval; CT – computerised tomography; MBS – Medicare Benefits Schedule. Highlighting indicates a significant difference 
between data periods. Only the most frequent test descriptors are presented in each MBS group. 
Imaging test ordering rates by status of back syndrome problem 
Table 5.8 shows the proportions of contacts generating an imaging order for new and old 
back syndrome problems in both data periods. About three-quarters of the GP contacts were 
for previously diagnosed back syndrome problems, in both 2002–05 and 2009–12. New cases 
of back syndrome problems were managed at a rate of 0.5 per 100 encounters in both periods 
(results not tabled). 
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In both data periods, the likelihood of ordering and the imaging order rate for back 
syndrome problems was about three times higher at initial presentations (30.3 orders per 100 
back syndrome problems in Period 1 and 33.1 per 100 in Period 2) than at follow-up 
consultations (10.0 orders per 100 problems in Period 1 and 11.6 in Period 2). There were no 
significant changes in the imaging order rate per 100 new, or old, back syndrome problems, 
between the two data periods. 
These results, combined with the increased GP visit rate, suggest that in Period 1, 155,000 
imaging orders were placed nationally per year by GPs for management of new back 
syndrome problems. In Period 2, about 160,000 imaging tests were ordered, nationally per 
year, or about 5,000 more per annum than in Period 1. 
In summary, there were no changes in: the management rate of new back syndrome 
problems (0.5 per 100 encounters in both periods); the likelihood of ordering a test (26.1% in 
Period 1 and 27.6% in Period 2); or the rate at which imaging tests were ordered (30.3 per 100 
problems in Period 1 and 33.1 in Period 2). There was also no change in the number of tests 
ordered per new back syndrome problem (1.16 per tested problem in both periods) (results 
not tabled). Therefore, we can conclude that the increase in the number of tests ordered 
nationally is entirely due to the increased GP visit rate. 
Table 5.8: Imaging ordering rates by status of back syndrome problems, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 1,550 4,162 5,712  1,317 3,963 5,280 
Per cent of back syndrome problems 27.1 72.9 100.0  25.0 75.0 100.0 
Total imaging orders generated for 
problems (n) 
469 424 893  436 459 895 
Imaging orders per 100 problems 
(95% CI) 
30.3  
(27.3–33.2) 
10.0  
(9.1–11.3) 
15.6  
(14.4–16.8) 
 33.1  
(29.8–36.4) 
11.6  
(10.4–12.8) 
17.0  
(15.7–18.2) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
26.1  
(23.7–28.4) 
8.9  
(8.0–9.8) 
13.6  
(12.6–14.6) 
 27.6  
(25.0–30.1) 
10.3  
(9.3–11.3) 
14.6  
(13.5–15.6) 
Note: CI – confidence interval. 
5.3 New back syndrome 
Age-specific and sex-specific management of new back syndrome 
In both data periods there was a higher likelihood of management of new back syndrome 
problems at encounters with males than females, but there were no changes in the sex-
specific likelihood of management between Period 1 and Period 2 (Table 5.9). 
The majority of patients for whom new back syndrome problems were managed were aged 
between 25 and 64 years, in both data periods. The age-specific likelihood of management 
decreased marginally in the 15–24, 25–44 and 45–64 year age groups. 
There was no change in the overall imaging ordering rate for new back syndrome problems 
between Period 1 and Period 2. 
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Table 5.9: Age-specific and sex-specific likelihood of management and test order rate for new back 
syndrome problems, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new 
problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 At least one 
new 
problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 716 0.6 
(0.6–0.7) 
31.4 
(27.4–35.4) 
 590 0.5 
(0.5–0.6) 
32.1 
(27.6–36.7) 
 Females 818 0.5 
(0.4–0.5) 
29.2 
(25.2–33.1) 
 717 0.4 
(0.4–0.5) 
34.1 
(29.6–38.7) 
Age        
 <15 years 24 0.1 
(0.0–0.1) 
33.3 
(8.0–58.7) 
 10 0.0 
(0.0–0.1) 
20.0 
(0.0–47.7) 
 15–24 years 138 0.5 
(0.4–0.6) 
17.4 
(9.8–25.0) 
 77 0.3 
(0.2–0.4) 
19.5 
(9.8–29.2) 
 25–44 years 418 0.6 
(0.5–0.6) 
28.9 
(23.6–34.3) 
 324 0.5 
(0.4–0.5) 
28.1 
(22.5–33.7) 
 45–64 years 555 0.7 
(0.6–0.8) 
36.1 
(30.9–41.3) 
 463 0.6 
(0.5–0.6) 
34.7 
(29.1–40.3) 
 65–74 years 216 0.6 
(0.5–0.7) 
27.3 
(20.7–33.9) 
 233 0.6 
(0.5–0.7) 
40.2 
(32.1–48.3) 
 75+ years 188 0.5 
(0.4–0.5) 
27.7 
(19.5–35.9) 
 197 0.4 
(0.4–0.5) 
35.0 
(26.8–43.2) 
Total  1,548 0.5 
(0.5–0.6) 
30.3 
(27.3–33.2) 
 1,315 0.5 
(0.4–0.5) 
33.1 
(29.8–36.4) 
(a) Missing data removed: 2002–05 n=9 (age), n=14 (sex); 2009–12 n=11 (age), n=8 (sex).  
(b) Number of encounters with at least one new back syndrome problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 5.8). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes over time in imaging test types ordered 
Between Period 1 and Period 2, there were no changes in either the proportions of each MBS 
test group, or in their order rates. In both data periods diagnostic radiology was by far the 
predominant test group (Table 5.10). Orders for x-ray of the lumbosacral spine significantly 
decreased, from 7.2 to 4.6 per 100 new back syndrome problems managed. 
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Table 5.10: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for new back syndrome problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI)  
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI) 
Diagnostic radiology 288 61.4 
(56.8–66.0) 
18.6 
(16.2–21.0) 
 254 58.3 
(53.1–63.4) 
19.3 
(16.5–22.0) 
 X-ray; spine; 
 lumbosacral 
111 23.7 
(19.6–27.8) 
7.2 
(5.7–8.6) 
 60 13.8 
(10.4–17.2) 
4.6 
(3.3–5.8) 
 X-ray; spine; lumbar 51 10.9 
(7.9–13.8) 
3.3 
(2.3–4.2) 
 61 14.0 
(10.5–17.5) 
4.6 
(3.4–5.9) 
 X-ray; hip 17 3.6 
(2.0–5.3) 
1.1 
(0.6–1.6) 
 26 
 
6.0 
(3.9–8.1) 
2.0 
(1.2–2.7) 
 X-ray; spine; thoracic 17 3.6 
(1.8–5.4) 
1.1 
(0.5–1.6) 
 18 4.1 
(2.3–6.0) 
1.4 
(0.7–2.0) 
 X-ray; back 17 3.6 
(1.9–5.3) 
1.1 
(0.6–1.6) 
 11 2.5 
(0.9–4.1) 
0.8 
(0.3–1.4) 
 X-ray; spine 14 3.0 
(1.4–4.5) 
0.9 
(0.4–1.4) 
 12 2.8 
(1.2–4.3) 
0.9 
(0.4–1.4) 
 X-ray; chest 11 2.3 
(0.9–3.8) 
0.7 
(0.3–1.2) 
 11 2.5 
(0.9–4.1) 
0.8 
(0.3–1.4) 
Computerised 
tomography 
167 35.6 
(31.1–40.1) 
10.8 
(9.2–12.4) 
 156 35.8 
(30.8–40.7) 
11.8 
(10.0–13.7) 
 CT scan; spine; 
 lumbosacral 
76 16.2 
(12.7–19.7) 
4.9 
(3.8–6.0) 
 45 10.3 
(7.3–13.3) 
3.4 
(2.4–4.4) 
 CT scan; spine; lumbar 59 12.6 
(9.5–15.7 
3.8 
(2.8–4.8) 
 80 18.3 
(14.5–22.2) 
6.1 
(4.7–7.4) 
 CT scan; spine 18 3.8 
(2.1–5.6) 
1.2 
(0.6–1.7) 
 12 2.8 
(1.2–4.3) 
0.9 
(0.4–1.4) 
Ultrasound 7 1.5 
(0.4–2.6) 
0.5 
(0.1–0.8) 
 7 1.6 
(0.4–2.8) 
0.5 
(0.1–0.9) 
Magnetic resonance 
imaging 
1 0.2 
(—) 
0.0 
(—) 
 14 3.2 
(1.5–4.9) 
1.1 
(0.5–1.6) 
Nuclear medicine 6 1.3 
(0.3–2.3) 
0.4 
(0.1–0.7) 
 5 1.1 
(0.1–2.1) 
0.4 
(0.0–0.7) 
Total imaging tests 469 100.0 30.3 
(27.3–33.2) 
 436 100.0 33.1 
(29.8–36.4) 
Note: CI – confidence interval; CT – computerised tomography; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too 
small to calculate a confidence interval. Highlighting indicates a significant difference between data periods. Only the most frequent test 
descriptors are presented in each MBS group. 
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5.4 Back symptom/complaint 
Table 5.11 shows the rate at which imaging was ordered in the management of back 
symptoms/complaints.  
In 2002–05, there were 5,434 back symptoms/complaints managed and at least one imaging 
test order resulted from 14.2% of these. A total of 907 imaging test orders were placed, at a 
rate of 16.7 imaging tests per 100 back symptoms/complaints managed.  
In 2009–12, there were 5,304 back symptoms/complaints managed, and for 14.3% of these, at 
least one imaging test order was made. In total, 881 imaging test orders were placed, with 
16.6 imaging tests being ordered for every 100 back symptoms/complaints managed. 
This shows that the rate of GP imaging ordering for back syndrome problems did not change 
between Period 1 and Period 2. 
These results, combined with the increased GP visit rate, suggest that in Period 1, about 
300,000 imaging orders were placed nationally by GPs per annum for the management of 
back symptom/complaint problems. In Period 2, we estimate that 360,000 imaging orders 
were placed on average per year, or about 60,000 per annum more than in Period 1. 
In summary, there were no changes in: the management rate of back symptom/complaint 
problems (1.8 per 100 encounters in both periods); the likelihood of ordering a test (14.2% in 
Period 1 and 14.3% in Period 2); or the rate at which imaging tests were ordered (16.7 per 100 
problems in Period 1 and 16.6 in Period 2). There was also no change in the number of tests 
ordered per back symptom/complaint problem (1.18 per tested problem in Period 1 and 1.16 
in Period 2) (results not tabled). Therefore, we can conclude that the increase in the estimated 
number of tests ordered nationally was entirely due to the increased GP visit rate. 
Table 5.11: Back symptom/complaint management generating GP imaging orders, 2002–05 and 
2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total back symptom/complaint problems managed 5,434  5,304 
Back symptom/complaint problems for which at least one 
imaging test was ordered (n) 
771  761 
Likelihood of ordering 1+ tests (per cent of problems)  
(95% CI) 
14.2 
(13.1–15.2) 
 14.3 
(13.3–15.4) 
Total imaging orders generated for back symptom/complaint 
problems (n) 
907  881 
Imaging orders per 100 back symptom/complaint problems 
(95% CI) 
16.7 
(15.4–18.0) 
 16.6 
(15.3–17.9) 
Note: CI – confidence interval.  
Age-specific and sex-specific management  
In both data periods, the sex-specific likelihood of management of back symptoms/ 
complaints was significantly higher at encounters with males than at those with females. 
There was no change in the management over time for either sex (Table 5.12). 
The age-specific likelihood of management marginally decreased for patients aged 25–44 
years, and marginally increased for patients aged 75 years or older. 
There were no changes in the age-specific or sex-specific imaging ordering rates for back 
symptom/complaint over the time period. 
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Table 5.12: Age-specific and sex-specific likelihood of management and test order rate for back 
symptom/complaint problems, 2002–05 and 2009–12  
 2002–05 (Period 1)  2009–12 (Period 2) 
Patient 
characteristic(a) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order 
rate per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order 
rate per 100 
problems 
(95% CI) 
Sex         
 Males 2,449 2.0 
(1.9–2.2) 
14.3 
(12.7–16.0) 
 2,331 2.0 
(1.9–2.1) 
14.3 
(12.6–16.0) 
 Females 2,934 1.7 
(1.6–1.8) 
18.6 
(16.7–20.4) 
 2,923 1.7 
(1.6–1.8) 
18.4 
(16.6–20.3) 
Age        
 <15 years 71 0.2 
(0.2–0.3) 
26.8 
(15.4–38.1) 
 47 0.1 
(0.1–0.2) 
27.7 
(13.4–41.9) 
 15–24 years 326 1.2 
(1.0–1.4) 
18.9 
(14.3–23.5) 
 273 1.1 
(1.0–1.2) 
20.9 
(15.6–26.1) 
 25–44 years 1,846 2.6 
(2.4–2.7) 
14.7 
(12.8–16.6) 
 1,514 2.3 
(2.1–2.4) 
16.3 
(14.1–18.5) 
 45–64 years 2,127 2.7 
(2.5–2.8) 
16.6 
(14.5–18.6) 
 2,143 2.7 
(2.5–2.8) 
14.1 
(12.4–15.9) 
 65–74 years 543 1.5 
(1.4–1.7) 
17.1 
(13.1–21.1) 
 654 1.8 
(1.6–1.9) 
20.3 
(16.5–24.1) 
 75+ years 463 1.1 
(1.0–1.2) 
21.2 
(16.6–25.8) 
 629 1.4 
(1.2–1.5) 
19.4 
(15.5–23.3) 
Total  5,428 1.8 
(1.7–1.9) 
16.7 
(15.4–18.0) 
 5,301 1.8 
(1.7–1.9) 
16.6 
(15.3–17.9) 
(a) Missing data removed: 2002–05 n=52 (age), n=45 (sex); 2009–12 n=41 (age), n=47 (sex). 
(b) Number of encounters with at least one back symptom/complaint problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 5.11). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes over time in imaging test types ordered 
Table 5.13 shows that there were considerable changes in the types of tests ordered across 
MBS groups. In both time periods, diagnostic radiology was the predominant test group; 
however, there was a general move away from these orders as a percentage of all imaging 
tests ordered, with a move toward CT and MRI. Between Period 1 and Period 2 the order 
rate for:  
• x-ray of the lumbosacral spine decreased significantly from 3.8 to 2.5 tests per 100 back 
symptoms/complaints managed 
• CT significantly increased, from 3.3 to 4.8 per 100 back symptoms/complaints managed, 
particularly CT of the lumbar spine. This increased by about 80% from 1.2 to 2.2 per 100 
back symptoms/complaints managed 
• MRI significantly increased from 0.3 to 0.7 per 100 back symptoms/complaints managed.  
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Table 5.13: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for back symptoms/complaints, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 660 72.8 
(69.7–75.8) 
12.1 
(11.0–13.3) 
 539 61.2 
(57.8–64.6) 
10.2 
(9.2–11.2) 
 X-ray; spine; lumbosacral 206 22.7 
(20.0–25.5) 
3.8 
(3.2–4.3) 
 135 15.3 
(12.8–17.8) 
2.5 
(2.1–3.0) 
 X-ray; spine; lumbar 103 11.4 
(9.2–13.5) 
1.9 
(1.5–2.3) 
 133 15.1 
(12.6–17.6) 
2.5 
(2.0–3.0) 
 X-ray; spine; thoracic 75 8.3 
(6.5–10.1) 
1.4 
(1.1–1.7) 
 55 6.2 
(4.7–7.8) 
1.0 
(0.8–1.3) 
 X-ray; back 52 5.7 
(4.1–7.3) 
1.0 
(0.7–1.2) 
 28 3.2 
(2.0–4.4) 
0.5 
(0.3–0.7) 
 X-ray; spine 34 3.7 
(2.4–5.1) 
0.6 
(0.4–0.8) 
 30 3.4 
(2.2–4.6) 
0.6 
(0.4–0.8) 
 X-ray; chest 31 3.4 
(2.3–4.6) 
0.6 
(0.4–0.8) 
 24 2.7 
(1.7–3.8) 
0.5 
(0.3–0.6) 
 X-ray; hip 28 3.1 
(2.0–4.2) 
0.5 
(0.3–0.7) 
 26 3.0 
(1.9–4.0) 
0.5 
(0.3–0.7) 
 X-ray; spine; thoracolumbar 23 2.5 
(1.5–3.6) 
0.4 
(0.2–0.6) 
 17 1.9 
(1.0–2.8) 
0.3 
(0.2–0.5) 
Computerised tomography 177 19.5 
(16.9–22.1) 
3.3 
(2.8–3.3) 
 257 29.2 
(26.0–32.3) 
4.8 
(4.2–5.5) 
 CT scan; spine; lumbar 67 7.4 
(5.6–9.1) 
1.2 
(0.9–1.5) 
 116 13.2 
(10.8–15.5) 
2.2 
(1.8–2.6) 
 CT scan; spine; lumbosacral 65 7.2 
(5.5–8.8) 
1.2 
(0.9–1.5) 
 70 7.9 
(6.0–9.8) 
1.3 
(1.0–1.7) 
 CT scan; spine 16 1.8 
(0.9–2.7) 
0.3 
(0.1–0.4) 
 18 2.0 
(1.1–3.0) 
0.3 
(0.2–0.5) 
Ultrasound 36 4.0 
(2.6–5.4) 
0.7 
(0.4–0.9) 
 33 3.7 
(2.4–5.1) 
0.6 
(0.4–0.9) 
 Ultrasound; pelvis 9 1.0 
(0.3–1.6) 
0.2 
(0.1–0.3) 
 9 1.0 
(0.4–1.7) 
0.2 
(0.1–0.3) 
Magnetic resonance imaging 14 1.5 
(0.7–2.4) 
0.3 
(0.1–0.4) 
 39 4.4 
(3.0–5.9) 
0.7 
(0.5–1.0) 
Nuclear medicine 20 2.2 
(1.2–3.2) 
0.4 
(0.2–0.5) 
 13 1.5 
(0.7–2.3) 
0.2 
(0.1–0.4) 
Total imaging tests 907 100.0 16.7 
(15.4–18.0) 
 881 100.0 16.6 
(15.3–17.9) 
Note: CI – confidence interval; CT – computerised tomography; MBS – Medicare Benefits Schedule. Highlighting indicates a significant difference 
between data periods. Only the most frequent test descriptors are presented in each MBS group. 
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Imaging test ordering rates by status of back symptom/complaint 
Table 5.14 shows the proportions of contacts generating an imaging order for new and old 
back symptom/complaint problems in both data periods. Three-quarters of the GP contacts 
were for follow-up of previously diagnosed back symptoms/complaints, in both 2002–05 
and 2009–12. New cases of back symptom/complaint problems were managed at a rate of 0.5 
per 100 encounters in both Period 1 and Period 2 (results not tabled). 
In both data periods, the imaging order rate for back symptoms/complaints was much 
higher at initial presentations (31.6 per 100 back symptoms/complaints in Period 1 and 29.5 
per 100 in Period 2) than at follow-up consultations (11.4 per 100 back symptoms/complaints 
in Period 1 and 12.3 per 100 in Period 2). There were no significant changes in the imaging 
order rate per 100 new, or old, back symptoms/complaints, between the two data periods. 
These results, combined with the increased GP visit rate, suggest that in Period 1, about 
150,000 imaging orders were placed nationally per year by GPs for the management of new 
back symptom/complaint problems. In Period 2, there were about 160,000 imaging orders 
placed per year, or about 10,000 more per annum than in Period 1. 
In summary, there were no changes in: the management rate of new back symptom/ 
complaint problems (0.5 per 100 encounters in both periods); the likelihood of ordering a test 
(26.4% in Period 1 and 25.4% in Period 2); or the rate at which imaging tests were ordered 
(31.6 per 100 problems in Period 1 and 29.5 in Period 2). There was also no change in the 
number of tests ordered per new back symptom/complaint problem (1.19 per tested 
problem in Period 1 and 1.16 in Period 2) (results not tabled). Therefore, the small increase in 
the number of tests ordered nationally was entirely due to the increased GP visit rate. 
Table 5.14: Imaging ordering rates by status of back symptoms/complaints, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 1,419 4,015 5,434  1,321 3,983 5,304 
Per cent of back symptom/complaint 
problems 
26.1 73.9 100.0  24.9 75.1 100.0 
Total imaging orders generated for 
problems (n) 
448 459 907  390 491 881 
Imaging orders per 100 problems 
(95% CI) 
31.6 
(28.3–34.9) 
11.4 
(10.2–12.6) 
16.7 
(15.4–18.0) 
 29.5 
(26.2–32.8) 
12.3 
(11.1–13.6) 
16.6 
(15.3–17.9) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
26.4 
(23.8–28.9) 
9.9 
(8.9–10.9) 
14.2 
(13.1–15.2) 
 25.4 
(22.8–28.1) 
10.7 
(9.6–11.7) 
14.3 
(13.3–15.4) 
Note: CI – confidence interval. 
5.5 New back symptom/complaint 
Age-specific and sex-specific management 
In both data periods, there was no difference in the likelihood of management of new back 
symptoms/complaints at encounters with males and females, and no changes between 
Period 1 and Period 2 for either sex. 
The majority of patients for whom new back symptoms/complaints were managed were 
aged between 25 and 64 years, in both data periods.  
49
  
 
There were no changes between Period 1 and Period 2 in either the age-specific or sex-
specific imaging test order rates for new back symptoms/complaints (Table 5.15).  
Table 5.15: Age-specific and sex-specific likelihood of management and test order rate for new back 
symptoms/complaints, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 583 0.5 
(0.4–0.5) 
30.2 
(25.5–34.9) 
 536 0.5 
(0.4–0.5) 
26.8 
(22.4–31.3) 
 Females 824 0.5 
(0.4–0.5) 
32.4 
(28.1–36.8) 
 772 0.5 
(0.4–0.5) 
31.3 
(26.9–35.8) 
Age        
 <15 years 50 0.1 
(0.1–0.2) 
28.0 
(13.8–42.2) 
 31 0.1 
(0.1–0.1) 
25.8 
(6.9–44.7) 
 15–24 years 140 0.5 
(0.4–0.6) 
22.7 
(15.2–30.2) 
 134 0.5 
(0.4–0.6) 
23.1 
(14.7–31.5) 
 25–44 years 490 0.7 
(0.6–0.8) 
23.5 
(18.8–28.1) 
 418 0.6 
(0.6–0.7) 
23.7 
(18.7–28.7) 
 45–64 years 477 0.6 
(0.5–0.7) 
36.8 
(31.0–42.6) 
 444 0.6 
(0.5–0.6) 
31.5 
(26.3–36.6) 
 65–74 years 129 0.4 
(0.3–0.4) 
37.2 
(25.9–48.6) 
 157 0.4 
(0.4–0.5) 
35.7 
(26.0–45.3) 
 75+ years 119 0.3 
(0.2–0.3) 
48.7 
(36.2–61.3) 
 130 0.3 
(0.2–0.3) 
42.3 
(29.8–54.9) 
Total  1,417 0.5 
(0.4–0.5) 
31.6 
(28.3–34.9) 
 1,320 0.5 
(0.4–0.5) 
29.5 
(26.2–32.8) 
(a) Missing data removed: 2002–05 n=12 (age), n=10 (sex); 2009–12 n=6 (age), n=12 (sex). 
(b) Number of encounters with at least one new back symptom/complaint problem managed at encounter. It is possible for more than one of 
the specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in 
Table 5.14). 
Note: CI – confidence interval. 
Changes in imaging tests ordered for new back symptom/complaint 
problems, 2002–05 and 2009–12 
Table 5.16 shows that there were considerable changes in the types of tests ordered across 
MBS groups. There was a general move away from diagnostic radiology orders as a 
percentage of all imaging tests ordered and a move toward CT and MRI orders.  
Between Period 1 and Period 2 the order rate for:  
• x-ray of the lumbosacral spine decreased significantly from 7.9 to 4.1 tests per 100 new 
back symptoms/complaints managed 
• CT significantly increased, from 3.6 to 7.1 per 100 new back symptoms/complaints 
managed, particularly CT of the lumbar spine, which increased by about 145%, from 1.3 
to 3.2 per 100 new back symptoms/complaints managed. 
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Table 5.16: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for new back symptoms/complaints, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI)  
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI) 
Diagnostic radiology 373 83.3 
(79.6–86.9) 
26.3 
(23.3–29.2)  
276 70.8 
(66.1–75.4) 
20.9 
(18.2–23.6) 
 X-ray; spine; lumbosacral 112 25.0 
(21.0–29.0) 
7.9 
(6.4–9.4)  
112 25.0 
(10.1–17.6) 
4.1 
(2.9–5.3) 
 X-ray; spine; lumbar 63 14.1 
(10.8–17.4) 
4.4 
(3.3–5.6)  
69 17.7 
(13.8–21.5) 
5.2 
(4.0–6.5) 
 X-ray; spine; thoracic 47 10.5 
(7.7–13.3) 
3.3 
(2.3–4.3)  
34 8.7 
(5.9–11.5) 
2.6 
(1.7–3.4) 
 X-ray; back 30 6.7 
(4.3–9.1) 
2.1 
(1.3–2.9)  
14 3.6 
(1.8–5.4) 
1.1 
(0.5–2.9) 
 X-ray; chest 19 4.2 
(2.4–6.1) 
1.3 
(0.7–1.9)  
16 4.1 
(2.2–6.1) 
1.2 
(0.6–1.6) 
 X-ray; hip 19 4.2 
(2.4–6.0) 
1.3 
(0.7–1.9)  
11 2.8 
(1.2–4.4) 
0.8 
(0.3–1.3) 
 X-ray; spine 18 4.0 
(2.0–6.0) 
1.3 
(0.6–1.9)  
13 3.3 
(1.6–5.1) 
1.0 
(0.5–1.5) 
 X-ray; spine; thoracolumbar 13 2.9 
(1.3–4.5) 
0.9 
(0.4–1.4)  
10 2.6 
(1.0–4.1) 
0.8 
(0.3–1.2) 
 X-ray; pelvis 10 2.2 
(0.9–3.6) 
0.7 
(0.3–1.1)  
9 2.3 
(0.8–3.8) 
0.7 
(0.2–1.1) 
 X-ray; spine; coccyx 8 1.8 
(0.6–3.0) 
0.6 
(0.2–1.0)  
13 3.3 
(1.5–5.1) 
1.0 
(0.4–1.5) 
 X-ray; back lower 8 1.8 
(0.6–3.0) 
0.6 
(0.2–1.0)  
8 2.1 
(0.6–3.5) 
0.6 
(0.2–1.0) 
Computerised tomography 51 11.4 
(8.4–14.4) 
3.6 
(2.6–4.6)  
94 24.1 
(19.8–28.4) 
7.1 
(5.7–8.6) 
 CT scan; spine; lumbosacral 24 5.4 
(3.3–7.4) 
1.7 
(1.0–2.4)  
27 6.9 
(4.4–9.4) 
2.0 
(1.3–2.8) 
 CT scan; spine; lumbar 18 4.0 
(2.2–5.8) 
1.3 
(0.7–1.9)  
42 10.8 
(7.5–14) 
3.2 
(2.2–4.2) 
 CT scan; spine; thoracic 4 0.9 
(0.0–1.8) 
0.3 
(0.0–0.6)  
6 1.5 
(0.3–2.8) 
0.5 
(0.1–0.8) 
 CT scan; spine 3 0.7 
(0.0–1.4) 
0.2 
(0.0–0.5)  
9 2.3 
(0.8–3.8) 
0.7 
(0.2–1.1) 
Ultrasound 14 3.1 
(1.3–4.9) 
1.0 
(0.4–1.6)  
12 3.1 
(1.3–4.9) 
0.9 
(0.4–1.5) 
Magnetic resonance imaging 1 0.2 
(—) 
0.1 
(—)  
5 1.3 
(0.2–2.4) 
0.4 
(0.0–0.7) 
Nuclear medicine 9 2.0 
(0.7–3.3) 
0.6 
(0.2–1.0)  
3 0.8 
(0.0–1.6) 
0.2 
(0.0–0.5) 
Total imaging tests 448 100.0 31.6 
(28.3–34.9) 
 390 100.0 29.5 
(26.2–32.8) 
Note: CI – confidence interval; CT – computerised tomography; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too 
small to calculate a confidence interval. Highlighting indicates a significant difference between data periods. Only the most frequent test 
descriptors are presented in each MBS group. 
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5.6 Summary of findings 
Changes over time 
Overall, management rates of back problems in total, and of the two subgroups investigated 
individually, did not change between the two data periods. The imaging ordering rates did 
not change over time either (Table 5.17). However, there were changes in the types of tests: 
there was a marginal decrease in diagnostic radiology, and small but significant increases in 
CT scan and MRI imaging orders. 
Table 5.17: Summary of changes over time for back problems 
Back problems 
Management rate  
(% change, rate)(a) 
Likelihood of 
testing  
(% change, rate)(a) 
Ordering rate per 
100 problems 
(% change, rate)(a) 
Number of tests ordered 
per tested problem 
(% change, rate)(a) 
All  No change 
(3.8, 3.6) 
No change 
(13.9, 14.5) 
No change 
(16.1, 16.8) 
No change 
(1.16, 1.16) 
Back syndrome No change 
(1.9, 1.8) 
No change 
(13.6, 14.6) 
No change 
(15.6, 17.0) 
No change 
(1.15, 1.15) 
 New  No change 
(0.5, 0.5) 
No change 
(26.1, 25.4) 
No change 
(30.3, 29.5) 
No change 
(1.16, 1.16) 
Back symptom/ 
complaint 
No change 
(1.8, 1.8) 
No change 
(14.2, 14.3) 
No change 
(16.7, 16.6) 
No change 
(1.18, 1.16) 
 New No change 
(0.5, 0.5) 
No change 
(26.4, 25.4) 
No change 
(31.6, 29.5) 
No change 
(1.19, 1.16) 
(a) Direction and proportion of change between 2002–05 and 2009–12. The management rate for Period 1 and Period 2, used to calculate the 
proportion of change, is shown in parentheses. 
Current imaging test order patterns 
In recent practice, for both back syndrome and back symptom/complaint problems, new 
cases were managed less often than continuing cases, but were more than twice as likely to 
result in an imaging test than those cases previously managed. 
When tests were ordered for back syndrome or for back symptom/complaint problems, they 
were most often diagnostic radiology tests or CT scans. On those occasions where ultrasound 
or MRI was ordered, there was no difference in the rate at which these tests were ordered for 
new problems or those previously managed (Table 5.18). 
Table 5.18: Summary of GP imaging ordering for back problems, Period 2, 2009–12 
Back 
problems 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%) 
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem contacts 
(95% CI) 
Diagnostic 
radiology US CT scan MRI 
All 3.6 
(3.5–3.7) 
14.5 
(13.7–15.2) 
1.16 16.8 
(15.8–17.7) 
9.1 
(8.4–9.8) 
0.6 
(0.4–0.7) 
6.1 
(5.6–6.6) 
0.8 
(0.6–1.0) 
Back 
syndrome 
1.8 
(1.7–1.9) 
14.6 
(13.5–15.6) 
1.15 17.0 
(15.7–18.2) 
8.0 
(7.1–9.0) 
0.5 
(03–0.8) 
7.3 
(6.5–8.1) 
0.9 
(0.6–1.2) 
 New  0.5 
(0.4–0.5) 
25.4 
(22.8–28.1) 
1.16 33.1 
(29.8–36.4) 
19.3 
(16.5–22.0) 
0.5 
(0.1–0.9) 
11.8 
(10.0–13.7) 
1.1 
(0.5–1.6) 
 Old  1.4 
(1.3–1.4) 
10.3 
(9.3–11.3) 
1.13 11.6 
(10.4–12.8) 
4.3 
(3.5–5.0) 
0.5 
(0.3–0.8) 
5.8 
(5.0–6.6) 
0.9 
(0.6–1.1) 
(continued) 
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Table 5.18 (continued): Summary of GP imaging ordering for back problems, Period 2, 2009–12 
Back 
problems 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%) 
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem contacts 
(95% CI) 
Diagnostic 
radiology US CT scan MRI 
Back 
symptom/ 
complaint 
1.8 
(1.7–1.9) 
14.3 
(13.3–15.4) 
1.16 16.6 
(15.3–17.9) 
10.2 
(9.2–11.2) 
0.6 
(0.4–0.9) 
4.8 
(4.2–5.5) 
0.7 
(0.5–1.0) 
 New  0.5 
(0.4–0.5) 
25.4 
(22.8–28.1) 
1.16 29.5 
(26.2–32.8) 
20.9 
(18.2–23.6) 
0.9 
(0.4–1.5) 
7.1 
(5.7–8.6) 
0.4 
(0.0–0.7) 
 Old  1.4 
(0.3–1.4) 
10.7 
(9.6–11.7) 
1.15 12.3 
(11.1–13.6) 
6.6 
(5.7–7.5) 
0.5 
(0.3–0.8) 
4.1 
(3.4–4.8) 
0.9 
(0.6–1.2) 
Note: CI – confidence interval; US – ultrasound; CT – computerised tomography; MRI – magnetic resonance imaging.  
5.7 Summary of guidelines for imaging of back 
problems 
An extensive review of guidelines for diagnostic imaging was undertaken using Medline, 
and national and international sources of guidelines such as the National Health and 
Medical Research Council (NHMRC), the United States Agency for Healthcare Research and 
Quality (AHRQ), the UK National Institute for Health and Care Excellence (NICE); and local 
and overseas colleges of radiology/radiologists. 
The final group of guidelines considered for this section of this report were: Government of 
Western Australia Department of Health (WADoH) Diagnostic Imaging Pathways11 (these 
guidelines could be considered as the successor of the now obsolete Royal Australian and 
New Zealand College of Radiologists [RANZCR] Imaging Guidelines 2001,19 and are 
endorsed by the RANZCR); the American College of Radiology Appropriateness Criteria 
(ACRAC);71 the New Zealand Guidelines Group guidelines;30 NHMRC guidelines;72 and the 
NICE guidelines.73 
The guidelines are generally developed by expert consensus (with little input from primary 
care physicians) with a variable research evidence base. As a result, there is significant 
variance between guidelines in the advice given regarding the appropriate imaging 
modalities to be used, however they suggest similar triggers for initiating investigation. 
In regard to back problems, the guidelines generally separate back problems caused by 
significant trauma (e.g. motor vehicle accidents and significant height falls) from other 
causes of back problems. As the former are infrequently managed in general practice in 
Australia, these guidelines have largely been excluded from consideration in this report. 
The NHMRC guidelines summarise well the overall approach of other guidelines for 
imaging of back problems: ‘The Australian Guideline Evidence-Based Management of Acute 
Musculoskeletal Pain74 recommends against routine use of plain x-rays or other imaging tests 
such as MRI or CT in the absence of ‘red flags’ in non-specific low back pain of less than 12 
weeks duration. This guideline states that x-rays are unhelpful in identifying the cause of 
pain and do not contribute to greater improvement in a patient’s physical function, pain or 
disability. Numerous other international clinical practice guidelines also recommend against 
imaging for acute non-specific low back pain’.75-77  
Virtually all guidelines suggest that imaging is not indicated at initial assessment of back 
problems unless there are ‘red flag’ issues that prompt investigation. Suggested ‘red flags’ 
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include: significant trauma; unexplained weight loss; unexplained fever; history of 
malignancy; immune suppression; long term glucocorticoid use; intravenous drug use; 
suspicion of ankylosing spondylitis or other inflammatory conditions; neurological defects; 
or age >70 years. Patients with ‘red flags’ account for only a small proportion of those 
presenting with low back problems.  
WADoH guidelines suggest that plain radiographs of the spine should be the initial 
investigation in patients with ‘red flags’ except for patients with neurological defects where 
MRI is advised as first investigation. The ACRAC and NICE guidelines suggest that MRI 
may be the appropriate initial investigation for patients with any ‘red flags’. All guidelines 
suggest that CT may be indicated if MRI is unavailable or contraindicated.  
5.8 Compliance with guidelines 
In order to estimate general practitioner compliance with guidelines, in this study we 
separated back problems into ‘back symptom/complaint’ which are undifferentiated back 
problems without a specific diagnosis; and ‘back syndrome’ which groups patients with back 
problems where the GP has applied a specific diagnostic label. The two groups have been 
further separated into ’new’ and ‘old’ problems to indicate whether this is the patient’s initial 
attendance for the problem.  
In the 10 years since the last BEACH report on imaging orders by general practitioners,1 the 
overall imaging rate for back problems at encounters with GPs has remained constant at over 
16 imaging orders per 100 back problems managed. However, the imaging rate for new 
presentations of back problems to GPs in both data periods was 30 per 100 problems 
managed, whereas the order rate in subsequent presentations was about 11 per 100 back 
problems managed. The rate of imaging referral was the same for new undifferentiated back 
problems (back symptom/complaint) and new differentiated back problems (back 
syndrome). 
The high rate of imaging at initial encounter for back problems is inconsistent with all 
established guidelines for the management of back problems.  
During the study period there was a marginal decrease in plain radiography of the spine and 
a small but significant increase in CT scan and MRI imaging orders. This change, although 
quantitatively small, is consistent with the change in the guidelines favouring the use of MRI 
investigation of complex back problems. The limited availability of MRI referrals to GPs 
probably explains the greater increase in orders for CT scans than in orders for MRIs. 
The pattern of GP ordering for back problems remained relatively constant in the last decade 
and continues to be at odds with guidelines. As reported in a 2010 study using BEACH 
data,78 a similar pattern of imaging orders by GPs occurs in the USA and Europe and seems 
resistant to alteration by passive distribution of imaging guidelines. 
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6 Osteoarthritis problems 
This chapter investigates the imaging orders for osteoarthritis problems (excluding 
osteoarthritis of the back, as these are included in the investigation of back problems in 
Chapter 5). As reported at the beginning of Section 2, GP imaging orders for osteoarthritis 
problems were selected for investigation because: 
• the management of osteoarthritis problems generates the second highest amount of GPs’ 
imaging orders  
• there was a statistically significant increase in the likelihood of GPs’ ordering imaging in 
the management of osteoarthritis over time 
• it is likely that the prevalence of osteoarthritis will increase in the future with Australia’s 
ageing population.  
Imaging orders are investigated for all osteoarthritis problems (excluding osteoarthritis of 
the back), and for new osteoarthritis problems (see Glossary). Changes in ordering over time 
between April 2002–March 2005 (Period 1) and April 2009–March 2012 (Period 2) are 
reported. 
6.1 All osteoarthritis problems 
Table 6.1 shows there was a marginal decrease in the management rate of osteoarthritis 
problems per 100 encounters between Period 1 and Period 2. However, when extrapolated, 
there was a significant increase in the estimated annual encounters involving osteoarthritis 
problems nationally, from 2.9 million encounters (95% CI: 2.8–3.0) in Period 1 to 3.4 million 
(95% CI: 3.3–3.5) in Period 2. This was due to the increased number of GP encounters 
claimed through Medicare nationally (as described in Chapter 2). 
The rate at which imaging tests were ordered in the management of osteoarthritis problems 
increased significantly over time. In Period 1, there were 8,857 osteoarthritis problems 
managed, and at least one imaging test was ordered for 1,099 of these (12.4% likelihood). A 
total of 1,264 imaging tests were ordered at a rate of 14.3 imaging tests per 100 osteoarthritis 
problems managed.  
In Period 2, there were 8,329 osteoarthritis problems managed, and GPs ordered at least one 
imaging test for 1,333 of these (16.0% likelihood). A total of 1,537 imaging tests were ordered 
at a rate of 18.5 tests per 100 osteoarthritis problems managed. Osteoarthritis problems 
contributed to 4.8% of total imaging orders generated for all problems in Period 1 and 5.1% 
in Period 2 (see Table 4.4).  
These results, combined with the increased GP visit rate, suggest that in Period 1, an average 
410,000 imaging tests were ordered by GPs nationally per year for osteoarthritis, and an 
average 630,000 per year in Period 2, about 220,000 more than in Period 1. 
In summary, despite the small but significant decrease in the management rate of 
osteoarthritis problems (by 6.7%) the imaging order rate significantly increased (by 29.4%, 
from 14.3 to 18.5 per 100 osteoarthritis problems managed) over the time period. As there 
was no change in the number of tests ordered per problem when ordering occurred (1.15 
tests per tested problem in both periods) this increase in the imaging order rate by GPs can 
be solely attributed to the increased likelihood (29.0%) of ordering at least one imaging test. 
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Table 6.1: Osteoarthritis problem management generating GP imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total osteoarthritis problems managed 8,857  8,329 
Management rate per 100 encounters (95% CI) 3.0 
(2.9–3.1) 
 2.8 
(2.8–2.9) 
Osteoarthritis problems for which at least one imaging test ordered (n) 1,099  1,333 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 12.4  
(11.7–13.2) 
 16.0  
(15.1–16.9) 
Total imaging orders generated for osteoarthritis problems (n) 1,264  1,537 
Imaging orders per 100 osteoarthritis problems (95% CI) 14.3  
(13.4–15.2) 
 18.5  
(17.4–19.5) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. For a list of inclusions refer to Appendix 5, 
Table A5.1. 
Age-specific and sex-specific management  
In both data periods the sex-specific likelihood of management of osteoarthritis problems 
was significantly higher at encounters with females than at those with males. Between 
Period 1 and Period 2, the likelihood of management marginally decreased for males and did 
not change for females. However, the sex-specific imaging ordering rates for both sexes 
increased significantly, with the trend for test order rates to be higher for males than females. 
On further investigation, this was not due to more tests being ordered per visit for males 
with osteoarthritis, but rather a greater likelihood of them having an imaging test ordered, 
perhaps because males visit the GP less often than females. 
The majority of patients for whom osteoarthritis problems were managed were aged 65 years 
or older in both data periods. There was a marginal decrease in the age-specific likelihood of 
management among those aged 25–44 years, and significant decreases for those aged 46–64 
years, and 65–74 years. 
Despite a marginal decrease in the overall management of osteoarthritis problems, the 
imaging ordering rate increased significantly, from 14.3 per 100 encounters to 18.5 per 100. 
Significant increases were noted at encounters with patients aged 45–64 years, and 65–74 
years (Table 6.2). 
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Table 6.2: Age-specific and sex-specific likelihood of management and test order rate for 
osteoarthritis problems, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Patient 
characteristic(a) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 3,208 2.7 
(2.6–2.8) 
15.7 
(14.2–17.2) 
 2,936 2.5 
(2.4–2.6) 
20.1 
(18.4–21.9) 
 Females 5,537 3.2 
(3.1–3.3) 
13.5 
(12.4–14.6) 
 5,282 3.1 
(2.9–3.2) 
17.5 
(16.3–18.7) 
Age        
 <15 years 21 0.1 
(0.0–0.1) 
33.3 
(0.1–66.6) 
 8 0.0 
(—) 
12.5 
(0.0–42.1) 
 15–24 years 38 0.1 
(0.1–0.2) 
15.8 
(3.6–27.9) 
 24 0.1 
(0.1–0.1) 
20.8 
(3.1–38.6) 
 25–44 years 496 0.7 
(0.6–0.8) 
23.0 
(18.4–27.5) 
 377 0.6 
(0.5–0.6) 
27.3 
(21.9–32.7) 
 45–64 years 3,104 3.9 
(3.7–4.1) 
16.9 
(15.3–18.5) 
 2,817 3.5 
(3.4–3.6) 
23.3 
(21.5–25.1) 
 65–74 years 2,361 6.7 
(6.4–7.0) 
14.4 
(12.8–16.0) 
 2,182 5.8 
(5.6–6.1) 
19.2 
(17.3–21.1) 
 75+ years 2,738 6.5 
(6.3–6.8) 
9.2 
(7.9–10.5) 
 2,824 6.1 
(5.9–6.4) 
11.9 
(10.4–13.3) 
Total  8,829 3.0 
(2.9–3.1) 
14.3  
(13.4–15.2) 
 8,299 2.8 
(2.7–2.9) 
18.5  
(17.4–19.5) 
(a) Missing data removed: 2002–05 n=71 (age), n=84 (sex); 2009–12 n=67 (age), n=81 (sex).  
(b) Number of encounters with at least one osteoarthritis problem managed at encounter. It is possible for more than one of the specified 
problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 6.1). 
Note: CI – confidence interval. (—) – indicates the number of cases was too small to calculate a confidence interval. Highlighting indicates a 
significant difference between data periods. 
Changes over time in imaging test types ordered 
In both Period 1 and Period 2, diagnostic radiology was by far the predominant test group 
(Table 6.3). Although diagnostic radiology orders accounted for significantly greater 
proportion of imaging tests ordered for osteoarthritis in Period 1 (92.6%) than in Period 2 
(88.9%), the order rate of diagnostic radiology increased significantly over the time period, 
from 13.2 to 16.4 per 100 osteoarthritis problems. A significant increase was noted for x-ray 
of the knee, marginal increase for hand x-rays, and significant decrease for hip x-rays. 
Ultrasound orders doubled from 0.6 per 100 osteoarthritis problems in Period 1 to 1.2 in 
Period 2. This was mostly related to a marginal increase in orders for ultrasound of the knee.  
MRI orders significantly increased, both as a proportion of all imaging tests for osteoarthritis 
and in the rate per 100 osteoarthritis problems, however, the numbers of these tests were 
small and the results should be interpreted with caution. 
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Table 6.3: Imaging test orders by MBS test group and the most frequent individual tests ordered for 
osteoarthritis problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI)  
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI) 
Diagnostic radiology 1,170 92.6 
(91.1–94.1) 
13.2 
(12.4–14.1)  
1,366 88.9 
(87.2–90.5) 
16.4 
(15.4–17.4) 
 X-ray; knee 471 37.3 
(34.5–40) 
5.3 
(4.8–5.8)  
581 37.8 
(35.4–40.2) 
7.0 
(6.4–7.5) 
 X-ray; hip 247 19.5 
(17.4–21.6) 
2.8 
(2.4–3.1)  
265 17.2 
(15.4–19.1) 
1.0 
(0.8–1.3) 
 X-ray; foot/feet 72 5.7 
(4.4–7.0) 
0.8 
(0.6–1.0)  
83 5.4 
(4.3–6.5) 
1.0 
(0.8–1.2) 
 X-ray; hand 55 4.4 
(3.2–5.5) 
0.6 
(0.5–0.8)  
87 5.7 
(4.5–6.9) 
1.0 
(0.8–1.3) 
 X-ray; shoulder 54 4.3 
(3.2–5.4) 
0.6 
(0.4–0.8)  
54 3.5 
(2.6–4.4) 
0.6 
(0.5–0.8) 
 X-ray; ankle 48 3.8 
(2.7–4.9) 
0.5 
(0.4–0.7)  
52 3.4 
(2.5–4.3) 
0.6 
(0.5–0.8) 
Ultrasound 52 4.1 
(3.0–5.2) 
0.6 
(0.4–0.7)  
98 6.4 
(5.1–7.6) 
1.2 
(0.9–1.4) 
 Ultrasound; shoulder 18 1.4 
(0.8–2.1) 
0.2 
(0.1–0.3)  
30 2.0 
(1.3–2.6) 
0.4 
(0.2–0.5) 
 Ultrasound; knee 11 0.9 
(0.4–1.4) 
0.1 
(0.1–0.2)  
23 1.5 
(0.9–2.1) 
0.3 
(0.2–0.4) 
 Ultrasound; hip N/Av — — 
 
16 1.0 
(0.4–1.6) 
0.2 
(0.1–0.3) 
Computerised 
tomography 
25 2.0 
(1.2–2.8) 
0.3 
(0.2–0.4)  
35 2.3 
(1.5–3.0) 
0.4 
(0.3–0.6) 
Magnetic resonance 
imaging 
4 0.3 
(0.0–0.7) 
0.0 
(0.0–0.1)  
26 1.7 
(1.0–2.4) 
0.3 
(0.2–0.4) 
Nuclear medicine 
imaging 
13 1.0 
(0.5–1.6) 
0.1 
(0.1–0.2)  
12 0.8 
(0.3–1.3) 
0.1 
(0.1–0.2) 
Total imaging tests 1,264 100.0 14.3 
(13.4–15.2)  
1,537 100.0 18.5 
(17.4–19.5) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule. Highlighting indicates a significant difference between data periods. 
Imaging test ordering rates by status of osteoarthritis problem 
Table 6.4 shows the proportions of osteoarthritis problems managed that were new cases (i.e. 
first presentation to a medical practitioner), and those that were old (i.e. managed 
previously) in both data periods. More than 80% GP contacts were follow-up of previously 
diagnosed osteoarthritis problems, in both Period 1 and Period 2. The management rate of 
new osteoarthritis problems increased over time (17.1 per 100 osteoarthritis problems to 19.8 
per 100), with a corresponding significant decrease in the management rate of old problems. 
In both data periods, the imaging order rate was much higher at initial presentations (38.0 
per 100 osteoarthritis problems in Period 1 and 44.0 per 100 in Period 2) than at follow-up 
consultations (9.4 per 100 in Period 1 and 12.1 per 100 in Period 2). Despite the decrease in 
management of old osteoarthritis problems, both the imaging ordering rate and the 
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likelihood of ordering imaging tests significantly increased between Period 1 and Period 2, 
for both new and old osteoarthritis problems. 
These results, combined with the increased GP visit rate, suggest that in Period 1, an 
estimated average 190,000 imaging orders were placed nationally per year by GPs for new 
osteoarthritis problems. In Period 2, about 300,000 imaging tests per year were ordered, 
about 110,000 more per year than in Period 1. 
Similarly, in Period 1, an estimated average 230,000 imaging orders were placed nationally 
by GPs per year for old osteoarthritis problems. In Period 2, about 330,000 imaging tests 
were ordered on average per year, or about 100,000 more per year than in Period 1. 
In summary, as there was no change in the number of imaging tests ordered per tested new 
osteoarthritis problem (1.15 per tested problem in Period 1 and 1.14 in Period 2) the 
increased imaging order rate for new osteoarthritis appears to be a result of the 16% increase 
in the management rate of new problems and the increased likelihood (29%) of GPs ordering 
an imaging test when managing new osteoarthritis problems.  
As the management rate of old osteoarthritis problems decreased and there was no change in 
the number of tests ordered per tested problem (1.16 in both periods), the increase in the 
imaging order rate per 100 problems managed was due to increased likelihood of ordering 
imaging tests for old osteoarthritis problems. 
Table 6.4: Imaging ordering rates by status of osteoarthritis problems, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 1,513 7,344 8,857  1,650 6,679 8,329 
Per cent of osteoarthritis problems 17.1 
(16.2–18.0) 
82.9 
(82.0–83.8) 
100.0  19.8 
(18.8–20.0) 
80.2 
(79.2–81.2) 
100.0 
Total imaging orders generated for 
problems (n) 
575 689 1,264  726 811 1,537 
Imaging orders per 100 problems 
(95% CI) 
38.0 
(35.0–41.0) 
9.4 
(8.6–10.2) 
14.3 
(13.4–15.2) 
 44.0 
(41.0–47.0) 
12.1 
(11.2–13.1) 
18.5 
(17.4–19.5) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
33.2 
(30.8–35.7) 
8.1 
(7.5–8.8) 
12.4 
(11.7–13.2) 
 38.5 
(36.0–41.0) 
10.5 
(9.7–11.2) 
16.0 
(15.1–16.9) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
6.2 New osteoarthritis problems 
Age-specific and sex-specific management 
In both data periods, the sex-specific likelihood of management for new osteoarthritis was 
similar for males and females, and increased marginally for male patients over time. There 
were no significant differences in the sex-specific imaging test order rates for either male or 
female patients in either data period. 
The age-specific rates show that the majority of patients for whom new osteoarthritis 
problems were managed were aged 45 years and over. There was a marginal increase in the 
likelihood of management for patients aged 65–74 years between Period 1 and Period 2. 
While there was a marginal increase in the overall imaging order rate, the age-specific order 
rate did not change for any individual age group (Table 6.5).  
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Table 6.5: Age-specific and sex-specific likelihood of management and test order rate for new 
osteoarthritis problems, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 552 0.5 
(0.4–0.5) 
41.5 
(36.5–46.5) 
 626 0.5 
(0.5–0.6) 
47.6 
(42.7–52.5) 
 Females 945 0.5 
(0.5–0.6) 
36.0 
(32.3–39.8) 
 1,010 0.6 
(0.5–0.6) 
41.8 
(38.1–45.5) 
Age        
 <15 years 8 0.0 
(—) 
75.0 
(0.0–161.5) 
 2 0.0 
(—) 
0.0 
(—) 
 15–24 years 16 0.1 
(0.0–0.1) 
18.8 
(0.0–40.2) 
 10 0.0 
(0.0–0.1) 
30.0 
(0.0–64.6) 
 25–44 years 147 0.2 
(0.2–0.2) 
39.5 
(30.1–48.8) 
 106 0.2 
(0.1–0.2) 
41.5 
(31.2–51.8) 
 45–64 years 685 0.9 
(0.8–1.0) 
42.6 
(38.0–47.1) 
 699 0.9 
(0.8–1.0) 
47.5 
(43.1–51.9) 
 65–74 years 356 1.0 
(0.9–1.1) 
34.6 
(28.8–40.3) 
 470 1.3 
(1.1–1.4) 
44.9 
(39.2–50.6) 
 75+ years 289 0.7 
(0.6–0.8) 
30.1 
(24.0–36.3) 
 349 0.8 
(0.7–0.8) 
37.5 
(31.3–43.8) 
Total  1,512 0.5 
(0.5–0.5) 
38.0 
(35.0–41.0) 
 726 0.6 
(0.5–0.6) 
44.0 
(41.0–47.0) 
(a) Missing data removed: 2002–05 n=11 (age), n=15 (sex); 2009–12 n=10 (age), n=10 (sex). 
(b) Number of encounters with at least one new osteoarthritis problem managed at encounter. It is possible for more than one of the specified 
problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 6.4). 
Note: CI – confidence interval; (—) – indicates the number of cases was too small to calculate a confidence interval. Highlighting indicates a 
significant difference between data periods. 
Changes in imaging test types ordered 
Between Period 1 and Period 2, there were very few changes in the distribution of test orders 
across MBS groups. Diagnostic radiology was the predominant test group in both data 
periods, accounting for similar proportions of all imaging tests and having similar imaging 
rates in both Period 1 and Period 2. There were no changes in either the proportions of other 
test types, or in their order rates (Table 6.6).  
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Table 6.6: Imaging test orders by MBS test group and the most frequent individual tests ordered for 
new osteoarthritis problem, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI)  
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI) 
Diagnostic radiology 541 94.1 
(92.2–96.0) 
35.8 
(32.8–38.7) 
 677 93.3 
(91.4–95.1) 
41.0 
(38.2–43.9) 
 X-ray; knee 222 38.6 
(34.5–42.7) 
14.7 
(12.8–16.5) 
 276 38.0 
(34.5–41.5) 
16.7 
(14.9–18.5) 
 X-ray; hip 110 19.1 
(16.0–22.3) 
7.3 
(5.9–8.6) 
 133 18.3 
(15.6–21.1) 
8.1 
(6.7–9.4) 
 X-ray; foot/feet 49 8.5 
(6.2–10.8) 
3.2 
(2.3–4.1) 
 45 6.2 
(4.5–7.9) 
2.7 
(2.0–3.5) 
Ultrasound 24 4.2 
(2.6–5.8) 
1.6 
(1.0–2.2) 
 31 4.3 
(2.8–5.7) 
1.9 
(1.2–2.6) 
Computerised tomography 5 0.9 
(0.1–1.6) 
0.3 
(0.0–0.6) 
 8 1.1 
(0.3–1.9) 
0.2 
(0.0–0.5) 
Magnetic resonance 
imaging 
1 0.2 
(—) 
0.1 
(—) 
 6 0.8 
(0.2–1.5) 
0.4 
(0.1–0.7) 
Nuclear medicine 4 0.7 
(0.0–1.4) 
0.3 
(0.0–0.5) 
 4 0.6 
(0.0–1.1) 
0.2 
(0.0–0.5) 
Total imaging tests 575 100.0 38.0 
(35.0–41.0) 
 726 100.0 44.0 
(41.0–47.0) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. 
6.3 Summary of findings 
Changes over time 
The overall management rate of osteoarthritis problems decreased over time. New cases 
accounted for a larger proportion of osteoarthritis problems in Period 2 than in Period 1. The 
imaging order rate increased over time in the management of all osteoarthritis problems, due 
solely to the increased likelihood that imaging was ordered (Table 6.7). Diagnostic radiology 
was the predominant test group in both data periods, and its ordering rate increased over 
time. Ordering rates of ultrasound and MRI also increased over time, but these test types 
were ordered in much smaller numbers.  
Table 6.7: Summary of changes over time for osteoarthritis 
Osteoarthritis 
Management rate  
(% change, rate)(a) 
Likelihood of 
testing  
(% change, rate)(a) 
Ordering rate per 
100 problems 
(% change, rate)(a) 
Number of tests ordered 
per tested problem 
(% change, rate)(a) 
All  ↓ 6.7% 
(3.0, 2.8) 
↑ 29.0% 
(12.4, 16.0) 
↑ 29.4% 
(14.3, 18.5) 
No change 
(1.15, 1.15) 
 New ↑ 15.8% 
(0.5, 0.6) 
↑ 16.0% 
(33.2, 38.5) 
↑ 15.8% 
(38.0, 44.0) 
No change 
(1.15, 1.14) 
(a) Direction and proportion of change between 2002–05 and 2009–12. The management rate for Period 1 and Period 2, used to calculate the 
proportion of change, is shown in parentheses. 
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Current imaging test order patterns 
In recent practice, new cases accounted for one-fifth of all contacts involving management of 
osteoarthritis, but they were four times more likely to result in an imaging order than 
previously diagnosed cases.  
Diagnostic radiology tests were the most common tests ordered, accounting for almost 90% 
of imaging ordered. On those occasions where ultrasound, CT scan or MRI was ordered, 
there was no difference in the rate at which these tests were ordered for new problems or 
those previously managed (Table 6.8). 
Table 6.8: Summary of GP imaging ordering for osteoarthritis, Period 2, 2009–12 
OA  
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%)  
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem contacts 
(95% CI) 
Diagnostic 
radiology US CT scan MRI 
All 2.8 
(2.8–2.9) 
16.0 
(15.1–16.9) 
1.15 18.5 
(17.4–19.5) 
16.4 
(15.4–17.4) 
1.2 
(0.9–1.4) 
0.4 
(0.3–0.6) 
0.3 
(0.2–0.4) 
 New  0.6 
(0.5–0.6) 
38.5 
(36.0–41.0) 
1.14 44.0 
(41.0–47.0) 
41.0 
(38.2–43.9) 
1.9 
(1.2–2.6) 
0.2 
(0.0–0.5) 
0.4 
(0.1–0.7) 
 Old  2.3 
(2.2–2.4) 
10.5 
(9.7–11.2) 
1.16 12.1 
(11.2–13.1) 
10.3 
(9.5–11.2) 
1.0 
(0.8–1.3) 
0.4 
(0.3–0.6) 
0.3 
(0.2–0.4) 
Note: OA – osteoarthritis; CI – confidence interval; US – ultrasound; CT – computerised tomography; MRI – magnetic resonance imaging.  
6.4 Summary of guidelines for imaging for 
osteoarthritis 
An extensive review of guidelines for diagnostic imaging was undertaken using Medline, 
and national and international sources of guidelines such as the National Health and 
Medical Research Council (NHMRC), the United States Agency for Healthcare Research and 
Quality (AHRQ), the UK National Institute for Health and Care Excellence (NICE); and local 
and overseas colleges of radiology/radiologists. 
The final group of guidelines considered for this section of this report were: Government of 
Western Australia Department of Health (WADoH) Diagnostic Imaging Pathways17 (these 
guidelines could be considered as the successor of the now obsolete Royal Australian and 
New Zealand College of Radiologists [RANZCR] Imaging Guidelines 2001,19 and are 
endorsed by the RANZCR), the American College of Radiology Appropriateness Criteria 
(ACRAC),24 and the NHMRC guidelines distributed by the Royal Australian College of 
General Practitioners.33,34 
Osteoarthritis is a common disease in Australia and costs 1 to 2.5% of gross national 
product.79 The frequency of ordering of imaging for osteoarthritis problems is relatively low 
at 18.5 per 100 problems. However due to the high prevalence and management frequency of 
osteoarthritis, it was second only to back problems in its contribution to the total number of 
imaging orders by GPs. While diagnostic guidelines exist for painful hips and knees, there 
are few reports of research into the use of radiology to measure progress and outcomes of 
osteoarthritis.  
All guidelines suggest that plain x-ray (preferably weight bearing) is the investigation of 
choice for assessment of non-traumatic joint pain where osteoarthritis is suspected. MRI may 
be indicated in a small number of situations, including assessment for surgery. 
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6.5 Compliance with guidelines 
Compliance with current guidelines is reported only for the 2009–12 period as current 
guidelines are not applicable to the first study sample. 
The majority of osteoarthritis problems seen in general practice are labelled at the level of 
‘Arthritis’ or ‘Osteoarthritis’ rather than as arthritis of specific joints, as multiple joints are 
frequently involved. Therefore compliance with guidelines can only be assessed at the upper 
level of imaging modality. 
The use of imaging other than diagnostic radiology is rare in the assessment of osteoarthritis 
problems. Ultrasound is used occasionally and MRI very rarely, possibly because the MBS 
rules limit GP ordering of MRI studies. 
Diagnostic radiology was ordered at the rate of 16.4 per 100 contacts with all osteoarthritis 
problems and 41.0 per 100 new osteoarthritis problems. This rate of ordering is consistent 
with the use of radiology in initial diagnosis, and more limited use in assessing progress and 
outcomes. Ordering of imaging for osteoarthritis by general practitioners appears consistent 
with existing guidelines. 
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7 Shoulder problems 
This chapter investigates imaging orders for shoulder problems, recorded by GPs from April 
2002–March 2005 (Period 1) to April 2009–March 2012 (Period 2). Throughout the chapter, 
‘shoulder problems’ include all problems of the shoulder excluding arthritis/osteoarthritis of 
the shoulder. As reported at the beginning of Section 2, GP imaging orders for shoulder 
problems were selected for investigation because there had been a statistically significant 
increase over time in the likelihood of GPs’ ordering imaging for this indication.  
Based on the rationale that guidelines recommend different management of shoulder 
problems depending on their status as a symptom/complaint or as a defined condition (see 
Chapter 2), shoulder problems were grouped and categorised as: 
• ‘shoulder symptom/complaint (all)’ 
• ‘shoulder syndrome (all)’.  
The full list of ICPC-2 rubrics and ICPC-2 PLUS codes and terms included in each group are 
provided in Appendix 5, Table A5.1.  
Imaging orders are investigated for: 
• all shoulder problems 
• all shoulder problems grouped as ‘shoulder syndrome’ 
• new problems grouped as ‘shoulder syndrome’ 
• all shoulder problems grouped as ‘shoulder symptom/complaint’ 
• new problems grouped as ‘shoulder symptom/complaint’. 
Changes in ordering over time between Period 1 and Period 2 are reported. 
7.1 All shoulder problems 
Table 7.1 shows the total number of shoulder problems managed, and the distribution of the 
shoulder problems across shoulder syndrome and shoulder symptoms/complaints in 
Period 1 and Period 2.  
While the management rate for shoulder symptom/complaint did not change between the 
two data periods, the management rate for shoulder syndrome increased marginally, from 
0.5 to 0.7 per 100 encounters. In both data periods, shoulder syndrome accounted for around 
three-quarters of all shoulder problems, and shoulder symptoms/complaints for the 
remaining quarter.  
The management rate of total shoulder problems per 100 encounters significantly increased 
over the time period, resulting in a significant increase in the estimated annual encounters 
involving shoulder problems nationally. These increased by 368,000, from 0.71 million 
encounters (95% CI: 0.67–0.74) in Period 1 to 1.08 million (95% CI: 1.03–1.13) in Period 2. This 
is due to a combination of the increased management rate and increased GP visit rate. 
 
  
64
  
 
Table 7.1: Shoulder problems managed by problem type, 2002–05 and 2009–12 
Shoulder problems(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
problems 
Per cent of 
shoulder 
problems 
Per 100 
encounters 
(95% CI)  
Number of 
problems 
Per cent of 
shoulder 
problems 
Per 100 
encounters 
(95% CI) 
Shoulder syndrome  1,556 72.0 0.5 
(0.5–0.6) 
 1,988 75.4 0.7 
(0.6–0.7) 
Shoulder 
symptom/complaint 
605 28.0 0.2 
(0.2–0.2) 
 649 24.6 0.2  
(0.2–0.2) 
Total shoulder problems 2,161 100.0 0.7 
(0.7–0.8)  
2,637 100.0 0.9 
(0.9–0.9) 
(a) For a list of inclusions refer to Appendix 5, Table A5.1. 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Table 7.2 shows that the rate at which imaging tests were ordered in the management of 
shoulder problems increased significantly over time. In 2002–05, there were 2,161 shoulder 
problems managed, and at least one imaging test was ordered for 524 of these (24.2% 
likelihood). A total of 703 imaging test orders were placed, at a rate of 32.5 tests per 100 
shoulder problems managed. 
In 2009–12, there were 2,637 shoulder problems managed, and GPs ordered at least one 
imaging test for 876 of these (33.2% likelihood). A total of 1,173 imaging test orders were 
placed at a rate of 44.5 imaging tests per 100 shoulder problems managed. Shoulder 
problems contributed a larger proportion of total imaging orders generated for all problems, 
increasing from 2.7% in Period 1 to 3.9% in Period 2 (see Table 4.4). 
These results, combined with the increased GP visit rate, suggest that nationally in Period 1, 
about 230,000 imaging orders were placed per year by GPs in the management of shoulder 
problems. In Period 2, there were about 480,000 imaging orders placed per year, or 250,000 
more per year than in Period 1. 
In summary, there was a 37% increase in the imaging ordering rate for all shoulder problems 
between Period 1 and Period 2. As the average number of tests per tested shoulder problem 
did not change (1.3 tests per tested problem in both periods), the increase in ordering is a 
result of the increased management rate (by 23%), the increased likelihood (by 37%) of 
ordering an imaging test when shoulder problems were managed, and the increased visit 
rate to GPs. 
Table 7.2: Shoulder problem management generating GP imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total shoulder problems managed 2,161  2,637 
Shoulder problems for which at least one imaging test ordered (n) 524  876 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 24.2 
(22.3–26.2) 
 33.2 
(31.3–35.2) 
Total imaging orders generated for shoulder problems (n) 703  1,173 
Imaging orders per 100 shoulder problems (95% CI) 32.5 
(29.7–35.4) 
 44.5 
(41.7–47.3) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
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Age-specific and sex-specific management of shoulder problems 
The likelihood of management of shoulder problems increased significantly over time, from 
0.7% to 0.9% of encounters. In both data periods, the likelihood of management was 
marginally higher at encounters with males than at those with females. Between Period 1 
and Period 2, there was a marginal increase in likelihood of management at encounters with 
males, and a significant increase at encounters with females. 
Patients aged between 45 and 64 years had the highest likelihood of management for 
shoulder problems in both data periods, and this increased significantly from 1.2% to 1.5%. 
There was also a marginal increase in management among patients aged 75 years and over, 
from 0.7% to 0.9%. 
The imaging order rate for shoulder problems significantly increased between Period 1 and 
Period 2, from 32.5 to 44.5 tests per 100 shoulder problems. The sex-specific imaging test 
order rates for shoulder problems significantly increased for both males (33.4 to 44.4 per 100 
shoulder problems) and females (32.0 to 44.4 per 100). The age-specific imaging ordering 
rates for shoulder problems significantly increased for the 45–64 and 65–74 year age groups, 
by 41% in the former and 56% in the latter. 
Table 7.3: Age-specific and sex-specific management of shoulder problems, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Patient 
characteristic(a) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 954 0.8 
(0.7–0.9) 
33.4 
(29.5–37.3) 
 1,175 1.0 
(0.9–1.1) 
44.4 
(40.2–48.5) 
 Females 1,183 0.7 
(0.6–0.7) 
32.0 
(28.3–35.8) 
 1,430 0.8 
(0.8–0.9) 
44.4 
(40.7–48.1) 
Age        
 <15 years 13 0.0 
(0.0–0.1) 
30.8 
(1.7–59.8) 
 21 0.1 
(0.0–0.1) 
66.7 
(33.4–99.9) 
 15–24 years 96 0.3 
(0.3–0.4) 
36.5 
(23.7–49.2) 
 93 0.4 
(0.3–0.5) 
54.8 
(40.2–69.5) 
 25–44 years 464 0.6 
(0.6–0.7) 
36.2 
(30.1–42.3) 
 434 0.7 
(0.6–0.7) 
44.3 
(37.7–50.8) 
 45–64 years 933 1.2 
(1.1–1.3) 
31.6 
(27.6–35.5) 
 1,242 1.5 
(1.5–1.6) 
44.7 
(40.8–48.6) 
 65–74 years 338 1.0 
(0.9–1.1) 
30.1 
(23.5–36.7) 
 431 1.2 
(1.0–1.3) 
47.0 
(40.1–53.9) 
 75+ years 297 0.7 
(0.6–0.8) 
32.0 
(24.3–39.7) 
 391 0.9 
(0.8–0.9) 
38.9 
(32.1–45.7) 
Total  2,159 0.7  
(0.7–0.8) 
32.5 
(29.7–35.4) 
 2,629 0.9 
(0.9–0.9) 
44.5 
(41.7–47.3) 
(a) Missing data removed: 2002–05 n=18 (age), n=22 (sex); 2009–12 n=17 (age), n=24 (sex). 
(b) Number of encounters with at least one shoulder problem managed at encounter. It is possible for more than one of the specified problem to 
be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 7.2). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
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Changes over time in imaging test types ordered 
Between Period 1 and Period 2, there was a move away from diagnostic radiology toward 
ultrasound and CT. Table 7.4 shows: 
• diagnostic radiology accounted for a significantly greater proportion of imaging tests 
ordered for shoulder problems in Period 1 (44.8%) than in Period 2 (32.1%)  
• a marginal decrease in diagnostic radiology orders per 100 shoulder problems managed, 
from 17.6 to 14.3 per 100 shoulder problems managed 
• ultrasound orders significantly increased from 17.6 to 28.9 per 100 shoulder problems, 
particularly ultrasound of the shoulder, which increased from 17.4 to 28.5 per 100 
shoulder problems 
• CT orders increased marginally from 0.2 to 0.8 per 100 shoulder problems managed 
• the number of MRI orders increased over time. However, the numbers were small and 
the results should be interpreted with caution. 
Table 7.4: Imaging tests ordered by MBS test group and the most frequent imaging tests ordered 
for shoulder problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 315 44.8 
(41.7–47.9) 
17.6 
(15.8–19.3) 
 377 32.1 
(30.0–34.3) 
14.3 
(12.8–15.8) 
 X-ray; shoulder 281 40.0 
(37.2–42.8) 
13.0 
(11.5–14.5) 
 341 29.1 
(27.1–31.1) 
12.9 
(11.6–14.3) 
 X-ray; chest 10 1.4 
(0.6–2.3) 
0.5 
(0.2–0.7) 
 8 0.7 
(0.2–1.1) 
0.3 
(0.1–0.5) 
Ultrasound  380 54.1 
(51.0–57.1) 
17.6 
(15.8–19.3) 
 762 65.0 
(62.7–67.2) 
28.9 
(27.0–30.8) 
 Ultrasound; shoulder 376 53.5 
(50.4–56.5) 
17.4 
(15.7–19.1) 
 751 64.0 
(61.8–66.3) 
28.5 
(26.6–30.3) 
Computerised tomography  4 0.6 
(0.0–1.1) 
0.2 
(0.0–0.4) 
 21 1.8 
(1.0–2.6) 
0.8 
(0.4–1.2) 
Magnetic resonance imaging 2 0.3 
(—) 
0.1 
(—) 
 13 1.1 
(0.5–1.8) 
0.5 
(0.2–0.8) 
Nuclear medicine 2 0.3 
(—) 
0.1 
(—) 
 0 0.0 
(—) 
0.0 
(—) 
Total imaging tests 703 100.0 35.2 
(29.7–35.4)  
1,173 100.0 44.5 
(41.7–47.3) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
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7.2 Shoulder syndrome 
Table 7.5 shows that the rate at which imaging tests were ordered in the management of 
shoulder syndrome increased significantly over time. In 2002–05, there were 1,566 shoulder 
syndrome problems managed, and at least one imaging test was ordered for 342 of these 
(22.0% likelihood). A total of 461 imaging test orders were placed, at a rate of 29.6 imaging 
tests per 100 shoulder syndrome problems managed.  
In 2009–12, there were 1,988 shoulder syndrome problems managed, and at least one 
imaging test was ordered for 651 of these (32.7% likelihood). GPs placed a total of 860 
imaging test orders, at a rate of 43.3 per 100 shoulder syndrome problems managed.  
These results, combined with the increased GP visit rate, suggest that in Period 1, 150,000 
imaging orders were placed per year nationally by GPs in management of shoulder 
syndromes. In Period 2, about 350,000 orders were placed per year, 200,000 more per year 
than in Period 1. 
In summary, the likelihood of GPs ordering an imaging test when managing shoulder 
syndrome increased by almost 50% (from 22.0% of problems, to 32.7%). However, when they 
decided to order, the number of tests ordered per tested problem did not change (1.30 to 1.35 
tests per tested shoulder syndrome) (results not tabled). The number of imaging tests 
ordered increased by 46% (from 29.6 to 43.3 per 100 shoulder syndrome problems managed), 
and this increase was totally due to an increased likelihood of ordering. 
Table 7.5: Shoulder syndrome management generating GP imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total shoulder syndrome problems managed 1,566  1,988 
Shoulder syndrome problems for which at least one imaging 
test ordered (n) 
342  651 
Likelihood of ordering 1+ tests (per cent of problems)  
(95% CI) 
22.0 
(19.8–24.2) 
 32.7 
(30.5–35.0) 
Total imaging orders generated for shoulder syndrome 
problems (n) 
461  860 
Imaging orders per 100 shoulder syndrome problems 
(95% CI) 
29.6 
(26.4–32.8) 
 43.3 
(40.1–46.4) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Age-specific and sex-specific management of shoulder syndrome 
The likelihood of management of shoulder syndrome significantly increased over time, from 
0.5% to 0.7% of encounters, and this was apparent at encounters with both males (0.6% to 
0.7% of male encounters) and females (0.5% to 0.6% of female encounters). 
The age-specific likelihood of management significantly increased for patients aged 45–64 
years, from 0.9% to 1.2% of encounters with patients in this age group, with a marginal 
increase observed for patients aged 65–74 years (0.7% to 0.9%). 
The increase in the overall rate at which imaging tests were ordered for shoulder syndrome 
(from 29.6 to 43.3 tests per 100 problems), was apparent for both males (30.9 to 43.2 per 100) 
and females (28.7 to 43.3 per 100). The age-specific imaging ordering rates significantly 
increased for patients aged 45–64 years (30.2 to 43.4 per 100 shoulder syndrome problems). 
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Table 7.6: Age-specific and sex-specific management of shoulder syndrome, 2002–05 and 2009–12  
 2002–05 (Period 1)  2009–12 (Period 2) 
Patient 
characteristic(a) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 689 0.6 
(0.5–0.6) 
30.9 
(26.3–35.4) 
 861 0.7 
(0.7–0.8) 
43.2 
(38.5–48.0) 
 Females 850 0.5 
(0.5–0.5) 
28.7 
(24.5–32.9) 
 1,102 0.6 
(0.6–0.7) 
43.3 
(39.1–47.4) 
Age        
 <15 years 7 0.0 
(—) 
42.9 
(0.0–92.3) 
 10 0.0 
(0.0–0.1) 
120.0 
(74.8–165.2) 
 15–24 years 56 0.2 
(0.1–0.3) 
32.1 
(15.7–48.6) 
 57 0.2 
(0.2–0.3) 
63.2 
(42.4–84.0) 
 25–44 years 298 0.4 
(0.4–0.5) 
31.2 
(24.0–38.4) 
 310 0.5 
(0.4–0.5) 
44.2 
(36.6–51.9) 
 45–64 years 701 0.9 
(0.8–1.0) 
30.2 
(25.7–34.7) 
 977 1.2 
(1.1–1.3) 
43.4 
(39.1–47.7) 
 65–74 years 261 0.7 
(0.6–0.8) 
29.1 
(21.6–36.6) 
 340 0.9 
(0.8–1.0) 
42.5 
(35.0–50.0) 
 75+ years 219 0.5 
(0.4–0.6) 
25.6 
(17.2–34.0) 
 276 0.6 
(0.5–0.7) 
36.6 
(28.8–44.4) 
Total  1,555 0.5 
(0.5–0.6) 
29.6 
(26.4–32.8) 
 1,981 0.7 
(0.6–0.7) 
43.3 
(40.1–46.4) 
(a) Missing data removed: 2002–05 n=13 (age), n=16 (sex); 2009–12 n=11 (age), n=18 (sex).  
(b) Number of encounters with at least one shoulder syndrome problem managed at encounter. It is possible for more than one of the specified 
problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 7.5). 
Note: CI – confidence interval. (—) – indicates the number of cases was too small to calculate a confidence interval. Highlighting indicates a 
significant difference between data periods. 
Changes over time in imaging test types ordered 
Table 7.7 shows there were considerable changes in the distribution of test orders across MBS 
groups. Over the time period, there was a general move away from diagnostic radiology as a 
proportion of tests for shoulder syndrome, although the rate of ordering these tests per 100 
shoulder syndrome problems did not change. Between Period 1 and Period 2 the order rate 
for ultrasound significantly increased from 17.4 to 30.1 per 100 shoulder syndrome problems 
managed, particularly ultrasound of the shoulder, which increased from 17.2 to 29.7 per 100 
shoulder syndrome problems. 
The number of orders for CT and MRI increased, however the numbers for both were very 
small and results should be interpreted with caution. 
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Table 7.7: Imaging test orders by MBS test group and the most frequent individual tests ordered for 
shoulder syndrome, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 187 40.6 
(36.8–44.3) 
12.0 
(10.2–13.8) 
 244 28.4 
(25.9–30.8) 
12.3 
(10.7–13.8) 
 X-ray; shoulder 172 37.3 
(33.9–40.7) 
11.1 
(9.4–12.7) 
 225 26.2 
(23.9–28.5) 
11.3 
(9.9–12.8) 
Ultrasound 271 58.8 
(55.1–62.5) 
17.4 
(15.4–19.4) 
 598 69.5 
(67.1–72.0) 
30.1 
(27.9–32.2) 
 Ultrasound; shoulder 268 58.1 
(54.5–61.8) 
17.2 
(15.2–19.2) 
 590 68.6 
(66.1–71.1) 
29.7 
(27.6–31.8) 
Computerised tomography 2 0.4 
(—) 
0.1 
(—) 
 10 1.2 
(0.4–1.9) 
0.5 
(0.2–0.8) 
Magnetic resonance imaging 1 0.2 
(—) 
0.1 
(—) 
 8 0.9 
(0.3–1.6) 
0.4 
(0.1–0.7) 
Nuclear medicine 0 0.0 
(—) 
0.0 
(—) 
 0 0.0 
(—) 
0.0 
(—) 
Total imaging tests 461 100.0 29.6 
(26.4–32.8) 
 860 100.0 43.3 
(40.1–46.4) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
Imaging test ordering rates by status of shoulder syndrome 
Table 7.8 shows the proportions of contacts generating an imaging order for new and old 
shoulder syndrome problems in both data periods. Approximately 60% of GP contacts were 
for previously diagnosed shoulder syndrome problems, in both 2002–05 and 2009–12.  
In both data periods, the likelihood of ordering and the imaging order rate for all shoulder 
syndrome problems were nearly three times higher at initial presentations (47.6 orders per 
100 shoulder syndrome problems in Period 1 and 67.4 per 100 in Period 2) than at follow-up 
consultations (17.0 orders per 100 shoulder syndrome problems in Period 1 and 26.1 per 100 
in Period 2). Both the imaging order rate and the likelihood of ordering at least one imaging 
test per 100 new and old shoulder syndrome problems, increased significantly over time. 
These results, combined with the increased GP visit rate, suggest that nationally in Period 1, 
GPs ordered about 100,000 imaging orders per year in management of new shoulder 
syndrome problems. In Period 2, there were about 230,000 imaging orders placed per year, 
130,000 test orders per year more than in Period 1. Similarly, in Period 1, on average each 
year about 50,000 imaging orders were placed nationally by GPs for the management of old 
shoulder syndrome problems. In Period 2, there were about 120,000 imaging orders placed 
per year, about 70,000 more per year than in Period 1. 
In summary, as there was no change in the management rate between Period 1 and Period 2, 
and no change in the number of imaging tests ordered per problem, the increase in the test 
order rate for both new and old shoulder syndrome problems was due to the increased 
likelihood of ordering an imaging test when either new or old shoulder syndrome problems 
were managed. 
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Table 7.8: Imaging ordering rates by status of shoulder syndrome problems, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 643 913 1,556  827 1,161 1,988 
Per cent of shoulder syndrome 
problems 
41.3 58.7 100.0  41.6 58.4 100.0 
Total imaging orders generated for 
problems (n) 
306 155 461  557 303 860 
Imaging orders per 100 problems 
(95% CI) 
47.6  
(41.7–53.4) 
17.0  
(13.8–20.1) 
29.6  
(26.4–32.8) 
 67.4  
(61.8–72.9) 
26.1  
(22.9–29.3) 
43.3  
(40.1–46.4) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
34.5  
(30.7–38.4) 
13.1  
(10.8–15.5) 
22.0  
(19.8–24.2) 
 48.6  
(45.0–52.3) 
21.4  
(18.9–24.0) 
32.7  
(30.5–35.0) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
7.3 New shoulder syndrome 
Age-specific and sex-specific management 
The overall likelihood of management of new shoulder syndrome problems increased 
significantly between Period 1 and Period 2, from 0.2% to 0.3% of encounters. In Period 1, 
there was no difference in the sex-specific likelihood of management, but in Period 2 the 
likelihood of management was marginally higher at encounters with males (than with 
females). The sex-specific likelihood of management increased marginally for both sexes 
between Period 1 and Period 2 (Table 7.9). The age-specific likelihood of management for 
new shoulder syndrome problems increased significantly for patients in all age groups, 
except children aged <15 years. 
There were several changes observed in the rate of imaging ordered for the management of 
new shoulder syndrome problems. The sex-specific rate of imaging ordering at encounters 
with female patients increased significantly, from 43.9 to 68.7 per 100 new shoulder 
syndrome problems managed, and age-specific rates increased significantly in the 45–64 year 
age group (50.7 to 69.2 per 100) between Period 1 and Period 2. In Period 1, there were 1.36 
tests per tested problem, and in Period 2 there were 1.39 tests per tested problem.  
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Table 7.9: Age-specific and sex-specific likelihood of management and test order rate for new 
shoulder syndrome problems, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order 
rate per 100 
new problems 
(95% CI) 
 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 280 0.2 
(0.2–0.3) 
53.0 
(44.3–61.8 
 375 0.3 
(0.3–0.4) 
65.3 
(57.1–73.6) 
 Females 358 0.2 
(0.2–0.2) 
43.9 
(36.4–51.3) 
 442 0.3 
(0.2–0.3) 
68.7 
(61.3–76.1) 
Age        
 <15 years 3 0.0 
(—) 
33.3 
(0.0–176.8) 
 5 0.0 
(—) 
140.0 
(72.0–208.0) 
 15–24 years 25 0.1 
(0.1–0.1) 
60.0 
(31.3–88.7) 
 31 0.3 
(0.2–0.4) 
96.8 
(66.1–127.4) 
 25–44 years 121 0.2 
(0.1–0.2) 
47.1 
(34.1–60.1) 
 126 0.5 
(0.4–0.5) 
67.5 
(54.1–80.8) 
 45–64 years 277 0.4 
(0.3–0.4) 
50.7 
(42.0–59.5) 
 402 0.6 
(0.5–0.6) 
69.2 
(61.6–76.9) 
 65–74 years 103 0.3 
(0.2–0.4) 
47.6 
(32.4–62.8) 
 151 0.6 
(0.5–0.7) 
65.8 
(52.5–79.4) 
 75+ years 107 0.3 
(0.2–0.3) 
37.4 
(24.5–50.2) 
 107 0.4 
(0.4–0.5) 
51.4 
(36.8–66.0) 
Total  642 0.2 
(0.2–0.2) 
47.6 
(41.7–53.4) 
 825 0.3 
(0.3–0.3) 
67.4 
(61.8–72.9) 
(a) Missing data removed: 2002–05 n=6 (age), n=4 (sex); 2009–12 n=3 (age), n=8 (sex).  
(b) Number of encounters with at least one new shoulder syndrome problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 7.8). 
Note: CI – confidence interval. (—) – indicates the number of cases was too small to calculate a confidence interval. Highlighting indicates a 
significant difference between data periods. 
Changes in imaging test types ordered 
Table 7.10 shows there were considerable changes in the distribution of test ordering across 
MBS groups, and changes in ordering of specific tests between Period 1 and Period 2. 
Ultrasound was the most commonly ordered group in both data periods, accounting for two-
thirds of imaging orders for new shoulder syndrome problems in Period 2. The order rate for 
ultrasound also increased significantly, from 26.6 to 44.9 per 100 new shoulder syndrome 
problems managed.  
There was a decrease in orders for diagnostic radiology as a proportion of imaging tests 
ordered for new shoulder syndrome management, but the imaging order rate did not 
change. CT and MRI technically increased, but the numbers are too small for reliability. 
Nuclear medicine was not employed in the management of new shoulder syndrome in either 
period. 
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Table 7.10: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for new shoulder syndrome problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI)  
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI) 
Diagnostic radiology 134 43.8 
(39.5–48.1) 
20.8 
(17.3–24.4) 
 178 32.0 
(29.0–34.9) 
21.5 
(18.5–24.6) 
 X-ray; shoulder 124 40.5 
(36.5–44.5) 
19.3 
(16.0–22.5) 
 165 29.6 
(26.9–32.4) 
20.0 
(17.1–22.8) 
Ultrasound 171 55.9 
(51.6–60.1) 
26.6 
(23.1–30.1) 
 371 66.6 
(63.6–69.6) 
44.9 
(41.3–48.5) 
 Ultrasound; shoulder 170 55.6 
(51.3–59.8) 
26.4 
(22.9–30.0) 
 370 66.4 
(63.4–69.4) 
44.7 
(41.2–48.3) 
Computerised tomography 1 0.3 
(—) 
0.2 
(—) 
 5 0.9 
(0.1–1.7) 
0.6 
(0.1–1.1) 
Magnetic resonance imaging 0 0.0 
(—) 
0.0 
(—) 
 3 0.5 
(0.0–0.1) 
0.4 
(0.0–0.8) 
Nuclear medicine 0 0.0 
(—) 
0.0 
(—) 
 0 0.0 
(—) 
0.0 
(—) 
Total imaging tests 306 100.0 47.6 
(41.7–53.4) 
 557 100.0 67.4 
(61.8–72.9) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only most frequent test descriptors are presented in each MBS 
group. 
7.4 Shoulder symptom/complaint 
Table 7.11 shows that the rate at which imaging was ordered in the management of shoulder 
symptom/complaint problems did not change significantly over time.  
In 2002–05, there were 605 shoulder symptom/complaint problems managed and GPs 
ordered at least one imaging test for 182 or these (30.1% likelihood). A total of 242 imaging 
test orders were placed at a rate of 40.0 imaging tests per 100 shoulder symptom/complaint 
problems managed.  
In 2009–12, there were 649 shoulder symptom/complaint problems managed, and GPs 
ordered at least one imaging test for 225 of these (34.7% likelihood). In total, 313 imaging test 
orders were placed at a rate of 48.2 per 100 shoulder symptom/complaint problems 
managed. 
In Period 1, an estimated 80,000 imaging orders per year were placed nationally by GPs for 
the management of shoulder symptom/complaint problems. In Period 2, there were about 
130,000 imaging orders placed per year, or about 50,000 more per year than in Period 1. 
In summary, there were no significant changes in: the management rate of shoulder 
symptom/complaint problems (0.2 per 100 problems in both periods); or the likelihood of 
GPs ordering an imaging test when managing these problems (30.1% in Period 1 and 34.7% 
in Period 2). There was also no change in the number of imaging tests ordered per tested 
problem (1.33 in Period 1 and 1.40 in Period 2) (results not tabled). Therefore, the increase in 
the total estimated number of tests ordered nationally for this problem is due solely to the 
increased GP visit rate. GP behaviour did not change.  
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Table 7.11: Shoulder symptom/complaint contacts involving imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total shoulder symptom/complaint problems managed 605  649 
Shoulder symptom/complaint problems for which at least one test ordered (n) 182  225 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 30.1 
(26.2–34.0) 
 34.7 
(30.8–38.5) 
Total imaging orders generated for shoulder symptom/complaint problems (n) 242  313 
Imaging orders per 100 shoulder symptom/complaint problems (95% CI) 40.0 
(34.4–45.6) 
 48.2 
(42.5–54.0) 
Note: CI – confidence interval.  
Age-specific and sex-specific management  
The sex-specific likelihood of management of shoulder symptoms/complaints was similar at 
encounters with males and with females in both time periods. There was no change in the 
likelihood of management over time for either sex (Table 7.12). 
The age-specific likelihood of management of shoulder symptoms/complaints was highest 
for patients aged 45–64 years in both data periods, and the rate marginally increased over 
time for patients aged 75 years or older. There were no changes in the age-specific or sex-
specific imaging ordering rates for shoulder symptoms/complaints over the time period. 
Table 7.12: Age-specific and sex-specific management of shoulder symptom/complaint, 2002–05 and 
2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood 
(%) 
(95% CI) 
Test order 
rate per 100 
problems 
(95% CI) 
 At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order 
rate per 100 
problems 
(95% CI) 
Sex         
 Males 265 0.2 
(0.2–0.3) 
40.0 
(32.2–47.8) 
 314 0.3 
(0.2–0.3) 
47.5 
(39.0–55.9) 
 Females 334 0.2 
(0.2–0.2) 
40.4 
(32.9–47.9) 
 329 0.2 
(0.2–0.2) 
48.3 
(40.5–56.1) 
Age        
 <15 years 6 0.0 
(—) 
16.7 
(0.0–59.5) 
 11 0.0 
(0.0–0.1) 
18.2 
(0.0–45.4) 
 15–24 years 40 0.1 
(0.1–0.2) 
42.5 
(21.6–63.4) 
 36 0.1 
(0.1–0.2) 
41.7 
(22.9–60.4) 
 25–44 years 166 0.2 
(0.2–0.3) 
45.2 
(34.2–56.2) 
 124 0.2 
(0.2–0.2) 
44.4 
(31.2–57.5) 
 45–64 years 232 0.3 
(0.3–0.3) 
35.8 
(27.7–43.8) 
 266 0.3 
(0.3–0.4) 
49.2 
(40.2–58.3) 
 65–74 years 78 0.2 
(0.2–0.3) 
33.3 
(19.3–47.4) 
 91 0.2 
(0.2–0.3) 
63.7 
(46.9–80.6) 
 75+ years 78 0.2 
(0.1–0.2) 
50.0 
(32.6–67.4 
 115 0.3 
(0.2–0.3) 
44.3 
(31.5–57.2) 
Total  605 0.2 
(0.2–0.2) 
40.0 
(34.4–45.6) 
 649 0.2 
(0.2–0.2) 
48.2 
(42.5–54.0) 
(a) Missing data removed: 2002–05 n=5 (age), n=6 (sex); 2009–12 n=6 (age), n=6 (sex).  
(b) Number of encounters with at least one shoulder symptom/complaint problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 7.11). 
Note: CI – confidence interval. (—) – indicates the number of cases was too small to calculate a confidence interval. Highlighting indicates a 
significant difference between data periods. 
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Changes over time in imaging test types ordered 
Table 7.13 shows that there were some changes in the distribution of test orders across MBS 
groups. There was a general move away from diagnostic radiology orders as a percentage of 
all imaging tests ordered, with a move toward ultrasound orders.  
Between Period 1 and Period 2 the order rate for ultrasound increased significantly, from 
18.0 to 25.3 tests per 100 shoulder symptoms/complaints managed. 
The number of orders for CT and MRI increased, however the numbers for both were very 
small and results should be interpreted with caution. 
Table 7.13: Imaging test orders by MBS test group and most frequent individual tests ordered for 
shoulder symptom/complaint, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 128 52.9 
(47.8–58.0) 
21.2 
(17.6–24.7)  
133 42.5 
(38.1–46.8) 
20.5 
(17.1–23.9) 
 X-ray; shoulder 109 45.0 
(40.4–49.7) 
18.0 
(14.9–21.1)  
116 37.1 
(33.2–40.9) 
17.9 
(14.9–20.8) 
Ultrasound 109 45.0 
(40.0–50.1) 
18.0 
(14.8–21.3)  
164 52.4 
(48.0–56.8) 
25.3 
(21.8–28.8) 
 Ultrasound; shoulder 108 44.6 
(39.6–49.7) 
17.9 
(14.6–21.1)  
161 51.4 
(47.0–55.8) 
24.8 
(21.4–28.2) 
Computerised tomography 2 0.8 
(—) 
0.3 
(—)  
11 3.5 
(1.3–5.7) 
1.7 
(0.6–2.8) 
Magnetic resonance imaging 1 0.0 
(—) 
0.0 
(—)  
5 1.6 
(0.0–3.3) 
0.8 
(0.0–1.6) 
Nuclear medicine 2 0.8 
(—) 
0.3 
(—)  
0 0.0 
(—) 
0.0 
(—) 
Total imaging tests 242 100.0 40.0 
(34.4–45.6)  
313 100.0 48.2 
(42.5–54.0) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
Imaging test ordering rates by status of shoulder 
symptom/complaint 
Table 7.14 shows the proportions of contacts generating an imaging order for new and old 
shoulder symptom/complaint problems in both data periods. Two-thirds of the GP contacts 
were for follow-up of previously diagnosed shoulder symptoms/complaints, in both 
Period 1 and Period 2.  
In both data periods, the imaging order rate for shoulder symptoms/complaints was much 
higher at initial presentations (54.8 per 100 shoulder symptom/complaint problems in 
Period 1 and 68.4 per 100 in Period 2) than at follow-up consultations (30.9 per 100 problems 
in Period 1 and 35.6 per 100 in Period 2). There were no significant changes in the imaging 
order rate per 100 new, or old, shoulder symptom/complaint problems. 
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In Period 1, an estimated 40,000 imaging orders were placed per year, nationally, by GPs in 
management of new shoulder symptom/complaint problems. In Period 2, there were about 
70,000 imaging orders placed per year—about 30,000 more per year than in Period 1. 
Similarly, in Period 1, an estimated 40,000 imaging orders were placed nationally per year by 
GPs in management of old shoulder symptom/complaint problems. In Period 2, there were 
about 60,000 imaging orders placed per year—20,000 more per year than in Period 1. 
In summary, there were no significant changes in: the management rate of shoulder 
symptom/complaint problems; the likelihood of GPs ordering an imaging test when 
managing new or old shoulder symptom/complaint problems; or the number of imaging 
tests ordered per problem. Therefore we can conclude that the increase in estimated total 
orders across the country was due solely to the increased GP visit rate. 
Table 7.14: Imaging ordering rates by status of shoulder symptoms/complaints, 2002–05 and 
2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 230 375 605  250 399 649 
Per cent of shoulder symptom/ 
complaint problems 
38.0 62.0 100.0  38.5 61.5 100.0 
Total imaging orders generated for 
problems (n) 
126 116 242  171 142 313 
Imaging orders per 100 problems 
(95% CI) 
54.8  
(45.1–64.4) 
30.9  
(24.7–37.1) 
40.0  
(34.4–45.6) 
 68.4  
(58.1–78.7) 
35.6  
(29.1–42.1) 
48.2  
(42.5–54.0) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
40.4  
(33.9–47.0) 
23.7  
(19.3–28.2) 
30.1  
(26.2–34.0) 
 46.8  
(40.5–53.1) 
27.1  
(22.5–31.6) 
34.7  
(30.8–38.5) 
Note: CI – confidence interval. 
7.5 New shoulder symptom/complaint 
Age-specific and sex-specific management 
There was no change in the likelihood of management of new shoulder symptoms/ 
complaints over time for either sex (Table 7.15). In both data periods, the likelihood of 
management for males and for females was the same (0.1% in both periods, for both sexes). 
There were no changes between Period 1 and Period 2 in the age-specific or sex-specific 
imaging order rates for new cases of shoulder symptom/complaint. In Period 1 there were 
1.35 tests per tested problem, and in Period 2 there were 1.46 tests per tested problem.  
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Table 7.15: Age-specific and sex-specific likelihood of management and test order rate for new 
shoulder symptom/complaint, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Tests per 100  
new problems 
(95% CI) 
 
At least one 
new problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Tests per 100  
new problems 
(95% CI) 
Sex         
 Males 100 0.1 
(0.1–0.1) 
49.0 
(35.1–62.9) 
 116 0.1 
(0.1–0.1) 
66.4 
(51.0–81.7) 
 Females 125 0.1 
(0.1–0.1) 
60.8 
(47.0–74.6) 
 133 0.1 
(0.1–0.1) 
69.2 
(55.3–83.0) 
Age        
 <15 years 3 0.0 
(—) 
33.3 
(0.0–176.8) 
 7 0.0 
(—) 
14.3 
(0.0–49.0) 
 15–24 years 23 0.1 
(0.1–0.1) 
47.8 
(18.3–77.4) 
 17 0.1 
(0.0–0.1) 
41.2 
(9.4–73.0) 
 25–44 years 67 0.1 
(0.1–0.1) 
55.2 
(36.3–74.1) 
 50 0.1 
(0.1–0.1) 
58.0 
(35.0–81.0) 
 45–64 years 75 0.1 
(0.1–0.1) 
48.0 
(33.4–62.6) 
 97 0.1 
(0.1–0.1) 
77.3 
(60.3–94.4) 
 65–74 years 27 0.1 
(0.1–0.1) 
55.6 
(25.8–85.3) 
 34 0.1 
(0.1–0.1) 
85.3 
(54.2–116.4) 
 75+ years 33 0.1 
(0.1–0.1) 
75.8 
(45.0–106.5) 
 42 0.1 
(0.1–0.1) 
71.4 
(45.8–97.0) 
Total  230 0.1 
(0.1–0.1) 
54.8 
(45.1–64.4) 
 250 0.1 
(0.1–0.1) 
68.4 
(58.1–78.7) 
(a) Missing data removed: 2002–05 n=2 (age), n=5 (sex); 2009–12 n=3 (age), n=1 (sex).  
(b) Number of encounters with at least one new shoulder symptom/complaint problem managed at encounter. It is possible for more than  
one of the specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in 
Table 7.14). 
Note: CI – confidence interval; (—) – indicates the number of cases was too small to calculate a confidence interval. 
Changes over time in imaging test types ordered 
Table 7.16 shows that there were some changes in the types of tests ordered across MBS 
groups. There was a general move away from diagnostic radiology orders as a percentage of 
all imaging tests ordered and a move toward ultrasound orders. Between Period 1 and 
Period 2 the order rate for ultrasound of the shoulder increased significantly from 23.5 to 
35.6 tests per 100 new shoulder symptoms/complaints managed. 
The number of orders for CT increased, however the numbers were very small and this 
result should be interpreted with caution. 
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Table 7.16: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for new shoulder symptoms/complaints, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI)  
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI) 
Diagnostic radiology 70 55.6 
(48.8–62.3) 
30.4 
(23.9–37.0)  
73 42.7 
(37.0–48.4) 
29.2 
(22.9–35.5) 
 X-ray; shoulder 60 47.6 
(41.2–54.0) 
26.1 
(20.4–31.8)  
63 36.8 
(32.1–41.6) 
25.2 
(19.8–30.6) 
 X-ray; chest 4 3.2 
(0.1–6.2) 
1.7 
(0.0–3.4)  
3 1.8 
(0.0–3.7) 
1.2 
(0.0–2.6) 
Ultrasound 54 42.9 
(36.2–49.5) 
23.5 
(17.9–29.0)  
91 53.2 
(47.4–59.0) 
36.4 
(30.2–42.6) 
 Ultrasound; shoulder 54 42.9 
(36.2–49.5) 
23.5 
(17.9–29.0)  
89 52.0 
(46.3–57.8) 
35.6 
(29.6–41.6) 
Computerised 
tomography 
0 0.0 
(—) 
0.0 
(—)  
6 3.5 
(0.3–6.7) 
2.4 
(0.2–4.6) 
Magnetic resonance 
imaging 
0 0.0 
(—) 
0.0 
(—)  
1 0.6 
(—) 
0.4 
(—) 
Nuclear medicine 2 1.6 
(—) 
0.9 
(—)  
0 0.0 
(—) 
0.0 
(—) 
Total imaging tests 126 100.0 54.8 
(45.1–64.4)  
171 100.0 68.4 
(58.1–78.7) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
7.6 Summary of findings  
Changes over time 
Management rates of total shoulder problems increased significantly between the two data 
periods. Of the two subgroups individually investigated, management of shoulder 
syndrome increased significantly but the rates for shoulder symptoms/complaints did not 
change. Both the likelihood of ordering imaging and the average number of tests ordered per 
100 shoulder problems managed increased significantly over time. There was a general move 
away from diagnostic radiology toward ultrasound (Table 7.17). 
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Table 7.17: Summary of changes over time for shoulder problems 
Shoulder problems 
Management rate  
(% change, rate)(a) 
Likelihood of 
testing  
(% change, rate)(a) 
Ordering rate per 
100 problems 
(% change, rate)(a) 
Number of tests ordered 
per tested problem 
(% change, rate)(a) 
All  ↑ 23.0% 
(0.7, 0.9) 
↑ 37.0% 
(24.2, 33.2) 
↑ 36.9% 
(32.5, 44.5) 
No change 
(1.34, 1.34) 
Shoulder syndrome ↑ 28.3% 
(0.5, 0.7) 
↑ 48.6% 
(22.0, 32.7) 
↑ 46% 
(29.6, 43.3) 
No change 
(1.35, 1.32) 
 New  No change 
(0.2, 0.3) 
↑ 40.9% 
(35.4, 48.6) 
↑ 27.5% 
(47.6, 34.5) 
No change 
(1.36, 1.38) 
Shoulder symptom/ 
complaint 
No change 
(0.2, 0.2) 
No change 
(30.1, 34.7) 
No change 
(40.0, 48.2) 
No change 
(1.33, 1.40) 
 New No change 
(0.1, 0.1) 
No change 
(40.4, 46.8) 
No change 
(54.8, 68.4) 
No change 
(1.35, 1.46) 
(a) Direction and proportion of change between 2002–05 and 2009–12 is shown. In parentheses the management rate for Period 1 and  
Period 2, used to calculate the proportion of change is shown. 
Current imaging test order patterns 
Shoulder syndrome problems were managed at a far higher rate than shoulder 
symptoms/complaints, and for both problem groups, follow-up consultations for previously 
managed cases were more common than management of initial presentations (Table 7.18).  
Nearly half of new cases, and one-fifth of previously managed cases of shoulder syndrome, 
resulted in an order for ultrasound. For shoulder symptoms/complaints, an ultrasound was 
ordered for one-third of new problems, and one-fifth of previously managed problems. 
For all shoulder problems, both problem subgroups, and for new and previously managed 
cases, ultrasounds were the most commonly ordered imaging test, followed by diagnostic 
radiology. 
Table 7.18: Summary of GP imaging ordering for shoulder problems, Period 2, 2009–12 
Shoulder 
problems 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%) 
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem 
contacts (95% CI) 
Diagnostic 
radiology US CT scan MRI 
All 0.9 
(0.9–0.9) 
33.2 
(31.3–35.2) 
1.34 44.5 
(41.7–47.3) 
14.3 
(12.8–15.8) 
28.9 
(27.0–30.8) 
0.8 
(0.4–1.2) 
0.5 
(0.2–0.8) 
Shoulder 
syndrome 
0.7 
(0.6–0.7) 
32.7 
(30.5–35.0) 
1.35 43.3 
(40.1–46.4) 
12.3 
(10.7–13.8) 
30.1 
(27.9–32.2) 
0.5 
(0.2–0.8) 
0.4 
(0.1–0.7) 
 New 0.3 
(0.3–0.3) 
48.6 
(45.0–52.3) 
1.38 67.4 
(61.8–72.9) 
21.5 
(18.5–24.6 
44.9 
(41.3–48.5) 
0.6 
(0.1–1.1) 
0.4 
(0.0–0.8) 
 Old 0.4 
(0.4–0.4) 
21.4 
(18.9–24.0) 
1.22 26.1 
(22.9–29.3) 
5.7 
(4.3–7.0) 
19.6 
(17.2–22.0) 
0.4 
(0.1–0.8) 
0.4 
(0.1–0.8) 
Shoulder 
symptom/ 
complaint 
0.2 
(0.2–0.2) 
34.7 
(30.8–38.5) 
1.40 48.2 
(42.5–54.0) 
20.5 
(17.1–23.9) 
25.3 
(21.8–28.8) 
1.7 
(0.6–2.8) 
0.8 
(0.0–1.6) 
 New 0.1 
(0.1–0.1) 
46.8 
(40.5–53.1) 
1.46 68.4 
(58.1–78.7) 
29.2 
(22.9–35.5) 
36.4 
(30.2–42.6) 
2.4 
(0.2–4.6) 
0.4 
(—) 
 Old  0.1 
(0.1–0.2) 
27.1 
(22.5–31.6) 
1.31 35.6 
(29.1–42.1) 
15.0 
(11.3–18.8) 
18.3 
(14.3–22.3) 
1.3 
(0.2–2.3) 
1.0 
(0.0–2.2) 
Note: CI – confidence interval; US – ultrasound; CT – computerised tomography; MRI – magnetic resonance imaging; (—) – indicates the number 
of cases was too small to calculate a confidence interval.  
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7.7 Summary of guidelines for imaging of shoulder 
 problems 
The Government of Western Australia Department of Health (WADoH) Diagnostic Imaging 
Pathways,14 the American College of Radiology Appropriateness Criteria (ACRAC),20 the 
New Zealand Accident Compensation Corporation guidelines,32 and some of the literature, 
suggest that plain x-ray of the shoulder is the first investigation of choice in patients with 
shoulder pain.80 Where there is a strong suspicion of rotator cuff or other soft tissue damage, 
then ultrasonography or magnetic resonance (MR) arthrography is the preferred second 
investigation. While plain x-ray accurately depicts bone damage following trauma, it does 
not provide accurate information regarding soft tissue injury.81 Ultrasound has a high 
predictive value for full thickness rotator cuff tears, similar to that of MRI, when both are 
judged against the ‘gold standard’ of arthroscopy.82-85 However, for partial thickness rotator 
cuff tears and other soft tissue injuries, MR arthrography is the preferred investigation when 
other imaging is negative.86-88 CT arthrography may be indicated if MR arthrography is 
unavailable. Most of the papers on imaging for shoulder problems comment on the 
difficulties of establishing a clinical diagnosis without imaging studies. 
7.8 Compliance with guidelines 
Compliance with current guidelines is reported only for the 2009–12 period, as some changes 
in guidelines have occurred in the period between the two samples used in this study. 
Shoulder problems managed by GPs were grouped almost equally between L08 Shoulder 
symptom/complaint (almost exclusively shoulder pain) and shoulder syndrome (ICPC code 
L92 Shoulder syndrome [including all soft tissue injuries/inflammation but excluding 
arthritis] and shoulder injury codes from L81 Injury musculoskeletal NOS). Osteoarthritis of 
the shoulder is included in Chapter 6 and sprain/strain of the shoulder is in Chapter 8. 
The rate of ordering plain x-rays of the shoulder did not increase over the study period and 
varied from 11.3 per 100 problems for all shoulder syndrome problems, to 25.2 per 100 
problems for new shoulder symptom/complaint problems in 2009–12. This use of plain x-ray 
is consistent with the recommendations for the use of plain x-ray as the initial test. 
The use of ultrasound has increased substantially over the period of the study with a recent 
rate of 44.7 tests per 100 new shoulder syndromes presenting to GPs. Fewer ultrasounds 
were done for the other categories of shoulder problems. The use of MRI for shoulder 
problems was relatively rare and assessment of increasing use not therefore reliable. The low 
use of MRI may reflect the Medicare restrictions on GPs ordering MRI studies for patients 
with shoulder problems. The use of ultrasound is therefore consistent with guidelines, 
considering the unavailability of MRI. 
GPs in this study used both x-ray and ultrasound in the imaging of shoulder syndrome. 
They tended to select ultrasound more frequently. This is consistent with WADoH Pathways 
but not with the ACRAC. The imaging test rate of 1.39 imaging orders per tested new 
shoulder syndrome problem, indicates that ultrasound and x-ray are frequently ordered 
together for this problem, which is consistent with the WA Pathways.  
These data indicate broad compliance with the published guidelines for the selection of 
imaging modalities. 
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8 Sprains and strains 
This chapter investigates the imaging orders for sprains and strains, recorded by GPs from 
April 2002–March 2005 (Period 1) to April 2009–March 2012 (Period 2). Throughout the 
chapter, ‘sprains/strains’ includes all sprains/strains, with the exception of those of the back. 
As reported at the beginning of Section 2, GP imaging orders for sprains/strains were 
selected for investigation because there had been a statistically significant increase over time 
in the likelihood of GPs’ ordering imaging for this indication. 
Imaging orders for sprains/strains are investigated for all and for new cases (see Glossary). 
Changes in ordering over time between Period 1 and Period 2 are reported. 
8.1 All sprains and strains 
Table 8.1 shows the total number of sprains/strains managed, and the distribution of the 
sprains/strains across ICPC-2 rubrics in Period 1 and Period 2.  
There were no significant changes between the two data periods in the management rates 
reported in each of the rubric groups, with the exception of strains/sprains classified as 
muscle symptoms/complaints (i.e. predominately unspecified muscle strains) which was 
managed at a marginally lower rate in Period 2 (0.2 per 100 encounters) than in Period 1 (0.3 
per 100). Sprains/strains of the joint (not otherwise specified) accounted for more than half 
of all sprains/strains managed in both data periods (0.6 per 100 encounters in both Period 1 
and Period 2). 
The management rate of sprains/strains per 100 encounters decreased marginally between 
Period 1 and Period 2, but there was a marginal increase in the estimated number of GP 
encounters involving sprains/strains nationally. These increased by 106,000, from 1.07 
million encounters (95% CI: 1.02–1.12) in Period 1, to 1.17 million (95% CI: 1.12–1.23) in 
Period 2. This was purely due to the increased GP visit rate described in Chapter 2. 
Table 8.1: Sprain/strain problems managed by ICPC-2 rubric, 2002–05 and 2009–12 
Sprain/strain(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of 
problems 
Per cent of 
sprains/ 
strains 
Per 100 
encounters 
(95% CI)  
Number 
of 
problems 
Per cent of 
sprains/ 
strains 
Per 100 
encounters 
(95% CI) 
Sprain/strain of joint NOS 1,672 51.5 0.6 
(0.5–0.6)  
1,630 57.0 0.6  
(0.5–0.6) 
Muscle symptom/complaint NOS 781 24.0 0.3 
(0.2–0.3)  
535 18.7 0.2 
(0.2–0.2) 
Sprain/strain of ankle 637 19.6 0.2 
(0.2–0.2)  
562 19.6 0.2 
(0.2–0.2) 
Sprain/strain of knee 159 4.9 0.1 
(0.0–0.1)  
134 4.7 0.0 
(0.0–0.1) 
Total sprain/strain problems 3,249 100.0 1.1 
(1.0–1.1)  
2,861 100.0 1.0 
(0.9–1.0) 
(a) Excludes strain/sprain of the back. For a list of inclusions refer to Appendix 5, Table A5.1. 
Note: CI – confidence interval; NOS – not otherwise specified. Highlighting indicates a significant difference between data periods. 
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Table 8.2 shows that both the likelihood of ordering imaging for sprains/strains, and the rate 
of imaging orders for sprains/strains increased significantly between the two time periods. 
In 2002–05, there were 3,249 sprains/strain problems managed and GPs ordered at least one 
imaging test for 696 of these (21.4% likelihood). A total of 804 imaging tests were ordered, at 
a rate of 24.7 tests per 100 sprain/strain problems managed.  
In 2009–12, there were 2,861 sprain/strain problems managed, and at least one imaging test 
was ordered for 765 of these (26.7% likelihood). In total, 940 imaging tests were ordered at a 
rate of 32.9 imaging tests per 100 sprains/strain problems managed. 
These two results, combined with the increased GP visit rate, suggests that in Period 1, 
260,000 imaging orders were placed on average per year nationally by GPs for the 
management of sprain/strain problems. In Period 2, there were 380,000 imaging orders 
placed per annum, or about 120,000 more per year than in Period 1. 
In summary, despite the marginal decrease in the management rate of sprain/strain 
problems (by 9.1%) the imaging order rate significantly increased by 33.2%, (from 24.7 to 32.9 
per 100 sprain/strain problems managed) over the time period. There was also little change 
in the number of tests ordered per tested problem (1.13 tests in Period 1 and 1.23 in Period 2). 
Therefore, the increase in imaging ordering was almost totally attributable to the increased 
likelihood (by 24.8%) of ordering at least one imaging test when managing sprains/strains. 
Table 8.2: Sprain/strain problems generating GP imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total sprain/strain problems managed 3,249  2,861 
Sprain/strain problems for which at least one imaging test 
ordered (n) 
696  765 
Likelihood of ordering 1+ tests (per cent of problems)  
(95% CI) 
21.4 
(19.9–23.0) 
 26.7 
(25.0–28.5) 
Total imaging orders generated for sprain/strain problems (n) 804  940 
Imaging orders per 100 sprain/strain problems (95% CI) 24.7 
(22.9–26.6) 
 32.9 
(30.5–35.2) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Age-specific and sex-specific management  
In both data periods, the sex-specific likelihood of management of sprain/strain problems 
was significantly higher at encounters with males than at those with females. However, there 
was no difference in the sex-specific order rate of imaging tests per 100 sprain/strain 
problems for males and females. While there was a marginal decrease in the likelihood of 
management at encounters with both sexes over time, the imaging order rate significantly 
increased, from 24.7 per 100 sprain/strain problems in Period 1, to 32.9 per 100 in Period 2 
(Table 8.3), and this increase was apparent in both sexes. 
For both time periods, the majority of patients for whom sprains/strains were managed were 
aged 25–44 years. The only change noted over time in the age-specific likelihood of 
management was a marginal decrease in the 25–44 year age group, from 1.5% to 1.3% of 
encounters in this age group.  
Significant increases over time were also noted in the age-specific rates of imaging ordering 
for patients in the 25–44, 45–64 and 65–74 year age groups.  
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Table 8.3: Age-specific and sex-specific likelihood of management and test order rate for 
sprain/strain problems, 2002–05 and 2009–12 
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 1,577 1.3 
(1.2–1.4) 
24.4 
(21.9–26.9) 
 1,357 1.2 
(1.1–1.2) 
34.9 
(31.5–38.2) 
 Females 1,625 0.9 
(0.9–1.0) 
24.9 
(22.4–27.4) 
 1,471 0.8 
(0.8–0.9) 
31.1 
(28.0–34.2) 
Age        
 <15 years 290 0.8 
(0.7–0.9) 
36.2 
(30.1–42.3) 
 245 0.7 
(0.6–0.8) 
32.9 
(26.5–39.3) 
 15–24 years 493 1.8 
(1.6–1.9) 
24.7 
(20.4–29.0) 
 412 1.7 
(1.5–1.8) 
32.5 
(27.1–38.0) 
 25–44 years 1,102 1.5 
(1.4–1.6) 
22.1 
(19.3–24.9) 
 844 1.3 
(1.2–1.4) 
28.8 
(25.0–32.5) 
 45–64 years 891 1.1 
(1.0–1.2) 
23.3 
(19.9–26.8) 
 873 1.1 
(1.0–1.2) 
35.2 
(31.0–39.5) 
 65–74 years 246 0.7 
(0.6–0.8) 
23.6 
(16.9–30.3) 
 239 0.6 
(0.6–0.7) 
42.3 
(33.5–51.2) 
 75+ years 186 0.4 
(0.4–0.5) 
29.9 
(21.2–38.7) 
 224 0.5 
(0.4–0.6) 
29.5 
(20.7–38.3) 
Total  3,236 1.1 
(1.0–1.1) 
24.7 
(22.9–26.6) 
 2,850 1.0 
(0.9–1.0) 
32.9 
(30.5–35.2) 
(a) Missing data removed: 2002–05 n=28 (age), n=34 (sex); 2009–12 n=13 (age), n=22 (sex).  
(b) Number of encounters with at least one sprain/strain problem managed at encounter. It is possible for more than one of the specified 
problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 8.2). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes over time in imaging test types ordered 
There was a general move away from diagnostic radiology orders as a percentage of all 
imaging tests ordered and a move toward ultrasound and MRI orders. The considerable 
changes in the types of tests ordered across MBS groups (Table 8.4) between Period 1 and 
Period 2 are described below.  
• X-ray of the shoulder increased significantly, from 2.3 to 5.3 tests per 100 sprains/strains 
managed. 
• Ultrasound significantly increased, from 6.2 per 100 sprain/strain problems managed, to 
11.5 per 100, particularly ultrasound of the shoulder. This increased by almost 90% from 
4.5 to 8.5 per 100 sprains/strains managed. Ultrasound of the ankle also more than 
trebled, from 0.2 to 0.7 per 100 sprains/strains managed between Period 1 and Period 2 
(results not tabled). 
• MRI significantly increased from 0.1 to 0.7 per 100 sprains/strains managed. 
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Table 8.4: Imaging test orders by MBS test group and the most frequent individual tests ordered for 
sprain/strain problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 576 71.6 
(68.5–74.8) 
17.7 
(16.3–19.2)  
576 61.3 
(58.5–64.0) 
20.1 
(18.4–21.8) 
 X-ray; ankle 242 30.1 
(26.6–33.6) 
7.4 
(6.5–8.4)  
186 19.8 
(16.9–22.7) 
6.5 
(5.5–7.5) 
 X-ray; shoulder 76 9.5 
(7.5–11.4) 
2.3 
(1.8–2.9)  
151 16.1 
(13.9–18.2) 
5.3 
(4.4–6.1) 
 X-ray; wrist 50 6.2 
(4.5–7.9) 
1.5 
(1.1–2.0)  
56 6.0 
(4.5–7.5) 
2.0 
(1.5–2.5) 
 X-ray; knee 43 5.3 
(3.8–6.9) 
1.3 
(0.9–1.7)  
37 3.9 
(2.7–5.2) 
1.3 
(0.9–1.7) 
 X-ray; foot/feet 33 4.1 
(2.8–5.5) 
1.0 
(0.7–4.1)  
41 4.4 
(3.0–5.7) 
1.4 
(1.0–1.9) 
 X-ray; finger(s)/thumb 20 2.5 
(1.4–3.6) 
0.6 
(0.3–0.9)  
21 2.2 
(1.2–3.2) 
0.7 
(0.4–1.1) 
 X-ray; spine; cervical 15 1.9 
(0.9–2.8) 
0.5 
(0.2–0.7)  
6 0.6 
(0.1–1.1) 
0.2 
(0.0–0.4) 
Ultrasound 203 25.2 
(22.2–28.3) 
6.2 
(5.3–7.2)  
329 35.0 
(32.3–37.7) 
11.5 
(10.3–12.7) 
 Ultrasound; shoulder 145 18.0 
(15.4–20.7) 
4.5 
(3.7–5.2)  
244 26.0 
(23.3–28.6) 
8.5 
(7.5–9.6) 
Computerised tomography 16 2.0 
(1.0–2.9) 
0.5 
(0.3–0.7)  
13 1.4 
(0.6–2.1) 
0.5 
(0.2–0.7) 
Magnetic resonance 
imaging 
4 0.5 
(0.0–1.1) 
0.1 
(0.0–0.3)  
19 2.0 
(1.1–2.9) 
0.7 
(0.4–1.0) 
Nuclear medicine 5 0.6 
(0.0–1.3) 
0.2 
(0.0–0.3)  
3 0.3 
(0.0–0.7) 
0.1 
(0.0–0.2) 
Total imaging tests 804 100.0 24.7 
(22.9–26.6)  
940 100.0 32.9 
(30.5–35.2) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule. Highlighting indicates a significant difference between data periods. Only the 
most frequent test descriptors are presented in each MBS group. 
Imaging test ordering rates by status of sprain/strain problem 
Table 8.5 shows the proportions of sprain/strain problems managed that were new cases (i.e. 
first presentation to a medical practitioner) and the proportion that were old (i.e. managed 
previously) in both data periods. Three-fifths of the GP contacts were for management of 
new sprains and strains in both Period 1 and Period 2.  
In both data periods, the imaging order rate for sprains/strains was much higher at initial 
presentations (29.3 per 100 in Period 1 and 39.5 per 100 in Period 2) than at follow-up 
consultations (17.4 per 100 in Period 1 and 21.4 per 100 in Period 2). Both the imaging 
ordering rate and the likelihood of ordering imaging tests increased significantly between 
Period 1 and Period 2 for new problems, but there was no change in either of these measures 
for old sprain/strain problems over the time period. 
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These results, combined with the increased GP visit rate, suggest that in Period 1, an 
estimated 190,000 imaging orders were placed nationally by GPs per year for the 
management of new sprain/strain problems. In Period 2, about 290,000 imaging tests were 
ordered per annum, or about 100,000 more per year than in Period 1. 
In summary, there was no change in the management rate of new sprain/strain problems 
(0.7 per 100 encounters in Period 1 and 0.6 per 100 in Period 2) or in the number of imaging 
tests ordered per new sprain/strain problem (1.17 per tested problem in Period 1 and 1.23 in 
Period 2). The increased imaging order rate for new sprain/strain problems (by 34.8%) 
appears to be a result of the increased likelihood of GPs ordering an imaging test when 
managing new sprain/strain problems (by 27.9%), and the increased GP visit rate.  
Table 8.5: Imaging ordering rates by status of sprain/strain problems, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 2,009 1,240 3,249  1,811 1,050 2,861 
Per cent of sprain/strain problems 61.8 38.2 100.0  63.3 36.7 100.0 
Total imaging orders generated for 
problems (n) 
588 216 804  715 225 940 
Imaging orders per 100 problems 
(95% CI) 
29.3  
(26.7–31.9) 
17.4  
(14.9–19.9) 
24.7  
(22.9–29.6) 
 39.5  
(36.3–42.6) 
21.4  
(18.3–24.6) 
32.9  
(30.5–35.2) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
25.1  
(23.0–27.2) 
15.4  
(13.3–17.5) 
21.4  
(19.9–23.0) 
 32.1  
(29.7–34.4) 
17.5  
(15.1–19.9) 
26.7  
(25.0–28.5) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
8.2 New sprains and strains  
Age-specific and sex-specific management 
In both data periods the sex-specific likelihood of management of new sprain/strain 
problems was significantly higher at encounters with males than at those with females. There 
was no change in the sex-specific likelihood of management over time. 
The sex-specific rates of imaging ordering increased significantly at encounters with males 
(28.5 to 40.9 per 100 new sprain/strain problems managed) and those with females (29.8 to 
38.2 per 100), although there were no significant differences between the sexes in either data 
period. 
There was no change in the age-specific likelihood of management between Period 1 and 
Period 2. However there was a significant increase in the imaging order rate for patients 
aged 45–64 (29.3 to 45.7 per 100 new sprain/strain problems) and 65–74 years (29.1 to 54.2 
per 100) (Table 8.6). 
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Table 8.6: Age-specific and sex-specific likelihood of management and test order rate for new 
sprain/strain problems, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 968 0.8 
(0.8–0.9) 
28.5 
(25.0–32.0) 
 896 0.8 
(0.7–0.8) 
40.9 
(36.5–45.2) 
 Females 1,012 0.6 
(0.5–0.6) 
29.8 
(26.3–33.2) 
 894 0.5 
(0.5–0.6) 
38.2 
(34.0–42.5) 
Age        
 <15 years 200 0.6 
(0.5–0.6) 
39.5 
(31.8–47.2) 
 184 0.5 
(0.5–0.6) 
35.3 
(27.6–43.0) 
 15–24 years 337 1.2 
(1.1–1.3) 
27.6 
(22.1–33.1) 
 285 1.1 
(1.0–1.3) 
36.8 
(29.8–43.8) 
 25–44 years 650 0.9 
(0.8–1.0) 
25.8 
(22.0–29.6) 
 547 0.8 
(0.7–0.9) 
33.1 
(28.2–38.0) 
 45–64 years 534 0.7 
(0.6–0.7) 
29.3 
(24.4–34.2) 
 504 0.6 
(0.6–0.7) 
45.7 
(39.7–51.8) 
 65–74 years 151 0.4 
(0.4–0.5) 
29.1 
(19.3–39.0) 
 143 0.4 
(0.3–0.5) 
54.2 
(41.9–66.4) 
 75+ years 117 0.3 
(0.2–0.3) 
35.9 
(23.6–48.2) 
 135 0.3 
(0.2–0.4) 
39.3 
(26.4–52.1) 
Total  2,003 0.7 
(0.6–0.7) 
29.3 
(26.7–31.9) 
 1,806 0.6 
(0.6–0.7) 
39.5 
(36.3–42.6) 
(a) Missing data removed: 2002–05 n=14 (age), n=23 (sex); 2009–12 n=8 (age), n=15 (sex).  
(b) Number of encounters with at least one new sprain/strain problem managed at encounter. It is possible for more than one of the specified 
problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 8.5). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes in imaging tests ordered for new sprain/strain problems, 
2002–05 and 2009–12 
There was a general move away from diagnostic radiology orders and a move toward CT 
and MRI orders. Table 8.7 shows that there were considerable changes in the types of tests 
ordered across MBS groups.  
Between Period 1 and Period 2, the order rate for x-ray of the shoulder significantly 
increased from 3.1 to 6.4 tests per 100 new sprain/strain problems managed. 
The order rate of ultrasound increased significantly from 6.9 to 13.6 per 100 new 
sprain/strain problems managed. In particular, ultrasound of the shoulder doubled from  
4.9 to 9.8 per 100 new sprain/strain problems managed. Ultrasound of the ankle also 
significantly increased from 0.2 to 7.8 per 100 new sprain/strain problems. 
The number of orders for MRI increased, however numbers are small and results should  
be interpreted with caution.  
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Table 8.7: Imaging test orders by MBS test group and the most frequent individual tests ordered for 
new sprain/strain problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI)  
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI) 
Diagnostic radiology 434 73.8 
(70.4–77.3) 
21.6 
(19.6–23.6)  
449 62.8 
(59.7–65.9) 
24.8 
(22.5–27.1) 
 X-ray; ankle 179 30.4 
(26.2–34.6) 
8.9 
(7.6–10.3)  
141 19.7 
(16.5–22.9) 
7.8 
(6.4–9.1 
 X-ray; shoulder 63 10.7 
(8.3–13.1) 
3.1 
(2.3–3.9)  
116 16.2 
(13.8–18.7) 
6.4 
(5.2–7.6) 
 X-ray; knee 36 6.1 
(4.2–8.1) 
1.8 
(12.–2.4)  
33 4.6 
(3.0–6.2) 
1.8 
(1.2–2.5) 
 X-ray; wrist 31 5.3 
(3.5–7.1) 
1.5 
(1.0–2.1)  
44 6.2 
(4.4–7.9) 
2.4 
(1.7–3.1) 
 X-ray; foot/feet 22 3.7 
(2.2–5.3) 
1.1 
(0.6–1.5)  
31 4.3 
(2.8–5.9) 
1.7 
(1.1–2.3) 
 X-ray; finger(s)/thumb 17 2.9 
(1.5–4.2) 
0.8 
(0.4–1.2)  
15 2.1 
(1.0–3.2) 
0.8 
(0.4–1.3) 
 X-ray; spine; cervical 12 2.0 
(0.9–3.2) 
0.6 
(0.3–0.9)  
3 0.4 
(0.0–0.9) 
0.2 
(0.0–0.4) 
 X-ray; elbow 11 1.9 
(0.8–3.0) 
0.5 
(0.2–0.9)  
4 0.6 
(0.0–1.1) 
0.2 
(0.0–0.4) 
 X-ray; chest 10 1.7 
(0.7–2.7) 
0.5 
(0.2–0.8)  
9 1.3 
(0.4–2.1) 
0.5 
(0.2–0.8) 
 X-ray; hip 7 1.2 
(0.3–2.1) 
0.3 
(0.1–0.6)  
14 2.0 
(1.0–3.0) 
0.8 
(0.4–1.2) 
Ultrasound 138 23.5 
(20.1–26.8) 
6.9 
(5.7–8.1)  
246 34.4 
(31.4–37.4) 
13.6 
(11.9–15.2) 
 Ultrasound; shoulder 99 16.8 
(13.9–19.8) 
4.9 
(3.9–5.9)  
178 24.9 
(22.0–27.8) 
9.8 
(8.4–11.3) 
 Ultrasound; knee 6 1.0 
(0.2–1.8) 
0.3 
(0.1–0.5)  
13 1.8 
(0.7–2.9) 
0.7 
(0.3–1.2) 
 Ultrasound; ankle 5 0.9 
(0.1–1.6) 
0.2 
(0.0–0.5)  
141 19.7 
(16.5–22.9) 
7.8 
(6.4–9.1) 
Computerised tomography 12 2.0 
(0.9–3.2) 
0.6 
(0.3–0.9)  
6 0.8 
(0.2–1.5) 
0.3 
(0.1–0.6) 
Magnetic resonance imaging 2 0.3 
(—) 
0.1 
(—)  
12 1.7 
(0.7–2.6) 
0.7 
(0.3–1.0) 
Nuclear medicine 2 0.3 
(—) 
0.1 
(—)  
2 0.3 
(—) 
0.1 
(—) 
Total imaging tests 588 100.0 29.3 
(26.7–31.9)  
715 100.0 39.5 
(36.3–42.6) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
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8.3 Summary of findings 
Changes over time 
The management rate of sprain/strain problems decreased marginally over time, but the 
likelihood of imaging being ordered for this problem, and the imaging test order rate both 
significantly increased between Period 1 and Period 2 (Table 8.8). 
Overall, there was a move away from diagnostic radiology as a proportion of all imaging 
tests ordered for sprain/strain problems, although there was a singular increase in x-rays of 
the sprain/strain of the shoulder. There was a general increase in ultrasounds and MRI 
orders, although each remained a small proportion of total imaging orders for this problem. 
A similar pattern was observed for management of new sprain/strain problems. There was 
no change in the management rate over the study period, but both the likelihood of imaging 
being ordered, and the imaging order rate increased significantly.  
There was again an overall move away from diagnostic radiology, with the exception of  
x-ray of the shoulder. Orders for ultrasound nearly doubled over time, and there was a 
significant increase in MRI test ordering. 
Table 8.8: Summary of changes over time for sprains/strains 
Sprains/strains 
Management rate  
(% change, rate)(a) 
Likelihood of 
testing  
(% change, rate)(a) 
Ordering rate per 
100 problems 
(% change, rate)(a) 
Number of tests ordered 
per tested problem 
(% change, rate)(a) 
All  ↓ 9.1% (Marginal) 
(3.0, 2.8) 
↑ 24.8% 
(21.4, 26.7) 
↑ 33.2% 
(24.7, 32.9) 
No change 
(1.16, 1.23) 
 New  No change 
(0.7, 0.6) 
↑ 27.9% 
(25.1, 32.1) 
↑ 34.8% 
(29.3, 39.5) 
No change 
(1.17, 1.23) 
(a) Direction and proportion of change between 2002–05 and 2009–12. The management rate for Period 1 and Period 2, used to calculate the 
proportion of change, is shown in parentheses. 
Current imaging test order patterns 
New cases of sprains/strains were managed at a significantly higher rate and were 
significantly more likely to result in an order for imaging than previously managed cases. 
Diagnostic radiology was the most common imaging test ordered for any sprain/strain 
problem, followed by ultrasound. Order rates for CT and MRI were low and did not differ 
between new and previously managed cases (Table 8.9). 
Table 8.9: Summary of GP imaging ordering for sprains/strains, Period 2, 2009–12 
Sprains/ 
strains 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%) 
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem contacts 
(95% CI) 
Diagnostic 
radiology US CT scan MRI 
All 1.0 
(0.9–1.0) 
26.7 
(25.0–28.5) 
1.23 32.9 
(30.5–35.2) 
20.1 
(18.4–21.8) 
11.5 
(10.3–12.7) 
0.5 
(0.2–0.7) 
0.7 
(0.4–1.0) 
 New  0.6 
(0.6–0.7) 
32.1 
(29.7–34.4) 
1.23 39.5 
(36.3–42.6) 
24.8 
(22.5–27.1) 
13.6 
(11.9–15.2) 
0.3 
(0.1–0.6) 
0.7 
(0.3–1.0) 
 Old  0.4 
(0.3–0.4) 
17.5 
(15.1–19.9) 
1.22 21.4 
(18.3–24.6) 
12.1 
(9.9–14.2) 
7.9 
(6.2–9.6) 
0.7 
(0.2–1.2) 
0.7 
(0.2–1.2) 
Note: CI – confidence interval; US – ultrasound; CT – computerised tomography; MRI – magnetic resonance imaging. 
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8.4 Summary of guidelines for imaging of 
sprain/strain problems 
An extensive review of guidelines for diagnostic imaging was undertaken using Medline, 
and national and international sources of guidelines such as the National Health and 
Medical Research Council (NHMRC), the United States Agency for Healthcare Research and 
Quality (AHRQ), the UK National Institute for Health and Care Excellence (NICE); and local 
and overseas colleges of radiology/radiologists. 
The final group of guidelines considered for this section of this report were: Government of 
Western Australia Department of Health (WADoH) Diagnostic Imaging Pathways11 (these 
guidelines could be considered as the successor of the now obsolete Royal Australian and 
New Zealand College of Radiologists [RANZCR] Imaging Guidelines 2001,19 and are 
endorsed by the RANZCR), the American College of Radiology Appropriateness Criteria 
(ACRAC),71 and the New Zealand Guidelines Group (NZGG) guidelines.30 
The guidelines are generally developed by expert consensus (with little input from primary 
care physicians) with a variable research evidence base. As a result there is significant 
variance between guidelines in the advice given regarding the appropriate imaging 
modalities to be used. However, they suggest similar triggers for initiating investigation. 
Virtually all guidelines suggest that imaging is not indicated at initial assessment of sprains 
and strains unless there are ‘red flag’ issues suggesting fracture or other underlying 
pathology that prompt investigation.  
Ankle sprain/strain 
In the case of ankle injury, the well-validated Ottawa decision rules for imaging have been 
adopted by the American College of Radiology as appropriate guidelines for the diagnosis of 
fracture.89-98 The WADoH Imaging Pathways also suggest the use of the Ottawa ankle rules 
to determine indications for imaging studies in patients with acute ankle sprain.13 The 
Ottawa rules have also been validated in the primary care setting in New Zealand by Wynn-
Thomas et al.99 Both the WADoH Imaging Pathways and the ACRAC suggest plain 
radiology for diagnosis of fracture.  
Shoulder sprain/strain 
The WADoH Imaging Pathways,14 the ACRAC,20 the New Zealand Accident Compensation 
Corporation guidelines32 and some of the literature suggest that plain x-ray of the shoulder is 
the first investigation of choice in patients with shoulder pain.80 Where there is a strong 
suspicion of rotator cuff or other soft tissue damage, then ultrasonography or MR 
arthrography are the preferred second investigation. While plain x-ray accurately depicts 
bone damage following trauma, it does not provide accurate information regarding soft 
tissue injury.81 Ultrasound has a high predictive value for full thickness rotator cuff tears, 
similar to that of MRI, when both are judged against the ‘gold standard’ of arthroscopy.82-85 
However, for partial thickness rotator cuff tears and other soft tissue injuries, MR 
arthrography is the preferred investigation when other imaging is negative.86-88 CT 
arthrography may be indicated if MR arthrography is unavailable. Most of the papers on 
imaging for shoulder problems comment on the difficulties of establishing a clinical 
diagnosis without imaging studies. 
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Knee sprain/strain 
The WADoH Imaging Pathways for post traumatic knee pain suggest application of the 
Ottawa knee rules as part of clinical assessment and knee x-ray only if indicated by the 
Ottawa rules. The pathway suggested for Ottawa rule negative patients (and those where  
x-ray is negative) include ultrasound for assessment of superficial soft issues and MRI where 
there is a high suspicion of ligament or meniscus damage. Investigation of non-traumatic 
knee pain includes initial x-ray or ultrasound following clinical assessment, followed by MRI 
if initial imaging is non-diagnostic and underlying pathology is suspected. 
The ACRAC for acute trauma to the knee also suggest x-ray only where signs similar to 
those in the Ottawa rules are present. If it is a twisting injury or fall with negative radiology 
and positive signs, then MRI is appropriate (or CT with contrast if a tibial plateau fracture is 
found on x-ray).  
The NZGG guidelines suggest a similar pathway to the WADoH and ACRAC guidelines. 
In a study of acute knee injuries managed in Emergency Departments in Canada, Stiell et al. 
found that 74.5% of patients had an x-ray and only 5.2% of these had fractures. Knee x-rays 
have the lowest yield for diagnosing clinical significant fractures.100 The Ottawa knee rules 
for acute trauma to the knee synthesises the research of several developers of decision rules 
for knee imaging including Stiell.101-103 The Ottawa knee rules have almost 100% sensitivity 
for knee fractures and about 50% specificity.104 
Wrist sprain/strain 
For wrist injuries, the ACRAC suggest plain x-ray if a fracture is suspected, followed by MRI 
if plain x-ray is negative and scaphoid fracture is suspected.28 The WADoH Imaging 
Pathways suggest a similar approach, with CT suggested if MRI is unavailable for suspected 
scaphoid fracture.10 
8.5 Compliance with guidelines 
Compliance with current guidelines is reported only for the 2009–12 period as some changes 
in guidelines have occurred in the period between the two samples used in this study. 
Sprains and strains reported in this chapter included problems classified in ICPC-2 rubrics: 
L79 Sprain/strain of joint NOS of which about 50% were shoulder problems and 10% wrist 
problems; L19 Muscle symptom/complaint NOS of which about 75% were labelled ‘muscle 
strain’; L77 Sprain/strain of ankle; and L78 Sprain/strain of knee. 
Ankle imaging 
In this study, GPs ordered ankle x-ray at the rate of 6.5 per 100 contacts with all sprain/strain 
problems and 33.1 per 100 problems labelled as sprain/strain of ankle. For new problems 
labelled as sprain/strain, the order rate was 7.8 per 100 problem contacts and 38.6 per 100 
new presentations of sprain/strain of ankle. Presumably these tests were ordered to exclude 
fracture and are therefore higher than would be expected if the Ottawa ankle rules were 
being used.  
Ultrasound of the ankle was also ordered at the rate of 38.6 per 100 new sprain/strain of 
ankle. The test order rate of 1.23 per tested new sprain/strain of ankle suggests that x-ray 
and ultrasound are not infrequently ordered together. Neither the Australian nor ACRAC 
guidelines suggest the use of ultrasound in the investigation of ankle sprain/strain.  
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Shoulder imaging 
About 50% of sprain/strain of joint NOS are sprain/strain of shoulder (results not tabled). 
GPs ordered shoulder x-ray at the rate of 5.3 per 100 contacts with all problems labelled 
sprain/strain and about 18.6 per 100 of all sprain/strain of shoulder. Ultrasound of the 
shoulder was ordered at the rate of 8.5 per 100 of all problems labelled sprain/strain and 
29.8 per 100 contacts with all problems labelled sprain/strain of shoulder. 
For new presentations of sprain/strain problems, GPs ordered shoulder x-rays at the rate of 
6.4 per 100 contacts with new sprain/strain problems and 24.0 per 100 new sprain/strain of 
shoulder. Ultrasound of the shoulder was ordered at the rate of 9.8 per 100 new 
sprain/strain problems and 36.7 per 100 new sprain/strain shoulder problems. 
These figures are almost identical to those seen in orders for shoulder syndrome (Chapter 7) 
and similar conclusions can be reached that these orders are consistent with published 
guidelines taking into consideration the unavailability of MRI. 
Knee imaging 
GPs ordered knee x-rays at the rate of 1.3 per 100 contacts with problems labelled 
sprain/strain and 17.6 per 100 contacts with problems labelled sprain/strain of knee. GPs 
ordered knee x-rays at the rate of 1.8 per 100 new sprain/strain problems and 24.3 per 100 
new sprain/strain knee problems (results not tabled). 
If the ACRAC were applied in the Australian context they have the potential to significantly 
reduce the need for diagnostic radiology of the knee without losing sensitivity of fracture 
detection. The current level of knee x-rays per 100 problem contacts for sprain/strain of 
knee, while well below North American Emergency Department levels quoted above, could 
probably be significantly reduced.  
Data for ultrasound, CT and MRI of the knee are too small to be reliable. The lack of 
availability of MRI due to MBS restrictions in general practice at the time of this study 
probably contributed to the low level of use. With increased availability under the MBS, the 
use of MRI of the knee would be expected to rise in line with guidelines. 
Wrist imaging 
Wrist sprain/strain made up about 10% of problems labelled sprain/strain of joint NOS. 
GPs ordered x-ray of wrist at the rate of 2.0 per 100 contacts with all sprain/strain problems 
and about 35 per 100 wrist sprain/strain problems. For new presentations, GPs ordered wrist 
x-ray at the rate of 2.4 per 100 sprain/strain problems, or about 48 per 100 new wrist 
sprain/strain problems (results not tabled). Plain x-ray is the preferred initial investigation if 
fracture is suspected, with MRI used if scaphoid fracture is suspected and a plain x-ray is 
negative. Current ordering of wrist x-ray is consistent with published guidelines.  
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9 Bursitis/tendonitis/synovitis 
This chapter investigates the imaging orders for bursitis/tendonitis/synovitis. In this 
analysis, bursitis/tendonitis/synovitis was defined as the ICPC-2 code L87 ‘Bursitis/ 
tendonitis/synovitis NOS’.  
As reported at the beginning of Section 2, GP imaging orders for bursitis/tendonitis/ 
synovitis were selected for investigation because of the increasing use of imaging tests by 
GPs for this group of problems. Imaging orders are investigated for all and for new cases 
(see Glossary). Changes in ordering over time between April 2002–March 2005 (Period 1) and 
April 2009–March 2012 (Period 2) are also reported. In this chapter, bursitis/tendonitis/ 
synovitis will collectively be called ‘bursitis’ for ease of reading.  
9.1 All bursitis/tendonitis/synovitis problems 
Table 9.1 shows there was a significant increase in the management rate of bursitis between 
Period 1 and Period 2. There were also increases in the likelihood of ordering imaging tests 
and in the rate of imaging tests ordered for bursitis between the two time periods. 
In Period 1, there were 2,751 bursitis problems managed, and at least one imaging test was 
ordered for 429 of these problems (15.6% likelihood). A total of 499 imaging tests were 
ordered, at a rate of 18.1 per 100 bursitis problems, and 1.16 tests per tested problems. 
In Period 2, there were 3,260 bursitis problems managed, and at least one imaging test was 
ordered for 770 of these problems (23.6% likelihood). In total, 911 imaging tests were 
ordered, at a rate of 27.9 per 100 bursitis problems and 1.18 tests per tested problems. 
We estimate that there were 41,000 more imaging tests ordered nationally for bursitis in 
Period 2 than in Period 1. Overall, there was a 54.1% increase in the tests ordered for bursitis 
per 100 problems between the two time periods. This increase was due to the combined 
effects of a significant increase (22.9%) in the management rate of these problems, a large 
(51.3%) increase in the likelihood of the GP ordering at least one imaging test for this 
problem, and the increased visit rate of the population to GPs. 
Table 9.1: Bursitis/tendonitis/synovitis management generating GP imaging orders, 2002–05 and 
2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Number of bursitis/tendonitis/synovitis problems managed  2,751  3,260 
Management rate per 100 encounters (95% CI) 0.9 
(0.9–1.0) 
 1.1 
(1.1–1.2) 
Bursitis/tendonitis/synovitis problems for which at least one imaging test 
ordered (n) 
429  770 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 15.6 
(14.2–17.0) 
 23.6 
(22.1–25.2) 
Total imaging orders generated for bursitis/tendonitis/synovitis problems (n) 499  911 
Imaging orders per 100 bursitis/tendonitis/synovitis problems (95% CI) 18.1 
(16.4–19.9) 
 27.9 
(26.0–29.9) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. For a list of inclusions refer to Appendix 5, 
Table A5.1. 
92
  
 
Age-specific and sex-specific management  
Between the two time periods, the likelihood of management of bursitis significantly 
increased for females, and marginally for males. The imaging order rate increased for both 
males and females between Period 1 and Period 2 (Table 9.2). The growth was greater for 
females than males, so in Period 2 the imaging order rate for females became significantly 
higher than for males. 
In both time periods, the majority of patients for whom bursitis was managed were in the 
45–64 year age group. The likelihood of management increased significantly over time for 
patients aged 45–64 and 65–74 years, and increased marginally for patients aged 25–44 years. 
In Period 1, the imaging ordering rate was significantly higher for patients aged less than 
15 years compared with the 45–64 and 75+ year age groups. In Period 2, there were no 
differences in the imaging ordering rates between the age groups, however the age-specific 
imaging ordering rate significantly increased in the 45–64, 65–74 and 75+year age groups 
(Table 9.2). 
Table 9.2: Age-specific and sex-specific likelihood of management and imaging order rates for 
bursitis/tendonitis/synovitis, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 1,102 0.9 
(0.9–1.0) 
17.8 
(15.1–20.5) 
 1,212 1.0 
(1.0–1.1) 
24.5 
(21.5–27.6) 
 Females 1,600 0.9 
(0.9–1.0) 
18.4 
(16.1–20.6) 
 1,999 1.2 
(1.1–1.2) 
30.2 
(27.7–32.8) 
Age        
 <15 years 88 0.3 
(0.2–0.3) 
30.7 
(19.7–41.6) 
 73 0.2 
(0.2–0.3) 
28.4 
(16.6–40.1) 
 15–24 years 176 0.6 
(0.5–0.7) 
18.2 
(10.5–25.9) 
 142 0.6 
(0.5–0.7) 
31.7 
(22.9–40.5) 
 25–44 years 673 0.9 
(0.9–1.0) 
20.4 
(16.7–24.1) 
 747 1.1 
(1.0–1.2) 
25.2 
(21.5–28.9) 
 45–64 years 1,122 1.4 
(1.3–1.5) 
16.3 
(13.8–18.9) 
 1,407 1.8 
(1.7–1.9) 
28.6 
(25.7–31.5) 
 65–74 years 355 1.0 
(0.9–1.1) 
18.8 
(14.0–23.5) 
 505 1.4 
(1.2–1.5) 
30.5 
(25.6–35.4) 
 75+ years 297 0.7 
(0.6–0.8) 
15.0 
(10.4–19.6) 
 340 0.7 
(0.7–0.8) 
25.5 
(19.9–31.1) 
Total  2,733 0.9 
(0.9–1.0) 
18.1 
(16.4–19.9) 
 3,230 1.1 
(1.1–1.2) 
27.9 
(26.0–29.9) 
(a) Missing data removed: 2002–05 n=22 (age), n=31 (sex); 2009–12 n=16 (age), n=19 (sex). 
(b) Number of encounters with at least one bursitis/tendonitis/synovitis problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 9.1). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods.  
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Changes over time in imaging test types ordered  
In both time periods, the vast majority of imaging tests ordered for bursitis were diagnostic 
radiology tests or ultrasounds, together incorporating 97.8% of tests for this problem in 
Period 1 and 96.9% in Period 2 (Table 9.3). 
In Period 1, diagnostic radiology was the imaging test ordered most frequently, accounting 
for 57.9% of all imaging tests ordered for bursitis, dropping in Period 2 to 33.7%. However, 
between the two time periods, there was no difference in the rate of diagnostic radiology 
ordered per 100 bursitis problems. There were fewer x-rays of the foot, heel, wrist and knee 
in Period 2 than in Period 1. 
As a proportion of imaging tests ordered for the management of bursitis, ultrasounds 
increased significantly from 39.9% in Period 1 to 63.2% in Period 2. For every 100 bursitis 
problems managed, the rate of ultrasounds ordered more than doubled, from 7.2 per 100 in 
Period 1 to 17.7 per 100 in Period 2. This was reflected in increases in the ordering of wrist, 
foot/toe(s), shoulder and ankle ultrasounds.  
Ultrasounds of the hip were the most frequent type of ultrasound recorded in Period 2. 
However, the ICPC-2 PLUS term for ultrasounds of the hip was not available in Period 1 and 
as such, a comparison between the two time periods is not possible. During Period 1, hip 
ultrasounds would have been captured using the term ‘Ultrasound’ which does not contain 
specificity about site. Given the relatively small number of general ultrasounds recorded in 
Period 1 (1.1 per 100 bursitis problems), compared with the high number of hip ultrasounds 
recorded in Period 2 (4.4 per 100 bursitis problems) it is reasonable to assume that the rate of 
hip ultrasounds has increased significantly between the two time periods. 
Table 9.3: Imaging test orders by MBS test group and the most frequent individual tests ordered for 
bursitis/tendonitis/synovitis problems, 2002–05 and 2009–12  
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 289 57.9 
(53.7–62.1) 
10.5 
(9.3–11.7)  
307 33.7 
(30.7–36.7) 
9.4 
(8.3–10.5) 
 X-ray; foot/feet 68 13.6 
(10.5–16.8) 
2.5 
(1.9–3.1)  
76 8.3 
(6.5–10.2) 
2.3 
(1.8–2.9) 
 X-ray; heel 54 10.8 
(8.0–13.6) 
2.0 
(1.4–2.5)  
40 4.4 
(3.1–5.7) 
1.2 
(0.9–1.6) 
 X-ray; wrist 38 7.6 
(5.3–9.9) 
1.4 
(0.9–1.8)  
32 3.5 
(2.3–4.7) 
1.0 
(0.6–1.3) 
 X-ray; knee 34 6.8 
(4.7–9.0) 
1.2 
(0.8–1.6)  
27 3.0 
(1.8–4.1) 
0.8 
(0.5–1.1) 
 X-ray; hip 26 5.2 
(3.3–7.1) 
0.9 
(0.6–1.3)  
53 5.8 
(4.3–7.3) 
1.6 
(1.2–2.1) 
 X-ray; hand 16 3.2 
(1.7–4.7) 
0.6 
(0.3–0.9)  
10 1.1 
(0.4–1.8) 
0.3 
(0.1–0.5) 
(continued) 
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Table 9.3 (continued): Imaging test orders by MBS test group and the most frequent individual 
tests ordered for bursitis/tendonitis/synovitis problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Ultrasound  199 39.9 
(35.7–44.1) 
7.2 
(6.1–8.3)  
576 63.2 
(60.2–66.3) 
17.7 
(16.2–19.1) 
 Ultrasound; knee 42 8.4 
(6.0–10.9) 
1.5 
(1.1–2.0)  
50 5.5 
(4.0–7.0) 
1.5 
(1.1–2.0) 
 Ultrasound; wrist 31 6.2 
(4.1–8.3) 
1.1 
(0.7–1.5)  
66 7.2 
(5.5–9.0) 
2.0 
(1.5–2.5) 
 Ultrasound 30 6.0 
(3.7–8.3) 
1.1 
(0.6–1.5)  
11 1.2 
(0.4–2.0) 
0.3 
(0.1–0.6) 
 Ultrasound; foot/toe(s) 21 4.2 
(2.5–6.0) 
0.8 
(0.4–1.1)  
99 10.9 
(8.8–12.9) 
3.0 
(2.4–3.6) 
 Ultrasound; shoulder 15 3.0 
(1.5–4.5) 
0.5 
(0.3–0.8)  
44 4.8 
(3.4–6.2) 
1.3 
(0.9–1.8) 
 Ultrasound; ankle 13 2.6 
(1.2–4.0) 
0.5 
(0.2–0.7)  
50 5.5 
(4.0–7.0) 
1.5 
(1.1–2.0) 
 Ultrasound; hand/finger(s) 11 2.2 
(0.9–3.5) 
0.4 
(0.2–0.6)  
51 5.6 
(4.0–7.2) 
1.6 
(1.1–2.0) 
 Ultrasound; elbow 5 1.0 
(0.1–1.9) 
0.2 
(0.0–0.3)  
18 2.0 
(1.1–2.9) 
0.6 
(0.3–0.8) 
 Ultrasound; hip N/Av — — 
 
144 15.8 
(13.3–18.3) 
4.4 
(3.7–5.2) 
Computerised tomography 5 1.0 
(0.1–1.9) 
0.2 
(0.0–0.3)  
12 1.3 
(0.5–2.1) 
0.4 
(0.1–0.6) 
Magnetic resonance imaging 1 0.2 
(—) 
0.0 
(—)  
8 0.9 
(0.3–1.5) 
0.2 
(0.1–0.4) 
Nuclear medicine 5 1.0 
(0.1–0.9) 
0.2 
(0.2–0.3)  
8 0.9 
(0.2–1.5) 
0.2 
(0.1–0.4) 
Total imaging tests 499 100.0 18.1 
(16.4–19.9) 
 911 100.0 27.9 
(26.0–29.9) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; N/Av – not available (the ICPC-2 PLUS code for ultrasounds of the hip was not 
available during Period 1); (—) – indicates the number of cases was too small to calculate a confidence interval. Highlighting indicates a significant 
difference between data periods. Only the most frequent test descriptors are presented in each MBS group. 
Imaging test ordering rates by status of bursitis/tendonitis/ 
synovitis 
Table 9.4 shows the proportion of bursitis problems that were new cases (i.e. first 
presentation to a medical practitioner) and the proportion that were old problems (i.e. seen 
before by a medical practitioner) in both data periods. Over half the contacts were for the 
management of new presentations of bursitis in both time periods. 
In Period 2, the imaging order rate for bursitis was higher at initial presentations (32.2 per 
100 problems) than at follow-up consultations (22.1). A similar trend was apparent in 
Period 1, but the difference was not significant. 
From Period 1 to Period 2, there were significant increases in the imaging order rates for both 
new and old bursitis, from 20.2 to 32.2 per 100 for new problems, and from 15.4 to 22.1 per 
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100 for old problems. The likelihood of ordering an imaging test for bursitis also increased 
for both new and old problems. For new problems, the likelihood of imaging being ordered 
increased from 17.0 to 27.1 per 100 problems, and for old problems the likelihood increased 
from 13.7 to 18.8 per 100 problems. 
When extrapolated, these results, combined with the increased GP visit rate, suggest that in 
Period 1, nationally an estimated 100,000 imaging orders were placed per year by GPs for the 
management of new bursitis problems. In Period 2, about 250,000 imaging tests per year 
were ordered, or about 150,000 more per year than in Period 1. 
Similarly, in Period 1, an average 60,000 imaging orders were placed nationally per year by 
GPs for the management of old bursitis problems. In Period 2, about 120,000 imaging tests 
were ordered per year, about 60,000 more than in Period 1. 
In summary, as there was no change in the management rate or number of imaging tests 
ordered per new problem (1.12 per tested problem in Period 1 and 1.18 in Period 2), the 
increased imaging order rate (by 59.4%) appears to be a result of the increased likelihood (by 
59.4%) of GPs ordering an imaging test when managing new bursitis problems.  
Similarly, there was no change in the management rate or in the number of tests ordered for 
old problems (1.12 in Period 1 and 1.18 in Period 2). The increased imaging ordering rate (by 
43.5%) seems due to the increased likelihood (by 37.2%) of GPs ordering imaging tests for 
these old problems.  
Table 9.4: Imaging ordering rates by status of bursitis/tendonitis/synovitis, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 1,564 1,187 2,751  1,892 1,368 3,260 
Per cent of bursitis/tendonitis/ 
synovitis problems 
56.9 43.1 100.0  58.0 42.0 100.0 
Total imaging orders generated for 
problems (n) 
316 183 499  609 302 911 
Imaging orders per 100 problems 
(95% CI) 
20.2  
(17.7–22.7) 
15.4  
(13.1–17.8) 
18.1  
(16.4–19.9) 
 32.2  
(29.6–34.8) 
22.1  
(19.4–24.8) 
27.9  
(26.0–29.9) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
17.0  
(15.1–19.0) 
13.7  
(11.7–15.8) 
15.6  
(14.2–17.0) 
 27.1  
(25.0–29.2) 
18.8  
(16.6–20.9) 
23.6  
(22.1–25.2) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
9.2 New bursitis/tendonitis/synovitis 
Age-specific and sex-specific management  
The sex-specific likelihood of management of initial presentations of bursitis increased 
significantly among females (from 0.5% of female encounters in Period 1 to 0.7% in Period 2), 
but did not change for males. Similarly, in females the sex-specific rate of imaging orders for 
new bursitis increased from 20.0 tests per 100 new cases in Period 1, to 35.3 per 100 in 
Period 2, with no change observed for males (Table 9.5). 
From Period 1 to Period 2, the age-specific likelihood of management of new cases increased 
among patients aged:  
• 25–44 years (from 0.5% of encounters in this age group to 0.7%) 
• 45–64 years (from 0.8% to 1.0%) 
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• 65–74 years (from 0.6% to 0.8%). 
The imaging order rate for new bursitis increased significantly from Period 1 to Period 2 in 
the older age groups, as follows: 
• 45–64 years (17.4 to 33.1 per 100 new cases) 
• 65–74 years (22.8 to 37.3 per 100) 
• 75+ years (14.0 to 28.4) (Table 9.5). 
Table 9.5: Age-specific and sex-specific likelihood of management and test order rate for new 
bursitis/tendonitis/synovitis problems, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 
At least one 
new problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 636 0.5 
(0.5–0.6) 
20.3 
(16.4–24.3) 
 716 0.6 
(0.6–0.7) 
27.7 
(23.8–31.6) 
 Females 899 0.5 
(0.5–0.6) 
20.0 
(16.9–23.4) 
 1,155 0.7 
(0.6–0.7) 
35.3 
(31.8–38.7) 
Age        
 <15 years 61 0.2 
(0.1–0.2) 
36.1 
(21.9–50.3) 
 56 0.2 
(0.1–0.2) 
25.0 
(12.2–37.8) 
 15–24 years 102 0.4 
(0.3–0.4) 
21.6 
(10.9–32.2) 
 75 0.3 
(0.2–0.4) 
29.3 
(17.6–41.1) 
 25–44 years 387 0.5 
(0.5–0.6) 
22.9 
(17.5–28.3) 
 448 0.7 
(0.6–0.7) 
29.8 
(24.7–34.9) 
 45–64 years 620 0.8 
(0.7–0.8) 
17.4 
(13.8–20.9) 
 790 1.0 
(0.9–1.1) 
33.1 
(29.1–37.1) 
 65–74 years 202 0.6 
(0.5–0.7) 
22.8 
(16.0–29.5) 
 311 0.8 
(0.7–0.9) 
37.3 
(30.4–44.2) 
 75+ years 168 0.4 
(0.3–0.5) 
14.0 
(7.6–20.5) 
 197 0.4 
(0.4–0.5) 
28.4 
(21.1–35.8) 
Total  1,552 0.5 
(0.5–0.6) 
20.0 
(17.7–22.7) 
 1,882 0.6 
(0.6–0.7) 
32.2 
(29.6–34.8) 
(a) Missing data removed: 2002–05 n=12 (age), n=17 (sex); 2009–12 n=5 (age), n=11 (sex).  
(b) Number of encounters with at least one new bursitis/tendonitis/synovitis problem managed at encounter. It is possible for more than one of 
the specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 9.4). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods.  
Changes in imaging tests ordered for new bursitis/tendonitis/ 
synovitis problems, 2002–05 and 2009–12 
As previously reported, the overall rate of imaging orders per 100 new bursitis problems 
increased significantly between Period 1 and Period 2. Table 9.6 shows the patterns of 
individual test types ordered for these problems in the two time periods. 
Considered as a proportion of all imaging tests for new cases of bursitis, there was a definite 
shift away from diagnostic radiology to ultrasound. In Period 1, diagnostic radiology tests 
accounted for 58.5% of all tests ordered for initial presentations of bursitis, dropping to 
37.4% in Period 2. In contrast, the ordering of ultrasounds as a proportion of all imaging tests 
increased from 39.9% to 60.6% between the time periods. The rate with which ultrasounds 
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were used for new presentations of bursitis more than doubled from 8.1 orders per 100 new 
cases in Period 1, to 19.5 per 100 in Period 2. There was no change in the use of diagnostic 
radiology as a rate per 100 new cases. 
Within the diagnostic radiology group, x-rays of the heel and wrist decreased significantly as 
a proportion of imaging tests for new presentations of bursitis. Types of ultrasounds that 
increased significantly as a rate per 100 new cases of bursitis included: 
• ultrasounds of the foot/toe (from 0.8 to 3.4 per 100 new cases) 
• ultrasounds of the ankle (from 0.5 to 2.1 per 100) 
• ultrasounds of the hand/finger (from 0.4 to 1.7 per 100). 
Ultrasounds recorded without specifying the site decreased significantly, from 1.3 per 100 
new cases in Period 1, to 0.3 per 100 in Period 2. As described in Section 9.1, the ICPC-2 
PLUS term for ultrasounds of the hip was not available in Period 1 and as such, a 
comparison between the two time periods is not possible. Ultrasounds of the hip were the 
most frequent type of ultrasound recorded in Period 2 (4.7 per 100 new bursitis problems). 
Table 9.6: Changes in imaging test orders and the most frequent imaging tests ordered for new 
bursitis/tendonitis/synovitis, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI)  
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI) 
Diagnostic radiology 185 58.5 
(53.5–63.6) 
11.8 
(10.1–13.6) 
 228 37.4 
(33.8–41.1) 
12.1 
(10.5–13.7) 
 X-ray; heel 39 12.3 
(8.6–16.1) 
2.5 
(1.7–3.3) 
 35 5.7 
(3.9–7.6) 
1.8 
(1.2–2.5) 
 X-ray; foot/feet 36 11.4 
(7.7–15.0) 
2.3 
(1.5–3.1) 
 61 10.0 
(7.7–12.3) 
3.2 
(2.4–4.0) 
 X-ray; wrist 28 8.9 
(5.7–12.0) 
1.8 
(1.1–2.5) 
 21 3.4 
(2.0–4.9) 
1.1 
(0.6–1.6) 
 X-ray; knee 20 6.3 
(3.7–9.0) 
1.3 
(0.7–1.8) 
 18 3.0 
(1.6–4.3) 
1.0 
(0.5–1.4) 
 X-ray; hip 18 5.7 
(3.2–8.2) 
1.2 
(0.6–1.7) 
 42 6.9 
(4.9–8.8) 
2.2 
(1.6–2.9) 
 X-ray; elbow 9 2.8 
(1.0–4.7) 
0.6 
(0.2–0.9) 
 8 1.3 
(0.4–2.2) 
0.4 
(0.1–0.7) 
 X-ray; hand 8 2.5 
(0.8–4.2) 
0.5 
(0.2–0.9) 
 8 1.3 
(0.4–2.2) 
0.4 
(0.1–0.7) 
Ultrasound 126 39.9 
(34.7–45.0) 
8.1 
(6.6–9.5) 
 369 60.6 
(56.9–64.3) 
19.5 
(17.6–21.4) 
 Ultrasound; knee 22 7.0 
(4.2–9.8) 
1.4 
(0.8–2.0) 
 36 5.9 
(4.0–7.9) 
1.9 
(1.3–2.5) 
 Ultrasound; wrist 21 6.6 
(3.8–9.5) 
1.3 
(0.7–2.0) 
 38 6.2 
(4.3–8.2) 
2.0 
(1.4–2.6) 
 Ultrasound 20 6.3 
(3.6–9.1) 
1.3 
(0.7–1.9) 
 6 1.0 
(0.2–1.8) 
0.3 
(0.1–0.6) 
 Ultrasound; leg 15 4.7 
(2.2–7.3) 
1.0 
(0.4–1.5) 
 15 2.5 
(1.2–3.7) 
0.8 
(0.4–1.2) 
(continued) 
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Table 9.6 (continued): Changes in imaging test orders and the most frequent imaging tests ordered 
for new bursitis/tendonitis/synovitis, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI)  
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI) 
 Ultrasound; foot/toe(s) 13 4.1 
(1.9–6.3) 
0.8 
(0.4–1.3) 
 64 10.5 
(8.1–12.9) 
3.4 
(2.6–4.2) 
 Ultrasound; ankle 8 2.5 
(0.8–4.3) 
0.5 
(0.2–0.9) 
 39 6.4 
(4.5–8.4) 
2.1 
(1.4–2.7) 
 Ultrasound; shoulder 7 2.2 
(0.6–3.8) 
0.4 
(0.1–0.8) 
 23 3.8 
(2.2–5.3) 
1.2 
(0.7–1.7) 
 Ultrasound; 
 hand/finger(s) 
7 2.2 
(0.6–3.8) 
0.4 
(0.1–0.8) 
 33 5.4 
(3.6–7.2) 
1.7 
(1.2–2.3) 
 Ultrasound; hip N/Av — —  89 14.6 
(11.7–17.5) 
4.7 
(3.7–5.7) 
Computerised 
tomography 
3 0.9 
(0.0–2.0) 
0.2 
(0.0–0.4) 
 5 0.8 
(0.1–1.5) 
0.3 
(0.0–0.5) 
Magnetic resonance 
imaging 
0 — —  1 0.2 
(—) 
0.1 
(—) 
Nuclear medicine imaging 2 0.6 
(—) 
0.1 
(—) 
 6 1.0 
(0.1–1.9) 
0.3 
(0.0–0.6) 
Total imaging 316 100.0 20.2 
(17.7–22.7) 
 609 100.0 32.2 
(29.6–34.8) 
Note: CI – confidence interval; N/Av – not available (the ICPC-2 PLUS code for ultrasounds of the hip was not available during Period 1).  
(—) – indicates the number of cases was too small to calculate a confidence interval. Highlighting indicates a significant difference between data 
periods.  
9.3 Summary of findings 
Changes over time 
Imaging tests were more likely to be ordered for bursitis/tendonitis/synovitis in Period 2 
than in Period 1. The imaging order rate increased between the two time periods for both 
new and all bursitis problems, although the increase was larger for new cases of bursitis 
(59.4%) than for all bursitis problems (54.1%). However, when GPs ordered imaging, on 
average they ordered the same number of tests (Table 9.7). With 41,000 more tests ordered in 
Period 2 than in Period 1, these findings indicate that the growth in GP ordering for bursitis 
is likely to be due to the aforementioned 54.1% increase in the management rate of bursitis, 
combined with GPs deciding to investigate bursitis using imaging more often, rather than 
ordering more imaging tests at encounters where they use imaging to investigate bursitis 
problems. 
Among females, the increase in imaging tests ordered per 100 bursitis problems between the 
two time periods was striking, although greater for new bursitis (increased by 76.5%) than 
for all bursitis (64.1% increase). The rate with which GPs ordered imaging for new cases of 
bursitis in patients aged 75 years and over doubled between the two time periods. 
Ordering of ultrasounds for bursitis more than doubled between the two time periods, but 
the ordering of diagnostic radiology did not change, suggesting that the growth in ordering 
for bursitis has been driven by the ordering of ultrasounds for this problem. 
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Table 9.7: Summary of changes over time for bursitis/tendonitis/synovitis 
Bursitis/tendonitis/ 
synovitis 
Management rate  
(% change, rate)(a) 
Likelihood of 
testing  
(% change, rate)(a) 
Ordering rate per 
100 problems 
(% change, rate)(a) 
Number of tests ordered 
- per tested problem 
(% change, rate)(a) 
All  ↑ 22.2% 
(0.9, 1.1) 
↑ 51.3% 
(15.6, 23.6) 
↑ 54.1% 
(18.1, 27.9) 
No change 
(1.16, 1.18) 
 New  No change 
(0.5, 0.7) 
↑ 59.4% 
(17.0, 27.1) 
↑ 59.4% 
(20.2, 32.2) 
No change 
(1.19, 1.19) 
(a) Direction and proportion of change between 2002–05 and 2009–12. The management rate for Period 1 and Period 2, used to calculate the 
proportion of change, is shown in parentheses. 
Current imaging test order patterns  
In recent years (2009–12), almost one-quarter of presentations of bursitis resulted in an 
imaging test order. Ultrasounds were ordered most frequently for bursitis, followed by 
diagnostic radiology (Table 9.8). 
Table 9.8 also compares the status of the bursitis problem (new/old) with the imaging 
ordered. New cases of bursitis were managed more often than old cases, and were more 
likely to have imaging ordered, although there was no difference in the number of tests 
ordered per problem. Ultrasounds and diagnostic radiology were ordered most often for 
both new and old bursitis, although both were ordered more often for new cases. 
Table 9.8 Summary of GP imaging ordering for bursitis/tendonitis/synovitis, Period 2, 2009–12 
Bursitis/ 
tendonitis/ 
synovitis 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%) 
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem contacts 
(95% CI) 
Diagnostic 
radiology US CT scan MRI 
All 1.1 
(1.1–1.2) 
23.6 
(22.1–25.2) 
1.18 27.9 
(26.0–29.9) 
9.4 
(8.3–10.5) 
17.7 
(16.2–19.1) 
0.4 
(0.1–0.6) 
0.2 
(0.1–0.4) 
 New  0.7 
(0.6–0.7) 
27.1 
(25.0–29.2) 
1.18 32.2 
(29.6–34.8) 
12.1 
(10.5–13.7) 
19.5 
(17.6–21.4) 
0.3 
(0.0–0.5) 
0.1 
(—) 
 Old  0.5 
(0.4–0.5) 
18.8 
(16.6–20.9) 
1.18 22.1 
(19.4–24.8) 
5.8 
(4.4–7.1) 
15.1 
(13.1–17.2) 
0.5 
(0.1–0.9) 
0.5 
(0.1–0.9) 
Note: CI – confidence interval; US – ultrasound; CT – computerised tomography; MRI – magnetic resonance imaging; (—) – indicates the number 
of cases was too small to calculate a confidence interval. 
9.4 Summary of guidelines for imaging of bursitis 
An extensive review of guidelines for diagnostic imaging was undertaken using Medline, 
and national and international sources of guidelines such as the National Health and 
Medical Research Council (NHMRC), the United States Agency for Healthcare Research and 
Quality (AHRQ), the UK National Institute for Health and Care Excellence (NICE); and local 
and overseas colleges of radiology/radiologists. 
The only applicable guideline for the heterogeneous group of bursitis problems classified to 
ICPC-2 rubric L87 Bursitis/tendonitis/synovitis NOS was the Government of Western 
Australia Department of Health (WADoH) Diagnostic Imaging Pathways for soft tissue 
mass.18 Bursitis occurring around specific joints such as shoulder or knee are discussed in the 
relevant chapters in this report where specific guidelines and compliance are examined.  
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9.5 Compliance with guidelines 
Compliance with current guidelines is reported only for the 2009–12 period, as some changes 
in guidelines have occurred in the period between the two samples used in this study. 
The WADoH Imaging Pathways for soft tissue mass suggests the use of ultrasound as the 
first investigation and this advice is consistent with the guidelines for the investigation of 
soft tissue problems around joints discussed in other chapters. Plain x-ray is suggested for 
peri-articular or suspected osseous masses, and MRI for situations of continuing clinical 
uncertainty.  
GPs ordered ultrasound imaging at the rate of 17.7 per 100 of all bursitis problems and 19.5 
per 100 new bursitis problems. Diagnostic radiology was ordered at the rate of 9.4 per 100 of 
all bursitis problems and 12.1 per 100 new bursitis problems. This range of investigation is 
consistent with the current guidelines. CT and MRI are infrequently ordered by GPs for these 
problems.  
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10 Abdominal pain problems 
This chapter investigates the imaging orders for abdominal pain problems. As reported at 
the beginning of Section 2, GP imaging orders for abdominal pain were selected for 
investigation because: 
• there was a significant increase in the rate at which imaging tests were ordered for the 
management of abdominal pain 
• there was a statistically significant increase over time in the likelihood of GPs ordering 
imaging for the management of abdominal pain.  
Imaging orders are reported for all and for new abdominal pain problems (see Glossary). 
Changes in ordering over time are investigated between April 2002–March 2005 (Period 1) 
and April 2009–March 2012 (Period 2). 
10.1 All abdominal pain problems 
Table 10.1 shows that while there was no significant change in the management rate of 
abdominal pain between Period 1 and Period 2, there was a significant increase in the 
imaging order rate between the two data periods. 
The imaging order rate increased from 35.5 imaging tests ordered for every 100 abdominal 
pain problems managed in Period 1, to 41.5 per 100 in Period 2. The likelihood of an imaging 
test being ordered for the management of abdominal pain also significantly increased from 
31.4% in Period 1, to 36.1% in Period 2. 
The 16.9% increase in the imaging ordering rate was largely due to the increased likelihood 
of ordering (which increased by 15.0%), combined with the increased attendance rate, rather 
than an increase in the number of tests ordered after the decision to order was made.  
When these results are extrapolated to encounters across Australia, we estimate that an 
average of 240,000 imaging tests were ordered per year in the management of abdominal 
pain in Period 1, and 370,000 imaging tests per year in Period 2. This is an estimated increase 
of 130,000 imaging tests per annum for abdominal pain between the two data periods.  
Table 10.1: Abdominal pain problems management generating GP imaging orders, 2002–05 and 
2009–12  
 2002–05 (Period 1)  2009–12 (Period 2) 
Number of abdominal pain problems managed 2,053  2,182 
Management rate per 100 encounters (95% CI) 0.7 
(0.7–0.7) 
 0.7 
(0.7–0.8) 
Abdominal pain problems for which at least one imaging test ordered (n) 645  787 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 31.4 
(29.3–33.5) 
 36.1 
(34.0–38.1) 
Total imaging orders for abdominal pain problems (n) 729  905 
Imaging orders per 100 abdominal pain problems (95% CI) 35.5 
(33.0–38.0) 
 41.5 
(38.9–44.1) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. For a list of inclusions refer to Appendix 5, 
Table A5.1. 
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Age-specific and sex-specific management of abdominal pain 
problems 
There were no significant changes in the sex-specific or age-specific likelihood of 
management of abdominal pain between Period 1 and Period 2 (Table 10.2). In both data 
periods, there was a significantly higher likelihood of management of abdominal pain 
problems at encounters with females than at those with males. 
Although there was no change in the management of abdominal pain problems across age 
groups, there were significant changes in the imaging order rate. The imaging order rate was 
significantly lower for patients aged less than 15 years in both data periods, when compared 
with other age groups. There was a 30% increase in tests ordered for those aged 45–64 years 
from 40.7 tests per 100 abdominal pain problems in Period 1, to 52.9 per 100 in Period 2. 
However the imaging order rate for all other age groups remained the same between the two 
data periods. 
Table 10.2: Age-specific and sex-specific likelihood of management and test order rate for 
abdominal pain problems, 2002–05 and 2009–12 
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 628 0.5 
(0.5–0.6) 
29.0 
(24.8–33.2) 
 661 0.6 
(0.5–0.6) 
34.9 
(30.7–39.2) 
 Females 1,406 0.8 
(0.8–0.9) 
38.5 
(35.5–41.6) 
 1,497 0.9 
(0.8–0.9) 
44.2 
(41.0–47.4) 
Age        
 <15 years 281 0.8 
(0.7–0.9) 
14.2 
(9.6–18.9) 
 283 0.8 
(0.7–0.9) 
18.4 
(12.9–23.8) 
 15–24 years 240 0.9 
(0.7–1.0) 
32.5 
(25.3–39.7) 
 269 1.1 
(0.9–1.2) 
33.1 
(26.7–39.5) 
 25–44 years 597 0.8 
(0.8–0.9) 
40.1 
(35.3–44.9) 
 568 0.9 
(0.8–0.9) 
42.9 
(38.1–47.6) 
 45–64 years 560 0.7 
(0.6–0.8) 
40.7 
(35.8–45.7) 
 592 0.7 
(0.7–0.8) 
52.9 
(47.7–58.0) 
 65–74 years 198 0.6 
(0.5–0.6) 
36.4 
(28.3–44.4) 
 233 0.6 
(0.5–0.7) 
46.2 
(38.0–54.3) 
 75+ years 154 0.4 
(0.3–0.4) 
40.3 
(31.1–49.4) 
 219 0.5 
(0.4–0.5) 
41.6 
(32.9–50.2) 
Total 2,050 0.7 
(0.7–0.7) 
35.5 
(33.0–38.0) 
 2,180 0.7 
(0.7–0.8) 
41.5 
(38.9–44.1) 
(a) Missing data removed: 2002–05 n=20 (age), n=16 (sex); 2009–12 n=16 (age), n=22 (sex). 
(b) Number of encounters with at least one abdominal pain problem managed at encounter. It is possible for more than one of the specified 
problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 10.1). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
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Changes over time in imaging tests ordered 
The overall rate of imaging test orders per 100 abdominal pain problems significantly 
increased between Period 1 and Period 2 (from 35.5 to 41.5 per 100 abdominal pain problems 
managed) (Table 10.3). 
Ultrasound was the most frequently ordered type of imaging test in both data periods. In 
Period 1, ultrasound was followed by orders for diagnostic radiology, which accounted for 
16.9% of imaging tests for abdominal pain. However in Period 2, CT became the second most 
frequently ordered type of imaging test, accounting for 17.6% of imaging for abdominal pain. 
The order rate for CT significantly increased, from 4.4 per 100 abdominal pain problems in 
Period 1, to 7.3 per 100 in Period 2. In particular, CT of the abdomen increased from 3.2 to 5.4 
per 100 abdominal pain problems, and CT of the pelvis increased from 0.2 to 1.1 per 100 
abdominal pain problems. However, the numbers were small and the results should be 
interpreted with caution 
Table 10.3: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for abdominal pain problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 123 16.9 
(14.1–19.7) 
6.0 
(4.9–7.1)  
111 12.3 
(10.0–14.5) 
5.1 
(4.1–6.1) 
 X-ray; abdomen 71 9.7 
(7.5–11.9) 
3.5 
(2.6–4.3)  
76 8.4 
(6.5–10.3) 
3.5 
(2.7–4.3) 
 X-ray; chest 15 2.1 
(1.0–3.1) 
0.7 
(0.4–1.1)  
17 1.9 
(1.0–2.8) 
0.8 
(0.4–1.1) 
 Barium meal 4 0.5 
(0.0–1.1) 
0.2 
(0.0–0.4)  
3 0.3 
(0.0–0.7) 
0.1 
(0.0–0.3) 
Ultrasound 513 70.4 
(66.9–73.9) 
25.0 
(22.9–27.1)  
632 69.8 
(66.6–73.1) 
29.0 
(26.8–31.1) 
 Ultrasound; abdomen 239 32.8 
(29.3–36.3) 
11.6 
(10.2–13.1)  
307 33.9 
(30.7–37.2) 
14.1 
(12.5–15.6) 
 Ultrasound; pelvis 153 21.0 
(17.9–24.0) 
7.5 
(6.3–8.6)  
194 21.4 
(18.7–24.1) 
8.9 
(7.6–10.1) 
 Ultrasound; abdomen upper 76 10.4 
(8.2–12.7) 
3.7 
(2.9–4.5)  
84 9.3 
(7.3–11.3) 
3.8 
(3.0–4.7) 
 Ultrasound; abdomen lower 14 1.9 
(0.9–2.9) 
0.7 
(0.3–1.0)  
9 1.0 
(0.3–1.7) 
0.4 
(0.1–0.7) 
Computerised tomography 90 12.3 
(9.7–15.0) 
4.4 
(3.4–5.4)  
159 17.6 
(14.7–20.5) 
7.3 
(6.0–8.6) 
 CT scan; abdomen 66 9.1 
(7.0–11.2) 
3.2 
(2.4–4.0)  
118 13.0 
(10.8–15.3) 
5.4 
(4.4–6.4) 
 CT scan; pelvis 4 0.5 
(0.0–1.1) 
0.2 
(0.0–0.4)  
24 2.7 
(1.6–3.7) 
1.1 
(0.6–1.6) 
Magnetic resonance imaging 1 0.1 
(—) 
0.0 
(—)  
1 0.1 
(—) 
0.0 
(—) 
Nuclear medicine 2 0.3 
(—) 
0.1 
(—)  
2 0.2 
(—) 
0.1 
(—) 
Total imaging tests 729 100.0 35.5 
(33.0–38.0) 
 905 100.0 41.5 
(38.9–44.1) 
Note: CI – confidence interval; (—) – indicates the number of cases was too small to calculate a confidence interval. Only the most frequently 
recorded imaging tests were included in this table. Highlighting indicates a significant difference between data periods. 
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Imaging test ordering rates by status of abdominal pain problem 
Table 10.4 shows the proportion of abdominal pain problems managed that were new cases 
(i.e. first presentation to a medical practitioner) and the proportion that were old problems 
(i.e. seen before by a medical practitioner) in both data periods.  
The imaging order rate and likelihood of ordering imaging was significantly higher at initial 
presentations of abdominal pain (new problems) than at follow-up in both periods. 
The imaging order rate for new abdominal pain problems significantly increased from 40.6 
per 100 new cases in Period 1 to 48.3 per 100 in Period 2. When we combined these results 
with the increased GP visit rate, we estimate that in Period 1, on average 140,000 imaging 
orders were placed per year nationally for GP management of new abdominal pain 
problems. In Period 2, about 220,000 imaging tests were ordered on average per year, or 
about 80,000 more per year than in Period 1. The increase can largely be explained by the 
significant increase (by 17.4%) in the likelihood of imaging being ordered for new abdominal 
pain problems, combined with the increased attendance rate.  
There was no change in the imaging order rate or the likelihood of ordering imaging for old 
abdominal pain problems between the two data periods. 
Table 10.4: Imaging ordering rates by status of abdominal pain problems, 2002–05 and 2009–12  
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 1,065 988 2,053  1,136 1,046 2,182 
Per cent of abdominal pain problems 51.9 48.1 100.0  52.1 47.9 100.0 
Total imaging orders generated for 
problems (n) 
432 297 729  549 356 905 
Imaging orders per 100 problems 
(95% CI) 
40.6  
(37.0–44.1) 
30.1  
(26.7–33.4) 
35.5  
(33.0–38.0) 
 48.3  
(44.6–52.0) 
34.0  
(30.6–37.5) 
41.5  
(38.9–44.1) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
35.6  
(32.6–38.5) 
26.9  
(24.1–29.8) 
31.4  
(29.3–33.5) 
 41.8  
(38.9–44.7) 
29.8  
(27.0–32.7) 
36.1  
(34.0–38.1) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
10.2 New abdominal pain problems 
Age-specific and sex-specific imaging order rates for new 
abdominal pain problems 
There were no significant changes in the sex-specific or age-specific likelihood of 
management of new abdominal pain between Period 1 and Period 2 (Table 10.5). However 
there were significant changes in the imaging order rate. These results follow a very similar 
pattern to those for all abdominal pain problems shown in Table 10.2. 
• The imaging order rate was significantly lower for patients aged less than 15 years in 
both data periods when compared with other age groups. 
• There was a 30% increase in tests ordered for the 45–64 year age group, from 50.9 tests 
per 100 new abdominal pain problems in Period 1, to 66.9 per 100 in Period 2. 
• The imaging order rate for all other age groups remained the same between the two data 
periods. 
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Table 10.5: Age-specific and sex-specific likelihood of management and test order rate for new 
abdominal pain problems, 2002–05 and 2009–12 
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 343 0.3 
(0.3–0.3) 
33.2 
(27.3–39.2) 
 375 0.3 
(0.3–0.4) 
40.5 
(34.9–46.2) 
 Females 712 0.4 
(0.4–0.4) 
44.0 
(39.5–48.4) 
 746 0.4 
(0.4–0.5) 
51.9 
(47.1–56.6) 
Age        
 <15 years 161 0.5 
(0.4–0.5) 
12.4 
(6.8–18.1) 
 174 0.5 
(0.4–0.6) 
14.4 
(9.0–20.0) 
 15–24 years 139 0.5 
(0.4–0.6) 
34.5 
(25.0–44.1) 
 138 0.6 
(0.5–0.7) 
37.0 
(27.5–46.4) 
 25–44 years 312 0.4 
(0.4–0.5) 
45.2 
(38.3–52.1) 
 294 0.4 
(0.4–0.5) 
48.6 
(42.0–55.3) 
 45–64 years 287 0.4 
(0.3–0.4) 
50.9 
(43.5–58.2) 
 308 0.4 
(0.3–0.4) 
66.9 
(59.3–74.5) 
 65–74 years 84 0.2 
(0.2–0.3) 
48.8 
(36.1–61.5) 
 118 0.3 
(0.3–0.4) 
58.5 
(46.5–70.5) 
 75+ years 69 0.2 
(0.1–0.2) 
43.5 
(30.2–56.8) 
 101 0.2 
(0.2–0.3) 
54.5 
(39.7–69.2) 
Total  1,065 0.4 
(0.3–0.4) 
40.6 
(37.0–44.1) 
 1,136 0.4 
(0.4–0.4) 
48.3 
(44.6–52.0) 
(a) Missing data removed: 2002–05 n=13 (age), n=8 (sex); 2009–12 n=3 (age), n=15 (sex). 
(b) Number of encounters with at least one new abdominal pain problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 10.4). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes over time in imaging tests ordered for new abdominal pain 
problems 
The overall rate of imaging test orders per 100 new abdominal pain problems significantly 
increased by 19%, from 40.6 per 100 new cases in Period 1, to 48.3 per 100 in Period 2.  
Ultrasounds were the most frequently ordered type of imaging test in both data periods. In 
Period 1, these were followed by orders for diagnostic radiology, which accounted for 16.7% 
of imaging tests for new abdominal pain. However in Period 2, CT became the second most 
frequently ordered type of imaging test after increasing by 70%, accounting for 16.2% of 
imaging tests for new abdominal pain.  
The order rate for CT scan doubled between the two data periods, from 3.8 per 100 new cases 
in Period 1, to 7.8 per 100 in Period 2. In particular, orders for CT of the abdomen doubled 
from 3.0 to 6.2 per 100 new cases (Table 10.6). 
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Table 10.6: Changes in imaging test orders and most frequent imaging tests ordered for new 
abdominal pain problem, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI)  
Number 
of tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI) 
Diagnostic radiology 72 16.7 
(13.1–20.3) 
6.8 
(5.1–8.4) 
 69 12.6 
(9.7–15.5) 
6.1 
(4.5–7.6) 
 X-ray; abdomen 44 10.2 
(7.3–13.1) 
4.1 
(2.9–5.4) 
 46 8.4 
(6.1–10.7) 
4.0 
(2.9–5.2) 
 X-ray; chest 7 1.6 
(0.4–2.8) 
0.7 
(0.2–1.1) 
 13 2.4 
(1.1–3.6) 
1.1 
(0.5–1.8) 
Ultrasound 318 73.6 
(69.2–78.0) 
29.9 
(26.9–32.8) 
 391 71.2 
(67.0–75.4) 
34.4 
(31.3–37.5) 
 Ultrasound; abdomen 152 35.2 
(30.7–39.7) 
14.3 
(12.1–16.5) 
 178 32.4 
(28.4–36.4) 
15.7 
(13.5–17.9) 
 Ultrasound; pelvis 97 22.5 
(18.4–26.5) 
9.1 
(7.3–10.9) 
 120 21.9 
(18.4–25.3) 
10.6 
(8.7–12.4) 
 Ultrasound; abdomen 
 upper 
46 10.6 
(7.6–13.7) 
4.3 
(3.1–5.6) 
 59 10.7 
(8.1–13.4) 
5.2 
(3.9–6.5) 
 Ultrasound; abdomen lower 7 1.6 
(0.4–2.8) 
0.7 
(0.2–1.1) 
 5 0.9 
(0.1–1.7) 
0.4 
(0.1–0.8) 
 Ultrasound; gallbladder 5 1.2 
(0.1–2.2) 
0.5 
(0.1–0.9) 
 4 0.7 
(0.0–1.6) 
0.4 
(0.0–0.8) 
 Ultrasound; kidney 2 0.5 
(—) 
0.2 
(—) 
 6 1.1 
(0.2–2.0) 
0.5 
(0.1–1.0) 
Computerised tomography 41 9.5 
(6.5–12.5) 
3.8 
(2.6–5.1) 
 89 16.2 
(12.6–19.8) 
7.8 
(6.0–9.7) 
 CT scan; abdomen 32 7.4 
(5.0–9.8) 
3.0 
(2.0–4.0) 
 70 12.8 
(10.0–15.5) 
6.2 
(4.8–7.6) 
 CT scan; pelvis 1 0.2 
(—) 
0.1 
(—) 
 12 2.2 
(1.0–3.4) 
1.1 
(0.5–1.7) 
Magnetic resonance 
imaging 
0 — —  0 — — 
Nuclear medicine 1 0.2 
(—) 
0.1 
(—) 
 0 — — 
Total imaging tests 432 100.0 40.6 
(37.0–44.1) 
 549 100.0 48.3 
(44.6–52.0) 
Note: Highlighting indicates a significant difference between data periods; CI – confidence interval; (—) – indicates the number of cases was too 
small to calculate a confidence interval. 
10.3 Summary of findings  
Changes over time 
Table 10.7 summarises the changes to the imaging ordering behaviour of GPs over time. 
There was a significant increase in the likelihood of ordering imaging, and this resulted in an 
increased imaging order rate per 100 abdominal pain problems managed. These changes 
were mirrored for new cases of abdominal pain. 
There was no change in the management rate of abdominal pain between the two data 
periods; however the management rate of abdominal pain and the imaging order rate were 
significantly higher at encounters with females than at those with males. 
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Ultrasound was the most frequently ordered type of imaging test for abdominal pain in both 
data periods. In Period 1, these were followed by orders for diagnostic radiology. In Period 2, 
there was a move away from diagnostic radiology toward CT, which was the second most 
frequently ordered type of imaging test.  
For new cases of abdominal pain, ultrasound was also the most frequently ordered type of 
imaging test. In Period 1, these were followed by orders for diagnostic radiology. In Period 2, 
the rate at which CT was ordered per 100 new abdominal pain problems doubled, and 
became the second most frequently ordered imaging test. 
Table 10.7: Summary of changes over time for abdominal pain 
Abdominal pain 
Management rate  
(% change, rate)(a) 
Likelihood of 
testing  
(% change, rate)(a) 
Ordering rate per 
100 problems 
(% change, rate)(a) 
Number of tests ordered 
per tested problem 
(% change, rate)(a) 
All  No change 
(0.7, 0.7) 
↑ 15.0% 
(31.4, 36.1) 
↑ 16.9% 
(35.5, 41.5) 
No change 
(1.13, 1.15) 
 New  No change 
(0.4, 0.4) 
↑ 17.4% 
(35.6, 41.8) 
↑ 18.2% 
(40.6, 48.3) 
No change 
(1.14, 1.16) 
(a) Direction and proportion of change between 2002–05 and 2009–12. The management rate for Period 1 and Period 2, used to calculate the 
proportion of change, is shown in parentheses. 
Current imaging test order patterns 
Table 10.8 summarises the recent imaging ordering behaviour of GPs. GPs ordered imaging 
for about one-third of abdominal pain problems seen and usually ordered only one test. As a 
result, they ordered 41.5 tests on average for every 100 abdominal pain problems managed. 
Ultrasound was by far the most frequently ordered test, accounting for about 70% of all 
imaging tests ordered, followed by CT scans (17.6%) and diagnostic radiology (12.3%). 
The imaging order rate and likelihood of ordering imaging was significantly higher for new 
presentations of abdominal pain than for old cases (Table 10.8). The average number of tests 
ordered per 100 problems was also higher for new abdominal pain. However, there was no 
change in the management rate of new and old cases of abdominal pain. 
The rate at which ultrasound and CT was ordered was significantly higher for new 
abdominal pain than old cases. There was no difference in the rate at which diagnostic 
radiology was ordered for new and old cases of abdominal pain. 
Table 10.8: Summary of GP imaging ordering for abdominal pain, Period 2, 2009–12 
Abdominal 
pain 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%)  
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem 
contacts (95% CI) 
Diagnostic 
radiology US CT scan MRI 
All 0.7 
(0.7–0.8) 
36.1 
(34.0–38.1) 
1.15 41.5 
(38.9–44.1) 
5.1 
(4.1–6.1) 
29.0 
(26.8–31.1) 
7.3 
(6.0–8.6) 
0.0 
(—) 
 New  0.4 
(0.4–0.4) 
41.8 
(38.9–44.7) 
1.16 48.3 
(44.6–52.0) 
6.1 
(4.5–7.6) 
34.4 
(31.3–37.5) 
7.8 
(6.0–9.7) 
0.0 
(—) 
 Old  0.4 
(0.3–0.4) 
29.8 
(27.0–32.7) 
1.14 34.0 
(30.6–37.5) 
4.0 
(2.8–5.3) 
23.0 
(20.2–25.8) 
6.7 
(4.9–8.4) 
0.0 
(—) 
Note: CI – confidence interval; US – ultrasound; CT – computerised tomography; MRI – magnetic resonance imaging; (—) – indicates the number 
of cases was too small to calculate a confidence interval.  
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10.4 Summary of guidelines for imaging of 
 abdominal pain problems 
Both the Government of Western Australia Department of Health (WADoH) Diagnostic 
Imaging Pathways,9 and the American College of Radiology Appropriateness Criteria 
(ACRAC) 21,23,26,27 divide the investigation of abdominal pain by location and/or presumptive 
diagnosis. WADoH Imaging Pathways generally advocate the use of ultrasound in 
elucidating the diagnosis in right upper and lower abdominal pain, particularly in women of 
child-bearing age and in children. Additional CT imaging is indicated when a negative 
examination is accompanied by high clinical suspicion. The common cause of left lower 
abdominal pain in older patients is diverticulitis and CT is the most discriminating 
investigation. In women of child-bearing age, gynaecological causes are the most common 
cause of left lower abdominal pain and ultrasound is the investigation of choice. The ACRAC 
advocate CT as the investigation of choice for most abdominal pain sites except in women 
and children. 
The limited literature on imaging orders for abdominal pain by GPs indicate both ultrasound 
and CT have reasonable sensitivity but both have low yield of diagnoses in the absence of 
‘red flag’ indicators.105-108 
The literature also indicates that GPs show similar discrimination to other medical specialists 
in requesting imaging orders for abdominal pain and demonstrate a high appreciation of the 
value of imaging in the management of this problem.109 
10.5 Compliance with guidelines 
The results of this study indicate that an appropriate range of modalities appear to be used 
by Australian GPs. The overall rate of imaging for abdominal pain problems increased 
significantly over the period of the study.  
Ultrasound remains the modality of choice for general practitioners. There has been a shift 
away from plain x-ray imaging to CT scanning. Both of these findings are consistent with the 
guidelines for the investigation of abdominal pain. Due to the generally low yield of imaging 
investigations in this area, advice to GPs regarding the use of ‘red flag’ symptoms and signs 
to guide imaging ordering may decrease unnecessary imaging. Lameris found that “using 
ultrasonography first and CT only in those with negative or inconclusive ultrasonography 
results in the best sensitivity and lowers the exposure to radiation”.105 This sequential 
approach to imaging orders should be considered in reviews of guidelines.  
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11 Knee problems 
This chapter investigates imaging orders for knee problems, recorded by GPs from April 
2002–March 2005 (Period 1), to April 2009–March 2012 (Period 2). Throughout the chapter, 
‘knee problems’ includes all problems of the knee excluding arthritis/osteoarthritis of the 
knee. As reported at the beginning of Section 2, GP imaging orders for knee problems were 
selected for investigation because, although the GPs’ imaging ordering rates did not change 
over time, knee problems were identified as an area of poor quality of GP imaging ordering 
in 2001 and warranted further investigation. 
Based on the rationale that guidelines recommend different management of knee problems 
depending on their status as a symptom/complaint or as a defined condition (see Chapter 2), 
knee problems were grouped and categorised as: 
• ‘knee symptom/complaint (all)’ and 
• ‘knee syndrome (all)’.  
The full list of ICPC-2 rubrics and ICPC-2 PLUS codes and terms included in each group are 
provided in Appendix 5, Table A5.1.  
Imaging orders are investigated for: 
• all knee problems 
• all knee problems grouped as ‘knee syndrome’ 
• new problems grouped as ‘knee syndrome’ 
• all knee problems grouped as ‘knee symptom/complaint’ 
• new problems grouped as ‘knee symptom/complaint’ 
Changes in ordering over time between Period 1 and Period 2 are reported. 
11.1 All knee problems 
Table 11.1 shows the total number of knee problems managed, and the distribution of the 
knee problems across knee syndrome and knee symptoms/complaints in Period 1 and 
Period 2.  
While the management rate for knee syndrome did not change between the two data 
periods, the management rate for knee symptom/complaint increased marginally, from 0.2 
to 0.3 per 100 encounters. Knee syndrome and knee symptoms/complaints each accounted 
for around half of all knee problems in both data periods.  
The management rate of total knee problems per 100 encounters significantly increased  
over the time period, resulting in a significant increase in the estimated annual encounters 
involving knee problems nationally. These increased from 0.5 million encounters (95% CI: 
0.5–0.5) in Period 1 to 0.7 million (95% CI: 0.7–0.7) in Period 2. This is due to the increased GP 
visit rate described in Chapter 2. 
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Table 11.1: Knee problems managed by problem type, 2002–05 and 2009–12 
Knee problems(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
problems 
Per cent of 
knee 
problems 
Per 100 
encounters 
(95% CI)  
Number of 
problems 
Per cent of 
knee 
problems 
Per 100 
encounters 
(95% CI) 
Knee syndrome  796 53.2 0.3 
(0.2–0.3) 
 874 50.8 0.3 
(0.3–0.3) 
Knee symptom/complaint 699 46.8 0.2 
(0.2–0.3) 
 845 49.2 0.3  
(0.3–0.3) 
Total knee problems 1,495 100.0 0.5 
(0.5–0.5)  
1,719 100.0 0.6 
(0.6–0.6) 
(a) For a list of inclusions refer to Appendix 5, Table A5.1. 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Table 11.2 shows that the rate at which imaging was ordered in the management of knee 
problems did not change between Period 1 and Period 2.  
In 2002–05, there were 1,495 knee problems managed and at least one imaging test was 
ordered for 485 of these (32.4% likelihood). A total of 515 imaging test orders were placed, at 
a rate of 34.4 tests per 100 knee problems managed. 
In 2009–12, there were 1,719 knee problems managed, and for 611 of these, at least one 
imaging test order was made (35.5% likelihood). In total, 676 imaging test orders were placed 
at a rate of 39.3 imaging tests per 100 knee problems managed. Knee problems contributed 
similar proportions of total imaging orders generated for all problems, in Period 1 (1.9%) and 
in Period 2 (2.2%) (see Table 4.4). 
When these two results are considered with the increased GP visit rate, we calculate that in 
Period 1, 170,000 imaging orders were placed nationally by GPs for the management of knee 
problems. In Period 2, there were 280,000 imaging orders placed, or about 110,000 more than 
in Period 1. 
In summary, there was a 14.2% increase in the imaging order rate for all knee problems 
between Period 1 and Period 2. As the rate of tests per tested problem did not change 
(average of 1.1 tests per problem in both periods), the increase in imaging orders for knee 
problems appears to be a result of the increased management rate (by 18.0%) and the 
increased likelihood (by 9.6%) of GPs ordering at least one imaging test when knee problems 
were managed. 
Table 11.2: Knee problem management generating GP imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total knee problems managed 1,495  1,719 
Knee problems for which at least one imaging test ordered (n) 485  611 
Likelihood of ordering 1+ tests (per cent of problems)  
(95% CI) 
32.4 
(30.0–34.9) 
 35.5 
(33.2–37.9) 
Total imaging orders generated for knee problems (n) 515  676 
Imaging orders per 100 knee problems (95% CI) 34.4 
(31.8–37.1) 
 39.3 
(36.5–42.1) 
Note: CI – confidence interval.  
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Age-specific and sex-specific management of knee problems 
There was a significant increase over time in the management of knee problems, from 0.5% 
to 0.6% of encounters. In both data periods, the likelihood of management of knee problems 
was marginally higher at encounters with males than at those with females. There was a 
marginal increase in the management at encounters with males between Period 1 and 
Period 2, and a significant increase in the management at encounters with females. 
The age-specific likelihood of management in the 45–64 year age group increased 
significantly, from 0.6% to 0.8% of encounters in this age group, with a marginal increase in 
the management among patients aged 75 years and over, from 0.2% to 0.3%.  
However, there were no changes in the imaging order rate per 100 knee problems between 
Period 1 and Period 2, for either sex or any age group (Table 11.3). 
Table 11.3: Age-specific and sex-specific likelihood of management and test order rate for knee 
problems, 2002–05 and 2009–12 
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 785 0.8 
(0.7–0.9) 
34.1 
(30.5–37.8) 
 818 1.0 
(0.9–1.1) 
40.2 
(36.1–44.3) 
 Females 694 0.7 
(0.6–0.7) 
34.6 
(30.7–38.4) 
 885 0.8 
(0.8–0.9) 
38.8 
(35.1–42.4) 
Age        
 <15 years 90 0.3 
(0.2–0.3) 
42.2 
(30.4–54.1) 
 81 0.2 
(0.2–0.3) 
45.7 
(32.0–59.4) 
 15–24 years 178 0.6 
(0.5–0.7) 
38.2 
(30.1–46.3) 
 153 0.6 
(0.5–0.7) 
42.5 
(32.9–52.1) 
 25–44 years 489 0.7 
(0.6–0.7) 
29.4 
(24.9–35.0) 
 503 0.8 
(0.7–0.8) 
33.8 
(29.3–38.3) 
 45–64 years 511 0.6 
(0.6–0.7) 
38.2 
(33.6–42.8) 
 653 0.8 
(0.8–0.9) 
40.4 
(36.0–44.7) 
 65–74 years 124 0.4 
(0.3–0.4) 
33.1 
(24.8–41.3) 
 173 0.5 
(0.4–0.5) 
47.4 
(37.7–57.1) 
 75+ years 91 0.2 
(0.2–0.3) 
27.5 
(17.4–37.5) 
 143 0.3 
(0.3–0.4) 
38.5 
(29.0–48.0) 
Total  1,495 0.5 
(0.5–0.5) 
34.4 
(31.8–37.1) 
 1,716 0.6 
(0.6–0.6) 
39.3 
(36.5–42.1) 
(a) Missing data removed: 2002–05 n=12 (age), n=16 (sex); 2009–12 n=10 (age), n=13 (sex). 
(b) Number of encounters with at least one knee problem managed at encounter. It is possible for more than one of the specified problem to be 
managed per encounter, therefore this total may differ from the total number of problems (reported in Table 11.2). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
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Changes over time in imaging test types ordered 
There were some changes in the types of tests ordered across MBS groups. While there was a 
move away from diagnostic radiology, and toward MRI, the former remained the 
predominant test group. Table 11.4 shows that the ordering rate for MRI per 100 knee 
problems managed significantly increased between Period 1 (1.5 per 100 knee problems 
managed) and Period 2 (5.0 per 100). There was an apparent increase in nuclear medicine, 
however the numbers are very small and should be considered with caution. 
Table 11.4: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for knee problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 436 84.7 
(81.6–87.7) 
29.2 
(26.8–31.6) 
 493 72.9 
(69.5–76.4) 
28.7 
(26.4–31.0) 
 X-ray; knee 425 82.5 
(79.3–85.7) 
28.4 
(26.1–30.8) 
 468 69.2 
(65.7–72.7) 
27.2 
(25.0–29.4) 
Ultrasound  48 9.3 
(6.8–11.8) 
3.2 
(2.3–4.1) 
 68 10.1 
(7.8–12.3) 
4.0 
(3.0–4.9) 
 Ultrasound; knee 45 8.7 
(6.3–11.2) 
3.0 
(2.1–3.9) 
 62 9.2 
(7.0–11.4) 
3.6 
(2.7–4.5) 
Computerised tomography  9 1.7 
(0.5–3.0) 
0.6 
(0.2–1.0) 
 23 3.4 
(2.0–4.8) 
1.3 
(0.8–1.9) 
Magnetic resonance imaging 22 4.3 
(2.5–6.1) 
1.5 
(0.8–2.1) 
 86 12.7 
(9.8–15.6) 
5.0 
(3.8–6.2) 
Nuclear medicine 0 0.0 
(—) 
0.0 
(—) 
 6 0.9 
(0.2–1.6) 
0.6 
(0.1–0.6) 
Total imaging tests 515 100.0 34.4 
(31.8–37.1)  
676 100.0 39.3 
(36.5–42.1) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
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11.2 Knee syndrome 
Table 11.5 shows the rate at which imaging was ordered in the management of knee 
syndrome over the two time periods, and that the imaging ordering rate for knee syndrome 
did not change.  
In 2002–05, there were 796 knee syndrome problems managed and GPs ordered at least one 
imaging test for 248 of these (31.2% likelihood). A total of 266 imaging test orders were 
placed, at a rate of 33.4 imaging tests per 100 knee syndrome problems managed.  
In 2009–12, there were 874 knee syndrome problems managed, and for 280 of these, GPs 
ordered at least one imaging test (32.0% likelihood). A total of 307 imaging test orders were 
placed, at a rate of 35.1 imaging tests per 100 knee syndrome problems managed.  
In Period 1, an estimated 90,000 imaging orders per annum were placed nationally by GPs in 
the management of knee syndrome problems. In Period 2, there were about 130,000 imaging 
orders placed per year, or about 40,000 more per year than in Period 1. 
In summary, there were no changes in: the management rate of knee syndrome problems 
(0.3 per 100 encounters in both periods); the likelihood of ordering a test (31.2% in Period 1, 
and 32.0% in Period 2); and the rate at which imaging tests were ordered for knee syndrome 
problems (33.4 per 100 problems in Period 1, and 35.1 per 100 in Period 2). There was also no 
change in the number of tests ordered per tested knee problem (1.1 per tested problem in 
both periods) (results not tabled). Therefore, the increase in the number of tests ordered 
nationally is entirely due to the increased GP visit rate. 
Table 11.5: Knee syndrome management generating GP imaging orders, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total knee syndrome problems managed 796  874 
Knee syndrome problems for which at least one imaging test 
ordered (n) 
248  280 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 31.2 
(27.7–34.6) 
 32.0 
(28.8–35.3) 
Total imaging orders generated for knee syndrome problems (n) 266  307 
Imaging orders per 100 knee syndrome problems (95% CI) 33.4 
(29.6–37.2) 
 35.1 
(31.3–38.9) 
Note: CI – confidence interval.  
Age-specific and sex-specific management  
In both data periods, the likelihood of management was significantly higher at encounters 
with males than at those with females. The sex-specific likelihood did not change over time 
at encounters with males, but marginally increased for females. 
The age-specific likelihood of management was highest for patients in the age groups 
ranging from 15 to 64 years, but there were no changes for any age groups between the two 
time periods. 
There were no changes in the overall rate at which imaging tests were ordered for knee 
syndrome problems, or for any age or sex (Table 11.6). 
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Table 11.6: Age-specific and sex-specific likelihood of management and test order rate for knee 
syndrome, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 471 0.4 
(0.4–0.4) 
34.8 
(29.8–39.9) 
 463 0.4 
(0.4–0.4) 
36.4 
(31.2–41.7) 
 Females 314 0.2 
(0.2–0.2) 
31.2 
(25.9–36.6) 
 404 0.2 
(0.2–0.3) 
33.9 
(28.6–39.2) 
Age        
 <15 years 38 0.1 
(0.1–0.1) 
36.8 
(19.0–55.0) 
 25 0.1 
(0.0–0.1) 
41.3 
(29.4–53.2) 
 15–24 years 110 0.4 
(0.3–0.5) 
35.5 
(25.0–45.9) 
 92 0.4 
(0.3–0.5) 
41.3 
(29.4–53.2) 
 25–44 years 305 0.4 
(0.4–0.5) 
31.1 
(25.1–37.2) 
 303 0.5 
(0.4–0.5) 
29.0 
(23.4–34.7) 
 45–64 years 271 0.3 
(0.3–0.4) 
35.1 
(28.5–41.6) 
 337 0.4 
(0.4–0.5) 
33.7 
(28.2–39.3) 
 65–74 years 42 0.1 
(0.1–0.2) 
33.3 
(18.8–47.9) 
 71 0.2 
(0.1–0.2) 
52.1 
(35.2–69.1) 
 75+ years 26 0.1 
(0.0–0.1) 
34.6 
(13.1–56.1) 
 42 0.1 
(0.1–0.1) 
45.2 
(25.8–64.7) 
Total  796 0.3 
(0.2–0.3) 
33.4 
(29.6–37.2) 
 873 0.3 
(0.3–0.3) 
35.1 
(31.3–38.9) 
(a) Missing data removed: 2002–05 n=4 (age), n=11 (sex); 2009–12 n=3 (age), n=6 (sex).  
(b) Number of encounters with at least one knee syndrome problem managed at encounter. It is possible for more than one of the specified 
problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 11.5). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes in imaging test types ordered 
There were considerable changes in the types of tests ordered across MBS groups. Table 11.7 
shows that, although the imaging ordering rate for diagnostic radiology did not change, 
there was a general move away from diagnostic radiology as a proportion of tests for knee 
syndrome toward MRI. Between Period 1 and Period 2, the order rate for MRI significantly 
increased from 2.0 to 7.0 per 100 knee syndrome problems managed. 
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Table 11.7: Imaging test orders by MBS and most frequent imaging tests ordered for knee 
syndrome, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 217 81.6 
(76.9–86.2) 
27.3 
(24.0–30.5) 
 205 66.8 
(61.3–72.3) 
23.5 
(20.4–26.5) 
 X-ray; knee 212 79.7 
(74.9–84.5) 
26.6 
(23.4–29.9) 
 195 63.5 
(58.0–69.0) 
22.3 
(19.4–25.2) 
Ultrasound 26 9.8 
(6.2–13.4) 
3.3 
(2.0–4.6) 
 28 9.1 
(5.9–12.4) 
3.2 
(2.0–4.4) 
 Ultrasound; knee 25 9.4 
(5.8–13.0) 
3.1 
(1.9–4.4) 
 27 8.8 
(5.6–12.0) 
3.1 
(1.9–4.3) 
Computerised tomography 7 2.6 
(0.5–4.8) 
0.9 
(0.1–1.6) 
 12 3.9 
(1.7–6.1) 
1.4 
(0.6–2.1) 
Magnetic resonance imaging 16 6.0 
(3.1–9.0) 
2.0 
(1.0–3.0) 
 61 19.9 
(14.7–25.1) 
7.0 
(5.0–8.9) 
Nuclear medicine 0 0.0 
(—) 
0.0 
(—) 
 1 0.3 
(—) 
0.1 
(—) 
Total imaging tests 266 100.0 33.4 
(29.6–37.2) 
 307 100.0 35.1 
(31.3–38.9) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
Imaging test ordering rates by status of knee syndrome problem 
Table 11.8 shows the proportions of contacts generating an imaging order for new and old 
knee syndrome problems in both data periods. GP contacts were divided equally between 
new and previously diagnosed knee syndrome problems, in both 2002–05 and 2009–12.  
In both data periods, the imaging order rate for knee syndrome problems was twice as high 
at initial presentations (45.7 orders per 100 knee syndrome problems in Period 1 and 48.5 per 
100 in Period 2) than at follow-up consultations (21.5 orders per 100 knee syndrome 
problems in Period 1 and 21.7 per 100 in Period 2). Similarly, the likelihood of ordering was 
higher at initial presentations than follow-up consultations. Neither the imaging order rate 
nor the likelihood of ordering at least one imaging test per 100 new, or old, knee syndrome 
problems, changed between the two data periods. 
These results, combined with the increased GP visit rate, suggest that in Period 1, about 
60,000 imaging orders per year were placed nationally by GPs for the management of new 
knee syndrome problems. In Period 2, there were about 90,000 imaging tests ordered per 
year, or about 30,000 more per annum than in Period 1. 
In summary, there were no changes in: the management rate of new knee syndrome 
problems (0.1 per 100 encounters in Period 1 and 0.2 in Period 2); the likelihood of ordering a 
test (42.1% in Period 1 and 43.7% in Period 2); the rate at which imaging tests were ordered 
(45.7 per 100 problems in Period 1 and 48.8 per 100 in Period 2); and no change in the 
number of tests ordered per new knee syndrome problem (1.08 per tested problem in 
Period 1 and 1.11 in Period 2). Therefore we can conclude that the increase in the number of 
tests ordered nationally was entirely due to the increased GP visit rate. 
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Table 11.8: Imaging ordering rates by status of knee syndrome problems, 2002–05 and 2009–12  
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 392 404 796  437 437 874 
Per cent of knee syndrome 
problems 
49.2 50.8 100.0  50.0 50.0 100.0 
Total imaging orders generated for 
problems (n) 
179 87 266  212 95 307 
Imaging orders per 100 problems 
(95% CI) 
45.7  
(39.8–51.5) 
21.5  
(17.1–25.9) 
33.4  
(29.6–37.2) 
 48.5  
(42.7–54.3) 
21.7  
(17.3–26.2) 
35.1  
(31.3–38.9) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
42.1  
(36.9–47.3) 
20.5  
(16.6–24.5) 
31.2  
(27.7–34.6) 
 43.7  
(38.9–48.5) 
20.4  
(16.4–24.3) 
32.0  
(28.8–35.3) 
Note: CI – confidence interval.  
11.3 New knee syndrome 
Age-specific and sex-specific management 
The likelihood of management of new knee syndrome problems did not change between 
Period 1 and Period 2. In both data periods, the likelihood of management at encounters 
with males was significantly higher than at encounters with females. The sex-specific 
likelihood of management at encounters with females increased significantly between 
Period 1 and Period 2, but did not change for encounters with males (Table 11.9). The age-
specific management likelihood increased significantly for patients aged 65–74 years. 
There were no changes in the rate of imaging ordered for the management of new knee 
syndrome problems for either sex or any age group. 
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Table 11.9: Age-specific and sex-specific likelihood of management and test order rate for new 
knee syndrome problems, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 232 0.2 
(0.2–0.2) 
48.7 
(40.9–56.5) 
 214 0.2 
(0.2–0.2) 
52.3 
(43.9–60.8) 
 Females 157 0.1 
(0.1–0.1) 
40.8 
(32.8–48.8) 
 220 0.1 
(0.1–0.1) 
45.5 
(37.9–53.0) 
Age        
 <15 years 25 0.1 
(0.0–0.1) 
46.8 
(31.6–61.9) 
 15 0.0 
(0.0–0.1) 
59.3 
(42.1–76.4) 
 15–24 years 62 0.2 
(0.2–0.3) 
46.8 
(31.6–61.9) 
 54 0.2 
(0.2–0.2) 
59.3 
(42.1–76.4) 
 25–44 years 144 0.2 
(0.2–0.2) 
44.4 
(34.2–54.7) 
 139 0.2 
(0.1–0.2) 
44.6 
(34.7–54.5) 
 45–64 years 124 0.2 
(0.1–0.2) 
50.0 
(40.0–60.0) 
 157 0.2 
(0.2–0.2) 
45.2 
(36.3–54.2) 
 65–74 years 19 0.1 
(0.0–0.1) 
52.6 
(27.9–77.4) 
 42 0.1 
(0.1–0.2) 
57.1 
(37.4–76.9) 
 75+ years 18 0.0 
(0.0–0.1) 
33.3 
(9.2–57.5) 
 28 0.1 
(0.0–0.1) 
53.6 
(28.9–78.3) 
Total  392 0.1 
(0.1–0.2) 
45.7 
(39.8–51.5) 
 437 0.2 
(0.1–0.2) 
48.5 
(42.7–54.3) 
(a) Missing data removed: 2002–05 n=0 (age), n=3 (sex); 2009–12 n=2 (age), n=3 (sex).  
(b) Number of encounters with at least one new knee syndrome problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 11.8). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes in imaging test types ordered 
Table 11.10 shows there were very few changes in the types of tests ordered across MBS 
groups, or in the ordering rate of specific tests over the data period.  
Between Period 1 and Period 2, orders for MRI increased significantly, both as a proportion 
of all imaging tests for new knee syndrome problems, and as a rate per 100 new knee 
syndrome problems managed. The latter had a more than threefold increase, from 2.8 to 8.9 
per 100 new knee syndrome problems managed. There were no changes over the time period 
for diagnostic radiology, ultrasound or CT. Nuclear medicine was not employed in the 
management of new knee syndrome in either data period. 
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Table 11.10: Imaging test orders by MBS test group and the most frequent imaging tests ordered for 
new knee syndrome problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number of 
tests 
Per cent of 
tests for this 
problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 142 79.3 
(73.6–85.0) 
36.2 
(31.2–41.2) 
 148 69.8 
(63.8–75.8) 
33.9 
(29.0–38.8) 
 X-ray; knee 140 78.2 
(72.4–84.0) 
35.7 
(30.7–40.7) 
 141 66.5 
(60.4–72.6) 
32.3 
(27.7–36.9) 
Ultrasound 21 11.7 
(7.2–16.3) 
5.4 
(3.1–7.6) 
 17 8.0 
(4.3–11.7) 
3.9 
(2.0–5.8) 
 Ultrasound; knee 20 11.2 
(6.7–15.6) 
5.1 
(2.9–7.3) 
 17 8.0 
(4.3–11.7) 
3.9 
(2.0–5.8) 
Computerised tomography 5 2.8 
(0.3–5.2) 
1.3 
(0.2–2.4) 
 8 3.8 
(1.2–6.4) 
1.8 
(0.6–3.1) 
Magnetic resonance imaging 11 6.1 
(2.4–9.9) 
2.8 
(1.1–4.6) 
 39 18.4 
(12.8–24.0) 
8.9 
(6.1–11.7) 
Nuclear medicine 0 0.0 
(—) 
0.0 
(—) 
 0 0.0 
(—) 
0.0 
(—) 
Total imaging tests 179 100.0 45.7 
(39.8–51.5) 
 212 100.0 48.5 
(42.7–54.3) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only most frequent test descriptors are presented in each MBS 
group. 
11.4 Knee symptoms/complaints 
Table 11.11 shows that the rate at which imaging was ordered in the management of knee 
symptoms/complaints increased significantly over time. 
In 2002–05, there were 699 knee symptoms/complaints managed and at least one imaging 
test was ordered for 237 of these (33.9% likelihood). A total of 249 imaging test orders were 
placed at a rate of 35.6 imaging tests per 100 knee symptoms/complaints managed.  
In 2009–12, there were 845 knee symptoms/complaints managed, and GPs ordered at least 
one imaging order for 331 of these (39.2% likelihood). In total, 369 imaging test orders were 
placed at a rate of 43.7 imaging tests per 100 knee symptoms/complaints managed. 
These results, combined with the increased GP visit rate, suggest that in Period 1, about 
140,000 imaging orders were placed per annum nationally by GPs for the management of 
knee symptom/complaint problems. In Period 2, there were 150,000 orders placed per year, 
or about 10,000 more per annum than in Period 1. 
In summary, there was a marginal increase in the management rate of knee 
symptom/complaint problems, from 0.2 to 0.3 per 100 encounters. However, there were no 
changes in: the likelihood of ordering a test (33.9% in Period 1 and 39.2% in Period 2); the 
rate at which imaging tests were ordered (35.6 per 100 problems in Period 1 and 43.7 in 
Period 2); and no change in the number of tests ordered per knee symptom/complaint 
problem (1.05 per tested problem in Period 1 and 1.11 in Period 2). Therefore, the increase in 
the number of tests ordered nationally was due to the increased management rate of knee 
symptom/complaint problems combined with the increased GP visit rate. 
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Table 11.11: Knee symptom/complaint management generating GP imaging orders, 2002–05 and 
2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Total knee symptom/complaint problems managed 699  845 
Knee symptom/complaint problems for which at least one imaging test 
ordered (n) 
237  331 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 33.9 
(30.3–37.5) 
 39.2 
(35.9–42.5) 
Total imaging orders generated for knee symptom/complaint problems (n) 249  369 
Imaging orders per 100 knee symptom/complaint problems (95% CI) 35.6 
(31.8–39.4) 
 43.7 
(39.6–47.7) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods.  
Age-specific and sex-specific management 
The likelihood of management of knee symptoms/complaints was similar at encounters with 
males and with females. Management at encounters with females increased significantly 
between Period 1 and Period 2 (Table 11.12). 
The age-specific likelihood of management of knee symptoms/complaints increased over 
time for patients aged 45–64 years, and decreased for those aged 75 years or older. Imaging 
orders increased over time, for males, and for patients aged 25–44 years. 
Table 11.12: Age-specific and sex-specific likelihood of management and test order rate for knee 
symptoms/complaints, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order 
rate per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order 
rate per 100 
problems 
(95% CI) 
Sex         
 Males 314 0.3 
(0.2–0.3) 
33.1 
(27.9–38.4) 
 357 0.3 
(0.3–0.3) 
45.1 
(38.9–51.3) 
 Females 380 0.2 
(0.2–0.2) 
37.4 
(32.0–42.8) 
 481 0.3 
(0.3–0.3) 
42.8 
(37.7–47.9) 
Age        
 <15 years 52 0.2 
(0.1–0.2) 
46.2 
(30.1–62.2) 
 56 0.2 
(0.1–0.2) 
48.2 
(30.7–65.7) 
 15–24 years 68 0.2 
(0.2–0.3) 
42.6 
(29.7–55.6) 
 61 0.2 
(0.2–0.3) 
44.3 
(27.8–60.7) 
 25–44 years 184 0.3 
(0.2–0.3) 
26.6 
(20.0–33.2) 
 200 0.3 
(0.3–0.3) 
41.0 
(33.8–48.2) 
 45–64 years 240 0.3 
(0.3–0.3) 
41.7 
(35.3–48.0) 
 318 0.4 
(0.4–0.4) 
47.5 
(40.9–54.1) 
 65–74 years 82 0.2 
(0.2–0.3) 
32.9 
(22.8–43.1) 
 102 0.3 
(0.2–0.3) 
44.1 
(32.3–56.0) 
 75+ years 65 0.2 
(0.1–0.2) 
24.6 
(13.7–35.5) 
 101 0.1 
(0.0–0.1) 
35.6 
(25.4–45.9) 
Total  699 0.2 
(0.2–0.3) 
35.6 
(31.8–39.4) 
 845 0.3 
(0.3–0.3) 
43.7 
(39.6–47.7) 
(a) Missing data removed: 2002–05 n=8 (age), n=5 (sex); 2009–12 n=7 (age), n=7 (sex).  
(b) Number of encounters with at least one knee symptom/complaint problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 11.11). 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods.  
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Changes over time in imaging test types ordered 
Table 11.13 shows that there were some changes in the types of tests ordered across MBS 
groups. While diagnostic radiology remained the predominant group in both data periods, 
there was a general move away from diagnostic radiology orders as a percentage of all 
imaging tests ordered, with a move toward CT and MRI orders. Between Period 1 and 
Period 2 the order rate for MRI increased significantly, from 0.9 to 3.0 tests per 100 knee 
symptoms/complaints managed. 
The number of orders for CT and nuclear medicine increased, however numbers are small 
and results should be interpreted with caution. 
Table 11.13: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for knee symptoms/complaints, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests for 
this problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI)  
Number 
of tests 
Per cent of tests for 
this problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI) 
Diagnostic radiology 219 88.0 
(83.9–92.0) 
31.3 
(27.8–34.9)  
288 78.0 
(74.0–82.1) 
34.1 
(30.7–37.5) 
 X-ray; knee 213 85.5 
(81.3–89.8) 
30.5 
(27.0–33.9)  
273 74.0 
(69.8–78.2) 
32.3 
(29.1–35.5) 
Ultrasound 22 8.8 
(5.4–12.3) 
3.1 
(1.9–4.4)  
40 10.8 
(7.7–14.0) 
4.7 
(3.2–6.3) 
 Ultrasound; knee 20 8.0 
(4.7–11.3) 
2.9 
(1.6–4.1)  
35 9.5 
(6.5–12.4) 
4.1 
(2.7–5.5) 
Computerised 
tomography 
2 0.8 
(—) 
0.3 
(—)  
11 3.0 
(1.2–4.7) 
1.3 
(0.5–2.1) 
Magnetic resonance 
imaging 
6 2.4 
(0.5–4.3) 
0.9 
(0.2–1.5)  
25 6.8 
(4.2–9.3) 
3.0 
(1.8–4.1) 
Nuclear medicine 0 0.0 
(—) 
0.0 
(—)  
5 1.4 
(0.2–2.5) 
0.6 
(0.1–1.1) 
Total imaging tests 249 100.0 35.6 
(31.8–39.4)  
369 100.0 43.7 
(39.6–47.7) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
Imaging test ordering rates by status of knee symptom/complaint 
problem 
Table 11.14 shows the proportion of contacts generating an imaging order for new and old 
knee symptom/complaint problems in both data periods. Just over half of the GP contacts 
were for follow-up of previously diagnosed knee symptoms/complaints, in both 2002–05 
and 2009–12.  
In both data periods, the imaging order rate for knee symptoms/complaints was much 
higher at initial presentations (52.6 per 100 knee symptoms/complaints in Period 1 and 58.3 
per 100 in Period 2) than at follow-up consultations (22.1 per 100 knee symptoms/complaints 
in Period 1 and 32.4 per 100 in Period 2). There were no significant changes in the imaging 
order rate per 100 new knee symptom/complaint problems between the two data periods, 
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but the order rate for old problems increased significantly from 22.1 to 32.4 per 100 old knee 
symptom/complaint problems managed. 
In Period 1, an estimated 55,000 imaging orders per year were placed nationally by GPs for 
the management of new knee symptom/complaint problems. In Period 2, there were about 
90,000 imaging orders placed per year, or about 35,000 more per annum than in Period 1. 
Similarly, in Period 1, an estimated 30,000 imaging orders per year were placed nationally by 
GPs for the management of old shoulder symptom/complaint problems. In Period 2, there 
were about 60,000 imaging orders placed per year, or about 30,000 more per annum than in 
Period 1 (double the number of tests). 
In summary, there was no change in the management rate of new knee symptom/ 
complaint problems (0.1 per 100 problems in both data periods), the likelihood of GPs 
ordering an imaging test when managing new knee symptom/complaint problems (49.7% 
and 50.9% respectively), or in the number of imaging tests ordered per tested problem (1.0 in 
Period 1 and 1.1 in Period 2) (results not tabled). Therefore we can conclude that the national 
increase in tests was due solely to the increased GP visit rate.  
In contrast to new problems, the national increase in tests ordered for old knee symptom/ 
complaint problems was due to multiple factors, including: a marginal increase in the 
management rate of these problems (increasing from 0.1 to 0.2 per 100 encounters over time) 
(results not tabled); a significant increase (by 40.8%) in the likelihood of GPs ordering 
imaging; and the increased GP visit rate. There was no change over time in the number of 
imaging tests ordered per tested old knee symptom/complaint problem (1.0 in Period 1 and 
1.1 in Period 2) (results not tabled). 
Table 11.14: Imaging ordering rates by status of knee symptoms/complaints, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 310 389 699  369 476 845 
Per cent of knee symptom/complaint 
problems 
44.3 55.7 100.0  43.7 56.3 100.0 
Total imaging orders generated for 
problems (n) 
163 86 249  215 154 369 
Imaging orders per 100 problems 
(95% CI) 
52.6  
(46.5–58.7) 
22.1  
(17.7–26.5) 
35.6  
(31.8–39.4) 
 58.3  
(51.7–64.9) 
32.4  
(27.8–36.9) 
43.7  
(39.6–47.7) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
49.7  
(44.0–55.3) 
21.3  
(17.2–25.5) 
33.9  
(30.3–37.5) 
 50.9  
(45.8–56.1) 
30.0  
(25.9–34.2) 
39.2  
(35.9–42.5) 
Note: CI – confidence interval. Highlighting indicates a significant difference between data periods. 
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11.5 New knee symptom/complaint 
Age-specific and sex-specific management 
In both data periods, there was no difference in the likelihood of management of new knee 
symptoms/complaints at encounters with males and females, and no changes between 
Period 1 and Period 2 for either sex. 
There were no changes between Period 1 and Period 2 in either the age-specific or sex-
specific imaging test order rates for new knee symptoms/complaints (Table 11.15).  
Table 11.15: Age-specific and sex-specific likelihood of management and test order rate for new 
knee symptoms/complaints, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 130 0.1 
(0.1–0.1) 
50.8 
(42.1–59.4) 
 147 0.1 
(0.1–0.2) 
61.2 
(50.5–72.0) 
 Females 178 0.1 
(0.1–0.1) 
53.4 
(44.9–61.9) 
 220 0.1 
(0.1–0.1) 
55.9 
(47.5–64.3) 
Age        
 <15 years 31 0.1 
(0.1–0.1) 
51.6 
(28.7–74.6) 
 26 0.1 
(0.1–0.1) 
53.8 
(27.7–80.0) 
 15–24 years 28 0.1 
(0.1–0.1) 
53.6 
(33.9–73.3) 
 32 0.1 
(0.1–0.2) 
56.3 
(31.4–81.1) 
 25–44 years 75 0.1 
(0.1–0.1) 
45.3 
(32.7–57.9) 
 83 0.1 
(0.1–0.2) 
51.8 
(39.0–64.6) 
 45–64 years 125 0.2 
(0.1–0.2) 
55.2 
(45.7–64.7) 
 144 0.2 
(0.2–0.2) 
63.2 
(52.2–74.2) 
 65–74 years 29 0.1 
(0.1–0.1) 
55.2 
(36.6–73.8) 
 39 0.1 
(0.1–0.1) 
66.7 
(45.2–88.1) 
 75+ years 19 0.1 
(0.0–0.1) 
63.2 
(39.3–87.0 
 44 0.1 
(0.1–0.1) 
52.3 
(35.5–69.0) 
Total  310 0.1 
(0.1–0.1) 
52.6 
(46.5–58.7) 
 369 0.1 
(0.1–0.1) 
58.3 
(51.7–64.9) 
(a) Missing data removed: 2002–05 n=3 (age), n=2 (sex); 2009–12 n=1 (age), n=2 (sex).  
(b) Number of encounters with at least one new knee symptom/complaint problem managed at encounter. It is possible for more than one  
of the specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in  
Table 11.14). 
Note: CI – confidence interval. 
Changes in imaging test types ordered 
Table 11.16 shows that there were no changes between Period 1 and Period 2 in the types of 
tests ordered across MBS groups, apart from a general move away from diagnostic radiology 
orders as a percentage of all imaging tests ordered.  
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Table 11.16: Imaging test orders by MBS group and the most frequent individual tests ordered for 
new knee symptoms/complaints, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 145 89.0 
(84.2–93.7) 
46.8 
(41.0–52.6)  
171 79.5 
(74.6–84.5) 
46.3 
(40.9–51.8) 
 X-ray; knee 141 86.5 
(81.3–91.7) 
45.5 
(39.9–51.0)  
163 75.8 
(70.6–81.1) 
44.2 
(39.0–49.3) 
Ultrasound 14 8.6 
(4.4–12.8) 
4.5 
(2.2–6.8)  
27 12.6 
(8.3–16.8) 
7.3 
(4.5–10.1) 
 Ultrasound; knee 12 7.4 
(3.4–11.3) 
3.9 
(1.7–6.0)  
24 11.2 
(7.2–15.1) 
6.5 
(4.0–9.0) 
Computerised tomography 1 0.6 
(—) 
0.3 
(—)  
6 2.8 
(0.6–5.0) 
1.6 
(0.3–2.9) 
Magnetic resonance imaging 3 1.8 
(0.0–3.9) 
1.0 
(0.0–2.1)  
8 3.7 
(1.2–6.3 
2.2 
(0.7–3.7) 
Nuclear medicine 0 0.0 
(—) 
0.0 
(—)  
3 1.4 
(0.0–3.0) 
0.8 
(0.0–1.7) 
Total imaging tests 163 100.0 52.6 
(46.5–58.7)  
215 100.0 58.3 
(51.7–64.9) 
Note: CI – confidence interval; MBS – Medicare Benefits Schedule; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. Only the most frequent test descriptors are presented in each MBS 
group. 
11.6 Summary of findings  
Changes over time 
Overall, management rates of knee problems in total increased significantly between the two 
data periods. Management of knee symptoms/complaints also increased significantly, the 
change entirely due to the increase in management of old knee symptom/complaint 
problems, as there was no change in the management of new symptoms/complaints of the 
knee. All knee problems, and old knee symptoms/complaints, were the only areas in which 
significant increases were noted in the likelihood of testing and in the test-ordering rate per 
100 problems. No other changes were observed. There was a general move away from 
diagnostic radiology toward ultrasound and MRI ordering (Table 11.17). 
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Table 11.17: Summary of changes over time for knee problems 
Knee problems 
Management rate  
(% change, rate)(a) 
Likelihood of 
testing  
(% change, rate)(a) 
Ordering rate per 
100 problems 
(% change, rate)(a) 
Number of tests ordered 
per tested problem 
(% change, rate)(a) 
All  ↑ 18.0% 
(0.5, 0.6) 
↑ 9.6% 
(32.4, 35.5) 
↑ 14.2% 
(34.4, 39.3) 
No change 
(1.06, 1.12) 
Knee syndrome No change 
(0.3, 0.3) 
No change 
(31.2, 32.0) 
No change 
(33.4, 35.1) 
No change 
(1.07, 1.10) 
 New  No change 
(0.1, 0.2) 
No change 
(42.1, 43.7) 
No change 
(45.7, 48.8) 
No change 
(1.08, 1.11) 
Knee symptom/ 
complaint 
↑ 20.8% 
(0.2, 0.3) 
No change 
(33.9, 39.2) 
No change 
(35.6, 43.7) 
No change 
(1.05, 1.11) 
 New No change 
(0.1, 0.1) 
No change 
(49.7, 50.9) 
No change 
(52.6, 58.3) 
No change 
(1.06, 1.14) 
 Old  ↑ 23.1% (Marginal) 
(0.1, 0.2) 
↑ 40.8% 
(21.3, 30.0) 
↑ 46.6% 
(22.1, 32.4) 
No change 
(1.04, 1.08) 
(a) Direction and proportion of change between 2002–05 and 2009–12. The management rate for Period 1 and Period 2, used to calculate the 
proportion of change, is shown in parentheses. 
Current imaging test order patterns 
The recent management rates of knee syndrome and knee symptom/complaint problems 
did not differ. For knee syndrome, the management rate of new and previously managed 
cases did not differ, but for knee symptoms/complaints, new cases were managed less often 
than previously managed cases.  
The likelihood of ordering an imaging test for knee syndrome was significantly lower than 
that for knee symptom/complaint problems, and for both, GPs were far more likely to order 
imaging in the management of a new problem, than for a previously managed problem. The 
test ordering rate was significantly higher for knee symptom/complaint than knee 
syndrome, and in both, far higher for new cases than those previously managed.  
The majority of tests for all knee problems were diagnostic radiology tests. MRIs ranked 
second in test choice to investigate knee syndrome problems (both new and old), but 
ultrasounds were the second choice when testing for new cases of knee symptom/complaint 
problems (Table 11.18). 
Table 11.18: Summary of GP imaging ordering for knee problems, Period 2, 2009–12 
Knee 
problems 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%) 
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem 
contacts (95% CI) 
Diagnostic 
radiology US CT scan MRI 
All 0.6 
(0.6–0.6) 
35.5 
(33.2–37.9) 
1.12 39.3 
(36.5–42.1) 
28.7 
(26.4–31.0) 
4.0 
(3.0–4.9) 
1.3 
(0.8–1.9) 
5.0 
(3.8–6.2) 
Knee 
syndrome 
0.3 
(0.3–0.3) 
32.0 
(28.8–35.3) 
1.10 35.1 
(31.3–38.9) 
23.5 
(20.4–26.5) 
3.2 
(2.0–4.4) 
1.4 
(0.6–2.1) 
7.0 
(5.0–8.9) 
 New  0.2 
(0.1–0.2) 
43.7 
(38.9–48.5) 
1.11 48.8 
(42.7–54.3) 
33.9 
(29.0–38.8) 
3.9 
(2.0–5.8) 
1.8 
(0.6–3.1) 
8.9 
(6.1–11.7) 
 Old  0.2 
(0.1–0.2) 
20.4 
(16.4–24.3) 
1.06 21.7 
(17.3–26.2) 
13.0 
(9.8–16.3) 
2.5 
(0.9–4.1) 
0.9 
(0.0–1.8) 
5.0 
(2.9–7.2) 
(continued) 
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Table 11.18 (continued): Summary of GP imaging ordering for knee problems, Period 2, 2009–12 
Knee 
problems 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%) 
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 selected problem 
contacts (95% CI) 
Diagnostic 
radiology US CT scan MRI 
Knee 
symptom/ 
complaint 
0.3  
(0.3–0.3) 
39.2 
(35.9–42.5) 
1.11 43.7 
(39.6–47.7) 
34.1 
(30.7–37.5) 
4.7 
(3.2–6.3) 
1.3 
(0.5–2.1) 
3.0 
(1.8–4.1) 
 New  0.1 
(0.1–0.1) 
50.9 
(45.8–56.1) 
1.14 58.3 
(51.7–64.9) 
46.3 
(40.9–51.8) 
7.3 
(4.5–10.1) 
1.6 
(0.3–2.9) 
2.2 
(0.7–3.7) 
 Old  0.2 
(0.2–0.2) 
30.0 
(25.9–34.2) 
1.08 32.4 
(27.8–36.9) 
24.6 
(20.6–28.5) 
2.7 
(1.3–4.2) 
1.1 
(0.1–2.0) 
3.6 
(1.9–5.2) 
Note: CI – confidence interval; US – ultrasound; CT – computerised tomography; MRI – magnetic resonance imaging.  
11.7 Summary of guidelines for imaging of knee 
problems 
The final group of guidelines considered for this section of this report were: Government of 
Western Australia Department of Health (WADoH) Diagnostic Imaging Pathways15,16 (these 
guidelines could be considered as the successor of the now obsolete Royal Australian and 
New Zealand College of Radiologists [RANZCR] Imaging Guidelines 2001,19 and are 
endorsed by the RANZCR), the American College of Radiology Appropriateness Criteria 
(ACRAC),22 and the New Zealand Guidelines Group (NZGG) guidelines.29,31 
The WADoH Imaging Pathways for post traumatic knee pain suggest application of the 
Ottawa knee rules as part of clinical assessment and knee x-ray only if indicated under the 
Ottawa rules. The pathway suggested for patients where the Ottawa rule does not suggest  
x-ray (and those where an indicated x-ray is negative) include ultrasound for assessment of 
superficial soft issues and MRI where there is a high suspicion of ligament or meniscus 
damage. Investigation of non-traumatic knee pain includes initial x-ray or ultrasound 
following clinical assessment followed by MRI if initial imaging is non-diagnostic and 
underlying pathology is suspected. 
The ACRAC for acute trauma to the knee also suggest x-ray only where signs similar to 
those in the Ottawa rules are present. If it is a twisting injury or fall with negative radiology 
and positive signs, then MRI is appropriate (or CT with contrast if a tibial plateau fracture is 
found on x-ray).  
The NZGG guidelines suggest a similar pathway to the WADoH and ACRAC guidelines. 
In a study of acute knee injuries managed in Emergency Departments in Canada, Stiell et al. 
found that 74.5% of patients had an x-ray and only 5.2% had fractures. Knee x-rays have the 
lowest yield for diagnosing clinical significant fractures.100 The Ottawa knee rules for acute 
trauma to the knee synthesise the research of several developers of decision rules for knee 
imaging including Stiell et al.101-103 The Ottawa knee rules have almost 100% sensitivity and 
about 50% specificity for knee fractures.104 
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11.8 Compliance with guidelines 
Compliance with current guidelines is reported only for the 2009–12 period as some changes 
in guidelines have occurred in the period between the two samples used in this study. 
Knee problems managed by GPs were grouped almost equally between L15 Knee 
symptom/complaint (predominantly knee pain or swelling) and knee syndrome (almost 
exclusively L96 Acute internal damage knee). Osteoarthritis of the knee is included in 
Chapter 6 and sprains/strains of the knee are in Chapter 8. 
Plain x-rays of the knee are primarily useful for the diagnosis of fracture in acute knee 
injuries. The yield of positive findings is very low in patients who do not have clinical 
findings consistent with the Ottawa knee rules. The reported levels of orders for knee x-rays 
in the management of knee problems in the current study (ranging from 27.2 per 100 contacts 
for all knee problems to 44.2 per 100 new knee symptoms/complaints) were well below the 
North American Emergency Department level reported above. However, they were still well 
above the rate required for the reported prevalence of knee fractures (5.2% of acute knee 
injuries100) and could probably be significantly reduced if the Ottawa rules were routinely 
implemented before deciding to order imaging studies. 
Ultrasound and CT of the knee were ordered infrequently and this is consistent with current 
guidelines. 
Ordering of MRI studies has increased significantly for new knee syndrome problems over 
the period of the study and are now ordered at the rate of 8.9 per 100 new knee syndrome 
problems. This is consistent with the guideline advice of the utility of MRI in defining 
internal knee damage. It could be expected that the order rate will increase in the future with 
increased access available under the MBS. The Direct Access to Magnetic Resonance 
Imaging: Assessment for Suspect Knees (DAMASK) trials in the United Kingdom have 
demonstrated some benefit from increased GP access to MRI for ‘suspect knees’ in that 
country.110-112 
It is notable that in this study there has been no increase in MRI orders for patients 
presenting with new knee symptoms/complaints. This may change in the future with 
greater availability of MBS rebates for MRI ordered by GPs. 
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12 Other musculoskeletal injuries 
This chapter investigates the imaging orders for other musculoskeletal injury (OMI) 
problems. Throughout this chapter, ‘other musculoskeletal injury’ includes all 
musculoskeletal injuries, with the exception of all sprains and strains, and all injuries of the 
shoulder, back and knee (see Appendix 5, Table A5.1).  
As reported at the beginning of Section 2, GP imaging orders for OMI were selected for 
investigation because there was a statistically significant increase in the likelihood of GPs’ 
ordering imaging for this indication. 
Imaging orders are investigated for all and for new OMI problems (see Glossary). Changes in 
ordering over time between April 2002–March 2005 (Period 1) and April 2009–March 2012 
(Period 2) are reported. 
12.1 All other musculoskeletal injury problems 
Table 12.1 shows there was no change between Period 1 and Period 2 in the management 
rate of OMI problems. There was a significant increase in the estimated annual encounters 
involving OMI problems nationally, from 500,000 (95% CI: 470,000–530,000) encounters in 
Period 1, to 620,000 (95% CI: 580,000–650,000) in Period 2, due to the increased number of GP 
encounters claimed through Medicare nationally (as described in Chapter 2). 
Table 12.1 shows that the rate at which imaging tests were ordered in the management of 
osteoarthritis problems increased significantly over time. In Period 1, there were 1,527 OMI 
problems managed and at least one imaging test was ordered for 485 of these (31.8% 
likelihood). A total of 538 imaging test orders were placed, at a rate of 35.2 imaging tests per 
100 OMI problems managed. 
In Period 2, there were 1,514 OMI problems managed, and for 580 of these at least one 
imaging test was ordered (38.3% likelihood). In total, 651 imaging test orders were placed, at 
a rate of 43.0 tests per 100 OMI problems managed. 
These results, combined with the increased GP visit rate, suggest that in Period 1, 180,000 
imaging orders were placed nationally per year by GPs in the management of OMI 
problems. In Period 2, there were about 270,000 orders placed per year, or about 90,000 more 
per annum than Period 1.  
In summary, while the management rate did not change, the imaging order rate significantly 
increased (by 22.4%) over the time period. As there was no change in the number of tests 
ordered per problem when ordering occurred (1.1 tests per tested problem in both periods) 
(results not tabled), the national increase was attributed to the increased likelihood (by 
20.4%) of ordering imaging for OMI problems, plus the increased GP visit rate. 
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Table 12.1: Other musculoskeletal injury (OMI) management generating GP imaging orders, 
2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Number of OMI problems managed  1,527  1,514 
Management rate per 100 encounters (95% CI) 0.5 
(0.5–0.6) 
 0.5 
(0.5–0.6) 
OMI problems for which at least one imaging test ordered (n) 485  580 
Likelihood of ordering 1+ tests (per cent of problems) (95% CI) 31.8 
(29.2–34.3) 
 38.3 
(35.8–40.8) 
Total imaging orders generated for OMI problems (n) 538  651 
Imaging orders per 100 OMI problems (95% CI) 35.2 
(32.2–38.2) 
 43.0 
(39.9–46.1) 
Note: OMI – other musculoskeletal injury; CI – confidence interval. Highlighting indicates a significant difference between data periods.  
For a list of inclusions refer to Appendix 5, Table A5.1. 
Age-specific and sex-specific management  
There was no change in the management rate of OMI at encounters with either sex between 
Period 1 and Period 2. In both data periods the likelihood of management was significantly 
higher at encounters with males than at those with females. However there was no difference 
in the imaging order rate per 100 OMI problems between the sexes. The overall increase in 
the imaging order rate previously reported was not significant when stratified by sex. 
Between Period 1 and Period 2, the age-specific imaging ordering rate increased in the  
25–44 year age group, from 32.8 to 44.1 per 100 OMI problems, and in the 45–64 year age 
group from 27.4 to 37.8 per 100 OMI problems. There were no significant changes over time 
in imaging order rates in the other age groups (Table 12.2). 
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Table 12.2: Age-specific and sex-specific likelihood of management and test order rate for OMI 
problems, 2002–05 and 2009–12 
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI)  
At least one 
problem 
managed(b) 
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 
problems 
(95% CI) 
Sex         
 Males 859 0.7 
(0.7–0.8) 
34.9 
(30.9–38.9) 
 849 0.7 
(0.7–0.8) 
42.1 
(38.0–46.2) 
 Females 648 0.4 
(0.3–0.4) 
35.9 
(31.6–40.3) 
 649 0.4 
(0.3–0.4) 
44.5 
(40.0–49.0) 
Age        
 <15 years 135 0.4 
(0.3–0.5) 
62.2  
(53.2–71.2) 
 138 0.4 
(0.3–0.5) 
61.6  
(52.5–70.6) 
 15–24 years 233 0.8 
(0.7–1.0) 
43.4  
(36.1–50.7) 
 178 0.7 
(0.6–0.8) 
43.0  
(34.7–51.3) 
 25–44 years 465 0.6 
(0.6–0.7) 
32.8  
(27.4–38.1) 
 465 0.7 
(0.6–0.8) 
44.1  
(38.8–49.4) 
 45–64 years 463 0.6 
(0.5–0.6) 
27.4  
(22.7–32.2) 
 474 0.6 
(0.5–0.6) 
37.8  
(32.3–43.2) 
 65–74 years 105 0.3 
(0.2–0.4) 
39.0  
(28.0–50.1) 
 143 0.4 
(0.3–0.5) 
44.4  
(34.1–54.8) 
 75+ years 110 0.3 
(0.2–0.3) 
27.3  
(17.5–37.0) 
 107 0.2 
(0.2–0.3) 
35.5  
(23.7–47.3) 
Total  1,523 0.5 
(0.5–0.6) 
35.2 
(32.2–38.2) 
 1,512 0.5 
(0.5–0.6) 
43.0 
(39.9–46.1) 
(a) Missing data removed: 2002–05 n=12 (age), n=16 (sex); 2009–12 n=7 (age), n=14 (sex).  
(b) Number of encounters with at least one other musculoskeletal injury problem managed at encounter. It is possible for more than one of the 
specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in Table 12.1). 
Note: OMI – other musculoskeletal injury; CI – confidence interval. Highlighting indicates a significant difference between data periods.  
Changes over time in imaging test types ordered  
Between Period 1 and Period 2, there was a general move away from ordering diagnostic 
radiology toward ultrasound and MRI, but diagnostic radiology remained predominant in 
Period 2, accounting for two-thirds of imaging tests ordered for OMI (Table 12.3). 
There was no change in the order rate of diagnostic radiology over time, but it decreased 
significantly as a proportion of all imaging tests ordered for OMI. 
Orders for ultrasound significantly increased both as a proportion of all imaging tests for 
OMI (from 17.7% in Period 1 to 26.0% in Period 2), and as a rate per 100 OMI problems 
managed (from 6.2 to 11.2 per 100 OMI problems managed). Orders for MRI also increased 
significantly, however the numbers were small and should be interpreted with caution. 
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Table 12.3: Imaging test orders by MBS test group and the most frequent individual tests ordered 
for OMI problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 problems 
(95% CI)  
Number 
of tests 
Per cent of tests 
for this problem 
(95% CI) 
Test rate per 
100 
problems 
(95% CI) 
Diagnostic radiology 430 79.9 
(76.5–83.3) 
28.2 
(25.5–30.8)  
441 67.7 
(64.1–71.3) 
29.1 
(26.6–31.7) 
 X-ray; ankle 79 14.7 
(11.4–17.9) 
5.2 
(4.0–6.4)  
59 9.1 
(6.7–11.4) 
3.9 
(2.8–5.0) 
 X-ray; finger(s)/thumb 56 10.4 
(7.7–13.1) 
3.7 
(2.7–4.6)  
65 10.0 
(7.6–12.4) 
4.3 
(3.2–5.3) 
 X-ray; hand 53 9.9 
(7.3–12.4) 
3.5 
(2.6–4.4)  
49 7.5 
(5.4–9.6) 
3.2 
(2.3–4.2) 
 X-ray; foot/feet 48 8.9 
(6.6–11.2) 
3.1 
(2.3–4.0)  
58 8.9 
(6.7–11.1) 
3.8 
(2.9–4.8) 
 X-ray; wrist 37 6.9 
(4.7–9.0) 
2.4 
(1.6–3.2)  
33 5.1 
(3.3–6.8) 
2.2 
(1.4–2.9) 
 X-ray; knee 27 5.0 
(2.8–7.2) 
1.8 
(1.0–2.6)  
10 1.5 
(0.6–2.5) 
0.7 
(0.3–1.1) 
 X-ray; elbow 19 3.5 
(2.0–5.1) 
1.2 
(0.7–1.8)  
18 2.8 
(1.5–4.0) 
1.2 
(0.6–1.7) 
 X-ray; shoulder 19 3.5 
(2.0–5.0) 
1.2 
(0.7–1.8)  
16 2.5 
(1.3–3.6) 
1.1 
(0.5–1.6) 
 X-ray; chest 18 3.3 
(1.6–5.1) 
1.2 
(0.6–1.8)  
22 3.4 
(2.0–4.8) 
1.5 
(0.9–2.1) 
Ultrasound 95 17.7 
(14.4–20.9) 
6.2 
(5.0–7.5)  
169 26.0 
(22.6–29.3) 
11.2 
(9.5–12.9) 
Computerised 
tomography 
3 0.6 
(0.0–1.2) 
0.2 
(0.0–0.4)  
12 1.8 
(0.8–2.9) 
0.8 
(0.3–1.2) 
Magnetic resonance 
imaging 
4 0.7 
(0.0–1.5) 
0.3 
(0.0–0.5)  
25 3.8 
(2.3–5.4) 
1.7 
(1.0–2.3) 
Nuclear medicine 
imaging 
6 1.1 
(0.2–2.0) 
0.4 
(0.1–0.7)  
4 0.6 
(0.0–1.2) 
0.3 
(0.0–0.5) 
Total imaging tests 538 100.0 35.2 
(32.2–38.2)  
651 100.0 43.0 
(39.9–46.1) 
Note: OMI – other musculoskeletal injury; CI – confidence interval; MBS – Medicare Benefits Schedule. Highlighting indicates a significant 
difference between data periods. Only the most frequent test descriptors are presented in each MBS group. 
Imaging test ordering rates by status of musculoskeletal injury 
problem 
Table 12.4 shows the proportions of OMI problems managed that were new cases (i.e. first 
presentation to a medical practitioner) and those that were old (i.e. seen before by a medical 
practitioner) in both data periods. More than half of OMI contacts were for the management 
of new cases, in both Period 1 and Period 2.  
In both data periods, the imaging order rate for OMI was much higher at initial 
presentations (44.1 per 100 new OMI problems in Period 1 and 55.4 per 100 in Period 2) than 
at follow-up (25.4 per 100 old OMI problems in Period 1 and 25.3 per 100 in Period 2).  
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There was a significant increase in the imaging order rate from 44.1 per 100 new OMI 
problems managed to 55.4 per 100, and a significant increase in the likelihood of at least one 
imaging order for new OMI problems managed (39.6% to 49.3%). However, for old OMI 
problems, neither the imaging order rate nor the likelihood of imaging being ordered 
changed over this study period. 
Considering these results with the increased GP visit rate, we estimate that in Period 1, about 
120,000 imaging orders were placed nationally per year by GPs in the management of OMI 
problems. In Period 2, about 200,000 imaging tests were ordered per year, or about 80,000 
more than in Period 1.  
While the management rate did not change, the imaging order rate significantly increased 
(by 25.6%) over the time period. As there was no difference in the number of tests ordered 
per problem when ordering occurred (1.1 tests per tested problem in both periods) (results 
not tabled), this increase was attributed to the increased likelihood (24.5%) of ordering at 
least one imaging test when OMI problems were managed, plus the increased GP visit rate. 
Table 12.4: Imaging ordering rates by status of OMI problems, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
 New Old Total  New Old Total 
Problem contacts (n) 803 724 1,527  890 624 1,514 
Per cent of OMI problems 52.6 47.4 100.0  58.8 41.2 100.0 
Total imaging orders generated for 
problems (n) 
354 184 538  493 158 651 
Imaging orders per 100 problems 
(95% CI) 
44.1  
(39.9–48.2) 
25.4  
(21.7–29.2) 
35.2  
(32.2–38.2) 
 55.4  
(51.2–59.6) 
25.3  
(21.4–29.3) 
43.0  
(39.9–46.1) 
Likelihood of ordering 1+ tests (per 
cent of problems) (95% CI) 
39.6  
(36.1–43.1) 
23.1  
(19.8–26.3) 
31.8  
(29.2–34.3) 
 49.3  
(45.9–52.7) 
22.6  
(19.2–26.0) 
38.3  
(35.8–40.8) 
Note: OMI – other musculoskeletal injury; CI – confidence interval; OMI – other musculoskeletal injury. Highlighting indicates a significant 
difference between data periods. 
12.2 New other musculoskeletal injury problems 
Age-specific and sex-specific management  
In both data periods the likelihood of management of new OMI problems was significantly 
higher at encounters with males than at those with females. However there was no difference 
in the sex-specific imaging order rate. The test order rate increased significantly for male 
patients (from 43.2 per 100 new cases in Period 1 to 56.1 per 100 in Period 2) but did not 
change for female patients.  
There was a significant increase in test ordering over time among patients aged 25–44 years 
(from 40.1 tests per 100 new OMI problems to 56.6 tests per 100) (Table 12.5). 
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Table 12.5: Age-specific and sex-specific likelihood of management and test order rate for new 
OMI problems, 2002–05 and 2009–12  
Patient 
characteristic(a) 
2002–05 (Period 1)  2009–12 (Period 2) 
At least one 
new 
problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
 
At least one 
new problem 
managed(b)  
Management 
likelihood (%) 
(95% CI) 
Test order rate 
per 100 new 
problems 
(95% CI) 
Sex         
 Males 447 0.4 
(0.3–0.4) 
43.2 
(37.8–48.5) 
 488 0.4 
(0.4–0.5) 
56.1 
(50.4–61.9) 
 Females 346 0.2 
(0.2–0.2) 
45.8 
(39.4–52.3) 
 396 0.2 
(0.2–0.3) 
54.8 
(48.8–60.8) 
Age        
 <15 years 85 0.2 
(0.2–0.3) 
61.2 
(49.6–72.8) 
 100 0.3 
(0.2–0.3) 
68.0 
(57.5–78.5) 
 15–24 years 117 0.4 
(0.3–0.5) 
51.7 
(41.2–62.2) 
 107 0.4 
(0.4–0.5) 
55.1 
(43.9–66.4) 
 25–44 years 227 0.3 
(0.3–0.4) 
40.1 
(32.3–47.8) 
 267 0.4 
(0.4–0.5) 
56.6 
(49.4–63.7) 
 45–64 years 234 0.3 
(0.3–0.3) 
40.2 
(33.1–47.3) 
 249 0.3 
(0.3–0.4) 
52.6 
(44.3–60.9) 
 65–74 years 69 0.2 
(0.2–0.2) 
47.8 
(33.0–62.6) 
 96 0.3 
(0.2–0.3) 
52.1 
(39.8–64.4) 
 75+ years 63 0.2 
(0.1–0.2) 
34.9 
(20.8–49.0) 
 68 0.2 
(0.1–0.2) 
47.1 
(30.5–63.7) 
Total  802 0.3 
(0.3–0.3) 
44.1 
(39.9–48.2) 
 890 0.3 
(0.3–0.3) 
55.4 
(51.2–59.6) 
(a) Missing data removed: 2002–05 n=795 (age), n=793 (sex); 2009–12 n=887 (age), n=884 (sex).  
(b) Number of encounters with at least one new other musculoskeletal injury problem managed at encounter. It is possible for more than  
one of the specified problem to be managed per encounter, therefore this total may differ from the total number of problems (reported in 
Table 12.4). 
Note: OMI – other musculoskeletal injury; CI – confidence interval. Highlighting indicates a significant difference between data periods. 
Changes in imaging tests ordered for new other musculoskeletal 
injury problems, 2002–05 and 2009–12 
As previously reported, the overall rate of imaging test orders per 100 OMI problems 
increased significantly between Period 1 and Period 2. Table 12.6 shows that there were 
changes in the types of tests ordered across MBS groups. There was a general move away 
from diagnostic radiology orders as a percentage of all imaging tests ordered for new OMI 
problems and a move toward ultrasounds.  
Between Period 1 and Period 2 orders for ultrasound significantly increased by about 80%, 
from 8.1 to 14.6 per 100 new OMI problems. 
The number of orders for MRI increased, however numbers are small and results should be 
interpreted with caution.  
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Table 12.6: Changes in imaging test orders and the most frequent imaging tests ordered for new 
OMI problems, 2002–05 and 2009–12 
Type of test ordered 
2002–05 (Period 1)  2009–12 (Period 2) 
Number 
of tests 
Per cent of tests for 
this problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI)  
Number 
of tests 
Per cent of tests for 
this problem 
(95% CI) 
Test rate 
per 100 
problems 
(95% CI) 
Diagnostic radiology 284 80.2 
(76.2–84.3) 
35.4 
(31.6–39.1) 
 
346 70.2 
(66.2–74.2) 
38.9 
(35.3–42.5) 
 X-ray; ankle 49 13.8 
(9.9–17.8) 
6.1 
(4.3–7.9) 
 
48 9.7 
(7.0–12.5) 
5.4 
(3.8–7.0) 
 X-ray; finger(s)/thumb 38 10.7 
(7.4–14.0) 
4.7 
(3.3–6.2) 
 
49 9.9 
(7.2–12.7) 
5.5 
(4.0–7.1) 
 X-ray; hand 36 10.2 
(7.0–13.3) 
4.5 
(3.1–5.9) 
 
42 8.5 
(6.0–11.0) 
4.7 
(3.3–6.1) 
 X-ray; foot/feet 35 9.9 
(6.9–12.9) 
4.4 
(3.0–5.7) 
 
43 8.7 
(6.2–11.3) 
4.8 
(3.4–6.3) 
 X-ray; wrist 27 7.6 
(4.8–10.4) 
3.4 
(2.1–4.6) 
 
22 4.5 
(2.6–6.3) 
2.5 
(1.4–3.5) 
 X-ray; knee 16 4.5 
(2.0–7.0) 
2.0 
(0.9–3.1) 
 
8 1.6 
(0.5–2.7) 
0.9 
(0.3–1.5) 
Ultrasound 65 18.4 
(14.4–22.3) 
8.1 
(6.2–10.0) 
 
130 26.4 
(22.5–30.2) 
14.6 
(12.1–17.1) 
 Ultrasound; shoulder 19 5.4 
(2.9–7.8) 
2.4 
(1.3–3.5) 
 
24 4.9 
(3.0–6.7) 
2.7 
(1.6–3.8) 
 Ultrasound; leg 17 4.8 
(2.6–7.0) 
2.1 
(1.1–3.1) 
 
32 6.5 
(4.3–8.7) 
3.6 
(2.4–4.8) 
Computerised 
tomography 
3 0.8 
(0.0–1.8) 
0.4 
(0.0–0.8) 
 
3 0.6 
(0.0–1.3) 
0.3 
(0.0–0.7) 
Magnetic resonance 
imaging 
1 0.3 
(—) 
0.1 
(—) 
 
12 2.4 
(1.1–3.8) 
1.3 
(0.6–2.1) 
Nuclear medicine 
imaging 
1 0.3 
(—) 
0.1 
(—) 
 
2 0.4 
(—) 
0.2 
(—) 
Total imaging tests 354 100.0 44.1 
(39.9–48.2) 
 
493 100.0 55.4 
(51.2–59.6) 
Note: OMI – other musculoskeletal injury; CI – confidence interval; (—) – indicates the number of cases was too small to calculate a confidence 
interval. Highlighting indicates a significant difference between data periods. 
12.3 Summary of findings  
Changes over time 
The management rate of OMI problems did not change over time. However, between 
Period 1 and Period 2, the order rate of imaging tests in the management of OMI problems 
increased significantly, due to the increased likelihood that at least one imaging test was 
ordered (Table 12.7). Overall, there was a move away from diagnostic radiology as a 
proportion of all imaging tests ordered for all OMI problems, and proportionately more 
ultrasound and MRI orders. The order rate of ultrasound and MRI increased significantly 
over time. 
A similar pattern was observed for management of new OMI problems. There was no 
change in the management rate between Period 1 and Period 2, but the imaging ordering 
rate increased significantly due to increased likelihood of ordering. Again, there was an 
overall move away from diagnostic radiology, and proportionately more ultrasounds.  
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Table 12.7: Summary of changes over time for OMI problems 
OMI 
Management rate  
(% change, rate)(a) 
Likelihood of testing  
(% change, rate)(a) 
Ordering rate per 
100 problems 
(% change, rate)(a) 
Number of tests ordered 
per tested problem 
(% change, rate)(a) 
All No change 
(0.5, 0.5) 
↑ 20.4% 
(31.8, 38.3) 
↑ 22.2% 
(35.2, 43.0) 
No change 
(1.11,1.12) 
 New  No change 
(0.3, 0.3) 
↑ 24.5% 
(39.6, 49.3) 
↑ 25.6% 
(44.1, 55.4) 
No change 
(1.11, 1.12) 
(a) Direction and proportion of change between 2002–05 and 2009–12. The management rate for Period 1 and Period 2, used to calculate the 
proportion of change, is shown in parentheses. 
Note: OMI – other musculoskeletal injury. 
Current imaging test order patterns 
In 2009–12, GPs managed OMI at approximately 620,000 encounters per annum, and about 
60% of these contacts involved management of new cases of OMI problems. For all OMI 
problems, imaging was ordered at a rate of 43.0 tests per 100 OMI problems, with GPs 
ordering at least one test at 38.3% of OMI contacts. The likelihood of an imaging order 
resulting from the management of new cases of OMI (49.3%) was more than double that of 
the likelihood at follow-up consultations (22.6%). Diagnostic radiology accounted for two-
thirds of all imaging ordered for OMI, and ultrasound accounted for one-quarter. These 
proportions were similar for new cases of OMI (Table 12.8). 
Table 12.8: Summary of GP imaging ordering for OMI problems, Period 2, 2009–12 
OMI 
Rate/100 
encounters 
(95% CI) 
Likelihood  
test (%) 
(95% CI) 
Tests/ 
tested 
problem 
Tests/100 
selected 
problem  
(95% CI) 
Tests ordered per 100 problem contacts (95% CI) 
Diagnostic 
radiology US CT scan MRI 
All 0.5 
(0.5–0.6) 
38.3 
(35.8–40.8) 
1.12 43.0 
(39.9–46.1) 
29.1 
(26.6–31.7) 
11.2 
(9.5–12.9) 
0.8 
(0.3–1.2) 
1.7 
(1.0–2.3) 
 New  0.3 
(0.3–0.3) 
49.3 
(45.9–52.7) 
1.12 55.4 
(51.2–59.6) 
38.9 
(35.3–42.5) 
14.6 
(12.1–17.1) 
0.3 
(0.0–0.7) 
1.3 
(0.6–2.1) 
 Old 0.2 
(0.2–0.2) 
22.6 
(19.2–26.0) 
1.12 25.3 
(21.4–29.3) 
15.2 
(12.3–18.2) 
6.3 
(4.3–8.2) 
1.4 
(0.5–2.4) 
2.1 
(0.9–3.3) 
Note: OMI – other musculoskeletal injury; CI – confidence interval; US – ultrasound; CT – computerised tomography; MRI – magnetic resonance 
imaging.  
12.4 Summary of guidelines for imaging of other 
 musculoskeletal injuries 
An extensive review of guidelines for diagnostic imaging was undertaken using Medline, 
and national and international sources of guidelines such as the National Health and 
Medical Research Council (NHMRC), the United States Agency for Healthcare Research and 
Quality (AHRQ), the UK National Institute for Health and Care Excellence (NICE); and local 
and overseas colleges of radiology/radiologists. 
Other musculoskeletal injuries are included in the ICPC rubric L81. This category contains a 
wide range of injuries, mainly soft tissue, and body locations. As the available guidelines are 
structured around type of injury and site, it is not possible to use the guidelines to measure 
GP compliance when ordering imaging for this category of patient problems. However, the 
rise in the use of ultrasound imaging from 8.1 per 100 new other musculoskeletal injury 
problems in 2002–05, to 14.6 per 100 in 2009–12, is consistent with the increasing use of 
ultrasound in soft tissue injuries as recommended in site-specific guidelines. 
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Section 3 
 
Test-based investigation 
 
Introduction 
Section 3 investigates GP’s use of each of the four types of tests: diagnostic radiology, 
ultrasound, CT, and MRI. Over time, there was a statistically significant decrease in the order 
rate of diagnostic radiology tests, and statistically significant increases in the order rates of 
ultrasound, CT scan and MRI tests. For each test group, we report the problems for which 
tests were most often ordered, and the extent to which management of each problem 
involves imaging from that test group, and the rate of test ordering for each specified 
problem. 
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13 Problems for which diagnostic 
 radiology, ultrasound, CT scan and 
 MRI were ordered 
Table 13.1 summarises the overall ordering rates and the extrapolated estimated average 
number of tests ordered by GPs per year, for each of the imaging test types discussed in this 
chapter. The ordering rates are reported as both ‘per 1,000 encounters’, and ‘per 1,000 
problems’. When discussing change in GPs’ ordering behaviour we focus on change 
measured as a rate per 1,000 problems (as discussed in Chapter 2). The rate per 1,000 
encounters is shown, as this is used when calculating extrapolations (see Chapter 2). 
As discussed in Chapter 4, the rate of imaging ordering increased from 58.6 per 1,000 
problems in Period 1, to 65.0 per 1,000 in Period 2. This was reflected in statistically 
significant increases in the order rates (per 1,000 problems) of ultrasound, CT scan and MRI 
tests between Period 1 and Period 2. In contrast, the order rate of diagnostic radiology tests 
significantly decreased over time (Table 13.1). 
Orders for ultrasound accounted for the greatest increase in volume of GP-ordered imaging 
tests over time. Between Period 1 and Period 2, GPs’ order rate of ultrasound increased by 
37%, generating an extra 6.4 orders per 1,000 problems managed in Period 2 compared with 
Period 1. The order rate of CT scan increased by 25%, generating an extra 1.5 CT scan orders 
per 1000 problems in Period 2 compared with Period 1, whereas the order rate for MRI 
increased by more than 200%, generating an extra 0.7 MRI orders per 1,000 problems 
managed over the period. The decrease in the rate of diagnostic radiology tests (–8.9% over 
time) meant that GPs ordered an average of 2.9 fewer diagnostic radiology tests per 1,000 
problems managed in Period 2 compared with Period 1.  
This chapter investigates the problems contributing to these changes for each imaging test 
type, and the extent to which there have been changes in GPs’ imaging ordering in the 
management of the specified problems. 
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Table 13.1: Imaging orders by selected Medicare imaging groups, 2002–05 and 2009–12 
 2002–05 (Period 1)  2009–12 (Period 2) 
Imaging type 
Number 
of tests  
Per cent 
of all 
imaging 
Per 1,000 
encounters  
(95% CI) 
Per 1,000 
problems  
(95% CI) 
Extrapolated number 
(millions) of tests 
ordered p.a. (95% CI)  
Number 
of tests 
Per cent 
of all 
imaging 
Per 1,000 
encounters  
(95% CI) 
Per 1,000 
problems  
(95% CI) 
Extrapolated number 
(millions) of tests 
ordered p.a. (95% CI) 
Diagnostic 
radiology* 
14,450 55.9 48.8 
(47.3–50.3) 
32.7 
(31.7–33.7) 
4.74 
(4.59–4.88) 
 13,774 45.9 47.0 
(45.7–48.3) 
29.8 
(29.0–30.6) 
5.64 
(5.48–5.79) 
Ultrasound* 7,560 29.2 25.5 
(24.5–26.6) 
17.1 
(16.4–17.8) 
2.48 
(2.38–2.58) 
 10,852 36.2 37.0 
(36.0–38.1) 
23.5 
(22.9–24.1) 
4.44 
(4.32–4.57) 
Computerised 
tomography* 
2,617 10.1 8.8 
(8.4–9.3) 
5.9 
(5.6–6.2) 
0.86 
(0.82–0.90) 
 3,440 11.5 11.7 
(11.2–12.3) 
7.4 
(7.1–7.8) 
1.41 
(1.35–1.47) 
Magnetic 
resonance imaging* 
116 0.4 0.4 
(0.3–0.5) 
0.3 
(0.2–0.3) 
0.04 
(0.03–0.05) 
 464 1.5 1.6 
(1.4–1.8) 
1.0 
(0.9–1.1) 
0.19 
(0.17–0.21) 
Total 25,863 100.0 87.3 
(85.0–89.7) 
58.6 
(57.0–60.1) 
8.48 
(8.26–8.71) 
 29,996 100.0 102.4 
(100.2–104.5) 
65.0 
(63.6–66.3) 
12.27 
(12.00–12.54) 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.3). 
Note: CI – confidence interval; p.a. – per annum. Highlighting indicates a significant difference between data periods. 
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13.1 Diagnostic radiology 
Diagnostic radiology was the imaging type most commonly ordered by GPs in Period 1 and 
Period 2. As discussed in Chapter 4, the order rate of diagnostic radiology per 1,000 
problems decreased over time. In Period 1, diagnostic radiology accounted for 55.9% of all 
imaging tests and in Period 2 it accounted for 45.9%. However, due to the increased GP visit 
rate, the extrapolated number of diagnostic radiology tests ordered per annum increased 
significantly from 4.7 million (95% CI: 4.6–4.9) in Period 1, to 5.6 million (95% CI: 5.5–7.8) in 
Period 2 (Table 13.1).  
Table 13.2 lists the problems for which diagnostic radiology was frequently ordered, the 
proportion of diagnostic radiology accounted for by each problem, the proportion of each 
problem that resulted in one or more diagnostic radiology test(s), and the number of 
diagnostic radiology tests ordered when at least one test was ordered.  
The problems generating orders for diagnostic radiology were similar in Period 1 and 
Period 2. The most common were osteoarthritis, back problems, fracture and sprain/strain, 
which together accounted for 28% of all diagnostic radiology–problem links in each period 
(Table 13.2).  
Individual problems contribute in different ways to the total volume of diagnostic radiology 
ordered in general practice. Three factors influence the total volume of test orders generated 
by a problem:  
• how often a problem is managed in general practice 
• the likelihood that diagnostic radiology will be ordered in the management of the 
specific problem 
• the number of diagnostic radiology tests ordered once the decision to order has been 
made.  
This is illustrated by looking at the more recent data (Period 2) in Table 13.2 for osteoarthritis 
and breast lump problems. Osteoarthritis management generated the highest proportion of 
diagnostic radiology orders (9.8%) in Period 2. It is a frequently managed problem in general 
practice,113 and GPs ordered diagnostic radiology at 14.7% of contacts, at an average of 1.1 
tests per order. In contrast, breast lump contributed to only 1.6% of diagnostic radiology 
orders. It was managed less often, but, when managed, 36.8% of contacts resulted in an order 
for diagnostic radiology and usually one test was ordered per occasion of testing 
(Table 13.2). This demonstrates that while orders for diagnostic radiology were more likely 
in the management of breast lump, osteoarthritis management generated a higher volume of 
orders because of its high management rate in general practice (despite a lower likelihood of 
testing).  
In Table 13.2, significant changes over time in the proportion of tests accounted for by the 
problem, and/or the likelihood of ordering diagnostic radiology for the specific problem are 
highlighted. Between Period 1 and Period 2, there were significant changes in the likelihood 
that diagnostic radiology would be ordered in the management of the following problems. 
• Osteoarthritis: GPs were significantly more likely to order diagnostic radiology in the 
management of osteoarthritis in Period 2 (14.7% of osteoarthritis problem contacts) than 
in Period 1 (11.8%). Correspondingly, the proportion of diagnostic radiology accounted 
for by osteoarthritis problems increased from 8.0% to 9.8%. GPs ordered 1.1 diagnostic 
radiology tests per tested osteoarthritis contact in Period 1 and this remained steady in 
Period 2 (1.1 tests per tested contact). GPs’ imaging ordering behaviour in the 
management of osteoarthritis is investigated in more detail in Chapter 6. 
139
  
 
• Back problems: GPs were significantly less likely to order diagnostic radiology in the 
management of back problems in Period 2 (7.8%) than in Period 1 (9.3%). Similarly the 
proportion of diagnostic radiology accounted for by back problems decreased from 8.0% 
to 6.9%. GPs ordered 1.1 diagnostic radiology tests per tested back problem contacts in 
Period 1 and 1.2 tests in Period 2. In this report, back problems are divided into two 
groups: back syndromes and back symptoms/complaints. The significant changes seen 
for testing of back problems as a whole were not reflected in these subgroups when 
investigated separately. GPs’ imaging ordering behaviour in the management of back 
problems is investigated in more detail in Chapter 5. 
• Osteoporosis: the proportion of contacts involving tests increased significantly from 
12.9% of osteoporosis contacts in Period 1, to 16.7% in Period 2. GPs ordered 1.1 tests per 
tested osteoporosis contact in Period 1 and 1.0 in Period 2. 
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Table 13.2: Problems for which diagnostic radiology was ordered, 2002–05 and 2009–12 
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem 
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links (95% 
CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c)  
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c) 
Osteoarthritis (excl back)** 8,857 1,170 8.0 
(7.5–8.6) 
11.8 
(11.1–12.5) 
1.12  8,329 1,366 9.8 
(9.2–10.4) 
14.7 
(13.9–15.6) 
1.11 
Back problems** 11,146 1,170 8.0 
(7.5–8.6) 
9.3 
(8.7–10.0) 
1.12  10,584 963 6.9 
(6.4–7.4) 
7.8 
(7.3–8.4) 
1.16 
 Back symptom/complaint** 5,434 660 4.5 
(4.1–4.9) 
10.7 
(9.7–11.6) 
1.14  5,304 539 3.9 
(3.5–4.3) 
8.9 
(8.1–9.8) 
1.14 
 Back syndrome** 5,712 510 3.5 
(3.1–3.9) 
8.1 
(7.3–8.9) 
1.11  5,280 424 3.0 
(2.7–3.4) 
6.7 
(6.0–7.5) 
1.19 
Fracture (excl head/back)* 2,936 1,164 8.0 
(7.4–8.5) 
37.1 
(35.2–39.0) 
1.07  2,586 934 6.7 
(6.2–7.2) 
33.8 
(31.8–35.8) 
1.07 
Sprain/Strain (excl back)** 3,249 576 4.0 
(3.6–4.3) 
17.0 
(15.6–18.4) 
1.04  2,861 576 4.1 
(3.8–4.5) 
19.4 
(17.8–21.0) 
1.04 
Knee problems** 1,495 436 3.0 
(2.7–3.3) 
28.8 
(26.5–31.2) 
1.01  1,719 493 3.5 
(3.2–3.9) 
28.0 
(25.8–30.2) 
1.03 
 Knee symptom/complaint** 699 219 1.5 
(1.3–1.7) 
30.6 
(27.2–34.0) 
1.02  845 288 2.1 
(1.8–2.3) 
33.0 
(29.8–36.2) 
1.03 
 Knee syndrome** 796 217 1.5 
(1.3–1.7) 
27.3 
(24.0–30.5) 
1.00  874 205 1.5 
(1.3–1.7) 
23.1 
(20.2–26.0) 
1.02 
Injury musculoskeletal (excl 
shoulder/back/knee)** 
1,527 430 2.9 
(2.6–3.3) 
26.9 
(24.4–29.3) 
1.05  1,514 441 3.2 
(2.8–3.5) 
27.8 
(25.5–30.2) 
1.05 
Female genital check-up/Pap 
smear* 
6,524 427 2.9 
(2.0–3.8) 
6.5 
(4.5–8.4) 
1.01  6,832 308 2.2 
(1.9–2.6) 
4.4 
(3.7–5.0) 
1.03 
Injury skin, other 1,869 412 2.8 
(2.5–3.2) 
20.2 
(18.1–22.3) 
1.09  1,487 313 2.2 
(1.9–2.6) 
19.4 
(17.2–21.5) 
1.09 
Acute bronchitis/bronchiolitis 7,017 384 2.6 
(2.3–2.9) 
5.4 
(4.9–6.0) 
1.01  6,879 433 3.1 
(2.8–3.4) 
6.3 
(5.7–6.9) 
1.01 
(continued) 
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Table 13.2 (continued): Problems for which diagnostic radiology was ordered 2002–05 and 2009–12 
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem 
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links (95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c)  
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c) 
Osteoporosis (excl osteoporotic 
fracture)* 
2,573 353 2.4 
(2.1–2.7) 
12.9 
(11.4–14.4) 
1.06  2,392 412 3.0 
(2.6–3.3) 
16.7 
(15.1–18.4) 
1.03 
Shoulder problems (excl 
arthritis/OA)* 
2,161 315 2.2 
(1.9–2.4) 
13.7 
(12.1–15.3) 
1.06  2,637 377 2.7 
(2.4–3.0) 
13.7 
(12.3–15.1) 
1.04 
 Shoulder syndrome (excl 
arthritis/OA)* 
1,556 187 1.3 
(1.1–1.5) 
11.4 
(9.7–13.1) 
1.06  1,988 244 1.8 
(1.5–2.0) 
11.9 
(10.4–13.4) 
1.03 
 Shoulder symptom/complaint 
(excl arthritis/OA)* 
605 128 0.9 
(0.7–1.0) 
19.7 
(16.5–22.9) 
1.08  649 133 1.0 
(0.8–1.1) 
19.3 
(16.2–22.3) 
1.06 
Bursitis/tendonitis/synovitis NOS 2,751 289 2.0 
(1.7–2.2) 
10.1 
(8.9–11.2) 
1.04  3,260 307 2.2 
(1.9–2.5) 
9.0 
(8.0–10.1) 
1.04 
Pneumonia 947 263 1.8 
(1.6–2.0) 
27.8 
(24.6–30.9) 
1.00  1,028 313 2.2 
(2.0–2.5) 
30.3 
(27.3–33.2) 
1.01 
Breast lump* 621 248 1.7 
(1.4–2.0) 
39.5 
(35.4–43.5) 
1.01  584 216 1.6 
(1.3–1.8) 
36.8 
(32.8–40.8) 
1.01 
Cough 1,472 235 1.6 
(1.4–1.8) 
15.3 
(13.3–17.3) 
1.04  1,907 278 2.0 
(1.7–2.2) 
14.5 
(12.8–16.2) 
1.01 
Subtotal  7,872 54.0 — —   7,730 55.5 — — 
Total 441,591 14,579 100.0 — —  461,761 13,926 100.0 — — 
(a) A test was counted more than once if it was ordered for the management of more than one problem at an encounter. There were 14,450 diagnostic radiology test orders and 14,591 problem–imaging links in Period 1, 
and 13,774 diagnostic radiology test orders and 13,926 problem–imaging links in Period 2. 
(b) The percentage of total contacts with the problem that generated at least one order for diagnostic radiology.  
(c) The rate of diagnostic radiology orders placed per problem contact with at least one order for diagnostic radiology. 
**  Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.1). 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.2). 
Note: No. – number; CI – confidence interval; excl – excluding; OA – osteoarthritis; NOS – not otherwise specified; UTI – urinary tract infection; Highlighting indicates a significant difference between data periods. 
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13.2 Ultrasound 
The order rate of ultrasounds increased significantly over time. In Period 2, orders for 
ultrasound accounted for 36.2% of all imaging ordered, and approximately 4.4 million tests 
per year were ordered nationally by GPs. This is an increase from Period 1, in which it 
accounted for 29.2% of imaging tests, and GPs ordered an average of 2.5 million ultrasounds 
per year nationally (Table 13.1). 
Table 13.3 lists the problems for which ultrasound was frequently ordered, the proportion of 
ultrasound accounted for by each problem, the proportion of each problem that resulted in at 
least one ultrasound test, and the number of ultrasound tests ordered when at least one test 
was ordered.  
The problems generating orders for ultrasound were similar in Period 1 and Period 2. The 
most common were: pregnancy and pregnancy-related check-ups, abdominal pain, and 
shoulder problems. Together these accounted for 21% of ultrasound–problem links in 
Period 1 and 24% in Period 2.  
Individual problems contribute in different ways to the total volume of ultrasound tests 
ordered in general practice. Three factors influence the total volume of test orders generated 
by a problem: 
• how often a problem is managed in general practice 
• the likelihood that ultrasound will be ordered in the management of the specific problem 
• the number of ultrasound tests ordered once the decision to order has been made.  
This is illustrated by looking at the more recent data (Period 2) in Table 13.3 for two 
problems: pregnancy and pregnancy-related check-ups, and female genital check-ups. 
Pregnancy and pregnancy-related check-ups generated the highest proportion of all 
ultrasound orders (10.8%) in Period 2. They are commonly managed in general practice, and 
GPs ordered ultrasound at 23.0% of pregnancy contacts, at an average of 1.0 test per order. In 
contrast, female genital check-ups only contributed to 1.5% of total ultrasound orders. It is 
also a commonly managed problem in general practice, but the likelihood of ordering 
ultrasound was far lower, only 2.3% of contacts resulting in an order for ultrasound, with an 
average of 1.0 test per order.  
In Table 13.3, significant changes over time in the proportion of tests accounted for by the 
problem, and/or the likelihood that ultrasound was ordered in the management of the 
problem are highlighted. Between Period 1 and Period 2, there were significant increases in 
the likelihood that ultrasound would be ordered in the management of the following 
problems. 
• Pregnancy and related check-ups: in Period 1, 15.1% of contacts involving management 
of these problems resulted in an order for ultrasound, and in almost all cases only one 
ultrasound was ordered (1.0 ultrasound tests per tested pregnancy problems). In 
Period 2, 23.0% of contacts involving these problems resulted in an order for ultrasound, 
and again only one ultrasound was ordered (1.0 per tested problem). The proportion of 
ultrasound tests accounted for by pregnancy and pregnancy-related check-ups did not 
change significantly over time (9.7% in Period 1 and 10.8% in Period 2). 
• Shoulder problems: ultrasounds were ordered at 17.5% of shoulder problem contacts in 
Period 1, increasing to 28.6% in Period 2. This increase was reflected in both subgroups 
of shoulder problems when investigated separately (shoulder syndromes and shoulder 
symptoms/complaints). GPs’ imaging ordering behaviour in the management of 
shoulder problems is investigated in more detail in Chapter 7. 
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• Menstrual problems: GPs were more likely to order ultrasound in Period 2 (21.4% of 
contacts with menstrual problems) than in Period 1 (15.4%). 
• Breast lump: ultrasounds were ordered at 49.1% of contacts in Period 1, increasing to 
62.7% in Period 2. 
• Sprain/strain (excluding sprain/strain of the back): likelihood of ultrasound being 
ordered increased from 6.1% of contacts in Period 1 to 11.3% in Period 2. GPs’ imaging 
ordering behaviour in the management of sprain/strain problems is investigated in 
more detail in Chapter 8. 
• Bursitis/tendonitis/synovitis: likelihood of ultrasound being ordered increased from 
testing at 7.0% of contacts in Period 1 to 17.2% in Period 2. GPs’ imaging ordering 
behaviour in the management of bursitis/tendonitis/synovitis problems is investigated 
in more detail in Chapter 9. 
• Swelling: likelihood of ordering ultrasound increased from 21.4% of contacts in Period 1, 
to 31.8% in Period 2. 
• ‘Other’ musculoskeletal injury (excluding shoulder, back and knee injuries): likelihood of 
ordering increased from 6.2% of contacts in Period 1 to 11.0% in Period 2. GPs’ imaging 
ordering behaviour in the management of other musculoskeletal injury is investigated in 
more detail in Chapter 12. 
• Abnormal test results: likelihood of ordering ultrasound increased from 3.7% of contacts 
in Period 1 to 5.4% in Period 2. 
• Pain breast (female): ultrasound ordering likelihood increased from 24.3% of contacts in 
Period 1 to 39.5% in Period 2.  
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Table 13.3: Problems for which ultrasound was ordered, 2002–05 and 2009–12 
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem 
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links (95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c)  
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c) 
Pregnancy & related check-up* 4,887 739 9.7 
(8.3–11.1) 
15.1 
(13.3–16.9) 
1.00  5,027 1,181 10.8 
(9.9–11.6) 
23.0 
(21.5–24.5) 
1.02 
Abdominal pain** 2,053 513 6.7 
(6.1–7.4) 
24.1 
(22.1–26.0) 
1.04  2,182 631 5.8 
(5.3–6.3) 
27.1 
(25.2–29.0) 
1.07 
Shoulder problems (excl 
arthritis/OA)** 
2,161 380 5.0 
(4.4–5.5) 
17.5 
(15.8–19.3) 
1.00  2,637 760 6.9 
(6.4–7.5) 
28.6 
(26.8–30.5) 
1.01 
 Shoulder syndrome (excl 
arthritis/OA)** 
1,556 271 3.6 
(3.1–4.0) 
17.4 
(15.3–19.4) 
1.00  1,988 597 5.5 
(5.0–5.9) 
29.8 
(27.7–32.0) 
1.01 
 Shoulder symptom/complaint 
(excl arthritis/OA)** 
605 109 1.4 
(1.1–1.7) 
18.0 
(14.8–21.3) 
1.00  649 163 1.5 
(1.3–1.7) 
25.0 
(21.5–28.4) 
1.01 
Menstrual problems* 2,265 351 4.6 
(4.1–5.1) 
15.4 
(13.8–16.9) 
1.01  2,238 478 4.4 
(4.0–4.8) 
21.4 
(19.5–23.2) 
1.00 
Breast lump* 621 306 4.0 
(3.4–4.6) 
49.1 
(44.2–54.0) 
1.00  584 367 3.4 
(3.0–3.7) 
62.7 
(58.6–66.7) 
1.00 
Cholecystitis/cholelithiasis 544 215 2.8 
(2.4–3.2) 
39.3 
(35.1–43.6) 
1.01  526 213 1.9 
(1.7–2.2) 
40.1 
(35.9–44.3) 
1.01 
Female genital check-up/Pap 
smear* 
6,524 207 2.7 
(1.1–4.3) 
3.2 
(1.3–5.0) 
1.01  6,832 162 1.5 
(1.2–1.7) 
2.3 
(1.9–2.7) 
1.01 
Genital disease, other (female) 665 202 2.6 
(2.3–3.0) 
30.1 
(26.5–33.6) 
1.01  656 188 1.7 
(1.5–2.0) 
28.2 
(24.8–31.6) 
1.02 
Sprain/strain (excl back)** 3,249 200 2.6 
(2.2–3.0) 
6.1 
(5.2–7.0) 
1.01  2,861 326 3.0 
(2.6–3.3) 
11.3 
(10.1–12.5) 
1.01 
Bursitis/tendonitis/synovitis 
NOS** 
2,751 196 2.6 
(2.2–3.0) 
7.0 
(5.9–8.0) 
1.02  3,260 572 5.2 
(4.8–5.7) 
17.2 
(15.8–18.6) 
1.02 
Urinary tract infection* 5,064 186 2.4 
(2.1–2.8) 
3.5 
(3.0–4.1) 
1.04  5,273 193 1.8 
(1.5–2.0) 
3.5 
(3.0–4.1) 
1.03 
(continued) 
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Table 13.3 (continued): Problems for which ultrasound was ordered 2002–05 and 2009–12 
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem 
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links (95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c)  
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c) 
Goitre 327 113 1.5 
(1.2–1.8) 
34.6 
(29.4–39.8) 
1.00  413 163 1.5 
(1.2–1.7) 
39.2 
(34.4–44.1) 
1.01 
Swelling* 487 106 1.4 
(1.1–1.7) 
21.4 
(17.7–25.0) 
1.02  594 194 1.8 
(1.5–2.0) 
31.8 
(27.9–35.7) 
1.03 
Fibrocystic disease breast 299 104 1.4 
(1.1–1.6) 
34.8 
(29.5–40.1) 
1.00  233 92 0.8 
(0.6–1.0) 
39.5 
(32.9–46.1) 
1.00 
Injury musculoskeletal (excl 
shoulder/back/knee)** 
1,527 95 1.2 
(1.0–1.5) 
6.2 
(4.9–7.4) 
1.01  1,514 167 1.5 
(1.3–1.8) 
11.0 
(9.4–12.7) 
1.00 
Abortion, spontaneous 260 95 1.2 
(1.0–1.5) 
36.2 
(30.6–41.7) 
1.01  271 91 0.8 
(0.7–1.0) 
33.6 
(28.0–39.1) 
1.00 
Abnormal test results* 2,488 91 1.2 
(0.9–1.4) 
3.7 
(2.9–4.4) 
1.00  3,771 206 1.9 
(1.6–2.1) 
5.4 
(4.6–6.1) 
1.02 
Pain, genital (female) 230 89 1.2 
(0.9–1.4) 
37.4 
(31.2–43.6) 
1.04  285 136 1.2 
(1.0–1.5) 
46.0 
(40.1–51.8) 
1.04 
Pain, breast (female) 358 87 1.1 
(0.9–1.4) 
24.3 
(19.7–28.9) 
1.00  365 146 1.3 
(1.1–1.6) 
39.5 
(34.5–44.4) 
1.01 
Endocrine/metabolic/nutritional 
disease, other 
1,586 59 0.8 
(0.6–1.0) 
3.7 
(2.7–4.6) 
1.02  1,769 99 0.9 
(0.7–1.1) 
5.4 
(4.4–6.5) 
1.03 
Subtotal  4,334 56.8 — —   6,331 57.9 — — 
Total 441,591 7,629 100.0 — —  461,761 10,939 100.0 — — 
(a) A test was counted more than once if it was ordered for the management of more than one problem at an encounter. There were 7,560 ultrasound test orders and 7,629 problem–imaging links in Period 1, and 10,852 
ultrasound test orders and 10,939 problem–imaging links in Period 2. 
(b) The percentage of total contacts with the problem that generated at least one order for ultrasound.  
(c) The rate of ultrasound orders placed per problem contact with at least one order for ultrasound. 
**  Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.1). 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.2). 
Note: No. – number; CI – confidence interval; excl – excluding; OA – osteoarthritis; NOS – not otherwise specified; Highlighting indicates a significant difference between data periods. 
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13.3 Computerised tomography scan 
The order rate of computerised tomography (CT) scan increased significantly over time. In 
Period 2, orders for CT scan accounted for 11.5% of all imaging ordered, and approximately 
1.4 million tests were ordered nationally by GPs per annum. In contrast, in Period 1 CT scans 
accounted for 10.1% of all imaging ordered, and approximately 860,000 tests were ordered 
nationally by GPs per annum (Table 13.1). 
The problems generating orders for CT scans were similar in Period 1 and Period 2. The most 
common were: back problems, headache, sinusitis, abdominal pain, and neck syndrome. 
Together these accounted for 40% of CT scan–problem links in Period 1 and 37% in Period 2 
(Table 13.4).  
Individual problems contribute in different ways to the total volume of CT scan ordered in 
general practice. Three factors influence the total volume of test orders generated by a 
problem: 
• how often a problem is managed in general practice 
• the likelihood that CT scan will be ordered in the management of the specific problem 
• the number of CT scan tests ordered once the decision to order has been made.  
This is illustrated by looking at the more recent data (Period 2) in Table 13.4 for back 
problems and kidney symptoms/complaints. Back problems generated the highest 
proportion of all CT scan orders (18.3%) in Period 2, but likelihood of management involving 
CT scan was quite low, with GPs ordering CT scans at 5.9% of back problem contacts, at an 
average of 1.0 test per order. The main reason back problems accounts for a large volume of 
CT scan orders is because they are very commonly managed in general practice. In contrast, 
kidney symptoms/complaints contributed 1.0% of CT scan orders. It is managed less often, 
but, when managed, 22.2% of contacts resulted in an order for CT scan, with an average of 
1.0 test per order (Table 13.4). 
In Table 13.4, significant changes over time in the proportion of tests accounted for by the 
problem, and/or the likelihood that CT scan was ordered in the management of the problem 
are highlighted. Between Period 1 and Period 2, there were significant increases in the 
likelihood that CT scan would be ordered in the management of the following problems. 
• Back problems: 4.7% of contacts for back problems resulted in an order for CT scan in 
Period 1, and only one CT scan was ordered (1.0 CT scan per tested back problem). In 
Period 2, 5.9% of back problem contacts resulted in an order for CT scan, and only one 
CT scan was ordered (1.0 CT scan per tested back problem). In this report, back problems 
are divided into two groups: back syndromes and back symptoms/complaints. The 
overall increase in back problems involving CT scans was only reflected in the subgroup 
of back symptoms/complaints. The likelihood that back symptoms/complaints involved 
CT scans increased from 3.2% of contacts in Period 1 to 4.7% in Period 2. GPs’ imaging 
ordering behaviour in the management of back problems is investigated in more detail 
in Chapter 5. 
• Abdominal pain: CT scans were ordered at 4.0% of contacts in Period 1, increasing to 
6.2% in Period 2, an overall increase in likelihood of more than 50%. GPs’ imaging 
ordering behaviour in the management of abdominal pain problems is investigated in 
more detail in Chapter 10. 
• Neck symptom/complaint: the likelihood of GPs ordering CT scan in the management 
of neck symptom/complaint more than doubled, from 2.6% of contacts in Period 1 to 
5.9% in Period 2. 
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• Kidney symptom/complaint: the likelihood that CT scan was ordered almost doubled 
between Period 1 (11.2% of contacts) and Period 2 (22.2%). 
• Neurological disease: the likelihood that CT scan was ordered more than doubled over 
time, increasing from 3.2% of contacts in Period 1 to 7.8% in Period 2. 
• Fracture (excluding fractures of the head/back): there was an almost threefold increase 
in the likelihood of ordering CT scan, from 0.5% of contacts in Period 1 to 1.4% in 
Period 2.
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Table 13.4: Problems for which CT scan was ordered, 2002–05 and 2009–12 
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem 
No. of 
problems 
No. of 
problem-
test links(a) 
Per cent of 
problem-
test links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c)  
No. of 
problems 
No. of 
problem-
test links(a) 
Per cent of 
problem-
test links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c) 
Back problems** 11,146 526 19.7 
(18.1–21.4) 
4.7 
(4.3–5.1) 
1.01  10,584 643 18.3 
(16.9–19.7) 
5.9 
(5.5–6.4) 
1.02 
 Back syndrome** 5,712 349 13.1 
(11.7–14.4) 
6.1 
(5.4–6.7) 
1.01  5,280 386 11.0 
(9.9–12.1) 
7.2 
(6.4–7.9) 
1.02 
 Back symptom/complaint** 5,434 177 6.6 
(5.6–7.6) 
3.2 
(2.8–3.7) 
1.01  5,304 257 7.3 
(6.4–8.3) 
4.7 
(4.1–5.3) 
1.02 
Headache* 3,943 273 10.2 
(9.0–11.4) 
6.7 
(5.9–7.5) 
1.04  3,236 245 7.0 
(6.1–7.9) 
7.2 
(6.3–8.1) 
1.06 
Sinusitis acute/chronic 3,721 108 4.1 
(3.3–4.8) 
2.7 
(2.2–3.3) 
1.06  3,962 151 4.3 
(3.6–5.0) 
3.7 
(3.1–4.3) 
1.04 
Abdominal pain** 2,053 90 3.4 
(2.6–4.1) 
4.0 
(3.1–4.9) 
1.10  2,182 159 4.5 
(3.7–5.3) 
6.2 
(5.2–7.2) 
1.18 
Neck syndrome 1,468 69 2.6 
(2.0–3.2) 
4.6 
(3.5–5.6) 
1.03  1,270 83 2.4 
(1.8–2.9) 
6.3 
(4.9–7.7) 
1.04 
Vertigo/dizziness 980 64 2.4 
(1.8–3.0) 
6.4 
(4.9–7.9) 
1.02  1,094 76 2.2 
(1.7–2.7) 
6.9 
(5.3–8.4) 
1.01 
Transient cerebral ischaemia 452 44 1.7 
(1.2–2.1) 
9.7 
(6.9–12.5) 
1.00  388 44 1.3 
(0.8–1.7) 
10.8 
(7.6–14.1) 
1.05 
Dementia (incl senile, 
Alzheimer's) 
1,401 41 1.5 
(1.0–2.0) 
2.9 
(1.9–3.8) 
1.03  1,627 32 0.9 
(0.6–1.3) 
1.9 
(1.2–2.6) 
1.03 
Stroke/cerebrovascular 
accident 
640 30 1.1 
(0.7–1.6) 
4.7 
(2.8–6.6) 
1.00  511 22 0.6 
(0.4–0.9) 
4.3 
(2.5–6.1) 
1.00 
Vertiginous syndrome 1,047 29 1.1 
(0.7–1.5) 
2.8 
(1.7–3.8) 
1.00  1,008 50 1.4 
(1.0–1.8) 
4.8 
(3.4–6.1) 
1.04 
Abnormal test results* 2,488 27 1.0 
(0.6–1.4) 
1.0 
(0.6–1.4) 
1.04  3,771 38 1.1 
(0.7–1.5) 
0.9 
(0.6–1.2) 
1.12 
(continued) 
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Table 13.4 (continued): Problems for which CT scan was ordered 2002–05 and 2009–12 
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem 
No. of 
problems 
No. of 
problem-
test links(a) 
Per cent of 
problem-
test links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c)  
No. of 
problems 
No. of 
problem-
test links(a) 
Per cent of 
problem-
test links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c) 
Injury head, other 276 27 1.0 
(0.6–1.4) 
9.8 
(5.9–13.7) 
1.00  302 32 0.9 
(0.6–1.3) 
10.3 
(6.7–13.8) 
1.03 
Neck symptom/complaint 984 26 1.0 
(0.6–1.4) 
2.6 
(1.6–3.7) 
1.00  919 55 1.6 
(1.1–2.0) 
5.9 
(4.3–7.5) 
1.02 
Kidney symptom/complaint 232 26 1.0 
(0.6–1.4) 
11.2 
(6.8–15.6) 
1.00  162 36 1.0 
(0.7–1.4) 
22.2 
(15.9–28.5) 
1.00 
Diverticular disease 573 25 0.9 
(0.5–1.3) 
4.0 
(2.4–5.6) 
1.09  689 51 1.5 
(1.0–1.9) 
6.1 
(4.3–7.9) 
1.21 
Osteoarthritis (excl back)** 8,857 25 0.9 
(0.5–1.3) 
0.3 
(0.2–0.4) 
1.00  8,329 35 1.0 
(0.7–1.3) 
0.4 
(0.3–0.6) 
1.00 
Respiratory disease, other 555 23 0.9 
(0.5–1.2) 
4.1 
(2.5–5.8) 
1.00  631 34 1.0 
(0.6–1.4) 
5.4 
(3.3–7.5) 
1.00 
Neurological disease, other 686 22 0.8 
(0.5–1.2) 
3.2 
(1.9–4.5) 
1.00  820 65 1.9 
(1.4–2.3) 
7.8 
(5.9–9.7) 
1.02 
Fracture (excl head/back)* 2,936 17 0.6 
(0.2–1.0) 
0.5 
(0.2–0.9) 
1.06  2,586 37 1.1 
(0.7–1.4) 
1.4 
(0.9–1.9) 
1.03 
Memory disturbance 190 15 0.6 
(0.3–0.8) 
7.9 
(4.1–11.7) 
1.00  252 37 1.1 
(0.7–1.4) 
14.7 
(10.2–19.1) 
1.00 
Subtotal  1,507 56.5 — —   1,925 54.8 — — 
Total 441,591 2,666 100.0 — —  461,761 3,510 100.0 — — 
(a) A test was counted more than once if it was ordered for the management of more than one problem at an encounter. There were 2,617 CT scan orders and 2,666 problem–imaging links in Period 1, and 3,440 CT 
scan orders and 3,510 problem–imaging links in Period 2. 
(b) The percentage of total contacts with the problem that generated at least one order for CT scan.  
(c) The rate of CT scan orders placed per problem contact with at least one order for CT scan. 
**  Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.1). 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.2). 
Note: No. – number; CI – confidence interval; incl – including; excl – excluding; Highlighting indicates a significant difference between data periods. 
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13.4 Magnetic resonance imaging 
Over the period investigated in this study, magnetic resonance imaging (MRI) was one of the 
least frequently ordered imaging test types by GPs. This was probably due to the Medicare 
Benefit Schedule rules in place when the data for this study were collected, restricting 
funding of MRI services to those ordered by non-GP specialists. GPs could order MRIs that 
were funded privately, but were not able to access those funded through Medicare. These 
rules have since changed, and from November 2012, GPs could order Medicare-claimable 
MRI services for selected patients and indications.114 Despite the Medicare reimbursement 
rules, the order rate of MRI tests did increase significantly over time. In Period 2, orders for 
MRI accounted for 1.5% of all imaging ordered, and we estimate about 200,000 tests were 
ordered nationally by GPs per annum (Table 13.1). 
The most common problems generating orders for MRI tests were: back problems, knee 
problems, osteoarthritis, sprain/strains, and ‘other’ musculoskeletal injuries (excluding 
shoulder, back and knee injuries). Together these accounted for 50% of MRI–problem links in 
Period 1 and 52% in Period 2 (Table 13.5).  
Individual problems contribute in different ways to the total volume of MRI tests ordered in 
general practice. Three factors influence the total volume of test orders generated by a 
problem: 
• how often a problem is managed in general practice 
• the likelihood that MRI will be ordered in the management of the specific problem 
• the number of MRI tests ordered once the decision to order has been made.  
This is illustrated by looking at the more recent data (Period 2) in Table 13.5 for back 
problems and knee syndrome problems. Back problems generated the highest volume of 
MRI orders (18.4%) in Period 2, but likelihood of management involving MRI was very low, 
with GPs ordering MRI at 0.8% of back problem contacts, at an average of 1.0 test per order. 
The main reason it accounts for a large volume of MRI orders is because the problem is very 
commonly managed in general practice. In contrast, knee syndrome contributed to 12.9% of 
MRI orders. These problems were managed less often, but when managed, 7.0% of contacts 
resulted in an order for MRI, with an average of 1.0 test per order (Table 13.5). 
In Table 13.5, significant changes over time in the proportion of tests accounted for by the 
problem, and/or the likelihood that MRI was ordered in the management of the problem are 
highlighted. The overall number of MRI orders was small and these results should be 
interpreted with caution. Between Period 1 and Period 2, there were significant increases in 
the likelihood that MRI would be ordered in the management of the following problems. 
• Back problems: GPs were significantly more likely to order MRI in Period 2 (0.8% of back 
problem contacts) than in Period 1 (0.2%). Only one MRI was ordered per tested contact 
in both periods. 
This increase was reflected in both subgroups of back problems when investigated 
separately (back syndromes and back symptoms/complaints). GPs’ imaging ordering 
behaviour in the management of back problems is investigated in more detail in 
Chapter 5. 
• Knee problems: GPs were more likely to order MRI in Period 2 (5.0% of knee problem 
contacts) than in Period 1 (1.5%). This increase was reflected in both subgroups of knee 
problems when investigated separately (knee syndromes and knee 
symptoms/complaints). GPs’ imaging ordering behaviour in the management of knee 
problems is investigated in more detail in Chapter 11. 
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• Osteoarthritis: there was a more than threefold increase in the likelihood of MRI 
ordering in the management of this problem, from 0.0% of contacts in Period 1 to 0.3% in 
Period 2. GPs’ imaging ordering behaviour in the management of osteoarthritis is 
investigated in more detail in Chapter 6. 
• Sprain/strain: the likelihood of MRI ordering increased from 0.1% of contacts in Period 1 
to 0.7% in Period 2. GPs’ imaging ordering behaviour in the management of 
sprain/strain is investigated in more detail in Chapter 8. 
• ‘Other’ musculoskeletal injuries: the likelihood of MRI ordering increased from 0.3% of 
contacts in Period 1 to 1.7% in Period 2. GPs’ imaging ordering behaviour in the 
management of other musculoskeletal injury is investigated in more detail in Chapter 12. 
• Headache: likelihood of MRI ordering increased from 0.1% of contacts in Period 1 to 
0.6% in Period 2.  
 
152
  
 
Table 13.5: Problems for which MRI was ordered, 2002–05 and 2009–12 
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem 
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links (95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c)  
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c) 
Back problems** 11,146 24 20.7 
(13.2–28.2) 
0.2  
(0.1–0.3) 
1.00  10,584 86 18.4 
(14.6–22.1) 
0.8  
(0.6–1.0) 
1.01 
 Back symptom/complaint** 5,434 14 12.1 
(5.8–18.4) 
0.3  
(0.1–0.4) 
1.00  5,280 48 10.1 
(7.2–13.0) 
0.9  
(0.6–1.2) 
1.00 
 Back syndrome** 5,712 10 8.6 
(3.7–13.5) 
0.2  
(0.1–0.3) 
1.00  5,304 38 8.2 
(5.6–10.8) 
0.7  
(0.5–0.9) 
1.03 
Knee problems** 1,495 22 19.0 
(11.8–26.1) 
1.5  
(0.8–2.1) 
1.00  1,719 86 18.1 
(14.4–21.9) 
5.0  
(3.8–6.2) 
1.00 
 Knee syndrome** 796 16 13.8 
(7.3–20.3) 
2.0  
(1.0–3.0) 
1.00  874 61 12.9 
(9.6–16.2) 
7.0  
(5.0–8.9) 
1.00 
 Knee symptom/complaint** 699 6 5.2 
(1.1–9.3) 
0.9  
(0.2–1.5) 
1.00  845 25 5.3 
(3.3–7.3) 
3.0  
(1.8–4.1) 
1.00 
Osteoarthritis (excl back)** 8,857 4 3.4 
(0.0–7.6) 
0.0  
(0.0–0.1) 
1.00  8,329 26 5.5 
(3.4–7.6) 
0.3  
(0.2–0.4) 
1.00 
Sprain/Strain (excl back)** 3,249 4 3.4 
(0.0–7.5) 
0.1  
(0.0–0.3) 
1.00  2,861 19 4.0 
(2.3–5.8) 
0.7  
(0.4–1.0) 
1.00 
Injury musculoskeletal (excl 
shoulder/back/knee)** 
1,527 4 3.4 
(0.0–6.9) 
0.3  
(0.0–0.5) 
1.00  1,514 25 5.3 
(3.2–7.4) 
1.7  
(1.0–2.3) 
1.00 
Malignancy NOS 235 3 2.6 
(0.0–5.5) 
1.3  
(0.0–2.7) 
1.00  286 0 0.0 
(—) 
0.0 
(—) 
— 
Headache* 3,943 3 2.6 
(0.0–5.4) 
0.1  
(0.0–0.2) 
1.00  3,236 20 4.4 
(2.4–6.4) 
0.6  
(0.3–0.9) 
1.05 
Fracture (excl head/back)* 2,936 3 2.6 
(0.0–5.5) 
0.1  
(0.0–0.2) 
1.00  2,586 3 0.6 
(0.0–1.3) 
0.1  
(0.0–0.2) 
1.00 
Foot/toe symptom/complaint 484 3 2.6 
(0.0–6.4) 
0.6  
(0.0–1.5) 
1.00  552 1 0.4 
(0.0–1.3) 
0.2  
(0.0–0.5) 
2.00 
 (continued) 
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Table 13.5 (continued): Problems for which MRI was ordered 2002–05 and 2009–12  
 Period 1 (2002–05)  Period 2 (2009–12) 
Problem 
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links (95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c)  
No. of 
problems 
No. of 
problem-
test 
links(a) 
Per cent of 
problem-test 
links 
(95% CI) 
Per cent of 
problems 
with test 
(95% CI)(b) 
Test order 
rate per 
tested 
problem(c) 
Shoulder problems (excl 
arthritis/OA)* 
2,161 2 1.7 
(0.0–4.2) 
0.1  
(0.0–0.2) 
1.00  2,637 13 2.7 
(1.2–4.3) 
0.5  
(0.2–0.7) 
1.08 
 Shoulder symptom/complaint 
(excl arthritis/OA)* 
605 1 0.9 
(0.0–2.6) 
0.2  
(0.0–0.5) 
1.00  1,988 8 1.7 
(0.5–2.8) 
0.4  
(0.1–0.7) 
1.00 
 Shoulder syndrome (excl 
arthritis/OA)* 
1,556 1 0.9 
(0.0–2.6) 
0.1  
(0.0–0.2) 
1.00  649 5 1.1 
(0.0–2.1) 
0.6 
(0.0–1.2) 
1.25 
Joint symptom/complaint NOS 849 2 1.7 
(0.0–4.0) 
0.2  
(0.0–0.6) 
1.00  740 8 1.7 
(0.5–2.8) 
1.1  
(0.3–1.8) 
1.00 
Neurological disease, other 686 2 1.7 
(0.0–4.1) 
0.3  
(0.0–0.7) 
1.00  820 9 1.9 
(0.5–3.3) 
1.0  
(0.2–1.7) 
1.13 
Musculoskeletal disease, other 1,444 2 1.7 
(0.0–4.2) 
0.1  
(0.0–0.3) 
1.00  1,436 7 1.5 
(0.3–2.7) 
0.5  
(0.1–0.9) 
1.00 
Neck syndrome 1,468 1 0.9 
(0.0–2.6) 
0.1  
(0.0–0.2) 
1.00  1,270 12 2.5 
(1.1–3.9) 
0.9  
(0.4–1.5) 
1.00 
Peripheral neuritis/neuropathy 601 1 0.9 
(0.0–2.5) 
0.2  
(0.0–0.5) 
1.00  850 10 2.1 
(0.8–3.4) 
1.2  
(0.5–1.9) 
1.00 
Bursitis/tendonitis/synovitis 
NOS** 
2,751 1 0.9 
(0.0–2.6) 
0.0  
(0.0–0.1) 
1.00  3,260 8 1.7 
(0.5–2.8) 
0.2  
(0.1–0.4) 
1.00 
Neurological 
symptom/complaint, other 
301 1 0.9 
(0.0–2.6) 
0.3  
(0.0–1.0) 
1.00  368 8 1.7 
(0.5–2.9) 
2.2  
(0.7–3.7) 
1.00 
Subtotal  82 70.7 — —   341 71.9 — — 
Total 441,591 116 100.0 — —  461,761 474 100.0 — — 
(a) A test was counted more than once if it was ordered for the management of more than one problem at an encounter. In Period 1, each MRI order was linked to only one problem, hence there were 116 MRI orders 
and 116 problem–imaging links. However, in Period 2 there were 464 MRI orders and 474 problem–imaging links. 
(b) The percentage of total contacts with the problem that generated at least one order for MRI.  
(c) The rate of MRI orders placed per problem contact with at least one order for MRI. 
**  Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.1). 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 5, Table A5.2). 
Note: No. – number; CI – confidence interval; excl – excluding; OA – osteoarthritis; NOS – not otherwise specified; Highlighting indicates a significant difference between data periods. 
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ACR American College of Radiology 
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AHRQ Agency for Healthcare Research and Quality 
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ICPC-2 PLUS a terminology classified according to ICPC-2 
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NOS not otherwise specified 
NZGG New Zealand Guidelines Group 
OA osteoarthritis 
OMI other musculoskeletal injury 
OR odds ratio 
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Glossary 
Aboriginal: The patient identifies himself or herself as an Aboriginal person. 
Activity level: The number of general practice A1 Medicare items claimed during the previous 
3 months by a participating GP. 
Allied health services: Clinical and other specialised health services provided in the 
management of patients by allied and other health professionals including physiotherapists, 
occupational therapists, dietitians, dentists and pharmacists. 
Chapters (ICPC-2): The main divisions within ICPC-2. There are 17 chapters primarily 
representing the body systems. 
Chronic problem: see Diagnosis/problem: Chronic problem. 
Complaint: A symptom or disorder expressed by the patient when seeking care. 
Component (ICPC-2): In ICPC-2 there are seven components that act as a second axis across all 
chapters. 
Consultation: See Encounter. 
Diagnosis/problem: A statement of the provider’s understanding of a health problem 
presented by a patient, family or community. GPs are instructed to record at the most 
specific level possible from the information available at the time. It may be limited to the 
level of symptoms. 
• New problem: The first presentation of a problem, including the first presentation of a 
recurrence of a previously resolved problem, but excluding the presentation of a 
problem first assessed by another provider. 
• Old problem: A previously assessed problem that requires ongoing care, including 
follow-up for a problem or an initial presentation of a problem previously assessed by 
another provider. 
• Chronic problem: A medical condition characterised by a combination of the following 
characteristics: duration that has lasted, or is expected to last, 6 months or more, a 
pattern of recurrence or deterioration, a poor prognosis, and consequences or sequelae 
that impact on an individual’s quality of life. (Source: O’Halloran J, Miller GC, Britt H 
2004. Defining chronic conditions for primary care with ICPC-2. Fam Pract 21(4):381–6).  
Encounter (enc): Any professional interchange between a patient and a GP. 
• Indirect: Encounter where there is no face-to-face meeting between the patient and the GP 
but a service is provided (for example, prescription, referral). 
• Direct: Encounter where there is a face-to-face meeting of the patient and the GP. 
General practitioner (GP): A medical practitioner who provides primary comprehensive and 
continuing care to patients and their families within the community (Royal Australian 
College of General Practitioners). 
GP consultation service items: Includes GP services provided under the MBS professional 
services category including MBS items classed as A1, A2, A5, A6, A7, A14, A17, A18, A19, 
A20, A22 and selected items provided by GPs classified in A11, A15 and A27. 
MBS/DVA items: MBS item numbers recorded as claimable for activities undertaken by GPs 
and staff under the supervision of GPs. In BEACH an MBS item number may be funded by 
Medicare or by the Department of Veterans’ Affairs (DVA). 
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Health care card: An entitlement card provided by the Australian Government, which entitles 
the holder to reduced-cost medicines under the Pharmaceutical Benefits Scheme and some 
other concessions from state and local government authorities. 
Indigenous: The patient identifies himself or herself as an Aboriginal and/or Torres Strait 
Islander person.  
Medication:  
• GP–supplied: The medication is provided directly to the patient by the GP at the 
encounter. 
• Over-the-counter (OTC): Medication that the GP advises the patient to purchase OTC (a 
prescription is not required for the patient to obtain an OTC medication). 
• Prescribed: Medications that are prescribed by the GP (that is, does not include 
medications that were GP–supplied or advised for over-the-counter purchase). 
Morbidity: Any departure, subjective or objective, from a state of physiological wellbeing. 
In this sense, sickness, illness and morbid conditions are synonymous. 
Non-English-speaking background: The patient’s primary language spoken at home is not 
English. 
Patient status: The status of the patient to the practice. 
• New patient: The patient has not been seen before in the practice. 
• Patient seen previously: The patient has attended the practice before. 
Problem managed: See Diagnosis/problem. 
Provider: A person to whom a patient has access when contacting the healthcare system. 
Reasons for encounter (RFEs): The subjective reasons given by the patient for seeing or 
contacting the general practitioner. These can be expressed in terms of symptoms, diagnoses 
or the need for a service. 
Recognised GP: A medical practitioner who is: 
• vocationally recognised under Section 3F of the Health Insurance Act, or 
• a holder of the Fellowship of the Royal Australian College of General Practitioners who 
participates in, and meets the requirements for, quality assurance and continuing 
medical education as defined in the Royal Australian College of General Practitioners 
(RACGP) Quality Assurance and Continuing Medical Education Program, or 
• undertaking an approved placement in general practice as part of a training program for 
general practice leading to the award of the Fellowship of the Royal Australian College 
of General Practitioners, or undertaking an approved placement in general practice as 
part of some other training program recognised by the RACGP as being of equivalent 
standard. (Source: Commonwealth Department of Health and Aged Care 2001. Medicare 
Benefits Schedule book. Canberra: DHAC).  
Referral: The process by which the responsibility for part, or all, of the care of a patient is 
temporarily transferred to another health care provider. Only new referrals to specialists and 
allied health services, and for hospital and residential aged care facility admissions arising at 
a recorded encounter are included. Continuation referrals are not included. Multiple 
referrals can be recorded at any one encounter. 
Rubric: The title of an individual code in ICPC-2. 
Significant: This term is used to refer to a statistically significant result. Statistical significance 
is measured at the 95% confidence level in this report.  
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Torres Strait Islander: The patient identifies himself or herself as a Torres Strait Islander 
person. 
Veteran’s Affairs Card: An entitlement card provided by the Department of Veterans’ Affairs 
that entitles the holder to access a range of repatriation health care benefits, including access 
to prescription and other medications under the Pharmaceutical Benefits Scheme. 
Work-related problem: See Diagnosis/problem. 
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Appendices 
Appendix 1: Example of a 2011–12 recording form 
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Appendix 2: GP characteristics questionnaire, 
2011–12 
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Appendix 3: Patient information card, 2011–12 
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Appendix 4: Initial results of analyses of the BEACH 
data by year, from 2002–03 to 2011–12 inclusive 
Available at <hdl.handle.net/2123/10610>, see ‘Electronic editions and downloads’. 
 
Table A4.1: Summary of BEACH data set and imaging ordering by GPs, 2002–03 to 2011–12 
Table A4.2: Imaging orders by Medicare imaging groups (rate per 1,000 problems), 2002–03 
to 2011–12 
Table A4.3: The most frequent imaging tests (rate per 1,000 problems), 2002–03 to 2011–12 
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Appendix 5: Code groups from ICPC-2 and 
ICPC-2 PLUS 
Available at <hdl.handle.net/2123/10610>, see ‘Electronic editions and downloads’. 
 
Eight problems selected for investigation 
Table A5.1: Code groups from ICPC-2 and ICPC-2 PLUS – eight problems selected for 
investigation 
Other problems managed 
Table A5.2: Code groups from ICPC-2 and ICPC-2 PLUS – other problems managed 
Imaging test orders 
Table A5.3: Code groups from ICPC-2 and ICPC-2 PLUS – imaging test orders (MBS groups)  
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This book reports changes in GP ordering of imaging 
tests in Australia from 2002–03 to 2011–12, and 
evaluates alignment between guidelines and recent 
GP test ordering for selected problems.
Over the decade, 9,802 GPs participated in BEACH, 
providing details of 980,200 GP–patient encounters. The 
likelihood of GPs ordering imaging in the management 
of a problem increased over time. In recent practice, at 
least one imaging test was ordered at 9% of encounters, 
at a rate of 10 imaging tests per 100 encounters.
Diagnostic radiology was the most commonly ordered 
type of imaging test, but the order rate decreased over 
time, with a shift toward orders for ultrasound, CT and 
MRI, which all signiﬁcantly increased.
Eight selected problems accounted for one-third of all 
imaging orders. Imaging ordering behaviour suggests 
broad compliance with published guidelines in the 
management of osteoarthritis, shoulder problems, 
bursitis/tendonitis/synovitis, abdominal pain and other 
musculoskeletal injuries. Current ordering patterns 
for knee problems and some sprains/strains have 
potential for improvement. The ordering pattern for 
new presentations of back problems was inconsistent 
with all established guidelines for management of 
back problems.
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